etoposide has been researched along with carboplatin in 1973 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (1.47) | 18.7374 |
| 1990's | 621 (31.47) | 18.2507 |
| 2000's | 618 (31.32) | 29.6817 |
| 2010's | 554 (28.08) | 24.3611 |
| 2020's | 151 (7.65) | 2.80 |
| Authors | Studies |
|---|---|
| Douek, E; Kingston, JE; Plowman, PN; Sebag-Montefiore, DJ | 1 |
| Crown, JP; Doherty, M; Fair, W; Gulati, SC; Herr, H; Motzer, RJ; Russo, P; Sheinfeld, J; Sogani, P; Weisen, S | 1 |
| Andersen, J; Fisher, H; Greer, J; Lazarus, HM; Loehrer, PJ; Nichols, CR; Stadtmauer, EA; Trump, DL | 1 |
| Burghouts, JT; Carney, DN; Festen, J; Palmen, FM; Planting, AS; Postmus, PE; Quoix, E; Roozendaal, K; Splinter, TA; Vendrik, C | 1 |
| Achterrath, W; Gatzemeier, U; Hossfeld, DK; Lenaz, L; Neuhauss, R; Reck, M | 3 |
| Collard, P; Francis, C; Rodenstein, DO; Weynants, P | 1 |
| Bishop, JF | 1 |
| Bonomi, P | 1 |
| DeVore, R; Greco, FA; Hainsworth, JD; Hande, KR; Johnson, DH | 1 |
| Goutsou, M; Green, MR; Herndon, JE; Lyss, AP; Mason-Coughlin, K; Perry, MC; Propert, K | 1 |
| Bishop, JF; Kefford, RF; Matthews, JP; Morstyn, G; Raghavan, D; Stuart-Harris, R; Zalcberg, J | 1 |
| Berendsen, HH; Haaxma-Reiche, H; Postmus, PE; Smit, EF | 1 |
| Bonfrer, JM; Jassem, E; Mooi, WJ; van Tinteren, H; van Zandwijk, N | 1 |
| DeVore, R; Greco, FA; Hainsworth, JD; Hande, KR; Johnson, DH; Thomas, M; Walls, J | 1 |
| Nyman, CR | 1 |
| Doughty, D; Plowman, PN; Sebag-Montefiore, DJ | 1 |
| Helle, L; Jakobson, M; Järvinen, M; Liippo, K; Nikkanen, V; Ojala, A; Paloheimo, S; Salmi, R; Salomaa, ER; Virén, M | 1 |
| Chariot, P; de Cremoux, H; Le Chevalier, T; Monnet, I; Quoix, E; Ruffié, P; Saltiel, JC; Voisin, S | 1 |
| Kudo, R; Sagae, S | 1 |
| Beyer, J; Grabbe, J; Huhn, D; Lenz, K; Siegert, W; Strohscheer, I; Weisbach, V | 1 |
| Childs, WJ; Horwich, A; Nicholls, EJ | 1 |
| Smith, IE | 1 |
| Hatae, M; Hokanishi, H; Kume, H; Maeda, Y; Nakagawa, S; Onishi, Y | 1 |
| Almadrones, L; Barakat, R; Curtin, J; Hakes, T; Hoskins, W; Jones, W; Lewis, JL; Markman, M; Reichman, B; Rubin, S | 3 |
| Bouffet, E; Brugiere, L; Chastagner, P; Frappaz, D; Gentet, JC; Hartmann, O; Lejars, O; Michon, J; Rubie, H; Sariban, E | 2 |
| Bryant, G; Carter, C; Cottler-Fox, M; Cowan, KH; Goldspiel, B; Jain, V; Longo, DL; Steinberg, SM; Wilson, WH; Wittes, RE | 1 |
| Hansen, HH; Hansen, M; Hansen, OP; Lund, B | 1 |
| Green, MR; Mason, JR; Mullen, M; Newton, B; Shea, TC; Storniolo, AM; Taetle, R | 1 |
| Higashihara, T; Hojo, K; Kajiyama, K; Kumasaka, Y; Nishiyama, S; Okada, M; Oku, Y | 1 |
| Bowman, LC; Brenner, MK; Mirro, J; Santana, VM; Schell, MJ; Thompson, EI; Williams, R | 1 |
| Boiardi, A; Botturi, M; Broggi, G; Milanesi, I; Silvani, A | 1 |
| Bais, E; Dubbelman, R; Israels, SP; Richel, DJ; Rodenhuis, S; Roodbergen, R; Schornagel, JH; Ten Bokkel Huinink, WW; Vlasveld, LT; Wanders, J | 1 |
| Anderson, N; Bern, M; Gonsalves, L; Lokich, J; Moore, C; Zipoli, T | 1 |
| Amici, A; Angioni, A; Caniglia, M; De Sio, L; Deb, G; Dominici, C; Donfrancesco, A; Fidani, P; Helson, L | 1 |
| D'Angio, G; Evans, A; Scher, C | 1 |
| Craft, AW; Gordon, SJ; Pearson, AD; Reid, MM | 1 |
| Corbett, R; Kingston, J; Lewis, I; McElwain, T; Meller, S; Pinkerton, R; Pritchard, J | 1 |
| Funatsu, M; Hada, Y; Kimura, T; Miyakawa, Z; Notake, Y; Shimizu, A; Taguchi, A; Tamura, K | 1 |
| Fritsch, HW; Holz, J; Jungclas, H; Köhl, P; Köppler, H; Pflüger, KH; Schmidt, L | 1 |
| Daniels, M; Estapé, J; Grau, JJ; Palombo, H; Solá, C; Viñolas, N | 1 |
| Madden, T; Rodman, JH; Santana, VM; Sunderland, M | 1 |
| Broun, ER; Einhorn, LH; Loehrer, PJ; Nichols, CR; Tricot, G; Williams, SD | 1 |
| Ball, D; Bishop, J; Bull, C; Duval, P; Laidlaw, C; Matthews, J; Ngan, S | 1 |
| Burt, P; Prendiville, J; Radford, J; Ranson, M; Steward, W; Stout, R; Thatcher, N | 1 |
| Cherryman, G; Hoskin, PJ; Parton, D; Smith, IE; Yarnold, JR | 1 |
| Gotoda, A; Kamiyama, T; Matsuoka, S; Nagabuchi, E; Nakajima, Y; Saito, M; Uchino, J; Une, Y | 1 |
| Albertazzi, L; Bassetto, MA; Marangolo, M; Pizzocaro, G; Rosti, G; Salvioni, R; Valzania, F | 1 |
| Broun, ER; Einhorn, LH; Nichols, CR; Tricot, GJ | 1 |
| Ashley, S; Holborn, J; Jones, AL; Smith, IE | 2 |
| Achterrath, W; Drings, P; Goerg, C; Havemann, K; Tessen, HW; Wolf, M | 1 |
| Lakomek, M; Schröter, W; Walka, MM | 1 |
| Baiocchi, G; Benedetti Panici, P; Foddai, ML; Greggi, S; Menichella, G; Paoloni, A; Pierelli, L; Scambia, G; Serafini, R; Vittori, M | 1 |
| Bajorin, D; Cooper, K; Fair, W; Geller, NL; Herr, H; Lin, SY; Morse, M; Motzer, RJ; Pfister, DG; Scher, HI | 1 |
| Hardy, JR; Pinkerton, CR | 1 |
| Broadbent, V; Horwich, A; Levitt, J; McElwain, TJ; Meller, ST; Mott, M; Oakhill, A; Pinkerton, CR; Pritchard, J | 1 |
| Cebon, J; Fox, R; Layton, J; Lieschke, G; Morstyn, G; Sheridan, W | 1 |
| Dearnaley, DP; Harland, S; Hendry, WF; Horwich, A; Jay, G; Mason, M; Nicholls, J; Peckham, MJ | 1 |
| Gumbrell, LA; Harland, SJ; Horwich, A | 1 |
| Akamatsu, K; Endo, K; Kaiho, S; Koizumi, K; Koizumi, M; Matsumoto, T; Mitsui, H; Morikawa, K; Tsunenari, T | 1 |
| Achterrath, W; Harstrick, A; Meyer, HJ; Preusser, P; Schmoll, HJ; Seeber, S; Stahl, M; Wilke, H | 1 |
| Hood, AF; Singal, R; Tunnessen, WW; Wiley, JM | 1 |
| Wiernik, PH | 1 |
| Ayass, M; Gross, S; Harper, J | 1 |
| Hausamen, TU; Loeffler, TM; Weber, FW | 1 |
| Itoh, A; Oguro, A; Okano, S; Sawai, K; Takahashi, T; Takeuchi, K; Taniguchi, H; Tsukuda, N; Ueshima, Y | 1 |
| Havemann, K; Köppler, H; Pflüger, KH | 1 |
| Bernard, JL; Bouffet, E; Coze, C; Gentet, JC; Lopez, M; Michon, J; Philip, I; Philip, T; Zucker, JM | 1 |
| Biron, P; Bouffet, E; Brunat-Mentigny, M; Chauvin, F; Ladenstein, R; Lasset, C; Philip, I; Philip, T | 1 |
| Emminger, W; Emminger-Schmidmeier, W; Gadner, H; Hawliczek, R; Höcker, P; Peters, C | 1 |
| Achterrath, W; Eiermann, W; Hepp, H; Lenaz, L | 1 |
| Clemm, C | 1 |
| Castello, MA; Clerico, A; Cozza, R; De Laurentis, C; De Sio, L; Deb, G; Dominici, C; Donfrancesco, A; Properzi, E; Schiavetti, A | 1 |
| Binet, C; Chazard, M; Colombat, P; Desbois, I; Haillot, O; Lamagnere, JP; Linassier, C; Reisenleiter, M | 2 |
| Dubbelman, R; Franklin, H; McVie, JG; Simonetti, G; ten Bokkel Huinink, WW; van Tinteren, H; van Zandwijk, N; Wanders, J | 1 |
| Bureau, G; Cordier, R; Dabouis, G; Klastersky, J; Lecomte, J; Libert, P; Ravez, P; Sculier, JP; Thiriaux, J; Vandermoten, G | 1 |
| Achterrath, W; Gatzemeier, U; Heckmayr, M; Hossfeld, D; Lenaz, L; Neuhauss, R | 1 |
| Lind, M; Thatcher, N | 1 |
| Ball, D; Bishop, JF; Bull, C; Friedlander, M; Kefford, R; Olver, IN; Raghavan, D; Stuart-Harris, R; Yuen, K; Zalcberg, J | 1 |
| Ashley, SA; Ford, HT; Forgeson, GV; Perren, TJ; Smith, IE; Woodiwiss, J; Yarnold, JR | 1 |
| Achterrath, W; Gatzemeier, U; Heckmayr, M; Hossfeld, DK; Neuhauss, R; Reck, M; Zschaber, R | 1 |
| Achterrath, W; Gatzemeier, U; Heckmayr, M; Hossfeld, DK | 1 |
| Bureau, G; Dabouis, G; Klastersky, J; Lacroix, H; Libert, P; Ravez, P; Richez, M; Sculier, JP; Thiriaux, J; Vandermoten, G | 1 |
| Castello, MA; Clerico, A; Deb, G; Dominici, C; Donfrancesco, A; Fidani, P | 1 |
| Lacroix, H; Sculier, JP | 1 |
| Beauduin, M; Bosly, A; Duprez, P; Humblet, Y; Majois, F; Prignot, J; Schallier, D; Symann, M; Weynants, P | 1 |
| Eiermann, W; Fateh-Moghadam, A; Hepp, H; Meier, W; Schneider, A; Stieber, P | 1 |
| Castello, MA; Clerico, A; Dominici, C; Jenkner, A | 1 |
| Bosman, C; Ceccamea, A; Clerico, A; De Sanctis, S; Dominici, C; Thorel, MF | 1 |
| Chan, KW; Fryer, CJ; Steinbok, P | 1 |
| Heinonen, E; Liippo, K; Nikkanen, V | 1 |
| Carrasco, CH; Charnsangavej, C; Feun, LG; Gianturco, C; Lee, YY; Savaraj, N; Wallace, S; Yung, WK | 1 |
| Markman, M | 1 |
| Peckham, MJ; Smales, E | 1 |
| Farhangi, M; Weinstein, SH | 1 |
| Harmer, C; Hoskin, PJ | 1 |
| Boxall, FE; Calvert, AH; Eeles, RA; Gumbrell, LA; Horwich, A; Newell, DR | 1 |
| Bush, C; Delic, JI; Schlappack, OK; Steel, GG | 1 |
| Akard, L; Goulet, R; Hoffman, R; Loehrer, PJ; Nichols, CR; Roth, BJ; Tricot, G; van Besien, K; Williams, SD; Wolff, SN | 1 |
| Ash, CM; Earl, HM; Geddes, DM; Goldstone, AH; Hajichristou, HT; Harper, PG; Miles, DW; Souhami, RL; Spiro, SG; Tobias, JS | 1 |
| Campbell, C; Carroll, KB; Lind, M; Moussalli, H; Payne, C; Stout, R; Thatcher, N | 1 |
| Abrams, JS; Aisner, J; Belani, CP; Egorin, MJ; Eisenberger, M; Hiponia, D; Van Echo, DA | 1 |
| Beauduin, M; Bosly, A; Delaunois, L; Duprez, P; Francis, C; Gailly, C; Humblet, Y; Machiels, J; Majois, F; Weynants, P | 1 |
| Cohen, JD; Robins, HI; Schmitt, CL | 1 |
| Jansen, J; Nichols, CR; Williams, SD | 1 |
| Eiermann, W; Fateh-Moghadam, A; Hepp, H; Meier, W; Stieber, P | 1 |
| Alimonti, A; Caroli, S; Castello, MA; Dominici, C; La Torre, F; Petrucci, F | 1 |
| Evans, WK; Feld, R; MacCormick, R; Shepherd, FA; Yau, JC | 1 |
| Aroney, R; Bishop, JF; Gianoutsos, P; Kefford, R; Lee, J; Morstyn, G; Olver, IN; Raghavan, D; Stuart-Harris, R; Yuen, K | 1 |
| Fukuoka, M; Kusunoki, Y; Masuda, N; Matsui, K; Negoro, S; Ryu, S; Sakai, N; Takada, M; Takifuji, N; Yamamoto, H | 1 |
| Klastersky, J | 1 |
| Ashley, SE; Cherryman, G; Glaholm, J; Magrini, S; Repetto, L; Smith, IE; Yarnold, JR | 1 |
| Ayoub, J; Eisenhauer, E; Evans, WK; Feld, R; Hughes, P; Maroun, JA; Shepherd, FA | 1 |
| Evans, BD; Smith, IE | 1 |
| Evans, BD; Ford, HT; Gore, ME; Repetto, L; Smith, IE; Vincent, MD; Yarnold, JR | 1 |
| Bouffet, E; Brunat-Mentigny, M; Carrie, C; Farge, A; Gentet, JC; Kremens, B; Meziane, F; Philip, T; Zucker, JM | 1 |
| Klastersky, J; Sculier, JP; Tueni, E | 1 |
| Bauer, U; Dittrich, C; Salzer, H; Sevelda, P; Vavra, N | 1 |
| Cattaneo, MT; Piazza, E; Varini, M | 1 |
| Akard, L; Chang, Q; English, D; Hanks, S; Harvey, K; Jansen, J; Thompson, J | 1 |
| Arjona, A; Corral, F; López Lozano, JJ; Provencio, M | 1 |
| Agranat, P; Epardeau, B; Extra, JM; Jedynak, P; Mignot, L | 1 |
| Bajorin, DF; Bosl, GJ; Mazumdar, M; Mencel, PJ; Motzer, RJ; Vlamis, V | 1 |
| Hamblin, T; Loehry, CA; McCullen, M; Parham, DM; Vyas, SK; Winwood, PJ | 1 |
| Abe, T; Fujii, H; Mikami, K; Nakagawa, S; Sonoda, Y; Sugimoto, K; Watanabe, H | 1 |
| Lokich, J | 1 |
| Bosl, GJ; Motzer, RJ; Parker, RJ; Perera, F; Poirier, MC; Reed, E; Shamkhani, H; Tang, D; Tsai, WY | 1 |
| Mukaiyama, T; Ogawa, M | 1 |
| Berenson, RJ; Brugger, W; Heimfeld, S; Henschler, R; Kanz, L; Mertelsmann, R | 1 |
| Chiang, Y; Cowan, KH; Dunbar, CE; Goldspiel, B; Kohler, D; McDonagh, KT; Nienhuis, AW; O'Shaughnessy, JA; Sorrentino, BP; Wilson, W | 1 |
| Ballester, OF; Elfenbein, GJ; Fields, KK; Foody, MC; Hiemenz, JW; Janssen, WE; Kronish, LE; Perkins, JB; Zorsky, PE | 2 |
| Dexter, TM; Pettengell, R; Testa, NG; Thatcher, N; Woll, PJ | 1 |
| Budinsky, A; Eibl, MM; Kaider, A; Krainer, M; Kratzik, C; Michl, I; Wiltschke, C; Wolf, H; Zielinski, CC | 1 |
| Dearnaley, DP; Hendry, WF; Horwich, A; Nicolls, J; Norman, A | 1 |
| Brugger, W; Frommhold, H; Kanz, L; Mertelsmann, R; Pressler, K | 1 |
| Hobisch, A; Joannidis, M; Krall, M; Nevinny-Stickel, M; Pfaller, W; Schober, M; Thorwartl, U | 1 |
| Bildet, F; Cour-Chabernaud, V; Hodgetts, J; Lomax, L; Thatcher, N; Woll, PJ | 1 |
| Dahrouge, S; Evans, WK; Goss, G; Logan, DM; Maroun, JA; Martins, H; Radwi, A; Stewart, DJ; Tomiak, E | 1 |
| Clark, RE; Creagh, MD; Shlebak, AA | 1 |
| Carpentier, AF; Chantelard, JV; Henin, D; Poisson, M | 1 |
| Alberto, P; Bacchi, M; Cerny, T; Hürny, C; Joss, RA; Leyvraz, S; Ludwig, C; Martinelli, G; Stahel, R; Thürlimann, B | 1 |
| Dercksen, MW; Dirkson, MK; Gerritsen, WR; Pinedo, HM; Rodenhuis, S; Schaasberg, WP; Slaper-Cortenbach, IC; van der Schoot, CE; von dem Borne, AE | 1 |
| Fuchsberger, P; Lakota, J | 1 |
| Feng, FY; Shi, YK; Sun, Y | 1 |
| Matsutani, M; Miyoshi, A; Nagashima, C; Yoshizawa, H | 1 |
| Crawford, J; George, M | 1 |
| Carey, RW; Elias, AD; Grossbard, ML; Jacobs, C; Jauss, S; Kwiatkowski, DJ; Lynch, TJ; Shulman, LN; Strauss, GM; Sugarbaker, DJ | 1 |
| Blackwell, S; Buchanan, M; Clark, RE; Crawford, J; Grichnik, JM; Hitchcock, MG; Jimenez, F; Kurtzberg, J | 1 |
| Carney, DN | 1 |
| Greco, FA; Hainsworth, JD | 5 |
| Bizjak, L; Jernej, B; Kapitanović, S; Osmak, M | 1 |
| Gastineau, DA; Hoagland, HC; Letendre, L; Noel, P; Solberg, LA; Tefferi, A | 1 |
| Athanassiou, A; Dimitriadis, M; Moutzourides, G; Pectasides, D; Varthalitis, J | 1 |
| Arakawa, M; Chou, T; Ebe, T; Hoshino, M; Kurita, Y; Yokoyama, A; Yoshizawa, H | 1 |
| Kasai, M; Kiyama, Y | 1 |
| Hayakawa, S; Sato, S; Yajima, A | 1 |
| Endo, M; Tanosaki, R | 1 |
| Akaza, H; Miyanaga, N | 1 |
| Fujimoto, A; Ishihara, O; Itoyama, S; Kinoshita, K; Saitou, M; Takeda, S | 1 |
| Bagnulo, S; Carli, M; Casale, F; De Bernardi, B; De Sio, L; Deb, G; Donfrancesco, A; Helson, L; Mancini, A; Nigro, M | 1 |
| Allen, C; Birch, R; Hazelton, B; Palmer, P; Schwartzberg, L; Weaver, CH; West, W | 1 |
| Brewster, AE; Burt, PA; Hopwood, P; Stout, R; Thatcher, N | 1 |
| Bonomi, PD; Comis, RL; Ettinger, DS; Johnson, DH; Neuberg, D; Ruckdeschel, JC; Wolff, AC | 1 |
| de Campos, E; Dougal, M; Milroy, R; Radford, J; Steward, W; Swindell, R; Testa, N; Thatcher, N | 1 |
| Meisenberg, BR | 1 |
| Castello, MA; Clerico, A; Gualdi, GF; Operamolla, P; Padula, A; Properzi, E; Schiavetti, A; Trasimeni, G; Varrasso, G | 1 |
| Chang, AY | 1 |
| Cairo, MS | 1 |
| Asbury, RF; Boros, L; Chang, AY; Garrow, GC | 1 |
| Betticher, D; Hanley, S; Hardy, C; Lee, SM; Lorigan, P; Thatcher, N; Weir, D; Woodhead, M | 1 |
| Elfenbein, GJ; Fields, KK; Perkins, JB | 1 |
| Asbury, RF; Boros, L; Chang, AY; Garrow, GC; Hsieh, S | 1 |
| Crown, J; Hamilton, N; Kritz, A; Norton, L; Raptis, G; Vahdat, L | 1 |
| Desai, SJ; Dickerman, JD; Goorin, AM; Harris, MB; Inoue, S; Krischer, JP; Kung, FH; Murphy, SB; Pratt, CB; Toledano, S | 1 |
| Richel, DJ; Rodenhuis, S; Schornagel, JH; ten Bokkel Huinink, WW; van der Wall, E; Vlasveld, LT | 1 |
| Andersen, J; Antman, K; Elias, A; Frel, E; Holden, S; Rosowsky, A; Schwartz, G; Tretyakov, O; Wheeler, C; Wright, JE | 1 |
| Klinke, F; Micke, O; Rübe, C; von Eiff, M; Wagner, W; Willich, N | 1 |
| Broun, ER; Cornetta, K; Einhorn, LH; Hanna, M; Hromas, R; Kneebone, PH; Loesch, D; Sledge, GW; Sridhara, R | 1 |
| Dearnaley, DP; Horwich, A; Lampe, H; Mehta, J; Nicholls, J; Powles, R; Price, A | 1 |
| Bonomi, P; Faber, LP; Lincoln, S; Recine, D | 1 |
| Bicknell, S; Cassidy, J; Hatton, MQ; Semple, P; Stack, B; Steward, WP | 1 |
| Indelli, M; Maestri, A; Malacarne, P; Santini, A | 1 |
| Beltrán, M; Canals, E; Dorca, J; Fuentes, R; Izquierdo, A; Viladiu, P | 1 |
| Hanaoka, J; Takayanagi, T; Takeuchi, Y; Tokunaga, A; Yanase, T | 1 |
| Chen, DF; Sun, Y; Yin, WB; Zhang, DW; Zhang, RG; Zhang, XR | 1 |
| Bontenbal, M; Kok, TC; Planting, AS; Splinter, TA; van der Gaast, A | 1 |
| Aster, JC; Inhorn, RC; Roach, SA; Slapak, CA; Soiffer, R; Stone, RM; Tantravahi, R | 1 |
| Douglass, EC; Gajjar, AJ; Greenwald, C; Heideman, RL; Jenkins, JJ; Kellie, SJ; Kovnar, EH; Langston, JA; Li, Y; Walter, AW | 1 |
| Albeck, M; Bruderman, I; Catane, R; Kalechman, Y; Kaufman, B; Shani, A; Shapira, J; Sredni, B; Tichler, T | 1 |
| Haku, T; Hanibuchi, M; Hiramatsu, K; Nabioullin, R; Pai, K; Sone, S; Tsuruo, T; Yanagawa, H; Yano, S | 1 |
| Bajorin, DF; Bosl, GJ; Motzer, RJ; Murphy, B; Rodriguez, E | 1 |
| Abe, T; Hirao, A; Kawano, Y; Okamoto, Y; Saito, S; Sato, J; Shimizu, T; Suzue, T; Takaue, Y; Watanabe, T | 1 |
| Blake, KI; Gerrard, MP | 1 |
| Levis, A | 1 |
| Jakobsen, A; Jakobsen, P; Strömgren, AS; Sørensen, BT | 1 |
| Crown, J; Gilewski, T; Hamilton, N; Harrison, M; Hudis, C; Kritz, A; Moore, M; Reich, L; Schneider, J; Vahdat, L | 1 |
| Hara, A; Niitsu, N; Shirai, T; Umeda, M | 1 |
| Bajorin, DF; Bosl, GJ; Gulati, SC; Lyn, P; Mazumdar, M; Motzer, RJ; Vlamis, V | 1 |
| Abate, G; Aglietta, M; Andorno, S; Colombi, S; D'Andrea, P; Marcolin, P; Monteverde, A; Silvestri, I; Tafuto, S; Volta, C | 1 |
| Pfeiffer, P; Rose, C; Sørensen, P | 1 |
| Ballestrero, A; Basta, P; Brema, F; Ferrando, F; Ghio, R; Gobbi, M; Moraglio, L; Patrone, F; Sessarego, M; Valbonesi, M | 1 |
| Bouffet, E; Courbon, B; Desjardins, L; Doz, F; Gentet, JC; Mechinaud, F; Mosseri, V; Neuenschwander, S; Plantaz, D; Vannier, JP | 1 |
| Arita, N; Inoue, K; Kasayama, M; Kimura, H; Kishimoto, T; Koga, M; Miyashita, Y; Nakahara, K; Ogawa, H; Sato, F | 1 |
| Higashide, K; Kikkawa, F; Maeda, O; Misawa, T; Obata, NH; Suganuma, N; Tomoda, Y | 1 |
| Arnaud, A; Blanchon, F; Bonnaud, F; Castelnau, O; Guérin, JC; Kleisbauer, JP; Pérol, M; Taytard, A; Vergnenegre, A | 1 |
| Coolen, L; Demedts, M; Deneffe, G; Van den Eeckhout, A; Vansteenkiste, J | 1 |
| Bando, K; Kannuki, S; Kuroda, Y; Matsumoto, K; Shirakawa, N; Takaue, Y | 1 |
| Heinonen, E; Hinkka, SM; Karnani, P; Klemi, PJ; Korpijaakko, TA; Kuoppala, TA; Lähde, MA; Laine, AM; Mäenpää, JU; Nuoranne, EK | 1 |
| Göbel, U; Harms, D; Pape, H; Spaar, HJ; Wessalowski, R; Willers, R | 1 |
| Comella, G; Comella, P; Conforti, S; Frasci, G; Mastrantonio, P; Persico, G; Zullo, F | 1 |
| Fujiwara, Y; Ohune, T; Sumiyoshi, H; Yamakido, M; Yamaoka, N | 1 |
| Abe, T; Kawano, Y; Makimoto, A; Nakagawa, R; Okamoto, Y; Saito, S; Sato, J; Shimizu, T; Suzue, T; Takaue, Y | 1 |
| Ogawa, M; Tanaka, H; Tanaka, T; Tanizawa, M; Watanabe, Y | 1 |
| Liu, YY; Sun, Y; Zhang, XR | 1 |
| Helle, L; Hinkka, S; Huovinen, R; Jakobsson, M; Järvinen, M; Liippo, K; Ojala, A; Paloheimo, S; Salmi, R; Viren, M | 1 |
| André, T; Bonnak, H; Bouleuc, C; Donsimoni, R; Esteso, A; Firmin, C; Gerota, J; Izrael, V; Lotz, JP; Merad, Z | 1 |
| Bell, D; Boyle, F; Pendlebury, S | 1 |
| Acimovic, L; Djuric, L; Jeremic, B; Shibamoto, Y | 1 |
| Ettinger, DS | 4 |
| Braly, PD; Howell, SB; Kim, S; Kirmani, S; McClay, EF; McClay, ME; Plaxe, SC; Wilgus, L | 2 |
| Burt, P; Hicks, F; Leahy, B; Lorigan, P; Prendiville, J; Stout, R; Thatcher, N | 1 |
| Comella, G; Comella, P; Frasci, G; Galizia, G; Iaffaioli, RV; Imbriani, A; Persico, G; Salzano, F | 1 |
| de Boer-Dennert, M; Ma, J; Planting, AS; Schellens, JH; Stoter, G; van der Burg, ME; van Ingen, HE; Verweij, J | 1 |
| Shi, YK; Su, M; Sun, Y | 1 |
| Shi, TZ; Yan, JL | 1 |
| Elfenbein, GJ; Fields, KK; Hiemenz, JW; Janssen, WE; Kronish, LE; Machak, MC; Perkins, JP; Zorsky, PE | 1 |
| Baurmann, H; Beyer, J; Bokemeyer, C; Huhn, D; Oettle, H; Schmoll, HJ; Siegert, W; Strohscheer, I; Zimmermann, R; Zingsem, J | 1 |
| Higashida, T; Koishi, Y; Koyama, H; Masuyama, M; Miyata, K; Mugitani, T; Takeuchi, K; Tanaka, H; Taniguchi, H; Yamaguchi, T | 1 |
| Frenkel, EP; Henner, WD; Mickey, BE; Neuwelt, EA; Wiliams, PC | 1 |
| Madden, T; Murry, DJ; Rodman, JH; Santana, VM | 1 |
| Ascensao, JL; Berkman, E; Desforges, JF; Dixon, P; Erban, JK; Miller, KB; Schenkein, DP | 1 |
| Asbury, R; Boros, L; Chang, AY; Hsieh, RK | 1 |
| Douglass, EC; Jones, DP; Marina, NM; Meyer, WH; Pratt, CB; Wilimas, JA | 1 |
| Bajorin, DF; Bosl, GJ | 1 |
| Antman, KH; Ayash, LJ; Elias, AD; Frei, E; Mazanet, R; McCauley, M; Schnipper, L; Schwartz, G; Tepler, I; Wheeler, C | 1 |
| Hayashi, I; Ichiki, M; Sakurai, M | 3 |
| Angelidou, M; Fountzilas, G; Klouvas, G; Kosmidis, P; Mylonakis, N; Palamidas, P; Papadakis, E; Provata, A; Samantas, E; Skarlos, DV | 1 |
| Ishizaki, T; Itoyama, T; Kuriyama, K; Nakamura, H; Sadamori, N; Soda, H; Tomonaga, M; Yamada, Y; Yoshida, Y | 1 |
| Barrett, A; Gaze, MN; Rampling, RP; Simpson, E; Smith, DB | 1 |
| Carstensen, J; Malmström, H; Simonsen, E | 1 |
| Formenti, SC; Mazumder, A; Muggia, FM; Uziely, B; Watkins, K | 1 |
| Elliott, WL; Howard, CT; Leopold, WR; Roberts, BJ | 1 |
| Jones, DN | 1 |
| Fanning, J; Hilgers, RD; Hutson, E | 1 |
| Apostolopoulou, F; Fountzilas, G; Kosmidis, PA; Pavlidis, N; Samantas, E; Skarlos, D | 1 |
| Gatzemeier, U; Hossfeld, DK; Laumen, R; Neuhauss, R; Pawel, JV | 1 |
| Burt, P; Lorrigan, P; Stout, R; Thatcher, N | 1 |
| Blackwell, S; Crawford, J; Deutsch, M; Foster, W; Herndon, J; Leopold, K; Wolfe, W; Yost, R | 1 |
| Bowman, LC; Douglass, EC; Furman, WL; Hudson, M; Marina, NM; Meyer, WH; Pappo, A; Rodman, J; Santana, VM; Shema, SJ | 1 |
| Ino, T; Kojima, H; Maruyama, F; Matsui, T; Miyazaki, H; Nomura, T; Okamoto, M; Sobue, R; Tsuzuki, M; Wakita, M | 1 |
| de Jonge, A; Karim, AB; Meyer, OW; Njo, KH; Slotman, BJ | 1 |
| Burghouts, JT; Haaxma-Reiche, H; Postmus, PE; van der Graaf, WT | 1 |
| Brancaccio, L; Comella, G; Curcio, C; D'Aprile, M; Ferrante, G; Gentile, M; Gridelli, C; Palmeri, S; Rossi, A; Veltri, E | 1 |
| Anania, C; Casaretti, R; Comella, G; Comella, P; Curcio, C; Daponte, A; Maiorino, A; Musetta, G; Scoppa, G | 1 |
| Bowman, WP; Dubowy, R; Land, V; Parmley, RT; Pollock, BH; Pratt, C; Sadowitz, PD; Souid, A; Vats, T; Weinstein, H | 1 |
| Bouffet, E; Chastagner, P; Doz, F; Gentet, JC; Kalifa, C; Mazingue, F; Plantaz, D; Roché, H; Sariban, E; Tron, P | 1 |
| Gazdar, AF; Ghosh, B; Johnson, BE; Kramer, BS; Minna, JD; Mitsudomi, T; Mulshine, JL; Pass, H; Phelps, R; Shaw, GL | 1 |
| Bonanad, S; Martín, G; Sanz, GF; Sanz, MA | 1 |
| Crown, JP; Hamilton, N; Heelan, RT; Heller, G; Kritz, A; Moore, MP; Motzer, RJ; Reich, LM; Schneider, JG; Yao, TJ | 1 |
| Burdach, S; Dilloo, D; Jürgens, H; Körholz, D; Koscielniak, E; Mauz-Körholz, C; Nürnberger, W; Pape, H; Paulussen, M; Peters, C | 1 |
| Earl, HM; Jones, A; Radford, JA; Smith, IE; Thatcher, N; Van Hoef, ME; Woll, PJ | 1 |
| Elfenbein, GJ; Fields, KK; Hiemenz, JW; Kronish, LE; Zorsky, PE | 1 |
| Bowman, LC; Furman, W; Jones, DP; Marina, NM; Meyer, WH; Murry, DJ; Pratt, CB; Rodman, JH; Shema, SJ | 1 |
| Brancaccio, L; Comella, G; Curcio, C; D'Aprile, M; Gentile, M; Gridelli, C; Ianniello, GP; Maiorino, A; Palmeri, S; Pedicini, T | 1 |
| Ahmed, T; Chun, H; Coleman, M; Cook, P; Coombe, N; Feldman, E; Helson, L; Mittelman, A; Puccio, C | 1 |
| Bouissou, F; Chancholle, A; Claeyssens, S; Fabre, J; Robert, A; Rubie, H; Tscherning, C | 1 |
| Boutard, P; Brunat-Mentigny, M; Deville, A; Dusol, F; Gentet, JC; Legall, E; Mechinaud, F; Pein, F; Tournade, MF; Zucker, JM | 1 |
| Fountzilas, G; Giannakakis, T; Skarlos, D; Stathopoulos, G; Theoharis, D | 1 |
| Akaogi, E; Inagaki, M; Ishibashi, O; Ishikawa, S; Kinoshita, T; Mitsui, K; Morita, R; Okazaki, H; Onizuka, M; Suga, M | 1 |
| Comis, R; Haas, N; Kilpatrick, D; Krigel, RL; Langer, C; Padavic, K; Palackdharry, CS | 1 |
| Hiraki, S; Kiura, K; Moritaka, T; Ohnoshi, T; Segawa, Y; Shibayama, T; Tabata, M; Takigawa, N; Ueoka, H; Yonei, T | 1 |
| Gohda, E; Hamasaki, K; Namba, M; Orita, K; Seshimo, K | 1 |
| Boutan-Laroze, A; Chazard, M; Culine, S; Droz, JP; Kattan, J; Kramar, A; Mahjoubi, M | 1 |
| Blackwell, S; Crawford, J; Deutsch, MA; Foster, W; Leopold, KA; Wolfe, W; Yost, R | 1 |
| Acimovic, LJ; Jeremic, B; Matovic, M | 1 |
| Beddoe, AM; Cohen, CJ; Dottino, PR | 1 |
| Bourhis, JH; Castagna, L; Chazard, M; Droz, JP; Ibrahim, A; Maraninchi, D; Pico, JL | 1 |
| Fujii, M; Kumamoto, T; Okamoto, M; Okamura, A; Saitoh, Y; Toyoda, T; Umemoto, M; Yonezu, S | 1 |
| Garin, AM; Gorbunova, VA; Ljubimova, NV; Mescheryakov, AA; Mironova, GT; Molchanov, GV; Ozols, RF; Perevodchikova, NI; Sokolov, AV; Tjulandin, SA | 1 |
| Barrada, M; Baur, M; Dittrich, C; Fazeny, B; Hudec, M; Salzer, H; Sevelda, P; Vavra, N | 1 |
| Hafström, L; Heath, DD; Howell, SB; Lindnér, P; Naredi, P; Shalinsky, DR | 1 |
| Bando, H; Shinohara, T; Sumitani, H; Takishita, Y; Tanaka, H; Yanagawa, H | 1 |
| Edmonds, PM; Evans, TR; Gallagher, CJ; Gore, ME; Harper, PG; Mansi, JL; Seymour, MT; Slevin, ML | 1 |
| Hirabayashi, M; Kuno, K; Nakagawa, M; Tanaka, Y; Yoshida, H | 1 |
| Fukazawa, M; Hashimoto, S; Ishii, A; Kawano, E; Kogure, K; Matsuura, Y; Nakamura, H; Nishimura, M; Oh, H; Okuyama, Y | 1 |
| Siegert, W | 1 |
| Barker, LJ; Jones, SE; Mennel, RG; Savin, MA | 1 |
| Chen, SC; Curtin, J; Groshen, S; Jeffers, S; Morrow, CP; Muggia, FM; Russell, C; Schlaerth, J | 1 |
| Kirkpatrick, A; Postmus, PE; Smit, EF; Splinter, TA | 1 |
| Difino, S; Goutsou, M; Green, MR; Luikart, SD; Mitchell, ED; Modeas, CR; O'Donnell, J; Perry, MC; Propert, KJ; Van Echo, DA | 1 |
| Hayashi, I; Ichiki, M; Ohashi, Y; Sakurai, M | 1 |
| Johnson, BE | 1 |
| Bajorin, DF; Fair, WR; Geller, NL; Herr, H; Mazumdar, M; Motzer, RJ; Pfister, DG; Sarosdy, MF; Scher, HI; Sogani, P | 1 |
| Droz, JP; Kramar, A; Pico, JL | 1 |
| Cassidy, J; Kaye, SB | 1 |
| Jeremic, B; Jevremovic, S; Mijatovic, L; Milisavljevic, S | 1 |
| Ishihara, T; Matsunaga, W; Yasuno, K | 1 |
| Bosl, GJ; Gulati, SC; Lin, S; Lyn, P; Mazumdar, M; Menendez-Botet, C; Motzer, RJ; Tong, WP; Vlamis, V | 1 |
| Bailey, CC; Giles, GR; Heney, D; Lewis, IJ; Lockwood, L | 1 |
| Barnett, MJ; Coppin, CM; Klingemann, HG; Murray, N; Nantel, SH; Nevill, TJ; Phillips, GL; Reece, DE; Shepherd, JD; Sutherland, HJ | 1 |
| Angioni, A; Boglino, C; Cozza, R; Deb, G; Donfrancesco, A; Helson, L; Jenkner, A; Landolfo, A; Maurizio, C | 1 |
| Beaujean, F; Bourhis, JH; Chazard, M; Hayat, M; Ibrahim, A; Lhomme, C; Maraninchi, D; Ostronoff, M; Viens, P; Zambon, E | 1 |
| Alcaraz, J; Andrews, P; Braly, P; Goel, R; Gorelick, S; Hoff, S; Kim, S; Kirmani, S; McClay, EF; Plaxe, S | 1 |
| Carter, C; Hodges, S; Lee, EJ; Reck, K; Schiffer, CA | 1 |
| Crown, J; Currie, V; Gilewski, T; Hakes, T; Hudis, C; Lebwohl, D; Reichman, B; Seidman, A; Surbone, A; Yao, TJ | 1 |
| Bowman, LC; Douglass, E; Furman, W; Hudson, M; Marina, NM; Meyer, W; Rodman, J; Santana, VM; Shema, SJ; Wilimas, J | 1 |
| Acimovic, L; Jeremic, B; Mijatovic, L | 1 |
| Ciavattini, A; Cignitti, M; De Nictolis, M; Garzetti, GG; Goteri, G; Romanini, C; Tranquilli, AL | 1 |
| Motzer, RJ | 3 |
| Confer, DL; Epstein, RB; Saez, RA; Selby, GB; Slease, RB; Strnad, C | 1 |
| Jeremic, B; Shibamoto, Y | 2 |
| Bando, T; Fukuse, T; Hirata, T; Hitomi, S; Ike, O; Inui, K; Mizuno, H; Tanaka, F; Wada, H; Yokomise, H | 1 |
| Juliusson, G | 1 |
| Broun, ER; Cornetta, K; Einhorn, LH; Hromas, R; Mandanas, R; Nichols, CR; Salzman, D; Turns, M | 1 |
| Ellis, PA; Jones, AL; Priest, K; Smith, IE; Talbot, DC | 1 |
| Bando, S; Fujita, J; Ikeda, T; Maeda, M; Ohnishi, T; Takahara, J; Yamaji, Y; Yamanouchi, H | 1 |
| Akimoto, K; Akimoto, S; Kasahara, T; Kato, M; Kinoshita, M; Kizu, O; Komatsu, T; Maeda, T; Minami, K; Nakaoka, Y; Sekikawa, S; Shimizu, T | 1 |
| Brummett, RE; Dahlborg, SA; Dana, BW; Henner, WD; Neuwelt, EA; Roman-Goldstein, S; Tableman, M; Williams, PC | 1 |
| Elfenbein, GJ; Fields, KK; Moscinski, LC; Perkins, JB | 1 |
| Ahmed, T; Akhtar, T; Chun, H; Feldman, E; Grima, K; Helson, L; Lake, D; Mittelman, A; Puccio, C; Seiter, K | 1 |
| Fujiwara, S; Fukui, M; Inamura, T; Morioka, T; Nishio, S; Shono, T; Takeshita, I | 1 |
| Ball, ED; Bloom, EJ; deMagalhaes-Silverman, M; Lembersky, B; Lister, J; Pincus, SM; Rybka, WB; Voloshin, M; Wilson, J | 1 |
| Goyal, R; Lueder, GT | 1 |
| Boddy, A; English, MW; Lowis, SP; Newell, DR; Pearson, AD; Peng, B; Price, L | 1 |
| Boneu, A; Hartmann, O; Hattchouel, JM; Lumbroso, J; Robert, A; Rodary, C; Rubie, H; Suc, A | 1 |
| Lasorella, A; Mastrangelo, R; Riccardi, R; Tornesello, A | 1 |
| Arriagada, R; Le Chevalier, T; Le Péchoux, C | 1 |
| Biron, P; Droz, JP | 1 |
| Ariyoshi, Y; Fujita, J; Fukuoka, M; Furuse, K; Ikegami, H; Katakami, N; Negoro, S; Ota, K; Takada, M | 1 |
| Bender, JG; Blake, M; Carreon, J; Lee, WJ; Oldham, F; Schilling, M; Smith, S; Swinney, P; Van Epps, D; Williams, DE; Williams, SF; Zimmerman, T | 1 |
| Baars, JW; de Glas-Vos, CW; Rodenhuis, S; Thomas, BL; van der Lelie, H; van Dijk, MA; van Oers, RH; von dem Borne, AE | 1 |
| Anderson, PM; Skubitz, KM | 1 |
| Ezawa, K; Fueki, N; Hoshino, H; Ishihara, S; Makimoto, T; Minato, K; Mori, M; Nakano, H; Naruse, I; Nomoto, T; Saito, R; Takei, Y; Takise, A; Tsuchiya, S; Watanabe, S | 1 |
| Andrews, F; Bolwell, B; Collins, R; Fay, J; LeFever, A; Levitt, D; List, A; Nemunaitis, J; Pallansch, P; Resta, D; Rosenfeld, CS; Schuster, MW; Taylor, R | 1 |
| Greco, FA; Hainsworth, JD; Stroup, SL | 1 |
| Dose, J; Freitag, K; Graeff, H; Jänicke, F; Kuhn, W; Pache, L; Schmalfeldt, B; Ulm, K | 1 |
| Acimovic, L; Jeremic, B; Milisavljevic, S; Shibamoto, Y | 3 |
| Amsterdam, A; Bajorin, DF; Bosl, GJ; Mazumdar, M; Motzer, RJ; Vlamis, V | 1 |
| Curcio, C; D'Aprile, M; Gridelli, C; Ianniello, G; Lorusso, V; Palmeri, S; Palmieri, G; Perrone, F; Rossi, A; Veltri, E | 1 |
| Elfenbein, GJ; Fields, KK; Janssen, WE; Moscinski, LC; Perkins, JB; Trudeau, WL | 1 |
| Amadori, S; Fazi, P; Mandelli, F; Montefusco, E; Petti, MC; Picardi, A; Testi, AM | 1 |
| Delva, R; Gamelin, E; Guérin, O; Larra, F; Lortholary, A; Maillart, P; Mege, M; Pein, F | 1 |
| Vose, JM | 1 |
| Effenbein, GJ; Fields, KK; Perkins, JB | 1 |
| Asbury, RF; Boros, L; Chang, AY; Garrow, GC; Hui, L | 1 |
| Niitsu, N; Umeda, M | 2 |
| Chauvergne, J; Chinet-Charrot, P; Stöckle, E; Thomas, L; Toulouse, C | 1 |
| Bando, T; Fujimura, M; Kasahara, K; Matsuda, T; Nakatsumi, Y; Shibata, K | 1 |
| Deguchi, S; Fujita, M; Honda, K; Kikuchi, T; Miyata, A | 1 |
| Furuta, T; Matsumoto, K; Ohmoto, T; Tada, E; Tomita, S | 1 |
| Avery, L; Fang, L; Furman, WL; Luo, X; Marina, N; Pratt, CB | 1 |
| Bucsky, P; d'Oleire, F; Eleftheriadis, S; Feyerabend, T; Freund, C; Gillis, W; Katschinski, DM; Mentzel, M; Robins, HI; Touhidi, RR; van Heek, R; Wagner, T; Weiss, C; Wiedemann, GJ | 1 |
| Akutsu, M; Kano, Y; Suzuki, K; Tsunoda, S | 1 |
| Aguilar-Ponce, L; Dueñas-Gonzalez, A; Frias-Mendivil, M; Gallardo-Rincon, D; Lara-Medina, F; Miranda-Lopez, E; Reynoso-Gomez, E; Sobrevilla-Calvo, P; Zinser-Sierra, J | 1 |
| Fujishiro, Y; Fuse, H; Katayama, T; Muraishi, Y | 1 |
| Shimada, K; Yano, S | 1 |
| Anderson, N; Bern, M; Coco, F; Dow, E; Lokich, J; Moore, C | 1 |
| Izrael, V; Lotz, JP | 1 |
| Nakanishi, Y | 1 |
| Kowada, M; Mineura, K; Sasajima, T; Takeda, O; Watanabe, A | 1 |
| Ariyoshi, Y; Fukuoka, M; Furuse, K; Kudoh, S; Kurihara, N; Kurita, Y; Ogawa, M; Sawa, T; Takada, M; Takaku, F | 1 |
| Friedman, HS; Heideman, RL; Murry, DJ; Petros, WP; Rodman, JH; Tonda, ME | 1 |
| Crowley, JJ; Figlin, RA; Goodwin, JW; Jacobs, EL; Livingston, RB; Muirhead, M; Rinehart, JJ | 1 |
| Bolzicco, G; Crinó, L; De Marinis, F; Emiliani, E; Figoli, F; Gentile, A; Marangolo, M; Maranzano, E; Masiero, P; Meacci, L; Morandi, MG; Ricardi, U; Rosti, G; Scagliotti, GV; Tonato, M | 1 |
| Grunberg, SM; Unger, P; Valentine, J; Zackon, I | 1 |
| Comella, G; Comella, P; Frasci, G; Menzella, G; Perillo, G; Persico, G; Polverino, M | 1 |
| Allen, JC; Siffert, J | 1 |
| Fujimura, T; Fushida, S; Hirono, Y; Kawamura, T; Kinami, S; Minami, M; Miwa, K; Miyazaki, I; Nishimura, G; Noguchi, M; Nojima, N; Sato, T; Shiobara, S; Yonemura, Y | 1 |
| Biondi, E; Cioffi, R; Comella, G; Comella, P; Curcio, C; De Cataldis, G; Frasci, G; Ianniello, GP; Micillo, E; Nicolella, D; Panza, N; Perchard, J | 1 |
| Ahn, C; Doroshow, JH; Hamasaki, V; Leong, L; Margolin, K; Morgan, R; Raschko, J; Shibata, S; Somlo, G; Tetef, M | 1 |
| Beyer, J; Bokemeyer, C; Diehl, A; Droz, JP; Einhorn, LH; Greinix, A; Kramar, A; Linkesch, W; Mandanas, R; Nichols, CR; Pico, JL; Schmoll, HJ; Siegert, W | 1 |
| Charitopoulos, K; Dimitriadis, K; Economides, D; Maglaveras, N; Papagiannis, A; Vamvalis, C; Zarogoulidis, K; Ziogas, E | 1 |
| Hayashi, N; Ikeba, K; Kinoshita, K; Ohokubo, T; Sodemoto, T; Takagi, A; Takeda, S; Yamamoto, T | 1 |
| Atagi, S; Fukuoka, M; Furuse, K; Kawahara, M; Kodama, N; Kubota, K; Kusunoki, Y; Masuda, N; Matsui, K; Negoro, S; Ogawara, M; Takada, M | 1 |
| Bosquée, L; Cetto, GL; Hamdan, O; Humblet, Y; Lange, A; Leyvraz, S; Marangolo, M; Pampallona, S; Pasini, F; Perey, L; Rosti, G | 1 |
| Nichols, CR | 1 |
| André, T; Bazelly, B; Bouleuc, C; Chapiro, J; Gattegno, B; Gligorov, J; Houry, S; Izrael, V; Lotz, JP; Péne, F; Selle, F | 1 |
| Beyer, J; Siegert, W | 1 |
| De Potter, P; Himelstein, BP; Maris, JM; Meadows, AT; Shields, CL; Shields, JA | 1 |
| Hungerford, JL; Kingston, JE; Madreperla, SA; Plowman, PN | 1 |
| Deegan, WF; Fisher, A; Gomer, CJ; Malogolowkin, M; Murphree, AL; Parker, R; Reed, E; Sato, JK; Villablanca, JG | 1 |
| De Potter, P; Needle, M; Shields, CL; Shields, JA | 1 |
| Brandt, A; Palmer, AJ | 1 |
| Burghouts, JT; Curran, D; Giaccone, G; Gozzelino, F; Groen, HJ; Kirkpatrick, A; Postmus, PE; Sahmoud, T; Scagliotti, G; Splinter, TA | 1 |
| Horn, TD; Prussick, R; Turner, MC; Wilson, WH | 1 |
| Abe, H; Ikeda, J; Ishii, N; Kato, T; Sawamura, Y; Shirato, H; Tada, M | 1 |
| Balmaceda, C; Diez, B; Finlay, JL; Heller, G; Kellie, S; Leibel, S; Maher, P; Rosenblum, M; Villablanca, JG; Vlamis, V; Walker, RW | 1 |
| Bianco, AR; Curcio, C; D'Aprile, M; Gebbia, V; Gridelli, C; Palmeri, S; Pepe, R; Pistillucci, G; Rossi, A; Veltri, E | 1 |
| Cannistra, SA; Korsmeyer, S; Strobel, T; Swanson, L | 1 |
| Hoskins, PJ; Lee, N; McMurtrie, EM; Pike, JA; Swenerton, KD | 1 |
| Fennelly, D; Gogas, H | 1 |
| Fuyuno, G; Kondo, T; Kumagai, M; Kutsuzawa, T; Ohta, Y; Shioya, S | 1 |
| Belli, M; Bianco, A; Cioffi, R; Comella, G; Comella, P; Curcio, C; De Cataldis, G; Della Vittoria, M; Frasci, G; Ianniello, G; Maiorino, L; Panza, N; Perchard, J | 1 |
| McMillan, R; Meisenberg, BR; Miller, WE | 1 |
| Asai, Y; Matsushita, K; Naitoh, T; Suetsugu, S | 1 |
| Beyer, J; Huhn, D; Kingreen, D; Krause, M; Schleicher, J; Schwaner, I; Schwella, N; Siegert, W | 1 |
| Boerrigter, L; Mooi, WJ; Rodenhuis, S; Slebos, RJ; Top, B; van Zandwijk, N; van't Veer, L | 1 |
| Delgado, FG; Garin, AM; Ljubimova, NV; Molchanov, GV; Sidorova, NJ; Sokolov, AV; Stenina, MB; Tjulandin, SA | 1 |
| Abrahamsen, D; Boddy, A; Brampton, M; Calvert, AH; Lind, M; Newell, D; Porter, D; Robson, L; Thomas, H; Winograd, B | 1 |
| Greenwald, MJ; Strauss, LC | 1 |
| Bunn, PA | 2 |
| Bury, T; Radermecker, MF; Skaventzos, I; Weber, T | 1 |
| Clamon, GH; Crawford, J; Green, MR; Herndon, JE; Hollis, DR; Luikart, SD; MacDonald, M; Maurer, LH; Ozer, H; Perry, MC; Wright, J | 1 |
| Ezawa, K; Fueki, N; Ishihara, S; Makimoto, T; Minato, K; Mori, M; Nakano, H; Naruse, I; Nomoto, T; Saitoh, R; Takei, Y; Takise, A; Tsuchiya, S; Watanabe, S | 1 |
| Brown, JM; Dorie, MJ | 1 |
| Koide, M; Matsuo, T; Sakamoto, S; Suzuki, S | 1 |
| Kojima, Y; Kotake, T; Maeda, O; Miki, T; Nonomura, N; Okuyama, A; Saiki, S; Sawada, M | 1 |
| Bliss, J; Horwich, A | 1 |
| Bokemeyer, C; Harstrick, A; Haupt, A; Köhrmann, O; Räth, U; Schmoll, HJ; Schöffski, P; Tischler, J; Weissbach, L | 1 |
| Ameri, A; Delattre, JY; Monjour, A; Poisson, M; Ronchin, P; Sahmoud, T; Sanson, M | 1 |
| Doughty, D; Kingston, JE; Plowman, PN; Sebag-Montefiore, D | 1 |
| Avet-Loiseau, H; Baranzelli, MC; Bénard, J; Bergeron, C; Chastagner, P; Courbon-Collet, B; Coze, C; Delattre, O; Favrot, M; Frappaz, D; Hartmann, O; Lemerle, J; Michon, J; Perel, Y; Peyroulet, MC; Plantaz, D; Rubie, H; Sommelet, D; Thyss, A; Vannier, JP | 1 |
| Mulder, NH; Sleijfer, DT | 1 |
| Carli, M; Frascella, E; Mancini, AF; Modak, S; Pinkerton, CR; Pritchard-Jones, K | 1 |
| Crahé, R; Deeken, M; Eleftheriadis, S; Gutsche, S; Katschinski, DM; Mentzel, M; Robins, HI; Storer, B; Wagner, T; Weiss, C; Wiedemann, GJ | 1 |
| Dearnaley, DP; Fisher, C; Horwich, A; Huddart, R; Husband, J; Nicholls, J; Norman, A; Paluchowska, B | 1 |
| Brugger, W; Engelhardt, R; Fetscher, S; Frommhold, H; Hasse, J; Kanz, L; Lange, W; Mertelsmann, R; Wenger, M | 2 |
| Alimena, G; Amadori, S; Avvisati, G; Capria, S; Celesti, F; Latagliata, R; Mandelli, F; Montefusco, E; Petti, MC | 1 |
| Benedetti Panici, P; Caracussi, U; Foddai, ML; Leone, G; Mancuso, S; Maneschi, F; Menichella, G; Pierelli, L; Salerno, MG; Scambia, G; Serafini, R; Vittori, M | 1 |
| Hatakeyama, S; Morita, M; Okano, H; Suzuki, K; Tachibana, A | 1 |
| Ameri, A; Chauveinc, L; Chen, QM; Delattre, JY; Poisson, M | 1 |
| De Filippis, S; Lalli, A; Nuzzo, A; Recchia, F; Torchio, P | 1 |
| De Filippis, S; Frati, L; Gulino, A; Quaglino, D; Rea, S; Recchia, F; Torchio, P | 1 |
| Bleyer, A; Fairclough, D; Furman, WL; Garrison, L; Luo, X; Marina, N; Meyer, WH; Pratt, CB | 1 |
| Jaehde, U | 1 |
| Katschinski, DM; Mentzel, M; Mulkerin, DL; Robins, HI; Touhidi, R; Wiedemann, GJ | 1 |
| Garcia, R; Mass, M; McCormick, CI; Neuwelt, EA; Pearse, HD; Remsen, LG; Roman-Goldstein, S; Sexton, G | 1 |
| De Mulder, PH; de Wit, R; Oosterhof, GO; Tjan-Heijnen, VC | 1 |
| Oliver, RT | 1 |
| Cook, PA; Cullen, MH; de Mulder, PH; de Wit, R; Dearnaley, DP; Fosså, SD; Horwich, A; Kaye, SB; Mead, GM; Oliver, RT; Sleijfer, DT; Stenning, SP; Sylvester, RJ | 1 |
| Ascensao, JL; Fontelonga, A; Hall, S; Kelly, AJ; MacKintosh, FR; Monroe, P; Ruthven, A; Shaft, D; Wilson, GS | 1 |
| Barakat, RR; Brown, C; Curtin, JP; Fennelly, D; Pizzuto, F; Venkatraman, ES | 1 |
| Arese, P; Camanni, M; Deltetto, F; Durando, A; Massobrio, M; Pesola, D; Sberveglieri, M | 1 |
| Bessho, A; Harada, M; Higuchi, M; Miyamoto, T; Miyoshi, T; Ohno, Y; Omoto, E; Shinagawa, K; Sunami, K; Teshima, T; Ueoka, H | 1 |
| Erland, JB; Greco, FA; Hainsworth, JD; Kalman, LA; Schreeder, MT | 1 |
| Gandara, DR; Lau, DH; Rosenthal, SA; Ryu, JK | 1 |
| Bardet, E; Charloux, A; Douillard, JY; Ducoloné, A; Henry-Amar, M; Le Groumellec, A; Pellae-Cosset, B; Rivière, A; Spaeth, D | 1 |
| Ikeba, K; Kimura, M; Kinoshita, K; Maeda, H; Ohkubo, T; Sodemoto, T; Suwata, J; Suzuki, Y; Takagi, A; Takeda, S; Yamamoto, T | 1 |
| Bajorin, DF; Bosl, GJ; Lyn, P; Mazumdar, M; Motzer, RJ; Vlamis, V | 1 |
| Bergman, I; Cnaan, A; Garvin, JH; Goldwein, JW; Grass, J; Molloy, P; Needle, MN; Phillips, PC; Sutton, L; Zhao, H | 1 |
| Hayashi, M; Ishimori, S; Kimura, K; Tabata, M; Tamada, T; Tsuburaya, T | 1 |
| Drake, DP; Kiely, EM; Misra, D; Pritchard, J; Spitz, L | 1 |
| Barlogie, B; Bracy, D; Desikan, KR; Jagannath, S; Mattox, S; Mehta, J; Munshi, N; Siegel, D; Singhal, S; Tricot, G; Vesole, D | 1 |
| Hirayama, Y; Koyama, R; Kuga, T; Matsunaga, T; Nagai, T; Niitsu, Y; Ohta, H; Sakamaki, S | 1 |
| Dodds, D; Mehta, M; Nonis, J; Rampling, R | 1 |
| Ikeba, K; Ishihara, O; Kinoshita, K; Okubo, T; Seki, H; Takagi, Y; Takeda, S | 1 |
| Baylis, PH; Foster, S; Harris, PE; Hurel, SJ; Kelly, WF; McNicol, AM | 1 |
| Goldberg, SL; Klumpp, TR; Magdalinski, AJ; Mangan, KF | 1 |
| Hasson, NK; Le, AT; Lum, BL | 1 |
| Junker, K; Rübe, C; Semik, M; Thomas, M; von Eiff, M | 1 |
| Akiyama, Y; Aori, T; Araki, K; Hattori, H; Kikuchi, H; Kubota, Y; Nagata, I; Nozaki, K; Takahashi, JA; Yokomizo, H; Yokoyama, M | 1 |
| Acimovic, L; Jeremic, B; Milicic, B; Milisavljevic, S; Nikolic, N; Shibamoto, Y | 1 |
| Buhles, W; Hersh, E; Issell, B; Neidhart, J; Rinehart, J; Triozzi, P | 1 |
| Carey, RW; Elias, AD; Grossbard, ML; Herbst, R; Jacobs, C; Kwiatkowski, DJ; Leong, T; Lynch, C; Lynch, TJ; Skarin, AT; Strauss, GM | 1 |
| Gandara, DR; Lau, DH; Ryu, JK | 1 |
| Bonomi, P; Faber, LP; LaFollette, S; Lincoln, S; Recine, D; Sharma, M; Warren, W | 1 |
| Clamon, GH; Crawford, J; Green, MR; Miller, AA; Neill, HB; Perry, MC | 1 |
| Birch, R; Bobo, C; Greco, FA; Hainsworth, JD; Weaver, CH | 1 |
| Gatzemeier, U; Jagos, U; Kaukel, E; Koschel, G; von Pawel, J | 1 |
| Anderson, IC | 1 |
| Oblon, DJ; Paul, S; Yankee, R | 1 |
| Broniek, A; Byszewska, D; Jereczek, B; Obłakowski, P; Roszkowski, K; Starzyńska, T; Zych, J | 1 |
| Camoriano, JK; Fitch, TR; Frytak, S; Rajkumar, SV; Rubin, J | 1 |
| Ozols, RF | 1 |
| Agaliotis, DP; Ballester, OF; Elfenbein, GJ; Fields, KK; Goldstein, SC; Hiemenz, JW; Mattox, T; Perkins, JB; Rosen, RM; Zorsky, PE | 1 |
| Gajjar, A; Heideman, R; Kun, LE; Langston, JW; Ochs, JS; Sanford, RA; Walter, AW | 1 |
| Kortmann, RD | 1 |
| Bertz, H; Brugger, W; Fetscher, S; Kanz, L; Krieger, G; Lange, W; Mertelsmann, R | 1 |
| Gray, JR; Greco, FA; Hainsworth, JD; Hopkins, LG; Kalman, LA; Patten, JE; Stroup, SL; Thomas, M | 1 |
| de Potter, P; Hamada, A; Kheterpal, S; Meadows, AT; Needle, M; Shields, CL; Shields, JA | 1 |
| Beyer, J; Kingreen, D; Lenz, K; Rick, O; Siegert, W; Weinknecht, S | 1 |
| Huhn, D; Kingreen, D; Kirsch, A; Kleiner, S; Schwaner, I; Schwella, N; Siegert, W | 1 |
| Malik, S; Oblon, DJ; Oblon, MB; Paul, SR | 1 |
| Kaufmann, SH; Rowinsky, EK | 1 |
| Davis, BJ; Leibel, SA; Merchant, TE; Sheldon, JM | 1 |
| Allen, JC; Bostrom, BC; Boyett, JM; Dunkel, IJ; Finlay, JL; Gardner, SL; Garvin, JH; Goldman, S; Li, H; Rosenblum, M; Sender, LS; Yates, A | 1 |
| Doughty, D; Hungerford, JL; Kingston, JE; Madreperla, SA; Plowman, PN; Singh, AD | 1 |
| Acimovic, L; Jeremic, B; Milicic, B; Milisavljevic, S; Shibamoto, Y | 1 |
| Clancy, L; de Wit, R; Fennelly, J; Frisch, J; Gatzemeier, U; Koschel, G; Pfeifer, W; Steward, WP; Thatcher, N; Verweij, J; von Eiff, M; von Pawel, J; Woll, P | 1 |
| Gornall, P; Gray, E; Imeson, J; Mann, JR; McKeever, P; Oakhill, A; Phillips, M; Raafat, F; Robinson, K; Sokal, M | 1 |
| Beyer, J; Höltl, W; Pont, J; Siegert, W; Weissbach, L | 1 |
| Minami, H; Saka, H; Sakai, S; Shimokata, K; Yamamoto, M | 1 |
| Agata, H; Fujimoto, T; Hamaguchi, N; Hirota, T; Iwata, A; Katano, N; Kitagawa, S; Kobayashi, S; Konno, K; Sato, T; Sawada, K; Takeuchi, M | 1 |
| Buckley, J; Cairo, M; Feig, S; Harris, RE; Matthay, K; Ozkaynak, MF; Reynolds, CP; Seeger, RC; Villablanca, JG | 1 |
| Aebi, S; Fink, D; Haas, M; Howell, SB; Kim, HK; Nebel, S; Norris, PS | 1 |
| Greco, FA; Hainsworth, JD; Hopkins, LG; Thomas, M | 1 |
| Keshelava, N; Reynolds, CP; Seeger, RC | 1 |
| Bishop, JF; Millward, MJ; Quinn, M; Rischin, D; Rome, R; Tebbutt, N; Toner, GC | 1 |
| Boyett, JM; Cairo, M; Dunkel, IJ; Ettinger, LJ; Finlay, JL; Garvin, JH; Goldman, S; Kaplan, AM; Li, H | 1 |
| Bacci, G; Bertoni, F; Briccoli, A; Campanacci, M; Cesari, M; Fabbri, N; Ferrari, S; Forni, C; Gasbarrini, A; Mercuri, M | 1 |
| Eisenhauer, E; Shepherd, FA | 1 |
| Masumori, N; Miyao, N; Niitsu, Y; Sakamaki, S; Sasamura, H; Shigyo, M; Takahashi, A; Takeda, K; Tsukamoto, T | 1 |
| Drumea, K; Goldsher, D; Ravkin, A; Stein, ME; Tzuk-Shina, Z | 1 |
| Confer, DL; Epstein, RB; Mandanas, RA; Saez, RA; Selby, GB | 1 |
| Hess, CF; Jürgens, H; Klingebiel, T; Koscielniak, E; Pertl, U; Pötter, R; Rossi, R; Schött, C; Spaar, HJ; Treuner, J; van Heek-Romanowski, R; Willnow, U | 1 |
| Barlogie, B; Bracy, D; Desikan, KR; Fassas, A; Jagannath, S; Mattox, S; Mehta, J; Munshi, N; Nelson, J; Siegel, D; Singhal, S; Tindle, S; Tricot, G; Vesole, DH | 1 |
| Hara, N; Hirose, N; Inutsuka, S; Kanegae, H; Kawarada, Y; Kurita, Y; Miyazaki, M; Miyazaki, N; Nakanishi, Y; Ninomiya, K; Ogata, K; Ohgushi, O; Yamazaki, H | 1 |
| Ballester, OF; Elfenbein, GJ; Fields, KK; Goldstein, SC; Heimenz, JW; Kronish, LA; Partyka, JS; Perkins, JB; Saez, RA; Sullivan, DM | 1 |
| Furudate, M; Hanada, T; Ishida, T; Isobe, H; Itoh, K; Kawakami, Y; Ogura, S; Saito, K; Takekawa, H; Tokuchi, Y | 1 |
| Baker, WJ; Burrell, LM; Lee, N; Perry, JJ; Vukelja, SJ | 1 |
| Bouffet, E; Desjardins, L; Doz, F; Gentet, JC; Lutz, P; Michon, J; Namouni, F; Neuenschwander, S; Pacquement, H; Plantaz, D; Quintana, E; Tanguy, ML; Validire, P; Vannier, JP; Zucker, JM | 1 |
| Dermitzakis, G; Fahantidou, E; Gioulekas, D; Papagiannis, A; Vamvalis, C; Zarogoulidis, K; Ziogas, E | 1 |
| Antman, KH; Ayash, LJ; Coleman, N; Elias, AD; Frei, E; Ibrahim, J; McCauley, M; Mills, L; Schnipper, L; Schwartz, G; Teicher, BA; Warren, D; Wheeler, C | 1 |
| Gehl, J; Mir, LM; Skovsgaard, T | 1 |
| Baranzelli, MC; Boutard, P; Chastagner, P; Coze, C; de Lumley, L; Frappaz, D; Hartmann, O; Leverger, G; Lutz, P; Margueritte, G; Méchinaud, F; Michon, J; Millot, F; Perel, Y; Peyroulet, MC; Plantaz, D; Rubie, H; Stéphan, JL | 1 |
| Chang, J; Chow, W; Correia, J; Dancey, J; Dulude, H; Franssen, E; Gallant, G; Girouard, M; Goel, R; Verma, S; Warner, E | 1 |
| Anderson, E; Eden, O; Isaksson, O; Robson, H; Shalet, S | 1 |
| Arimoto, T; Hashimoto, S; Inaba, T; Iwasaki, Y; Kubota, Y; Nakagawa, M; Shimazaki, C; Toda, S; Ueda, M; Yokomura, I | 1 |
| Hirota, S; Hishikawa, Y; Honda, K; Kono, K; Obayasi, K; Soejima, T; Takada, Y; Watanabe, H | 1 |
| Anderson, E; Eden, OB; Isaksson, O; Robson, H; Shalet, S | 1 |
| Boyett, JM; Dunkel, IJ; Finlay, JL; Gardner, S; Garvin, JH; Goldman, S; Gollamudi, S; Guruangan, S; Merchant, TE; Rosenblum, M | 1 |
| Atagi, S; Fukuoka, M; Furuse, K; Hirashima, T; Kawahara, M; Kobayashi, M; Komiya, T; Kudoh, S; Masuda, N; Matsui, K; Negoro, S; Ogawara, M; Yana, T | 1 |
| Jürgens, H; Kleta, R; Wagner, A | 1 |
| Christensen, TB; Daugaard, G; Geertsen, PF; von der Maase, H | 1 |
| Anagnostopoulos, A; Andreopoulou, E; Aravantinos, G; Aspropotamitis, A; Dimopoulos, MA; Fountzilas, G; Michalas, S; Papadimitriou, C; Papadopoulou, M; Pavlidis, N; Pectacides, D | 1 |
| Emanuele, S; Giuliano, M; Lauricella, M; Tesoriere, G; Vento, R | 1 |
| Biesma, B; Cox, A; Festen, J; Postmus, PE; Splinter, TA; Tjan-Heijnen, VC; Wagener, DJ | 1 |
| Albain, KS; Crowley, JJ; Fletcher, WS; Gandara, DR; Hazuka, MB; Keiser, WL; Lanier, KS; Lau, DH; Leigh, B; Livingston, RB | 1 |
| Abramson, DH; Dunkel, IJ; Madden, T; Mendelsohn, ME; Tong, W; Tran, HT | 1 |
| Choh, S; Fukuoka, K; Hamada, K; Mikasa, K; Narita, N; Tomoda, K; Tsujimoto, M; Tsukaguchi, K; Yoneda, T | 1 |
| Akasaka, Y; Igarashi, H; Kondou, N; Kuroda, A; Madarame, J; Nakata, J; Ohishi, Y; Tomita, M; Yanada, S | 1 |
| Benesch, M; Kerbl, R; Lackner, H; Oberbauer, R; Pakisch, B; Schwinger, W; Urban, C | 1 |
| Bow, EJ; Gallant, G; Rubinger, M; Schacter, BA; Shore, TB; Williams, GJ; Woloschuk, D | 1 |
| Bergeron, S; Blazar, BR; Cairo, MS; Garrison, L; Krailo, MD; Reaman, GH; Secola, R; van de Ven, C; Weinthal, JA | 1 |
| Ishigaki, T; Kodaira, T; Matsubara, K; Taniguchi, H; Yamakawa, K | 1 |
| Baranzelli, MC; Bergeron, C; Boutard, P; Frappaz, D; Gentet, JC; Hartmann, O; Michon, J; Pein, F; Philip, T; Quintana, E; Stephan, JL; Thyss, A; Tournade, MF; Valteau-Couanet, D; Vannier, JP; Zucker, JM | 1 |
| Giaccone, G; Gregor, A; Scagliotti, GV | 1 |
| Battaglia, A; Bonanno, G; Fattorossi, A; Leone, G; Mancuso, S; Menichella, G; Panici, PB; Perillo, A; Pierelli, L; Scambia, G | 1 |
| Akaza, H; Iida, K; Imada, S; Kawai, K; Miyanaga, N; Tsukamoto, S | 1 |
| Clavier, J; Daniel, C; Gouva, S; Guillodo, MP; Guillou, B; Robinet, G | 1 |
| Aebi, S; Fink, D; Fink, JL; Gordon, R; Howell, SB; Kim, HK; Zheng, H | 1 |
| Campion, M; Hersh, E; Levitt, D; Margolin, KA; Resta, D; Rinehart, J; Triozzi, P | 1 |
| Garcia, R; McCormick, CI; Neuwelt, EA; Pearse, HD; Remsen, LG; Sexton, G | 1 |
| Hafström, L; Heath, D; Howell, S; Lindnér, P; Naredi, P | 1 |
| de Tribolet, N; Dietrich, PY; Pizzolato, G; Zona, G | 1 |
| Furuta, T; Maeda, Y; Matsumoto, K; Mizumatsu, S; Ohmoto, T; Tamiya, T | 2 |
| Bernhardt, G; Czech, T; Fuiko, R; Hawliczek, G; Köller, U; Nirnberger, G; Pillwein, K; Slavc, I | 1 |
| Baruchel, S; Chan, H; Fouladi, M; Grant, R; Greenberg, ML; Malkin, D; Weitzman, S | 1 |
| Fuchs, J; Haindl, J; Leuschner, I; von Schweinitz, D; Wenderoth, M | 1 |
| Bergman, B; Helsing, M; Hero, U; Thaning, L | 1 |
| Groshen, S; Keshelava, N; Reynolds, CP; Seeger, RC | 1 |
| Haga, N; Honda, K; Itoh, M; Muraki, O; Ohto, H; Tsuruya, Y; Yamaguchi, O | 1 |
| Kondo, E; Miura, A; Mizuno, H; Yamao, H; Yuge, M | 1 |
| Cater, J; Gross, N; Gündüz, K; Meadows, AT; Needle, M; Shields, CL; Shields, JA | 1 |
| Murray, TG; O'Brien, JM; Scott, IU; Toledano, S | 1 |
| Cuomo, AM; Pavesi, L; Poggi, G; Preti, P; Robustelli della Cuna, FS; Zambelli, A | 1 |
| Fujii, H; Igarashi, T; Itoh, K; Minami, H; Ohtsu, T; Sasaki, Y; Wakita, H; Watanabe, Y | 1 |
| Arias-Gomez, J; Cerecedo-Diaz, F; Lopez-Aguilar, E; Quintana-Roldan, G; Rivera-Marquez, H; Santacruz-Castillo, E; Sepulveda-Vildosola, AC; Valdez-Sanchez, M | 1 |
| Christmas, TI; Lee, YC; McCrystal, MR | 1 |
| Cioffi, R; Comella, G; Comella, P; De Cataldis, G; Del Gaizo, F; Della Vittoria, M; Frasci, G; Gravina, A; Marcatili, P; Monfardini, S; Panza, N; Pozzo, C; Ruffolo, P | 1 |
| Beyer, J; Rick, O; Siegert, W | 2 |
| Asselain, B; Desjardins, L; Doz, F; Levy, C; Michon, J; Pacquement, H; Quintana, E; Schlienger, P; Validire, P; Zucker, JM | 1 |
| Armand, JP; Couteau, C | 1 |
| Idezuki, Y; Ishizuka, N; Kobayashi, M; Murata, N; Suwata, J; Takada, S | 1 |
| Albiani, R; Bacci, G; Brach del Prever, A; Busca, A; Fagioli, F; Madon, E; Miniero, R; Nesi, F; Picci, P; Vassallo, E | 1 |
| Beyer, J; Huhn, D; Kingreen, D; Kirsch, A; Krusch, A; Rick, O; Schleicher, J; Schwella, N; Siegert, W | 1 |
| Bar-Am, A; Inbar, MJ; Kraminsky, N; Ron, IG; Vishne, TH | 1 |
| Fountzilas, G; Kalofonos, C; Klouvas, G; Panoussaki, E; Pavlidis, N; Pectasides, D; Poulakis, N; Samantas, E; Skarlos, DV; Tsiakopoulos, E | 1 |
| Lauer, AK; Neuwelt, EA; Shults, WT; Wilson, MW; Wobig, JL | 1 |
| Akashi, T; Fukutomi, M; Funakoshi, A; Iguchi, H; Kuniyoshi, M; Ohnishi, Y; Wakasugi, H; Yokota, M | 1 |
| Arriola, EL; Chresta, CM; Hickman, JA; Rodriguez-Lopez, AM | 1 |
| Gysler, J; Jaehde, U; Schunack, W | 1 |
| Castello, MA; Maurizi, P; Schiavetti, A; Varrasso, G | 1 |
| Asano, S; Matsuoka, M; Ohata, J; Tani, K; Tojo, A; Yamashita, T | 1 |
| Jobe, DR; Kuhn, J; Rizzo, J; Schreeder, MT; Walton, GD | 1 |
| Chikazawa, H; Fujimoto, S | 1 |
| Aoki, Y; Kase, H; Kodama, S; Kurata, H; Tanaka, K | 1 |
| Bokemeyer, C; Culine, S; Fosså, SD; Gerl, A; Germa-Luch, JR; Jones, WG; Mead, GM; Pont, J; Schmoll, HJ; Tjulandin, S | 1 |
| Hara, N; Harada, T; Inoue, K; Minami, T; Nakanishi, Y; Osaki, S; Takano, K; Takayama, K | 1 |
| Fukuoka, K; Kanzawa, F; Nishio, K; Saijo, N; Sunami, T | 1 |
| Coleman, RE; Dobson, LS; Gillespie, AM; Hancock, BW | 1 |
| Hennequin, C; Maylin, C | 1 |
| Fountzilas, G; Kalofonos, H; Kosmidis, P; Mylonakis, N; Nicolaides, P; Pavlidis, N; Pectasides, D; Samantas, E; Skarlos, DV; Vardoulakis, Th | 1 |
| Boiardi, A; Broggi, G; Fariselli, L; Pozzi, A; Salmaggi, A; Silvani, A | 1 |
| Abe, T; Hori, S; Kawashima, H; Mori, T; Morikawa, N; Takeyama, M | 1 |
| Biron, P; Blay, JY; Droz, JP; Fléchon, A; Philip, I | 1 |
| Cavalli, F; Conti, A; de Jong, J; Ghielmini, M; Maestroni, G; Pagani, O; Pampallona, S; Sessa, C | 1 |
| Constantopoulos, S; Elisaf, M; Konstantinidis, A; Panteli, K | 1 |
| Fujiwara, Y; Isobe, T; Katoh, O; Kurata, T; Miyazaki, M; Oguri, T; Ohashi, N; Takahashi, T; Yamakido, M; Yokozaki, M | 1 |
| Aleksandrovic, J; Dagovic, A; Grujicic, D; Jeremic, B; Milicic, B; Nikolic, N; Shibamoto, Y; Stojanovic, M | 2 |
| Arand, M; Becker, R; Dornhöfer, N; Hengstler, JG; Kett, A; Knapstein, PG; Lange, J; Meinert, R; Oesch, F; Tanner, B | 1 |
| Dagovic, A; Jeremic, B; Milicic, B; Milisavljevic, S; Nikolic, N; Radosavljevic-Asic, G; Shibamoto, Y | 1 |
| Abbasciano, V; Bianchi, MP; Bononi, A; Crepaldi, G; Ferrazzi, E; Gilli, G; Nielsen, I; Sartori, S; Toso, S; Trevisani, L; Zavagli, G | 1 |
| Drumea, K; Goldsher, D; Kuten, A; Stein, ME; Tzuk-Shina, Z | 1 |
| Brugger, W; Engelhardt, R; Fetscher, S; Frommhold, H; Hasse, J; Kanz, L; Lange, W; Mertelsmann, R | 2 |
| Kashiwabara, K; Kishi, K; Kobayashi, K; Matsuoka, T; Nakamura, H; Sarashina, G; Yagyu, H | 1 |
| Fleming, DR; Goldsmith, GC; Herzig, RH; Stevens, DA | 1 |
| Cho, S; Kanayama, Y; Maeda, N; Nishizaki, S; Sonoda, T; Yoshida, T | 1 |
| Boente, P; Costa, LJ; del Giglio, A; Luzzi, JR; Mota, A; Neves, P; Pinczowski, H; Sampaio, C; Varella, PC | 1 |
| Berkman, E; Hurley, C; Kanteti, R; McCann, J; Miller, K; Morelli, J; Roitman, D; Schenkein, D | 1 |
| Belt, R; Coon, J; Cord, M; Dix, S; Geller, R; Howard, S | 1 |
| Billy, C; Carette, MF; Ferroir, JP; Milleron, B; Nahum, L; Ropert, A; Tcherakian, S | 1 |
| Garbe, L; Magnan, A; Payan, MJ; Pinet, C; Vervloet, D | 1 |
| Gardner, RV; Shetty, AK; Warrier, RP; Yu, LC | 1 |
| Aleksandrovic, J; Dagovic, A; Jeremic, B; Milicic, B; Milisavljevic, S; Nikolic, N; Radosavljevic-Asic, G; Shibamoto, Y | 2 |
| Hayashi, I; Isobe, H; Kurita, Y; Masutani, M; Mori, K; Nakata, K; Nishiwaki, Y; Okamoto, H; Saijo, N; Tsuchiya, S; Watanabe, K | 1 |
| Chastagner, P; Chouffai, Z; Couanet, D; Doireau, V; Grignon, Y; Grill, J; Kalifa, C; Lellouch-Tubiana, A; Marchal, JC; Zerah, M | 1 |
| Endoh, T; Fujiwara, O; Hasegawa, J; Kimura, T; Narabayashi, A; Notake, Y; Okuyama, D; Ookubo, K; Shimizu, A; Takahashi, J; Yoda, A | 1 |
| Keyaki, A; Nabeshima, S; Waga, S | 1 |
| Bosquée, L; Canon, JL; Humblet, Y; Rosier, JF; van de Velde, H; Weynants, P | 1 |
| Arakawa, S; Gohji, K; Gotoh, A; Hara, I; Hara, S; Kamidono, S; Miyake, H; Nakamura, I; Nomi, M; Oka, Y; Takechi, Y; Yamada, Y; Yamanaka, K | 1 |
| Bauernhofer, T; Kasparek, AK; Kotz, R; Kuss, I; Pieber, TR; Ploner, F; Samonigg, H; Stöger, H | 1 |
| Agus, DB; Bertino, JR; Childs, B; Coady-Lyons, N; Filippa, D; Frank, R; Glassman, JR; Goy, A; Hedrick, EE; Hunte, S; Jurcic, J; Louie, D; Moskowitz, CH; Nimer, SD; Noy, A; O'Brien, J; Portlock, CS; Straus, DS; Yahalom, J; Zelenetz, AD | 1 |
| Balaña, C; Martin, C; Rosell, R | 1 |
| Förster, B; Loddenkemper, R; Pannhorst, J; Riedel, U; Schönfeld, N; Serke, M | 1 |
| Bosl, GJ; Morris, MJ | 1 |
| Asbury, R; Boros, L; Chang, AY; Garrow, G; Hui, L; Rubins, J | 1 |
| Bunin, GR; Friedman, DL; Himelstein, B; Meadows, AT; Miller, D; Needle, M; Shields, CL; Shields, JA | 1 |
| Amill, B; Aventín, A; Blanco, A; Boqué, C; Brunet, S; González, JR; Grañena, A; Larriba, I; Martín-Henao, GA; Martino, R; Petit, J; Sierra, J; Sureda, A | 1 |
| Gotoh, M; Mizutani, K; Naoe, T; Ohshima, S; Okamura, K; Ono, Y; Yuba, H | 1 |
| Akaza, H; Hara, I; Hoshi, S; Miki, T; Naito, K; Naito, S; Nakagawa, S; Nishiyama, T; Nonomura, N; Okano, T; Ozono, S; Sonoda, Y; Terachi, T; Tsukamoto, T; Yoshida, O | 1 |
| Le Guen, Y; Lebeau, B | 1 |
| Fabisiak, JP; Johnson, CS; Lazo, JS; Vogt, A; Wang, AS; Wipf, P | 1 |
| Bakker, PJ; de Mulder, PH; de Vries, EG; de Wit, R; Keizer, HJ; Kooi, M; Lalisang, RI; Mandjes, I; Rodenhuis, S; Sleijfer, DT | 1 |
| Arakawa, M; Chou, D; Gejyo, F; Ito, K; Kagamu, H; Sakai, K; Shimbo, T; Suzuki, E; Takahashi, M; Tanaka, H; Tanaka, J; Wakabayashi, M; Yoshizawa, H | 1 |
| Brummett, RE; Doolittle, ND; Egorin, MJ; Kroll, RA; Muldoon, LL; Neuwelt, EA; Pagel, MA; Zuhowski, EG | 1 |
| Kurano, R; Ono, K; Semba, H; Seto, M; Seto, T | 1 |
| Plummer, ER; Roberts, JT | 1 |
| Bianco, AR; Caputo, R; Ciardiello, F; De Laurentiis, M; De Placido, S; Pomatico, G; Tortora, G | 1 |
| Menéndez, B; Salar, A; Sierra, J; Sureda, A | 1 |
| Cavenagh, JD; Eden, AG; Hughes, A; Kelsey, SM; Lamont, A; McBride, NC; Mills, MJ; Newland, AC; Ward, MC | 1 |
| Bashey, A; Corringham, RE; Corringham, S; Garrett, J; Gilpin, EA; Ho, AD; Lane, TA; Law, P | 1 |
| Bains, M; Bajorin, DF; Bosl, GJ; Flombaum, C; Macapinlac, HA; Mariani, T; Mazumdar, M; Motzer, RJ; Reich, L; Sheinfeld, J; Tong, WP | 1 |
| Bhatia, S; Einhorn, LH; Porcu, P; Sharma, M | 1 |
| Horikoshi, T; Naganuma, H; Nukui, H; Ohashi, Y; Ueno, T | 1 |
| Choy, H; Cmelak, AJ; Johnson, DH; Mohr, PJ; Shyr, Y | 1 |
| Carapella, C; Castello, MA; Maurizi, P; Schiavetti, A; Trasimeni, G; Varrasso, G | 1 |
| Filejski, W; Gerke, P; Robins, HI; Steinhoff, J; Wiedemann, GJ | 1 |
| Chow, E; Heideman, RL; Jenkins, JJ; Kun, LE; Langston, J; Merchant, TE; Reardon, DA; Sanford, RA; Shah, AB | 1 |
| Bakhshandeh, A; Bruns, I; Eberhardt, K; Wiedemann, GJ | 1 |
| Anderson, H; Ashcroft, L; Jayson, GC; Ranson, M; Thatcher, N; White, SC | 1 |
| Bussar-Maatz, R; Flechtner, H; Hartmann, M; Keller, L; Pichlmeier, U; Weissbach, L | 1 |
| Benz, MS; Kramer, D; Murray, TG; Scott, IU; Toledano, S | 1 |
| Berkowitz, R; Cannistra, SA; Kim, Y; Matulonis, U; Niloff, J; Quartulli, M; Seiden, M; Tung, N | 1 |
| Halme, M; Isokangas, OP; Joensuu, H; Mäntylä, M; Mattson, K; Pekonen, M; Pyrhönen, S; Ruotsalainen, T; Sarna, S | 1 |
| Jin, X; Liu, Z; Luo, B; Yin, L; Zeng, P | 1 |
| Ahmed, T; Ali, MF; Bar, M; Chun, HG; Durrani, H; Farley, T; Goldberg, R; Kancherla, R; Lake, D; Lipshutz, M; Mannancheril, A; Mittelman, A; Preti, R; Puccio, C; Qureshi, Z; Seiter, K | 1 |
| Hamana, T; Miyagi, N; Takahashi, M | 1 |
| Decatris, MP; Dougall, M; Metzner, M; Morgenstern, GR; Welch, RS; Wilkinson, PM | 1 |
| Thongprasert, S | 1 |
| Akaza, H; Kawai, K; Miyanaga, N; Miyazaki, J; Shimazui, T; Takeshima, H | 1 |
| Bardou, VJ; Bertucci, F; Delpero, JR; Faucher, C; Houvenaeghel, G; Maraninchi, D; Viens, P | 1 |
| Balmer, A; Beck, MN; Dessing, C; Munier, F; Pica, A | 1 |
| Chan, LY; Wong, SF; Yu, VS | 1 |
| Iino, K; Oki, Y; Sasano, H | 1 |
| Fowler, JM; Greer, BE; Horowitz, IR; McGuire, WP; Rodriguez, M; Rose, PG; Waggoner, S | 1 |
| Okamoto, H; Watanabe, K | 2 |
| Jacky, E; Jost, LM; Stahel, RA; Tscherry, G | 1 |
| Donnelly, GB; Hedrick, EE; Hunte, S; Kewalramani, T; Lyons, NC; Moskowitz, CH; Nimer, SD; Priovolos, AC; Qin, J; Yahalom, J; Zelenetz, AD | 1 |
| Abonour, R; Bhatia, S; Cornetta, K; Einhorn, LH; Nichols, CR; Porcu, P; Seshadri, R | 1 |
| Hatano, H; Hatano, N; Kajita, Y; Kinoshita, T; Takasu, S; Usui, T; Wakabayashi, T; Yoshida, J | 1 |
| Ballestrero, A; Clavio, M; Ferrando, F; Garuti, A; Ghio, R; Gobbi, M; Gonella, R; Patrone, F; Sessarego, M | 1 |
| Olver, IN; Schulze, D; Stephenson, J | 1 |
| Adachi, K; Kobayashi, S; Mizunari, T; Murai, Y; Ohaki, Y; Teramoto, A | 1 |
| Deichmann, M; Goldschmidt, H; Hartschuh, W; Hegenbart, U; Ho, A; Jäckel, A; Näher, H; Waldmann, V | 1 |
| Bailey, S; Gornall, P; Gray, E; Hale, J; Imeson, J; Mann, JR; McKeever, P; Oakhill, A; Raafat, F; Robinson, K; Sokal, M | 1 |
| Fraser, G; Nicoll, J; Rampling, R; Smith, C; Stephen, M | 1 |
| Bonilla, F; Corbacho, C; Dominguez, G; España, P; Garcia, JM; Portero, JL; Provencio, M; Rodriguez, R; Silva, J; Silva, JM | 1 |
| Bernassola, F; Lovat, PE; Malcolm, AJ; Melino, G; Pearson, AD; Piacentini, M; Ranalli, M; Redfern, CP; Tilby, M | 1 |
| Bondiau, PY; Foa, C; Magné, N; Otto, J; Thyss, A | 1 |
| Cullen, MH; Dearnaley, DP; Fossa, SD; Harland, SJ; Horwich, A; Lallemand, E; Mead, GM; Oliver, RT; Roberts, JT; Stenning, SP; Wilkinson, PM | 1 |
| Beijnen, JH; Mathôt, RA; Schellens, JH; van den Bongard, HJ | 1 |
| Chow, W; Coluzzi, P; Doroshow, JH; Hamasaki, V; Leong, LA; Margolin, KA; Morgan, RJ; Raschko, JW; Shibata, SI; Somlo, G; Synold, TW; ter Veer, A; Tetef, ML; Yen, Y | 1 |
| Burris, HA; Erland, JB; Gray, JR; Greco, FA; Hainsworth, JD; Kalman, LA; Schreeder, MT | 1 |
| Brown, JM; Gurney, EM; Hepburn, PM; Johnson, PW; Muers, MF; Napp, VV; Peake, MD; Poulter, KM | 1 |
| Gallagher, CJ; Gupta, RK; Kelsey, S; Lister, TA; Newland, AC; O'Doherty, CA; Oliver, RT; Shamash, J | 1 |
| Czorny, A; Godard, J; Jacquet, G; Miny, J; Plouvier, E; Raul, JS; Viennet, G | 1 |
| Ayash, LJ; Cronin, S; Raith, C; Ratanatharathorn, V; Uberti, JP | 1 |
| Burt, PA; Davies, R; Hodgetts, J; Lee, SM; Lomax, L; Pettengell, R; Simms, T; Stout, R; Thatcher, N; Woll, PJ | 1 |
| Dowell, JE; Garrett, AM; Hande, KR; Johnson, DH; Shyr, Y | 1 |
| Bauer, M; Blatt, J; Blazar, BR; Cairo, MS; Frierdich, S; Krailo, MD; Liu-Mares, W; Miser, JS; Reaman, GH; Sato, JK; Shen, V | 1 |
| Ames, MM; Bergeron, S; Blazar, BR; Bracho, F; Cairo, MS; Davenport, V; Krailo, MD; Liu-Mares, W; Panoskaltsis-Mortari, A; Reaman, GH; Reid, JM; Secola, R; Shen, V; van de Ven, C | 1 |
| Hashiguchi, Y; Inoue, T; Kobayashi, Y; Maed, K; Tsuda, H; Umesaki, N; Yamamoto, K | 1 |
| Bonomi, P; Shirazi, W | 1 |
| Belani, CP; Calvo, AR | 1 |
| Chastagner, P; Couanet, D; Doz, F; Edan, C; Frappaz, D; Gambarelli, D; Gentet, JC; Grill, J; Habrand, JL; Kalifa, C; Le Deley, MC; Pierre-Kahn, A; Raquin, MA | 1 |
| Merriman, KW; Pisters, KM; Putnam, JB; Roth, JA; Siegenthaler, MP; Smythe, WR; Swisher, SG; Vaporciyan, AA; Walsh, GL | 1 |
| Acimovic, L; Aleksandrovic, J; Dagovic, A; Jeremic, B; Milicic, B; Milisavljevic, S; Nikolic, N; Radosavljevic-Asic, G; Shibamoto, Y | 1 |
| Beck, JD; Greil, J; Hertzberg, H; Kremens, B; Velten, I | 1 |
| Doolittle, ND; Jones, G; Lacy, C; Neuwelt, EA; Nickolson, HS; Osztie, E; Várallyay, P | 1 |
| Ancín, I; Berlanga, JJ; Ferrá, C; Gallardo, D; González, JR; Grañena, A; Marín, D; Muñoz, J; Peris, J; Sarrá, J | 1 |
| Asterling, S; LeVay, JH; McLaren, B; Murray, P; Oliver, RT; Ong, J; Shamash, J | 1 |
| Acimovic, L; Jeremic, B; Milicic, B; Nikolic, N; Shibamoto, Y | 1 |
| Araki, K; Fukuda, H; Hanada, S; Hotta, T; Ikeda, S; Kawano, F; Kozuru, M; Niimi, M; Sano, M; Shimoyama, M; Takatsuki, K; Tara, M; Tobinai, K; Tomonaga, M; Utsunomiya, A; Yamada, Y | 1 |
| Ratain, MJ; Sawyer, M | 1 |
| Adams, PT; Ayash, LJ; Braun, T; Broun, ER; Clarke, M; Ferrara, J; Ratanatharathorn, V; Reynolds, C; Silver, SM; Uberti, J | 1 |
| Ferrandina, G; Greggi, S; Leone, G; Mancuso, S; Menichella, G; Pierelli, L; Salerno, MG; Scambia, G | 1 |
| Fukui, M; Ikezaki, K; Inamura, T; Inoha, S; Nakamizo, A; Uesaka, T; Yoshimoto, K | 1 |
| Berthold, F; Fichtner, I; Fulda, S; Hero, B | 1 |
| Cole, M; Ellershaw, C; Lewis, IJ; Pearson, AD; Pinkerton, CR; Tweddle, DA | 1 |
| Baranzelli, MC; Chastagner, P; Coze, C; Frappaz, D; Hartmann, O; Michon, J; Peyroulet, MC; Plantaz, D; Rubie, H | 1 |
| Jacobson, EL; Katschinski, DM; Robins, HI; Wiedemann, GJ | 1 |
| Burris, HA; Greco, FA; Hainsworth, JD | 1 |
| Fukuoka, M; Hirashima, T; Kobayashi, M; Masuda, N; Matsui, K; Nitta, T; Takada, Y; Yana, T | 1 |
| Chen, P; Gomer, CJ; Keshelava, N; Luna, MC; Reynolds, CP; Triche, TJ; Waidyaratne, SN; Zuo, JJ | 1 |
| Steele, JP | 1 |
| Ainslie, J; Hamilton, C; Harvey, J; Keller, J; Macintosh, J; Poulsen, M; Rischin, D; Tripcony, L; Walpole, E | 1 |
| Alfieri, E; Cirillo, S; D'Amore, R; Fiorillo, A; Greco, N; Maggi, G; Marano, I; Martone, A; Migliorati, R | 1 |
| Breton, JL; Coëtmeur, D; Daniel, C; Debieuvre, D; Jacoulet, P; Kessler, R; Lemarié, E; Milleron, B; Moreau, L; Paillot, N; Quoix, E | 1 |
| Iwahashi, K; Kitaoka, Y; Sakurai, N; Shiraishi, S; Tanaka, Y | 1 |
| Hudes, GR; Obasaju, C | 1 |
| Carvalho, C; Meadows, AT; Shields, CL; Shields, JA; Smith, AF | 1 |
| Baruchel, S; Fouladi, M; Gammon, J; Grant, R; Greenberg, ML; Klein, J; Koren, G; Stempak, D | 1 |
| Grimm, J; Jaehde, U; Kingreen, D; Kloft, C; Reif, S; Schunack, W; Siegert, W | 1 |
| Baiardi, P; Cuomo, AM; Preti, P; Robustelli della Cuna, FS; Robustelli della Cuna, G; Torazzo, R | 1 |
| Abonour, R; Cornetta, K; Gharpure, VS; Hanna, N; Loehrer, PJ | 1 |
| Droz, JP; Fléchon, A | 1 |
| Le Chevalier, T; Novello, S | 1 |
| Bello, L; Bikfalvi, A; Black, PM; Carrabba, G; Carroll, RS; Cerutti, F; Giussani, C; Landré, J; Lucini, V; Pluderi, M; Scaglione, F; Tomei, G; Villani, R | 1 |
| Hosomi, Y; Shibuya, M | 1 |
| Fujita, S; Hasegawa, T; Ikeda, A; Kaneshiro, E; Katakami, N; Nishimura, T; Nishio, C; Okazaki, M; Umeda, B | 1 |
| Nishimura, S; Sato, T; Ueda, H; Ueda, K | 1 |
| Briassoulis, E; Fountzilas, G; Kalofonos, HP; Kardamakis, D; Kosmidis, P; Kouvatseas, G; Panoussaki, E; Pavlidis, N; Samantas, E; Skarlos, DV; Tsavdaridis, D; Tsekeris, P; Tsiakopoulos, E; Tzitzikas, J; Zamboglou, N | 1 |
| Kobayashi, K; Matano, S; Minouchi, K; Ohta, H; Sanada, T; Sugimoto, T | 1 |
| Bertè, R; Cavanna, L; Civardi, G; Lazzaro, A; Moroni, CF; Vallisa, D | 1 |
| du Bois, A | 1 |
| Cook, AM; Dzik-Jurasz, AS; Huddart, RA; Norman, A; Padhani, AR | 1 |
| Boccieri, MG; Bruschi, G; Lo Re, G; Saracchini, S; Toffoli, G; Tumolo, S | 1 |
| Abraham, D; Abri, H; Aharinejad, S; Fink, M; Höltl, E; Höltl, W; Macfelda, K; Miksovsky, A; Nedwed, S; Schlag, MG | 1 |
| Bombaron, P; Dussopt, C; Fournel, P; Larive, S; Lecaer, H; Lena, H; Perol, M; Philip-Joet, F; Riou, R; Souquet, PJ; Touraine, F | 1 |
| Murray, N | 1 |
| Arai, T; Fujimura, H; Hayashi, S; Kimura, H; Morishita, H; Naba, I; Nakamori, M; Nakatsuji, Y; Osaki, T; Sugai, F; Suzuki, M; Tachibana, I | 1 |
| Fischer, L; Foss, HD; Koch, HC; Korfel, A; Thiel, E | 1 |
| Akiba, M; Bessho, M; Hirashima, K; Itoh, K; Itoh, Y; Kashimura, T; Kawai, N; Kishimoto, K; Matsuda, A; Murohashi, I; Sakata, T; Suzuki, T; Takahashi, T; Tominaga, K; Wakao, D; Yagasaki, F; Yoshida, K | 1 |
| De Giorgi, U; Marangolo, M; Papiani, G; Rosti, G | 1 |
| Coen, PG; Gombos, DS; Hungerford, JL; Kelly, A; Kingston, JE | 1 |
| de Wit, R; Hilkens, PH; van den Bent, MJ; van der Burg, ME; van Putten, WL | 1 |
| Feng, J; Pang, L; Wang, X | 1 |
| Thigpen, T | 1 |
| Bookman, MA | 2 |
| Nakahara, I; Nishikawa, M; Sugimoto, K | 1 |
| Mineta, H; Miura, K; Tsutsui, Y; Yokota, N | 1 |
| Hayashi, Y; Iinuma, K; Imaizumi, M; Ito, E; Kikuta, A; Konno, T; Ohi, R; Shimizu, T; Takano, T; Tsuchiya, S; Watanabe, A | 1 |
| Arush, MW; Beck, D; Ben-Izhak, O; Postovsky, S | 1 |
| Castellino, SM; DeVoe, M; Kalwinsky, D; Powers, R | 1 |
| Bartelink, I; Boddy, AV; Calvert, AH; Cole, M; Elliott, S; Highley, M; Newell, DR; Nobbs, JR; Porter, DJ; Thomas, HD | 1 |
| Newton, HB; Santi, M; Stevens, C | 1 |
| Aiba, K; Akaza, H; Blackledge, G; Boku, N; Ikeda, T; Isonishi, S; Kato, M; Kawai, K; Mikami, O; Ohashi, Y; Saeki, T; Saijo, N; Sone, S; Stribling, D; Tsukagoshi, S; Tsuruo, T | 1 |
| Martín, M | 1 |
| Fushimi, H; Nakajima, S; Obana, T; Okuda, K; Takenaka, M; Tanio, Y; Tsubakihara, Y; Watanabe, D; Yanagita, M | 1 |
| Boletis, J; Chiras, T; Kosmas, C; Kostakis, A; Tsavaris, NB; Vadiaka, M | 1 |
| Hisada, T; Ito, T; Masuda, S; Mochida, A; Morinari, H; Nakahara, K; Nishi, K; Saito, K; Sasaki, S; Tahara, M; Yakumaru, K | 1 |
| Demirci, H; Honavar, SG; Meadows, AT; Naduvilath, TJ; Shields, CL; Shields, JA | 2 |
| Bielawski, K; Falkiewicz, B; Granetzny, A; Klinke, F; Vogt, U; Zaczek, A | 1 |
| Balmer, A; Munier, F; Zografos, L | 1 |
| Baujan, MA; Bourekas, EC; Chakeres, DW; Christoforidis, GA; Newton, HB; Slivka, MA; Stevens, CL | 1 |
| Braun, T; Ferrara, JL; Hubers, D; Hutchinson, RJ; Levine, JE; Matthay, KK; Shapiro, B; Shulkin, BL; Sisson, JC; Spalding, S; Yanik, GA | 1 |
| Aglietta, M; Bacci, G; Biasin, E; Brach del Prever, A; Fagioli, F; Ferrari, S; Madon, E; Palmero, A; Picci, P; Tienghi, A; Vassallo, E | 1 |
| Cooke-Yarborough, C; Martin, HC; Onikul, E; Sharathkumar, A; Shaw, PJ | 1 |
| Brichard, B; Cornu, G; De Bruycker, JJ; De Potter, P; Neven, B; Vermylen, C | 1 |
| Berg, S; Bernstein, M; Blaney, SM; Cherrick, I; Kuttesch, N; Murry, DJ; Salama, V | 1 |
| Creamer, K; Flores, Y; Roberts, S; Robie, D; Shoupe, B | 1 |
| Demirci, H; Friedman, DL; Honavar, SG; Meadows, AT; Naduvilath, TJ; Shields, CL; Shields, JA; Singh, A | 1 |
| Abu-Ghosh, AM; Cairo, MS; Davenport, V; Goldman, SC; Krailo, MD; Laver, JH; Morris, E; Reaman, GH; Slack, RS | 1 |
| Broxson, EH; Dole, MG; Dunkel, IJ; Filippa, DA; George, D; Heath, JA; Lyden, D | 1 |
| Aebi, S; Betticher, DC; Calderoni, A; Solenthaler, M; von Briel, C | 1 |
| Kato, H; Komatsu, K; Koshida, K; Kou, E; Mizokami, A; Morishita, H; Namiki, M; Seto, C; Shiobara, S; Uchibayashi, T | 1 |
| Aoe, K; Eguchi, K; Harita, S; Hiraki, S; Hiraki, Y; Hiyama, J; Kamei, H; Kawahara, S; Kiura, K; Kobayashi, M; Sato, T; Shibayama, T; Tabata, M; Tada, A; Takemoto, M; Tanimoto, M; Ueoka, H; Yamane, H | 1 |
| Moskowitz, C | 1 |
| Hagemeister, FB | 1 |
| Kawasaki, T; Morii, K; Okazaki, H; Tamura, T; Tanaka, R | 1 |
| Beyer, J; Jaehde, U; Kloft, C; Siegert, W | 1 |
| Watanabe, H | 1 |
| Antoniolli, SZ; Bassetto, MA; Beltrami, P; Curti, P; Maffei, N; Porcaro, AB | 1 |
| Berger, MS; Boyett, JM; Bruggers, CS; Bruner, JM; Chan, KW; Dusenbery, KE; Ettinger, LJ; Fitz, CR; Holmes, E; Jennings, MT; Lafond, D; Mandelbaum, DE; Massey, V; McGuire, W; McNeely, L; Moulton, T; Pollack, IF; Shen, V; Sposto, R; Vezina, LG | 1 |
| Bowman, LC; Douglass, EC; Finegold, MJ; Katzenstein, HM; London, WB; Plaschkes, J; Reynolds, M | 1 |
| Iwamoto, Y; Matsuda, S; Matsunobu, T; Sakamoto, A; Tanaka, K | 1 |
| Berghmans, T; Efremidis, A; Klastersky, J; Lafitte, JJ; Lecomte, J; Mommen, P; Ninane, V; Paesmans, M; Sculier, JP; Thiriaux, J; Van Cutsem, O | 1 |
| Bunin, N; Stern, JW | 1 |
| Kellie, SJ; Lockwood, L; Mauger, DC; Pozza, LD; Waters, KD; White, L; Wong, CK | 1 |
| Matsui, H; Nagai, Y; Seki, K; Sekiya, S; Suzuka, K; Tanaka, N | 1 |
| Fukuno, K; Goto, H; Hara, T; Kanemura, N; Kasahara, S; Moriwaki, H; Oyama, M; Sawada, M; Shimizu, M; Takami, T; Tsurumi, H; Yamada, T; Yoshikawa, T | 1 |
| Asai, M; Iwahori, K; Komuta, K; Kouga, K; Minami, S; Nishiyama, A | 1 |
| Bassetti, C; Lövblad, KO; Russmann, S; Stanga, Z; Winkler, A | 1 |
| Cosaert, J; Quoix, E | 1 |
| Berdel, WE; Dölken, G; Kienast, J; Klinke, F; Macha, H; Mohr, M; Oelmann, E; Schmidt, EW; Serve, H; Thomas, M; Zühlsdorf, M | 1 |
| Arpaci, F; Caglar, K; Kinalp, C; Komurcu, S; Ozet, A; Ozturk, B; Saglam, K; Turan, M; Vural, A; Yavuz, I; Yenicesu, M | 1 |
| Kusanagi, H; Takahashi, H; Teramoto, A; Yamaguchi, F; Yoshida, D | 1 |
| Chaudhry, A; Forsyth, P; Russell, J; Stewart, DA; Zia, MI | 1 |
| Krüger, I; Lindenfelser, R; Scherwitz, P | 1 |
| Berger, C; Bernard, JL; Coze, C; Frappaz, D; Michon, J; Perol, D; Philip, T; Zucker, JM | 1 |
| Hagiwara, N; Makino, H; Maruyama, H; Miyashita, M; Nagasawa, S; Nomura, T; Onda, M; Sasajima, K; Tajiri, T; Takubo, K; Tsuchiya, Y; Yamashita, K | 1 |
| Gerinière, L; Souquet, PJ | 1 |
| Chen, XB; Li, DX | 1 |
| Buglova, SE; Ismail-zade, RS; Potapnev, MP; Rud'ko, VS; Sachivko, NV; Semenov, AS; Shman, TV; Zhavrid, EA | 1 |
| Berardi, R; Cappelletti, C; Cellerino, R; Latini, L; Lippe, P; Massacesi, C; Mattioli, R | 1 |
| Harada, H; Iwasaki, Y; Nagata, K; Nakagawa, M; Ohsugi, S; Takemura, Y | 1 |
| Finckenstein, FG; Graf, N; Gruhn, B; Hasan, C; Hero, B; Klingebiel, T; Koscielniak, E; Kremens, B; Laws, HJ; Niemeyer, C; Schulz, A; Selle, B; Wawer, A; Zintl, F | 1 |
| Fujiyama, Y; Kanaya, H; Kim, P; Watanabe, K | 1 |
| Hagiwara, S; Iyama, S; Kato, J; Kobayashi, D; Kogawa, K; Kuribayashi, K; Matsunaga, T; Niitsu, Y; Oku, T; Sato, T; Sato, Y; Takada, K; Takahashi, M; Takahashi, S; Terui, T | 1 |
| Bornfeld, N; Havers, W; Heimann, H; Jurklies, C; Schueler, AO; Wieland, R | 1 |
| Bajorin, DF; Ryan, CJ | 1 |
| Gatzemeier, U; Grunwald, F; Hessler, S; Jagos, U; Kaukel, E; Koschel, G; Reck, M; von Pawel, J | 1 |
| Antón, LM; Constenla, M; Domínguez, S; Dorta, J; Esteban, E; García-Girón, C; Gómez Aldavarí, JL; Gonzalez-Barón, M; Gracia, M; Lacave, AJ; López, E; López, R; Martín, G; Mel, JR; Peláez, I; Rodríguez, R; Sevilla, I; Valladares, M; Vieitez, JM | 1 |
| Smit, EF | 1 |
| Mornex, F | 1 |
| Brunetto, AL; de Almeida, SG; de Castro, CG; Gregianin, LJ; Loss, JF; Rivero, LF; Schwartsmann, G | 1 |
| Baker, J; Hand, S; Macbeth, FR; Smith, AP | 1 |
| Catalano, GP; Curigliano, G; De Braud, F; De Pas, T; Leo, F; Pastorino, U; Solli, PG; Spaggiari, L; Veronesi, G | 1 |
| Liu, J; Tang, WJ; Yu, RC | 1 |
| Baujan, MA; Bourekas, EC; Chakeres, DW; Christoforidis, GA; Newton, HB; Slivka, MA; Slone, W; Volpi, C | 1 |
| Behar, C; Bellaton, E; Bertozzi, AI; Brisse, H; Chastagner, P; Desjardins, L; Doz, F; Sainte-Rose, C | 1 |
| Bakhshandeh, A; Bruns, I; Dalhoff, K; Demedts, A; Eberhardt, K; Ehlers, EM; Gatzemeier, U; Gruber, Y; Hegewisch-Becker, S; Kaukel, E; Kohlmann, T; Koschel, G; Peters, SO; Robins, HI; Traynor, A; Wiedemann, GJ; Zumschlinge, R | 1 |
| Aass, N; Christian, JA; Dearnaley, DP; Fossa, S; Horwich, A; Huddart, RA; Mason, M; Nicholl, EJ; Norman, A | 1 |
| Beitler, JJ | 1 |
| Ohtsuka, M; Satoh, H; Sekizawa, K | 1 |
| Aleksandrovic, J; Dagovic, A; Jeremic, B; Milicic, B; Nikolic, N | 1 |
| Hamlin, PA; Kewalramani, T; Moskowitz, CH; Nimer, SD; Noy, A; Portlock, CS; Qin, J; Satagopan, JM; Straus, DJ; Verbel, D; Yahalom, J; Zelenetz, AD | 1 |
| Bailey, CC; Ellison, D; Gilbertson, R; Imeson, J; Ironside, J; Lashford, LS; Lucraft, H; Pizer, BL; Robinson, K; Tait, DM; Taylor, RE; Walker, DA; Weston, CL | 1 |
| al Rabi, N; Artibani, W; Dalpiaz, O; Ficarra, V; Galfano, A; Martignoni, G | 1 |
| Huls, G; ten Bokkel Huinink, D | 1 |
| Hamlin, P; Kewalramani, T; Moskowitz, CH; Nimer, S; Yahalom, J; Zelenetz, AD | 1 |
| Benson, W; Bradstock, KF; Crombie, C; Gottlieb, D; Hertzberg, MS; Taper, J | 2 |
| Sneller, V; Vose, J | 1 |
| Bailey, H; Bakhshandeh, A; Finet, J; Gillis, W; Jager, D; Jager, E; Katschinski, DM; Knuth, A; Longo, W; Neumann, A; Peters, SO; Robins, HI; Tiggelaar, CL; Van Dijk, JD; Vörde Sive Vörding, PZ; Westermann, AM; Wiedemann, GJ | 1 |
| Johnson, RS; Katschinski, DM; Mohamed, HG; Nadrowitz, R; Ressel, A; Richter, E; Unruh, A; Wenger, RH | 1 |
| Doolittle, ND; Kraemer, DF; Lacy, C; Neutwelt, EA; Siegal, T; Tyson, RM | 1 |
| Horiguchi, H; Kageji, T; Kuroda, Y; Nagahiro, S; Okamoto, Y; Suzuya, H; Watanabe, T | 1 |
| Snee, MP | 1 |
| Amdur, RJ; Hinerman, RW; Mendenhall, WM; Monroe, AT; Morris, CG | 1 |
| Fujita, T; Honoki, H; Inomata, M; Kashii, T; Kawagishi, Y; Kobayashi, M; Maruyama, M; Matsui, S; Miwa, T; Oda, H | 1 |
| Benz, MS; Cicciarelli, N; Escalona-Benz, E; Feuer, W; Hayden, BC; Markoe, A; Murray, TG; Sussman, DA; Toledano, S | 1 |
| Bentley, S; Brecher, ME; Bruner, R; Capel, E; Dent, G; Gabriel, DA; Moore, DT; Sailer, S; Serody, JS; Shea, TC; Wiley, JM | 1 |
| Chay, CH; Dunn, RL; Esper, P; Fardig, J; Olson, K; Pienta, KJ; Smith, DC | 1 |
| Ahn, HS; Choi, HS; Khwarg, SI; Kim, JH; Shin, HY; Yu, YS | 1 |
| Bergeron, C; Chastagner, P; Hartmann, O; Mechinaud, F; Michon, J; Rubie, H; Schleiermacher, G | 1 |
| Johnson, DH; Laskin, J; Sandler, A | 1 |
| Bonnet, R; Deppermann, KM; Gatzemeier, U; Hessler, S; Kaukel, E; Macha, HN; Reck, M; Ulm, K; von Pawel, J | 2 |
| Demirci, H; Eagle, RC; Shields, CL; Shields, JA | 1 |
| Aass, N; Alfsen, GC; Fossa, SD; Lien, HH; Oldenburg, J; Waehre, H | 1 |
| Aquino-Parsons, C; Hoskins, PJ; Lee, N; Lim, P; Pike, JA; Swenerton, KD; Wong, F | 1 |
| Bar-Sela, G; Gaitini, D; Haim, N; Steiner, M; Tsalic, M | 1 |
| Alfaro, PA; Goto, H; Kohn, DB; Pepper, KA; Petersen, D; Reynolds, CP; Yang, B | 1 |
| Bavieri, M; Cavazza, A; Crinò, L; Facciolongo, N; Longo, L; Marchioni, A; Migaldi, M; Petruzzelli, S; Rossi, G; Tamberi, S | 1 |
| Greco, FA | 1 |
| Eckardt, J; Green, M; Thatcher, N | 1 |
| Kaur, H; Peereboom, DM; Singh, D | 1 |
| Brega-Massone, PP; Cataldo, I; Conti, B; Ferro, F; Lequaglie, C | 1 |
| Cater, J; Meadows, AT; Shelil, A; Shields, CL; Shields, JA | 1 |
| Cerecedo-Díaz, F; Delgado-Huerta, S; Hernández-Contreras, I; López-Aguilar, E; Ramón-García, G; Rivera-Márquez, H; Rodríguez-Jiménez, H; Romo-Rubio, HA; Santacruz-Castillo, E; Sepúlveda-Vildósola, AC; Valdés-Sánchez, M; Wanzke-del Angel, V | 1 |
| Clarke, E; Glaser, AW; Picton, SV | 1 |
| Ekinci, C; Günalp, I; Gündüz, K; Taçyildiz, N; Unal, E; Yavuz, G | 1 |
| Anagnostopoulos, I; Hummel, MW; Jonas, S; Oertel, SH; Papp-Váry, M; Riess, HB | 1 |
| Ainslie, J; Hamilton, C; Harvey, J; Keller, J; Mackintosh, J; Poulsen, M; Rischin, D; Tripcony, L; Walpole, E | 1 |
| Frank, R; Kelly, WK; Reuter, V; Scher, HI; Schwartz, L; Steineck, G | 1 |
| Hoshino, H; Saitoh, K; Seki, H; Sodemoto, T; Takada, T; Uekusa, T | 1 |
| Gomi, K; Inoue, A; Kikuchi, T; Maemondo, M; Miki, M; Nukiwa, T; Saijo, Y; Sato, T; Suzuki, T | 1 |
| Arima, N; Arimura, K; Hamada, H; Kukita, T; Matsushita, K; Tei, C | 1 |
| Chansky, K; Crowley, J; Edelman, MJ; Gandara, DR; Gaspar, LE; Leigh, B; Livingston, R; Taylor, SA; Weiss, GR | 1 |
| Hammerschmidt, S; Pohlink, C; Rother, T; Wirtz, H | 1 |
| Farmakis, D; Kostopoulou, V; Koumpou, M; Mylonakis, N; Nikolaou, M; Pectasides, D; Pectasides, M | 1 |
| Filippa, DA; Gencarelli, A; Kewalramani, T; Moskowitz, CH; Nimer, SD; Noy, A; O'Connor, O; Portlock, C; Qin, J; Straus, D; Teruya-Feldstein, J; Waxman, A; Yahalom, J; Zelenetz, AD | 1 |
| Fujisawa, M; Ishikawa, T; Kamidono, S | 1 |
| Amato, RJ; Ayala, AG; Ro, JY; Swanson, DA | 1 |
| Brunetto, AL; Leone, LD; Loss, JF; Santos, PP | 1 |
| Casak, S; Chantada, G; Dávila, MT; Fandiño, A; Manzitti, J; Raslawski, E; Schvartzman, E | 1 |
| Kitawaki, T; Nishikori, M; Ohno, H; Uchiyama, T; Ueda, C | 1 |
| Ali, K; Fung, MF; Hopkins, L; Le, T; Leis, A; Pahwa, P; Reeder, B; Wright, K | 1 |
| Ishizuka, O; Mizuno, H; Mizusawa, H; Nishizawa, O; Satoh, T; Seki, S | 1 |
| Bailey, CC; Ellison, D; Gilbertson, R; Ironside, J; Lashford, LS; Lucraft, H; Pizer, BL; Robinson, KJ; Saran, F; Tait, DM; Taylor, RE; Walker, DA; Weston, CL | 1 |
| Aboulafia, DM; Waddington, TW | 1 |
| Barceló, R; Ferreiro, J; Fuente, N; López Vivanco, G; Muñoz, A; Rubio, I | 1 |
| Berdel, WE; Braunheim, M; Heinecke, A; Hoffknecht, P; Klinke, F; Macha, HN; Riesenbeck, D; Schmidt, EW; Schumacher, A; Semik, M; Thomas, M; Wewers, D; Willich, N | 1 |
| Burholt, DR; Donovan, M; George, LD; Kornblith, PL; Marsh, JW | 1 |
| Buffardi, F; D'Amico, A; De Caro, MD; Fiorillo, A; Greco, N; Maggi, G; Migliorati, R; Sabbatino, MS | 1 |
| Edelman, MJ; Hoffman, PC; Karnauskas, R; Kozloff, M; Rudin, CM; Szeto, L; Tomek, R; Vokes, EE | 1 |
| Dubs, A; Honegger, H; Jacky, E; Stahel, R; Taverna, C | 1 |
| Driver, D; Giles, C; Harland, SJ; Haynes, R; Kanfer, EJ; McNeish, IA; Newlands, ES; Rustin, GJ; Seckl, MJ | 1 |
| Gisselbrecht, C; Mounier, N | 1 |
| Bakhshandeh, A; Bruns, I; Kohlmann, T; Wiedemann, GJ | 1 |
| Fujioka, T; Ishida, Y; Konda, R; Matsushita, Y; Murai, K; Obara, W; Ohmori, S; Sugimura, J; Tanji, S; Tokunaga, H | 1 |
| Fukuhara, S; Ishii, K; Nomura, S; Yamamoto, Y | 1 |
| Ikeba, K; Kinoshita, K; Maeda, H; Okubo, M; Takeda, S | 1 |
| Karlsson, J; Påhlman, S; Pörn-Ares, I; Øra, I | 1 |
| Demirci, H; Mashayekhi, A; Meadows, AT; Shields, CL; Shields, JA | 1 |
| Cardarelli, N; Carle, F; Cellerino, R; Cetto, GL; Contu, A; D'Aprile, M; Fedeli, SL; Fiorentini, G; Gesuita, R; Giorgi, F; Montironi, R; Nortilli, R; Parziale, AP; Piga, A | 1 |
| Abker, S; Bosse, U; Junker, K; Klinke, F; Müller, KM; Thomas, M | 1 |
| Qiao, TK; Shu, L; Wu, W; Xin, L; Zhou, DA | 1 |
| Abonour, R; Einhorn, LH; Houck, W; Vance, G | 1 |
| Castellano, A; Cozza, R; De Laurentis, C; De Sio, L; Deb, G; Dominici, C; Donfrancesco, A; Fidani, P; Ilari, I; Inserra, A; Jenkner, A; Milano, GM | 1 |
| Fisher, C; Hemmings, C | 1 |
| Jackson, AS; Plowman, PN | 1 |
| Cook, A; Izawa, JI; Mack, DP; Moussa, M | 1 |
| Campbell, AD; Cohn, SL; Duerst, R; Geissler, G; Haut, PR; Kalapurakal, J; Kletzel, M; Marymount, M; Morgan, E; Rademaker, A; Reynolds, M; Seshadri, R | 1 |
| Bokemeyer, C; Clemm, C; Gerl, A; Hartmann, JT; Horwich, A; Kanz, L; Kollmannsberger, C; Meisner, C; Oliver, T; Rückerl, CP; Schmoll, HJ; Stenning, S | 1 |
| Holte, H; Jerkeman, M; Kvaløy, S; Leppä, S | 1 |
| Aleksandrovic, J; Dagovic, A; Jeremic, B; Milicic, B; Milisavljevic, S | 2 |
| Bartolini, S; Cavallo, G; Conforti, R; Crinò, L; Esposti, RD; Franceschi, E; Magrini, E; Paioli, A; Palmerini, E; Pession, A; Rimondini, S; Scopece, L | 1 |
| Cappelli, C; Foco, M; Mizzoni, F; Noto, C; Toscano, D; Trasimeni, G; Valentini, D | 1 |
| deVere White, RW; Ellison, LM; Gandour-Edwards, R; Goldberg, Z; Karpman, E; Saffarian, A | 1 |
| Cater, J; Mashayekhi, A; Meadows, AT; Shelil, A; Shields, CL; Shields, JA | 2 |
| Harbour, JW | 1 |
| Abdel-Rahman, S; Fahn, W; Fiegl, M; Issels, RD; Schlemmer, M; Wendtner, CM | 1 |
| Chuman, H | 1 |
| Doyle, A; Edelman, MJ; Gamliel, Z; Hausner, P; Krasna, M; Patel, AB; Sonett, JR; Suntharalingam, M | 1 |
| Erden, E; Geyik, PO; Günalp, I; Gündüz, K; Taçyildiz, N; Unal, E; Yalçindağ, N | 1 |
| Beaudoin, A; De Gramont, A; El Mesbahi, O; Louvet, C | 1 |
| Akansel, G; Arisoy, AE; Calişkan, M; Corapcioglu, F; Dillioğlugil, O; Sarper, N | 1 |
| Amano, H; Ishigatsubo, Y; Kakemizu, N; Kaneko, T; Kobayashi, M; Komatsu, S; Matsuse, T; Mishima, W; Miura, K; Miyashita, A; Nishihira, R; Nishiyama, H; Noda, K; Saito, H; Satoh, T; Shinohara, T; Tsukiji, J; Yamakawa, Y | 1 |
| Anderson, B; Angiolillo, A; Cairo, MS; Cheung, YK; Davenport, V; Krailo, M; Reaman, G; Van Winkle, P | 1 |
| Sadahira, Y; Suemori, S; Sugihara, T; Tsujioka, T; Wada, H | 1 |
| Casak, SJ; Chantada, GL; de Dávila, MT; Fandiño, AC; Manzitti, J; Raslawski, EC; Schvartzman, E; Scopinaro, MJ | 1 |
| Burris, HA; Erland, JB; Greco, FA; Hainsworth, JD; Hermann, R; Litchy, S; Morrissey, LH; Rodriguez, GI; Shaffer, DW; Yardley, DA | 1 |
| Herzog, TJ | 1 |
| Ishida, Y; Udagawa, I; Watanabe, S | 1 |
| Sugiura, H; Suzuki, Y; Takahashi, M; Yamada, K | 1 |
| Adachi, M; Horichi, N; Ichikawa, I; Imai, T; Kashiwabara, Y; Kiuchi, Y; Kogo, M; Koichi, K; Murayama, J; Saito, Y | 1 |
| Aghajanian, C; Armstrong, DK; Burnett, AF; Kauderer, J; Lentz, SS; Williams, SD | 1 |
| Dörken, B; Hildebrandt, B; Lippek, F; Mapara, MY; Oertel, S; Plotkin, M; Riess, H; Royer-Pokora, B; Schumacher, V; Trappe, RU; Zuber, J | 1 |
| Berg, SL; Bessmertny, O; Cairo, MS; Davenport, V; Goldman, SC; Kreissman, SG; Laver, J; Reaman, GH; Secola, R; Shen, V; van de Ven, C | 1 |
| Bonci, E; Castello, MA; Clerico, A; Hadjistilianou, T; Ragni, G; Schiavetti, A | 1 |
| Berta, M; Bertoni, F; del Prever, AB; Fagioli, F; Ferrari, S; Mercuri, M | 1 |
| Ballard, ET; Dickens, DS; Dothage, JA; Heideman, RL; Jubinsky, PT | 1 |
| Biron, P; Bui, B; Caty, A; Culine, S; Curé, H; De Revel, T; Delva, R; Droz, JP; Duclos, B; Fizazi, K; Gligorov, J; Gomez, F; Gravis, G; Guillemaut, S; Lotz, JP; Peny, J; Provent, S; Ségura, C; Théodore, C; Viens, P | 1 |
| Sugiyama, T | 1 |
| Bouvet, N; Ellershaw, C; Flamant, F; Habrand, JL; Marsden, HB; Martelli, H; Oberlin, O; Rey, A; Sanchez de Toledo, J; Spicer, RD; Spooner, D; Stevens, MC; Terrier-Lacombe, MJ; van Unnik, A | 1 |
| Nakayama, H; Takahashi, H; Teramoto, A; Yamada, S; Yamada, SM | 1 |
| Buchdunger, E; García-Echeverría, C; Hofmann, F; Krystal, GW; Litz, J; Warshamana-Greene, GS | 1 |
| Bode, U; Deinlein, F; Emser, A; Graf, N; Kortmann, RD; Kuehl, J; Ottensmeier, H; Pietsch, T; Rutkowski, S; Soerensen, N; Warmuth-Metz, M; Wolff, JE | 1 |
| Castine, M; Greco, FA; Hainsworth, JD; Kalman, L; Sylvester, L | 1 |
| Honna, T; Kawashima, N; Kitano, Y; Kuroda, T; Matsuda, H; Miyauchi, J; Morikawa, N; Nakano, M; Tanaka, K | 1 |
| Chaudhary, UB; Damon, LE; Linker, CA; Navarro, W; Rugo, HS; Small, EJ | 1 |
| Angiolillo, AL; Ayello, J; Bonilla, MA; Cairo, MS; Davenport, V; Krailo, M; Militano, O; Miller, LL; Reaman, G; van de Ven, C | 1 |
| Ariyoshi, Y; Fukuoka, M; Furuse, K; Hatae, M; Hirabayashi, K; Noda, K; Ogawa, M; Takaku, F; Yakushiji, M | 1 |
| Ansari, R; Belani, CP; Lee, JS; Lilenbaum, R; Natale, RB; Robert, F; Rowland, K; Socinski, MA; Waterhouse, D | 1 |
| Hakamada, A; Isoda, K; Mizutani, H; Nomura, E; Yamaguchi, M; Yamanaka, K | 1 |
| Ashcroft, LF; Lorigan, P; O'Brien, ME; Sampson, MR; Thatcher, N; Woll, PJ | 1 |
| Fantini, M; Fattori, PP; Fochessati, F; Genestreti, G; Imola, M; Ioli, G; Lazzari-Agli, L; Mianulli, AM; Papi, M; Pasquini, E; Poggi, B; Ravaioli, A; Sartori, S; Tamburini, E; Tassinari, D | 1 |
| Fukuhara, T; Imafuku, Y; Kimura, S; Kiya, K; Monzen, Y; Okimoto, T; Turudome, T; Yamatogi, S | 1 |
| Allen, K; Barth, NM; Beutel, LD; Chico, S; Dillman, RO; VanderMolen, LA | 1 |
| Kitahara, N; Sano, M; Toma, M | 1 |
| Biron, P; Bouzy, J; Droz, JP; Horwich, A; Koza, V; Kramar, A; Lelli, G; Linkesch, W; Marangolo, M; Pico, JL; Pizzocaro, G; Rosti, G; Salvioni, R; Schmoll, HJ; Siegert, W; Theodore, C; Wandt, H | 1 |
| Burnier, MN; Caissie, AL; Erwenne, CM; Fernandes, LH; Martins, MC; Souza Filho, JP; Torres, VL | 1 |
| Besse, B; Le Chevalier, T; Soria, JC | 1 |
| Katayama, Y; Watanabe, T; Yoshino, A | 1 |
| Cater, J; Mashayekhi, A; Meadows, AT; Ness, S; Shelil, A; Shields, CL; Shields, JA | 1 |
| Keefe, D; Myers, M; Olver, I | 1 |
| Agostini, V; Arcangeli, V; Fantini, M; Fattori, PP; Fochessati, F; Genestreti, G; Imola, M; Ioli, G; Mianulli, AM; Oliverio, G; Papi, M; Pasquini, E; Poggi, B; Ravaioli, A; Tamburini, E; Tassinari, D | 1 |
| Abelairas Gómez, JM; Calvo, JM; Olivier Pascual, N | 1 |
| Bauduceau, O; Ceccaldi, B; Fayolle, M; Le Moulec, S; Védrine, L | 1 |
| Adjei, AA; Creagan, ET; Croghan, G; Frytak, S; Giordano, KF; Jatoi, A; Jett, JR; Marks, R; Molina, J; Okuno, S; Richardson, RL | 1 |
| Chaku, J; Kellie, SJ; Lockwood, LR; O'Regan, P; Waters, KD; Wong, CK | 1 |
| Babin, A; Bours, D; Carrie, C; Chastagner, P; Doz, F; Edan, C; Frappaz, D; Gentet, JC; Kalifa, C; Le Gales, C; Mosseri, V; Neuenschwander, S; Oyharcabal-Bourden, V; Pagnier, A; Pichon, F; Ruchoux, M; Sariban, E; Vinchon, M | 1 |
| Hamilton, C; Harvey, J; Keller, J; Porter, I; Poulsen, MG; Rischin, D; Tripcony, L; Walpole, E | 1 |
| Forbes, TJ; Paules, M; Singh, HR; Zilberman, MV | 1 |
| Cardillo, F; Carle, F; Catalano, V; Cellerino, R; Cetto, G; Gesuita, R; Giorgi, F; Montironi, R; Nortilli, R; Piga, A; Porfiri, E; Riva, N | 1 |
| Dolezal, J; Dolezel, M; Moravek, P; Odrazka, K; Petera, J; Prosvic, P; Simakova, E; Vaculikova, M; Vosmik, M; Zoul, Z | 1 |
| Alberts, SR; Erlichman, C; Furth, A; Lathia, CD; Molina, JR; Reid, JM; Safgren, SL; Sloan, JA | 1 |
| Enschede, SH; Gregory, SA; Larson, ML | 1 |
| Bunn, P; Kelly, K; Magree, L; Rabinovitch, R; Sunpaweravong, P | 1 |
| Donahue, A; Faucette, S; Gillenwater, HH; Kirstein, MN; Lindley, C; McCune, JS; Moore, D; Shord, S; Socinski, MA; Stewart, CF; Zamboni, WC | 1 |
| Johnson, CS; Kreissman, SG; Pradhan, KR; Sender, LS; Vik, TA | 1 |
| Fujikawa, N; Hirai, K; Hirokawa, S; Kita, K; Kitami, K; Mikata, K; Sano, H; Ueki, T | 1 |
| Jordan, K; Kegel, T; Maher, G; Müller, L; Schmoll, HJ; Voigt, W | 1 |
| Kaneda, T; Narita, Y; Suzuki, A; Takahashi, N; Tsunematsu, K | 1 |
| Arimoto, T; Hara, H; Iwasaki, Y; Kubota, Y; Nagata, K; Nakanishi, M; Natuhara, A; Ueda, M | 1 |
| Dyer, MA; Egorin, M; Gray, JK; Laurie, NA; Leggas, M; Relling, M; Stewart, C; Zhang, J | 1 |
| Igawa, Y; Kinebuchi, Y; Nishizawa, O; Noguchi, W | 1 |
| Burris, HA; Corso, SW; Erland, JB; Greco, FA; Hainsworth, JD; Joseph, G; Morrissey, LH; Spigel, DR; Spremulli, E; Thompson, DS | 1 |
| Collette, L; de Mulder, PH; de Prijck, L; de Wit, R; Fosså, SD; Horwich, A; Kaiser, G; Koriakine, O; Paluchowska, B; van Oosterom, AT | 1 |
| Alvarnas, J; Chow, W; Doroshow, JH; Frankel, P; Kogut, N; Leong, LA; Lim, D; Margolin, KA; McNamara, M; Morgan, RJ; Schriber, J; Shibata, S; Somlo, G; Stalter, S; Twardowski, P; Yen, Y | 1 |
| Handa, M; Hirai, S; Ihaya, A; Imamura, Y; Kawabe, M; Morioka, K; Sasaki, K; Shinoda, T; Tanabe, S; Tanaka, K; Uesaka, T; Yamada, N | 1 |
| Endou, K; Kaira, K; Kamiyoshihara, M; Mori, M; Takise, A; Watanabe, R | 1 |
| Demirci, H; Meadows, AT; Shields, CL; Shields, JA | 1 |
| Materin, MA; Shields, CL; Shields, JA | 1 |
| Clark, PI; Girling, DJ; Hopwood, P; Owens, R; Qian, W; Sambrook, RJ; Stephens, RJ; Thatcher, N | 1 |
| Bagatell, R; Bowman, LC; Brodeur, GM; Castleberry, R; Cohn, SL; Frantz, C; Joshi, V; London, WB; Look, AT; Rao, PV; Rumcheva, P; Thorner, P | 1 |
| Bruns, PK; Daman, M; Doolittle, ND; Fortin, D; Hall, WA; Muldoon, L; Neuwelt, EA | 1 |
| Cheon, HC; Jung, S; Jung, TY; Kang, SS; Kim, IY; Kim, SH; Lee, MC; Moon, KS | 1 |
| Addeo, A; Barone, C; Berruti, A; Bertetto, O; Buffoni, L; Dongiovanni, D; Dongiovanni, V; Fissore, C; Grillo, R | 1 |
| Chan, EL; Collins, MH; Emery, KH; Gelfand, MJ; Gruppo, RA; Harris, RE | 1 |
| Burhenne, J; Foell, JL; Reiss, T; Rengelshausen, J; Staege, MS; Stiefel, M; Wawer, A | 1 |
| Casanova, M; Cefalo, G; Collini, P; Ferrari, A; Fossati-Bellani, F; Gandola, L; Giangaspero, F; Luksch, R; Massimino, M; Meazza, C; Pignoli, E; Podda, M; Poggi, G; Polastri, D; Ravagnani, F; Simonetti, F; Spreafico, F; Terenziani, M | 1 |
| Franc, B; Groshen, S; Horn, B; Maris, JM; Matthay, KK; Reynolds, CP; Seeger, RC; Tan, JC; Twomey, E; Veatch, J; Villablanca, JG; Yanik, GA | 1 |
| Cheung, IY; Cheung, NK; Kramer, K; Kushner, BH; Modak, S | 1 |
| Fischer von Weikersthal, L; Hortig, P; Keilholz, U; Martus, P; Reeb, M; Schmittel, A; Schulze, K; Sebastian, M; Thiel, E | 1 |
| De Giorgi, U; Rosti, G | 1 |
| Yamada, Y | 1 |
| Kamani, N; Lafond, D; Loechelt, B; MacDonald, TJ; Packer, RJ; Perez-Albuerne, E; Rood, B; Thorarinsdottir, HK | 1 |
| Hiramatsu, Y; Hongo, A; Kodama, J; Nakamura, K; Ojima, Y; Seki, N | 1 |
| Doi, S; Fukuda, M; Kasai, T; Kawabata, S; Kinoshita, A; Kohno, S; Nagashima, S; Oka, M; Soda, H; Soejima, Y; Takatani, H | 1 |
| Baas, P; Belderbos, JS; Burgers, JA; Kwa, HB; Senan, S; van Bochove, A; van Meerbeeck, JP; van Tinteren, H | 1 |
| Bourekas, EC; Figg, GM; Newton, HB; Slone, HW | 1 |
| Forrest, DL; Hogge, DE; Lavoie, JC; Nantel, SH; Nevil, TJ; Savoie, ML; Shepherd, JD; Smith, CA; Song, KW; Sutherland, HJ; Toze, CL | 1 |
| Al-Kgodary, T; Mabed, M | 1 |
| Boldrini, R; Cozza, R; De Ioris, M; De Sio, L; Dominici, C; Donfrancesco, A; Ilari, I; Inserra, A; Jenkner, A; Milano, GM | 1 |
| Akioka, T; Hanafusa, T; Hara, S; Kobayashi, K; Oka, S; Tsuji, M; Yokote, T | 1 |
| Amikura, T; Aoki, Y; Banzai, C; Nishikawa, N; Sekine, M; Suzuki, M; Tanaka, K; Yokoo, T | 1 |
| Eberhardt, W; Pöttgen, C; Stuschke, M | 1 |
| Couturier, J; de Cremoux, P; Delattre, O; Doz, F; Fehlbaum, P; Jourdan-Da-Silva, N; Klijanienko, J; Michon, J; Mosseri, V; Schleiermacher, G; Tran-Perennou, C; Vielh, P | 1 |
| Bisogno, G; Casale, F; Cecchetto, G; De Salvo, G; Di Martino, M; Di Tullio, MT; Donfrancesco, A; Donofrio, V; Ferrari, A; Indolfi, P; Martone, A | 1 |
| Cloughesy, TF; Lai, A; Mischel, P; Nghiemphu, P; Pope, WB | 1 |
| Berzioli, C; Cavallo, G; Conforti, R; Crinò, L; Esposti, RD; Franceschi, E; Paioli, A; Paioli, G; Palmerini, E; Scopece, L; Spagnolli, F | 1 |
| Gridelli, C; Maione, P; Rossi, A | 1 |
| Gisselbrecht, C; Hagberg, H | 1 |
| Chayama, K; Date, I; Ichikawa, T; Takao, S; Tamiya, T | 1 |
| Depierre, A | 1 |
| Dabbas, B; Ford, CD; Gabor, F; Morgan, R | 1 |
| Antoneli, CB; Chojniak, MM; Malogolowkin, M; Novaes, PE; Ribeiro, KC; Steinhorst, F | 1 |
| Daly, BD; Dipetrillo, TA; Fernando, HC; Kachnic, LA; Ketchedjian, A; Morelli, DM; Shemin, RJ | 1 |
| Abbey-Toby, A; Aparicio, T; Bouarioua, N; Chosidow, D; Karila Cohen, P; Mathieu, N; Soulé, JC; Stefanescu, C | 1 |
| Dearnaley, DP; Gilbert, DC; Horwich, A; Huddart, RA; Nicholl, J; Norman, AR | 1 |
| Brichard, B; Chantrain, C; De Potter, P; Gala, JL; Sibille, C; Vermylen, C | 1 |
| Brunetto, AL; Castro, CG; Cruz, LB; Rech, A; Ribeiro, AS; Rosa, LG | 1 |
| De Braud, F; Di Meglio, G; Fazio, N; Grana, C; Lorizzo, K; Pelosi, G; Torrisi, R; Tradati, N | 1 |
| Akutsu, M; Furukawa, Y; Izumi, T; Kano, Y; Kobayashi, H; Mano, H; Tsunoda, S | 1 |
| Asgharzadeh, S; Belasco, J; Chi, SN; Diez, B; Dubowy, R; Dunkel, I; Finlay, J; Gardner, S; Hukin, J; Ji, L; Kellie, S; Levy, A; Miller, DC; Rosenblum, M; Sposto, R; Termuhlen, A; Zacharoulis, S | 1 |
| Greco, FA; Hainsworth, JD; Litchy, S; Spigel, DR | 1 |
| Anan, M; Ishii, K; Katayama, S; Kobayashi, H; Nagatomi, H; Nakamura, T; Sainoo, M; Yamashita, M | 1 |
| Leahey, A; Manquez, ME; Meadows, AT; Shields, CL; Shields, JA; Sun, H | 1 |
| Berry, WS; Diller, LR; Guinan, EC; Kalish, LA; Lehmann, LE; McDaniel, S | 1 |
| Katakami, N | 1 |
| Mabed, M; Shamaa, S | 1 |
| Friere, J; Komarnicky, L; Mashayekhi, A; Shields, CL; Shields, JA; Sun, H; Uysal, Y | 1 |
| Alapetite, C; Bertozzi, AI; Bours, D; Bracard, S; Chastagner, P; Doz, F; Edan, C; Frappaz, D; Gentet, JC; Kalifa, C; Le Gales, C; Mosseri, V; Pagnier, A; Pichon, F; Rialland, X; Sariban, E; Tubiana, AL; Verlooy, J; Zerah, M | 1 |
| Chastagner, P; Doz, F; Dufour, C; Frappaz, D; Gentet, JC; Grill, J; Kalifa, C; Lellouch-Tubiana, A; Pichon, F; Plantaz, D; Puget, S; Raquin, MA | 1 |
| Fang, C; Song, MQ; Sun, Q; Wang, L; Zhu, JS; Zhu, L | 1 |
| Berdel, WE; Frickhofen, N; Haas, R; Heimpel, H; Hinke, A; Hossfeld, DK; Kreienberg, R; Kuhn, W; Möbus, V; Opri, F; Sandherr, M; Schneeweiss, A; Thomssen, C | 1 |
| Fangusaro, J; Finlay, J; Rook, J; Rosser, T | 1 |
| Au, AK; Czyz, C; Leahey, A; Mashayekhi, A; Meadows, AT; Shields, CL; Shields, JA | 1 |
| Fujisawa, M; Furukawa, J; Hara, I; Kumano, M; Miyake, H; Takenaka, A; Yamada, Y; Yamanaka, K | 1 |
| Boscherini, B; Ingrosso, A; Picone, S; Schiavetti, A | 1 |
| Allen, J; Atlas, MP; Dunkel, IJ; Fangusaro, JR; Finlay, JL; Gardner, S; Gonzalez-Gomez, I; Jubran, RF; Miller, D; Rosenblum, M | 1 |
| Belevtsev, MV; Ismail-zade, RS; Konoplia, NE; Potapnev, MP; Savitskiĭ, VP; Vashkevich, EP | 1 |
| Al Omari, A; Case, D; Miller, AA; Murry, DJ | 1 |
| Ashley, S; Banerji, U; Benepal, T; Coward, J; Eisen, T; Hughes, S; Norton, A; O'Brien, M; Zee, Y | 1 |
| Cicciarelli, N; Feuer, W; Murray, TG; Schefler, AC; Toledano, S | 1 |
| Chan, JK; Chow, SM; Ho, CM; Law, SC; Tang, DL; Tse, LL | 1 |
| Al-Asaad, TG; Al-Sulami, GA; Atra, AA; Elimam, NA; Fayea, NY; Felimban, SK; Khattab, TM | 1 |
| Chansky, K; Crowley, JJ; Davies, AM; Gandara, DR; Gaspar, LE; Lau, DH; Leigh, BR; Weiss, GR; Wozniak, AJ | 1 |
| Buslei, R; Doerfler, A; Fahlbusch, R; Hofmann, B; Kottler, U; Kreutzer, J; Nimsky, C; Radek, M; Seiz, M | 1 |
| Anderson, E; Andrews, C; Bjurstrom, T; Blackwell, S; Campagna, L; Crawford, J; Garst, J; Herndon, JE; Maravich-May, D; Padilla, K; Shafman, T | 1 |
| Kudriavtsev, DV; Mardynskiĭ, IuS; Zolotkov, AG | 1 |
| Datsenko, PV; Kharchenko, VP; Mel'nik, IuD; Panyshin, GA; Sotnikov, VM | 1 |
| Bacik, J; Bains, M; Bajorin, D; Bosl, GJ; Budnick, A; Deluca, J; Ishill, N; Kondagunta, GV; Mazumdar, M; Motzer, RJ; Reich, L; Sheinfeld, J | 1 |
| Akaza, H; Hara, I; Miki, T; Mizutani, Y; Naito, K; Nonomura, N; Ozono, S; Terachi, T; Tsukamoto, T; Yoshida, O | 1 |
| Kageji, T; Kanematsu, Y; Matsuzaki, K; Nagahiro, S; Nakatani, M; Okamoto, Y; Watanabe, T | 1 |
| Boudrias, M; Fortin, D; Garant, MP; Gendron, C | 1 |
| Hongo, T; Nishizawa, S; Ohzeki, T; Okada, S; Sakaguchi, K; Suzuki, K | 1 |
| Alagaratnam, J; Ariffin, H; George, TM; Ho, C; Ibrahim, H; Juraida, E; Khuzaiah, R; Menon, BS; Mohammad, M; Peng, LH | 1 |
| Ichioka, M; Ishiga, T; Saito, K; Tanigawa, M | 1 |
| Bacik, J; Bajorin, DF; Bosl, GJ; Einhorn, L; Lara, PN; Margolin, KA; Mazumdar, M; Motzer, RJ; Nichols, CJ; Richardson, PG; Vogelzang, NJ | 1 |
| Bieth, E; Brennetot, C; Hofman, P; Pedeutour, F; Rouzier, C; Soler, C | 1 |
| Al Harbi, T; Al-Faris, N; Doyle, J; Gassas, A; Goia, C; Pappo, A | 1 |
| Banerjee, S; Chiritescu, G; Dahrouge, S; Stewart, DJ; Tomiak, EM | 1 |
| Lambert, MP; Meadows, AT; Shields, C | 1 |
| Anderson, MG; Chen, J; Elmore, SW; Fesik, SW; Morgan-Lappe, SE; Ng, SC; Rosenberg, SH; Sarthy, AV; Tahir, SK; Tse, C; Warner, RB; Yang, X | 1 |
| Berishvili, G; Blum, WF; Figge, AM; Flyvbjerg, A; Frystyk, J; Klöppel, G; Lankisch, PG; Nauck, MA; Perren, A; Reinecke, M; Schmiegel, W; Zapf, J; Zwimpfer, C | 1 |
| Jeremić, B; Milićić, B | 1 |
| Kasai, S; Nishine, H; Otsuka, Y; Tokuda, H; Yoshikawa, M | 1 |
| Arceci, RJ; Chen, AR; Colombani, P; Higman, MA; Schwartz, CL; Wharam, M; Williams, KM | 1 |
| Abdel-Rahman, S; Baumert, J; Falk, M; Hentrich, M; Hiddemann, W; Issels, RD; Licht, T; Salat, C; Schlemmer, M; Straka, C; Wendtner, CM | 1 |
| Ono, A; Yamamoto, N | 1 |
| Ido, K; Kubota, T; Matsuda, K; Nakagawa, T; Sakuma, T | 1 |
| Buchholz, E; Drings, P; Manegold, C; Pilz, L; Thatcher, N | 1 |
| Ben Arush, MW; Eran, A; Guilburd, J; Postovsky, S; Vlodavsky, E | 1 |
| Häring, HU; Horger, M; Müssig, K; Wehrmann, M | 1 |
| Feng, YL; Li, JD; Li, MD; Liu, JH; Shi, HL; Xiao, Y | 1 |
| Chang, CC; Gondo, G; Hayashi, A; Ito, S; Kanno, H; Kyuma, Y; Nishimura, S; Ono, A; Sasaki, T; Sato, H; Shimizu, N; Tanaka, M; Yamamoto, I | 1 |
| Buyyounouski, MK; Cohen, RB; D'Ambrosio, DJ; Feigenberg, SJ; Glass, J; Konski, A | 1 |
| Fizazi, K; Loriot, Y | 1 |
| Bamias, A; Bozas, G; Dimopoulos, MA; Gika, D; Kastritis, E; Markaki, S; Papadimitriou, CA; Rodolakis, A; Voulgaris, Z; Zorzou, MP | 1 |
| Ferraldeschi, R; Lorigan, P; Thatcher, N | 1 |
| Beckwith, JB; Breslow, NE; Coccia, P; Coppes, MJ; Cotton, CA; D'Angio, GJ; Donaldson, M; Green, DM; Grundy, PE; Haase, GM; Huff, V; Kletzel, M; Macklis, R; Malogolowkin, M; Miser, J; Newbury, R; Perlman, E; Ritchey, ML; Shamberger, RC; Shearer, P; Thomas, PR; Tomlinson, G; Weeks, D; Weetman, R | 1 |
| Einhorn, LH; Papiani, G | 1 |
| Chan, JK; Chan, WK; Epstein, RJ; Leong, CH; Liang, RH; Yau, T | 1 |
| Asakawa, T; Kudoh, S; Kunikane, H; Kunitoh, H; Okamoto, H; Saijo, N; Shibata, T; Tamura, T; Watanabe, K; Yokoyama, A | 1 |
| Ang, LC; Dennis, KE; Fisher, BJ | 1 |
| Berdel, WE; Beyer, J; Bokemeyer, C; Egerer, G; Haas, A; Hartmann, JT; Kollmannsberger, C; Lorch, A; Metzner, B; Rick, O; Schirren, R; Schleicher, J; Schmidt-Wolf, IG; Weissinger, F | 1 |
| Ansell, SM; Colgan, JP; Habermann, TM; Inwards, DJ; Johnston, PB; Markovic, SN; Micallef, IN; Porrata, LF; Ristow, KM; Simpson, L; Witzig, TE | 1 |
| All-Ericsson, C; Economou, MA; Landau, I; Seregard, S; Träisk, F | 1 |
| Chiba, S; Izutsu, K; Kako, S; Kanda, Y; Kurokawa, M; Motokura, T; Oshima, K; Sato, H | 1 |
| Abromowitch, M; Allen, J; Asgharzadeh, S; Comito, M; Diez, B; Dubowy, R; Dunkel, I; Fangusaro, J; Finlay, J; Gardner, S; Halpern, S; Hukin, J; Ji, L; Kellie, S; Miller, DC; Olshefski, R; Rosenblum, M; Saly, M; Sposto, R; Zacharoulis, S | 1 |
| Chiba, N; Gamoh, M; Ishioka, C; Kakudo, Y; Kato, S; Murakawa, Y; Nishino, Y; Ohori, H; Ohtsuka, K; Sakayori, M; Shibata, H; Shimodaira, H; Suzuki, T; Takahashi, M; Takahashi, S; Yamaura, G; Yasuda, K; Yoshioka, T | 1 |
| Aoyama, T; Hagiwara, S; Imataki, O; Inoue, N; Kataoka, T; Katsumata, M; Katsuta, T; Kawakami, K; Mochizuki, T; Motokawa, S; Tamai, Y; Yoshida, T | 1 |
| Artac, H; Caliskan, U; Ilerisoy-Yakut, Z; Koksal, Y; Reisli, I; Ucar, C; Yurtcu, M | 1 |
| Goldman, S; Greenwald, MJ; Mets, MB; Reitman, AJ; Seshadri, R; Strauss, LC; Weinstein, JL; Zage, PE; Zeid, JL | 1 |
| Kishimoto, R; Matsushima, M; Motomura, M; Nakadate, M; Sasaki, H; Shiraishi, H; Tsuji, S; Yabe, I; Yaguchi, H | 1 |
| Biesma, B; de Jong, WK; Groen, HJ; Koolen, MG; Kwa, HB; Smit, EF; van Bochove, A; van Tinteren, H; Willems, LN | 1 |
| Betanzos-Cabrera, Y; Cerecedo-Díaz, F; del Angel, VW; Diegopérez-Ramírez, J; López-Aguilar, E; Rivera-Márquez, H; Sepúlveda-Vildósola, AC; Siordia-Reyes, G | 1 |
| Seto, T | 1 |
| Duffy, A; Gallagher, DJ; McCaffrey, J | 1 |
| Björk-Eriksson, T; Hallqvist, A; Nyman, J; Rylander, H | 1 |
| Albers, P; Langenkamp, S | 1 |
| Gullbo, J; Johnsen, JI; Kogner, P; Larsson, R; Lewensohn, R; Lindskog, M; Lövborg, H; Ponthan, F; Segerström, L; Sveinbjörnsson, B; Viktorsson, K; Wickström, M | 1 |
| Imai, M; Ishikawa, T; Kamimura, H; Kamimura, T; Ohta, H; Seki, K; Togashi, T; Tsuchiya, A; Watanabe, K; Yoshida, T | 1 |
| Buchler, T; Ellis, P; Hackshaw, A; James, L; Lee, SM; Snee, M | 1 |
| Aydin, Y; Cicin, I; Eralp, Y; Ozluk, Y; Saip, P; Selam, M; Topuz, E; Topuz, S | 1 |
| Imataki, O; Kawakami, K; Tamai, Y | 1 |
| Aoyama, T; Imataki, O; Kawakami, K; Tamai, Y | 1 |
| Choi, LM; Kamani, N; La Fond, D; Macdonald, TJ; Packer, RJ; Rood, B; Santi, MR | 1 |
| Fukuda, H; Fukushima, T; Hanada, S; Hotta, T; Ikeda, S; Kawano, F; Masuda, M; Momita, S; Nagoshi, H; Sano, M; Shibata, T; Shimoyama, M; Takatsuka, Y; Tamura, K; Tobinai, K; Tomonaga, M; Tsukasaki, K; Ueda, R; Utsunomiya, A; Yamaguchi, K | 1 |
| Brown, MA; Logothetis, C; Millikan, RE; Pagliaro, LC; Thall, PF; Wen, S; Williams, D | 1 |
| Cho, YH; Hah, JH; Heo, DS; Kim, DW; Kim, KH; Lee, SH; Rhee, CS; Sung, MW; Wu, HG | 1 |
| Lehoczky, O; Pulay, T | 1 |
| Bell, S; Doolittle, ND; Fortin, D; Jahnke, K; Knight, KR; Kraemer, DF; Muldoon, LL; Neuwelt, EA | 1 |
| Czyzewicz, G; Jasiówka, M; Kojs-Pasińska, E; Rolski, J; Zemełka, T | 1 |
| Balta, Z; Büttner, R; Fischer, HP; Hirner, A; Sauerbruch, T | 1 |
| Aerts, I; Asselain, B; Bours, D; Dendale, R; Desjardins, L; Doz, F; Esteve, M; Lévy-Gabriel, C; Lumbroso-Le Rouic, L; Sastre, X | 1 |
| Baker, N; Barker, P; Boogaerts, M; Canizo, CD; Johnsen, HE; Mesters, R; Russell, N; Schmitz, N; Schubert, J; Skacel, T | 1 |
| Green, M; Hodgson, LD; Masters, GA; Rudin, CM; Salgia, R; Vokes, EE; Wang, X | 1 |
| Duh, MS; Lefebvre, P; Neary, M; Reynolds Weiner, J; Skarin, AT | 1 |
| Beske, F; Boos, J; Dantonello, T; Gadner, H; Hallmen, E; Int-Veen, C; Kazanowska, B; Klingebiel, T; Koscielniak, E; Marky, I; Treuner, J | 1 |
| Al-Saleem, T; Jambusaria, A; Perlis, C; Shafer, D; Wu, H | 1 |
| Ikari, H; Kamimura, H; Kamohara, R; Tamashima, S; Yoshioka, H | 1 |
| Affolter, A; Ahmed, M; Marais, R; Nutting, CM; Pritchard-Jones, K; Sharma, AK; Thomas, V; Venkitaraman, R | 1 |
| Bishton, MJ; Fox, CP; Haynes, AP; McMillan, AK; Russell, NH | 1 |
| Cheerva, AC; Gross, TG; Kadota, RP; Levine, JE; Ozkaynak, MF; Richards, MK; Rozans, MK; Sahdev, I; Shaw, PJ | 1 |
| Lau, CP; Leung, WK | 1 |
| Aversa, S; Brunsvig, P; Lange, A; Leyvraz, S; Martinelli, G; Montes, A; Pampallona, S; Perey, L; Peters, S; Ploner, F; Rosti, G; Yilmaz, U | 1 |
| Losonczy, G; Magyar, P; Müller, V; Tamási, L | 1 |
| Bosl, GJ; Feldman, DR; Ishill, N; Jathavedam, A; Motzer, RJ; Patil, S; Turkula, S; Weinstock, DM | 1 |
| Alexandrova, EN; Istomin, YP; Petrovich, SV; Sergeyeva, OP; Zhavrid, EA | 1 |
| Chabaud, S; Court-Fortune, I; Falandry, C; Fournel, C; Freyer, G; Girard, P; Ribba, B; Souquet, PJ; Tod, M; Tranchand, B; Trillet-Lenoir, V; You, B | 1 |
| Abali, H; Budakoğlu, B; Güler, T; Oksüzoğlu, B; Ozet, G; Urün, Y; Yildirim, N; Zengin, N | 1 |
| Becker, H; Lübbert, M; Schäfer, HS; Schmitt-Gräff, A | 1 |
| Hirose, S; Hojo, T; Ikeuchi, S; Isobe, Y; Kinoshita, T; Kubochi, K; Matsumoto, S; Sadako, AT; Shien, T; Terada, K | 1 |
| Dixon, AK; Mazhar, D; Raj, S; Robson, J; Williams, MV | 1 |
| Bacillo, E; Calogero, R; Cappia, S; Ceppi, P; Longo, M; Novello, S; Papotti, M; Saviozzi, S; Scagliotti, GV; Selvaggi, G; Volante, M | 1 |
| Arpaci, F; Ataergin, S; Beyzadeoglu, M; Caglar, K; Kaya, A; Oysul, K; Ozyigit, G; Surenkok, S; Yenicesu, M | 1 |
| Anhalt, GJ; Hosler, GA; Liégeois, N; Moresi, JM | 1 |
| Buxton, N; Pilling, D; Pizer, B; Wilkins, S | 1 |
| Amoroso, L; Benhamou, E; Cacchione, A; Couanet, DV; Hartmann, O; LeMaitre, A; Simonnard, N | 1 |
| Ashley, DM; Dobrovic, A; Drummond, KJ; Friedman, HS; Gan, HK; Hawkins, CJ; Johns, TG; Kaye, AH; Lovric, MM; Maxwell, JA; Mikeska, T; Riffkin, CD | 1 |
| de Wilde, PC; Groot-Loonen, J; Hulsbergen-van der Kaa, C; Merkx, MA; Neven, J | 1 |
| Chow, L; Eckhardt, SG; Gore, L; Lieu, C; Morrow, M; O'Bryant, CL; Pierson, AS; Tran, ZV; Wright, JJ | 1 |
| Ahn, JS; Ahn, MJ; Ahn, YC; Han, J; Hwang, IG; Kim, J; Lee, S; Park, BB; Park, K; Shim, YM | 1 |
| Chung, SE; Ham, DI; Koo, HH; Sa, HS; Sung, KW; Yoo, KH | 1 |
| Bleibel, WK; Cook, E; Eileen Dolan, M; Hennessy, K; Innocenti, F; Liu, W; Mirkov, S; Nagasubramanian, R; Ramírez, J; Ratain, MJ; Rosner, GL; Shukla, SJ | 1 |
| Cohen, VM; Hungerford, JL; Kingston, J | 1 |
| Castleberry, R; Kletzel, M; Kretschmar, C; London, WB; Marcus, R; Murray, K; Zage, PE; Zhang, Y | 1 |
| Berkowitz, RS; Fülöp, V; Szepesi, J; Szigetvŕi, I; Török, M | 1 |
| Azad, A; Chionh, F; Lee, C | 1 |
| Algara, M; Fernández-Velilla, E; Foro, P; Lacruz, M; López, JL; Lozano, J; Membrive, I; Quera, J; Reig, A; Rodríguez, N; Sanz, X | 1 |
| Choong, NW; Dancey, JE; Grushko, T; Haraf, DJ; Hoffman, PC; Kozloff, M; Lester, E; Lin, S; Mauer, AM; Olopade, OI; Salgia, R; Szeto, L; Vokes, EE | 1 |
| Fukuoka, M; Nakagawa, K; Okamoto, I; Takezawa, K | 1 |
| Ross, HJ; Seung, SK | 1 |
| Budning, A; Chan, HS; Dai, S; Dimaras, H; Doyle, J; Drake, J; Gallie, BL; Halliday, W; Héon, E | 1 |
| Aasebø, U; Bergman, B; Bremnes, R; Ek, L; Fluge, S; Hermes, A; Sederholm, C; Sörenson, S; Sundstrøm, S; Thaning, L; Vilsvik, J | 1 |
| Scorilas, A; Thomadaki, H | 1 |
| Eisen, T; Ferry, DR; Gilligan, D; Gower, NH; Harper, PG; Hocking, M; James, LE; Lee, SM; Prendiville, J; Qian, W; Rudd, RM; Spiro, S | 1 |
| Friedrichs, N; Gorschlüter, M; Gressner, O; Mey, U; Popp, H; Sauerbruch, T; Schmidt-Wolf, IG; Strehl, J | 1 |
| Yamaguchi, M | 3 |
| Boyett, JM; Dhall, G; Dunkel, IJ; Finlay, JL; Gardner, SL; Goldman, S; Packer, RJ; Pollack, IF; Rosenblum, MK; Stanley, P; Wallace, D; Yates, AJ; Zimmerman, RA | 1 |
| Barnich, M; Cairo, M; Chang, M; Griffin, TC; Gross, TG; Hutchison, R; Shiramizu, B; Weinstein, H; Weitzman, S; Wiley, J; Woods, D | 1 |
| Hirami, Y; Kawagoe, N; Mandai, M; Mio, T; Mishima, M; Sakuma, K; Takahashi, M; Yoshimura, N | 1 |
| Becker, M; Fichtner, I; Hammer, S; Hoffmann, J; Merk, J; Rolff, J; Sommer, A; Soong, R | 1 |
| Daw, NC; Gregornik, D; Jenkins, JJ; Jones, DP; Kun, LE; Marina, N; McPherson, V; Rodman, J; Wilimas, J; Wu, J | 1 |
| Agarwal, R; Dvorak, CC; Johnston, L; Srinivas, S; Stockerl-Goldstein, KE | 1 |
| Ball, DL; Macmanus, MP; Michael, M; Millward, MJ; Plumridge, NM; Rischin, D; Wirth, A; Yuen, K | 1 |
| Acerno, S; Biassoni, V; Casanova, M; Cefalo, G; Collini, P; Ferrari, A; Fossati-Bellani, F; Gandola, L; Luksch, R; Mariani, L; Massimino, M; Meazza, C; Modena, P; Pecori, E; Pignoli, E; Podda, M; Poggi, G; Polastri, D; Potepan, P; Ravagnani, F; Simonetti, F; Solero, CN; Spreafico, F; Terenziani, M | 1 |
| Jarkowski, A | 1 |
| Kawase, T; Mikami, S; Oya, M; Takahashi, S; Yoshida, K | 1 |
| Gutweiler, JR; Kim, HB; Kozakewich, HP; Marcus, KJ; Shamberger, RC; Weldon, CB; Yu, DC | 1 |
| Boldrini, R; Cozza, R; De Ioris, MA; De Sio, L; Donfrancesco, A; Fidani, P; Garrè, ML; Ilari, I; Milano, GM; Serra, A | 1 |
| Aurer, I; Labar, B; Mitrović, Z; Mrsić, M; Nemet, D; Nola, M; Radman, I; Santek, F; Sertić, D; Serventi-Seiwerth, R; Stern-Padovan, R | 1 |
| Berretta, S; Biassoni, V; Cefalo, G; Collini, P; Favre, C; Ferrari, A; Fossati-Bellani, F; Gandola, L; Giangaspero, F; Luksch, R; Massimino, M; Pecori, E; Pignoli, E; Poggi, G; Pollo, B; Riva, D; Sardi, I; Solero, C; Spreafico, F; Terenziani, M | 1 |
| Aguero, EG; Fortney, JA; Garrett-Mayer, E; Sharma, AK; Sherman, CA; Shirai, K; Wahlquist, AE; Watkins, JM | 1 |
| Nagai, T; Okubo, T; Sakaguchi, R; Seki, H; Takeda, S | 1 |
| Abu-Rustum, NR; Aghajanian, C; Alektiar, K; Chi, DS; Diaz, JP; Konner, J; Leitao, MM; Park, KJ; Zhao, H; Zivanovic, O | 1 |
| Bregni, M; Pedrazzoli, P | 1 |
| Angrilli, F; Baldini, L; Brugiatelli, M; Cervetti, G; Di Renzo, N; Federico, M; Gobbi, PG; Iannitto, E; La Sala, A; Luminari, S; Marcheselli, L; Mazza, P; Merli, F; Montanini, A; Musto, P; Polimeno, G; Pozzi, S; Scalone, R; Stelitano, C | 1 |
| Arakawa, T; Dalmau, J; Fujisaki, A; Hattori, K; Kimura, M; Onozawa, M; Takeda, K | 1 |
| Hartzell, K; Leahey, A; Meadows, AT; Ramasubramanian, A; Shields, CL; Shields, JA; Thangappan, A | 1 |
| Sun, YK; Wang, JW; Zhan, XK; Zhang, W | 1 |
| Bossi, A; Di Palma, M; Escudier, B; Fizazi, K; Gross-Goupil, M; Loriot, Y; Massard, C | 1 |
| Baggstrom, MQ; Burdette-Radoux, S; Govindan, R; Green, MR; Hodgson, L; Vokes, EE; Wang, X | 1 |
| Aziz, A; Bruce, J; Humphrey, G; Kapur, P; Khalil, BA; Morabito, A | 1 |
| Atchaneeyasakul, LO; Sanpakit, K; Thephamongkhol, K; Trinavarat, A; Uiprasertkul, M; Wongsiwaroj, C | 1 |
| Mavridis, K; Scorilas, A; Talieri, M; Thomadaki, H | 1 |
| Gatzemeier, U; Heigener, DF; Jäger, E; Manegold, C; Saal, JG; Zuna, I | 1 |
| Arpaci, F; Ataergin, S; Kilic, S; Komurcu, S; Kuzhan, O; Ozet, A; Ozturk, B; Ozturk, M | 1 |
| Karp, J | 1 |
| Bryar, PJ; Mets, MB; Parness-Yossifon, R; Srikumaran, D; Weinstein, JL | 1 |
| Fujii, M; Ito, M; Natsume, A; Ohno, M; Wakabayashi, T | 1 |
| Hara, T; Hatano, M; Kinoshita, Y; Koga, Y; Kohashi, K; Matsuzaki, A; Oda, Y; Saito, Y; Suminoe, A; Taguchi, T; Tajiri, T; Tsuneyoshi, M | 1 |
| Leahey, A; Meadows, AT; Palamar, M; Ramasubramanian, A; Sharma, P; Shields, CL; Shields, JA | 1 |
| Heianna, J; Maruya, J; Minakawa, T; Miyauchi, T; Narita, E; Nishimaki, K | 1 |
| Kakavelas, P; Kontakiotis, T; Lithoxopoulou, H; Mylonaki, E; Rapti, E; Tsiouda, T; Zarogoulidis, K; Zarogoulidis, P; Zarogoulidou, V | 1 |
| Grodman, H; Kretschmar, C; Wolfe, L | 1 |
| Chikugo, T; Kitano, M; Komaki, T; Kudo, M; Noda, K; Sakamoto, H | 1 |
| Allen, J; Chan, KW; Donahue, B; Holmes, E; Jakacki, R; Mehta, M; Miller, DC; Muraszko, K; Prados, M; Puccetti, D; Robertson, P; Rorke, LB; Sposto, R; Vezina, G | 1 |
| Beaven, AW; Chao, N; Gabriel, DA; Garcia, RA; Gockerman, JP; Moore, DT; Rizzieri, DA; Serody, JS; Shea, TC | 1 |
| Fukushima, T; Inoue, T; Komatsu, F; Ohmura, T; Ohta, M; Oshiro, S; Sakamoto, S; Tsugu, H | 1 |
| Abe, H; Fukushima, T; Komatsu, F; Matsumoto, S; Nabeshima, K; Nomura, Y; Oshiro, S; Takano, K; Tsugu, H; Utsunomiya, H; Yanai, F | 1 |
| Al-Hussaini, M; Ali, HM; Almousa, A; Ghandour, K; Ismael, T; Masarweh, M; Rodriguez-Galindo, C; Sultan, I | 1 |
| Chekerov, R; Fotopoulou, C; Karavas, A; Lichtenegger, W; Sehouli, J; Trappe, R | 1 |
| Al Balushi, Z; Bulduc, S; Lallier, M; Mulleur, C | 1 |
| Dieckmann, KP; Georgiew, A; Kleinschmidt, K; Loy, V; Weissbach, L | 1 |
| Baba, T; Hanagiri, T; Ichiki, Y; Ohga, T; Sugio, K; Takenoyama, M; Uramoto, H; Yasuda, M; Yasumoto, K | 1 |
| Fouladi, M; Gajjar, A; Gronewold, L; Gururangan, S; Heideman, R; Kun, LE; Moghrabi, A; Phillips, P; Sanford, RA; Wallace, D | 1 |
| Borovskaya, TG; Gol'dberg, VE; Pachomova, AV; Perova, AV; Poluektova, ME | 1 |
| Romanick, M; Shiu, JR; Stobart, K | 1 |
| Hansen, KH; Hansen, O; Sørensen, P | 1 |
| Aoki, T; Matsutani, M; Miyatake, S; Mizutani, T; Nojima, K; Nozaki, K; Okumura, R; Takagi, T; Takahashi, JA; Taki, W; Ueba, T; Yuba, Y | 1 |
| Diez, B; Hasselblatt, M; Jeibmann, A; Kortmann, RD; Kutluk, T; Mahajan, A; Moghrabi, A; Paulus, W; Peters, O; Pietsch, T; Rutkowski, S; Thall, PF; Wang, X; Wolff, JEA; Wrede, B | 1 |
| Fujigaki, H; Hoshi, M; Ito, H; Ohtaki, H; Ohyama, M; Saito, K; Seishima, M; Takahashi, T; Takemura, M; Tanaka, R; Tomita, E | 1 |
| Egan, A; Khan, MF; Martin, ST; Ryan, RS; Tobbia, I; Waldron, R; Walshe, T | 1 |
| Hongo, H; Inui, K; Kishi, Y; Kodawara, T; Takahashi, J; Yano, I; Yano, Y | 1 |
| Deutsch, E; Loriot, Y; Mordant, P; Olaussen, KA; Soria, JC | 1 |
| Kanemoto, M; Karahashi, T; Kato, T; Kobayashi, C; Morita, S; Tanabe, J | 1 |
| Choe, DH; Kang, MS; Kim, CH; Lee, JC; Noh, GY | 1 |
| Chan, HS; Dimaras, H; Gallie, BL; Halliday, W; Héon, E; Khetan, V | 1 |
| Conrad, AL; Go, RS | 1 |
| Esparza, J; Hinojosa, J; Iglesias, S; Muñoz, MJ; Otero-Rodríguez, A; Ricoy, JR; Rodríguez-Gil, Y | 1 |
| Chen, J; Dong, L; Gu, LJ; Jiang, H; Pan, C; Tang, JY; Xue, HL; Ye, QD; Zhou, M | 1 |
| Basu, S; Faber, LP; Kim, AW; Liptay, MJ; Miller, C; Milman, S; Warren, WH | 1 |
| Cui, H; Filatov, A; Moskowitz, CH; Persky, DO; Saxena, R; Teruya-Feldstein, J | 1 |
| Boddy, AV; Cole, M; Ellershaw, C; Errington, J; Gerrard, M; Pearson, AD; Veal, GJ; Whyman, G | 1 |
| Grün, R; Koch, B; Tannapfel, A; Vieth, M | 1 |
| Akhurst, TJ; Cheung, NK; Kramer, K; Kushner, BH; Modak, S | 1 |
| Blakely, J; Ciuleanu, T; Dediu, M; Guba, SC; Hanauske, AR; Hong, S; Jassem, J; Karaseva, NA; Konduri, K; Lorigan, P; Obasaju, CK; Reck, M; Serwatowski, P; Smit, EF; Socinski, MA; Szczesna, A; Thatcher, N; Visseren-Grul, C | 1 |
| Abe, H; Aizawa, R; Aizawa, Y; Kitahara, T; Kubo, Y; Matsuoka, M; Tajiri, H; Takakura, K; Yoshizawa, K | 1 |
| Buffa, P; Castellano, A; Clerico, A; Conte, M; D'Ippolito, C; De Bernardi, B; Di Cataldo, A; Fagnani, AM; Garaventa, A; Gigliotti, AR; Granata, C; Parodi, S; Prete, A; Provenzi, M; Rizzo, A; Sementa, AR; Sorrentino, S; Tonini, GP | 1 |
| Duerst, R; Evans, L; Fouts, M; Goldman, S; Haut, P; Jacobsohn, D; Kletzel, M; Rademaker, A; Rosenfeld, A; Schaefer, C; Weinstein, J | 1 |
| Boersma, L; Bootsma, G; De Ruysscher, D; Dehing-Oberije, C; Dingemans, AM; Geraedts, W; Hochstenbag, M; Lambin, P; Oellers, M; Pitz, C; Rhami, A; Simons, J; Snoep, G; Teule, J; Thimister, W; van Loon, J; Wanders, R | 1 |
| Glisson, BS; Johnson, FM | 1 |
| Hotta, T; Ishikura, S; Ishizawa, K; Ishizuka, N; Isobe, Y; Itoh, K; Kagami, Y; Kinoshita, T; Kobayashi, Y; Maseki, N; Matsuno, Y; Nawano, S; Oguchi, M; Ohshima, K; Oshimi, K; Terauchi, T; Tobinai, K; Usui, N; Wasada, I; Yamaguchi, M | 1 |
| Català-Mora, J; Medina-Zurinaga, M; Parareda-Salles, A; Prat-Bartomeu, J; Vicuña-Muñoz, CG | 1 |
| Brökers, N; Hagos, Y; Katschinski, DM; Kleinschmidt, M; Le-Huu, S; Vogel, S | 1 |
| Fernandez, CV; Golobi, M; Gundogan, M; Irie, T; Luna-Fineman, S; Magee, JF; Quackenbush, KE | 1 |
| Inagaki, H; Iwashima, Y; Kusumoto, S; Kutsuna, T; Maeno, K; Miyazaki, M; Nakamura, A; Nakao, M; Oguri, T; Ota, C; Ozasa, H; Sato, S; Takakuwa, O; Ueda, R; Uemura, T | 1 |
| de Wit, R; Sternberg, CN; Troost, MM | 1 |
| Beyer, J; Bokemeyer, C; Kollmannsberger, C | 1 |
| Bagg, A; Carroll, M; Dierov, JK; Frey, NV; Gewirtz, AM; Goldstein, SC; Hexner, EO; Kasner, MT; Loren, AW; Luger, SM; Nasta, SD; Perl, AE; Porter, DL; Schuster, SJ; Stadtmauer, EA; Swider, CR; Tsai, DE; Vogl, DT | 1 |
| Musallam, KM; Taher, AT | 1 |
| Brentrup, A; Frühwald, MC; Hasselblatt, M; Holling, M; Jeibmann, A; Niederstadt, T; Paulus, W; Pfister, S; Sträter, R | 1 |
| Abramson, DH; Chantada, GL; Dunkel, IJ; Finlay, JL; Goldman, S; Gururangan, S; Jubran, RF; Khakoo, Y; O'Brien, JM; Orjuela, M; Rodriguez-Galindo, C; Souweidane, MM | 1 |
| Kinoshita, T | 1 |
| Adachi, M; Hirose, T; Nakamura, A; Ohnishi, T; Okuda, K; Yamaoka, T; Yashiki, C | 1 |
| Budning, A; Chan, HS; Dimaras, H; Doyle, JJ; Gallie, BL; Halliday, W; Héon, E | 1 |
| Enting, D; Forster, M; Nicholson, AG; O'Brien, M; Popat, S | 1 |
| Gopalan, D; Raj, V; Shaida, N | 1 |
| Bensimhon, P; Kreissman, SG; London, WB; Matthay, KK; Park, JR; Seeger, R; Sender, LS; Villablanca, JG; Yap, JS | 1 |
| Fujiwara, M; Haba, R; Imachi, H; Ishida, T; Kushida, Y; Murao, K; Nishiuchi, T; Nishiuchi, Y; Sato, M; Shindo, A; Tamiya, T | 1 |
| Arimoto, T; Hara, H; Iwasaki, Y; Kubota, Y; Nakanishi, M; Ueda, M | 1 |
| Cappellano, AM; Cavalheiro, S; da Silva, NS; Diez, B; Finlay, J; Gardner, S; Garvin, J; Kellie, S; Parker, R; Wisoff, J | 1 |
| Filippa, D; Hamlin, P; Horowitz, S; Kewalramani, T; Maragulia, J; Moskowitz, AJ; Moskowitz, CH; Nimer, SD; Noy, A; O'Connor, OA; Portlock, C; Rice, RD; Straus, D; Teruya-Feldstein, J; Trippett, T; Vanak, J; Yahalom, J; Zelenetz, AD; Zhang, Z | 1 |
| Crvenkova, S; Krstevska, V | 1 |
| Govindan, R; Subramanian, J | 1 |
| Dunkel, IJ; Finlay, JL; Gardner, SL; Garvin, JH; Goldman, S; Shi, W | 1 |
| Bains, M; Bajorin, DF; Bosl, GJ; Feldman, DR; Fischer, P; Ishill, N; Motzer, RJ; Patil, S; Reich, LM; Sheinfeld, J; Turkula, S | 1 |
| Ikegame, K; Imai, Y; Inoue, D; Kimura, T; Kurata, M; Matsushita, A; Mori, M; Nagai, K; Nagai, Y; Ogawa, H; Shimoji, S; Tabata, S; Takahashi, T; Togami, K | 1 |
| Dhall, G; Fan, J; Finlay, JL; Gilles, F; Gonzalez, I; Jubran, R; Khatua, S; Krieger, M; Lavey, R; Marachelian, A; McComb, G; Nastia, A; Nelson, M; O'Neil, S; Olch, AJ; Panigrahy, A; Sposto, R; Villablanca, JG | 1 |
| Arnold, D; Behlendorf, T; Jordan, K; Kegel, T; Mueller, LP; Schmoll, HJ; Sippel, C; Voigt, W; Wolf, HH | 1 |
| Charpidou, A; Gkiozos, I; Makrilia, N; Stratakos, G; Syrigos, K; Tsagouli, S; Tsimpoukis, S; Vassias, A | 1 |
| Beckles, M; Chao, D; Lang, B; McCabe, DJ; Ng, K; Simister, RJ | 1 |
| Atsumi, K; Hirata, H; Honda, H; Isoyama, Y; Matsuura, S; Nomoto, S; Nonoshita, T; Ohga, S; Onishi, K; Shioyama, Y; Terashima, K | 1 |
| Guan, Y; Lin, D; Liu, Y; Liu, Z; Ott, J; Shen, Y; Wu, C; Xu, B; Yu, D; Yuan, P | 1 |
| Beyer, J; Bokemeyer, C; Hartmann, JT; Lorch, A; Rick, O; Wündisch, T | 1 |
| Auvrignon, A; Chastagner, P; Corradini, N; Doz, F; Gentet, JC; Giraud, C; Leblond, P; Rey, E; Rubie, H; Treluyer, JM; Urien, S; Vassal, G | 1 |
| Bakhshi, S; Malik, PS | 1 |
| Bartels, U; Bouffet, E; Greenberg, M; Halliday, W; Kamaly-Asl, ID; Kulkarni, AV; Lafay-Cousin, L; Mabbott, DJ; Tabori, U; Taylor, MD | 1 |
| Chu, Z; Huang, L; Huang, R; Jiang, J; Liang, X; Zhan, Q; Zhou, X | 1 |
| Abonour, R; Agarwala, AK; Brames, MJ; Einhorn, LH; Perkins, SM | 1 |
| Fijuth, J; Jesien-Lewandowicz, E; Kordek, R; Spych, M | 1 |
| Batum, O; Emin Erbaycu, A; Gunduz, A; Tuksavul, F; Zeki Guclu, S; Zeren Ucar, Z | 1 |
| Dupre, S; Francesconi, AB; Hughes, BG; Lickliter, JD; Martin, D; Matos, M; Wyld, DK | 1 |
| Aliev, MD; Chernov, IS; Machak, GN; Meluzova, OM; Polotskiĭ, BE | 1 |
| Fukunaga, K; Hajiro, T; Hashimoto, S; Ikezoe, K; Kaji, Y; Minakuchi, M; Nakajima, T; Okumura, N; Sakuramoto, M; Sato, E; Sugimura, M; Taguchi, Y; Tanaka, E; Tanizawa, K; Yasuda, T | 1 |
| Endo, M; Kaira, K; Murakami, H; Naitou, T; Nakamura, Y; Takahashi, T; Tamiya, A; Tsuya, A; Yamamoto, N | 1 |
| Bernard, S; Chiu, M; Davies, JM; Dees, EC; Dhruva, NS; Hayes, DN; Hilbun, LR; Ivanova, A; Keller, K; Kim, WY; Socinski, MA; Stinchcombe, TE; Walko, CM | 1 |
| Gruellich, C; Hasskarl, J; Schroettner, P; Waller, CF | 1 |
| Brown, E; Hebra, A; Hudspeth, M; Jenrette, J | 1 |
| Nallasamy, S; Ramasubramanian, A; Shields, CL; Shields, JA; Tipperman, R | 1 |
| Bosly, A; Brière, J; Gisselbrecht, C; Glass, B; Hagberg, H; Ketterer, N; Linch, DC; Ma, D; Moskowitz, CH; Mounier, N; Schmitz, N; Shpilberg, O; Singh Gill, D; Trneny, M | 1 |
| Baandrup, L; Hauggaard, A; Holm, B; Winberg, BH | 1 |
| Ainslie, J; Hui, AC; Seel, M; Stillie, AL | 1 |
| Alapetite, C; Baranzelli, MC; Ben-Hassel, M; Bernier, V; Bouffet, E; Brisse, H; Carrie, C; Cuilliere, JC; Frappaz, D; Gaboriaud, G; Habrand, JL; Patte, C; Raquin, MA; Thiesse, P | 1 |
| Kewalramani, T; Maragulia, JC; Moskowitz, AJ; Moskowitz, CH; Vanak, JM; Yahalom, J; Zelenetz, AD | 1 |
| Brigulová, K; Cervinka, M; Sedláková, I; Tošner, J | 1 |
| Bamberg, M; Eckert, F; Fehm, T; Müller, AC | 1 |
| Behlendorf, T; Jahn, F; Jahn, P; Jordan, K; Kegel, T; Ruessel, J; Schmoll, HJ; Stein, A | 1 |
| Davis, D; Guha, S; Richards, D; Yan, P | 1 |
| Billaud, EM; Bobin-Dubigeon, C; Boisdron-Celle, M; Boyer, JC; Chatelut, E; Concordet, D; Durdux, C; Etienne-Grimaldi, MC; Evrard, A; Floquet, A; Gladieff, L; Laffont, CM; Lafont, T; Lansiaux, A; Le Guellec, C; Mazières, J; Mousseau, M; Ollivier, F; Pinguet, F; Schmitt, A | 1 |
| Bazan, F; Chaigneau, L; Demarchi, M; Dobi, E; Ivanaj, A; Kalbacher, E; Maurina, T; Montange, D; Nguyen, T; Pivot, X; Royer, B; Thiery-Vuillemin, A; Villanueva, C | 1 |
| Baker, DL; Buxton, A; Castleberry, RP; Cohn, SL; London, WB; Look, AT; Maris, JM; Matthay, KK; Reynolds, CP; Sandler, A; Schmidt, ML; Seeger, RC; Shamberger, RC; Shimada, H; Stram, D | 1 |
| Athanasopoulos, A; Daladimos, T; Karabelis, A; Kosmas, C; Mylonakis, N; Theotikos, E; Tsakonas, G | 2 |
| Aziz, HA; Aziz-Sultan, MA; Boutrid, H; Fernandes, CE; Houston, SK; Markoe, AM; Moftakhar, R; Murray, TG; Piña, Y; Reichbach, J; Schefler, AC; Wolfe, SQ | 1 |
| Agarwala, S; Bhatnagar, V; Garg, R | 1 |
| Hishiki, T; Hiyama, E; Horie, H; Ida, K; Kamimatsuse, A; Kondo, S; Matsunaga, T; Ohnuma, N; Oue, T; Sasaki, F; Tajiri, T; Watanabe, K; Yano, M | 1 |
| Cantor, A; Miley, D; Reddy, V; Robert, F; Rossman, J | 1 |
| Bakhshi, S; Chawla, B; Kashyap, S; Meel, R; Mohanti, BK | 1 |
| Aguero, EG; Garrett-Mayer, E; Sharma, AK; Sherman, CA; Shirai, K; Silvestri, GA; Wahlquist, AE; Watkins, JM; Zauls, AJ | 1 |
| Berrak, SG; Liu, DD; Wolff, JE; Wrede, B | 1 |
| Albain, K; Bae, K; Curran, WJ; Gore, EM; Komaki, R; Machtay, M; Movsas, B; Paulus, R; Sause, WT | 1 |
| Abonour, R; Einhorn, LH; Kesler, KA | 1 |
| Castellano, A; De Ioris, MA; De Pasquale, MD; De Vito, R; Donfrancesco, A; Garganese, MC; Ilari, I; Inserra, A; Jenkner, A; Locatelli, F; Natali, G; Ravà, L | 1 |
| Guan, Y; Lin, D; Liu, Y; Miao, X; Shen, H; Wu, C; Wu, T; Xu, B; Xu, J; Yu, D; Yuan, P; Zhang, T | 1 |
| Bozhenko, VK; Datsenko, PV; Pan'shin, GA; Podol'skiĭ, PN; Sotnikov, VM | 1 |
| Abdel-Rahman, FA; Tuffaha, H | 1 |
| Patel, J; Shields, CL; Turaka, K | 1 |
| Chung, J; Shields, CL; Turaka, K | 1 |
| Kumabe, T; Niizuma, H; Osawa, S; Saito, R; Sonoda, Y; Tominaga, T; Watanabe, M | 1 |
| Fishman, M; Kim, JW; Moshfeghi, D; Yau, JW | 1 |
| Bomken, S; Chong, L; Cole, M; Davies, B; McDermott, M; Tweddle, DA; Wood, KM | 1 |
| Ferreti Bonan, PR; Martelli-Júnior, H; Miranda Soares, PB; Pereira DE Souza, W; Quirino Filho, S | 1 |
| Binder, D; Caca, K; Eberhardt, WE; Fischer von Weikersthal, L; Fischer, B; Fischer, JR; Gauler, TC; Hortig, P; Kaufmann, C; Keilholz, U; Link, H; Martus, P; Schmittel, A; Sebastian, M | 1 |
| Engel-Riedel, W; Gieseler, F; Guetz, S; Kellner, O; Nagel, S; Schuette, W; Schumann, C | 1 |
| Ashley, DM; Bandopadhayay, P; Cohn, RJ; Downie, PA; Hassall, TE; Kirby, ML; Rosenfeld, JV; Sullivan, MJ; Wheeler, GC | 1 |
| Lima, BR; Rychwalski, PJ; Schoenfield, L | 1 |
| Chen, BF; Choi, YS; Hou, JY; Liang, DC; Liu, HC; Sheu, JC; Yeh, TC | 1 |
| Lee, DW; Lee, HN; Lee, KH; Lee, YS; Park, EK; Park, JS | 1 |
| Azuma, A; Gemma, A; Kitamura, K; Kosaihira, S; Kudoh, S; Kuribayashi, H; Minegishi, Y; Mizutani, H; Okano, T; Seike, M; Yoshimura, A | 1 |
| Balwierz, W; Kobylarz, J; Moryl-Bujakowska, A; Pawińska-Wasikowska, K; Pietrys, D; Romanowska-Dixon, B | 1 |
| Maceneaney, P; Moylan, EJ; O'Reilly, SP; Power, DG; Ryan, SA | 1 |
| Babyn, P; Chan, HS; Dimaras, H; Doyle, J; Gallie, BL; Halliday, W; Héon, E; Paton, KE; Strahlendorf, C | 1 |
| Al-Futaisi, A; Al-Kharusi, N; Biswas, J; Ganesh, A; Khetan, V; Kumar, K; Raja, T | 1 |
| Cassier, P; Chapet, O; Chekrine, T; De Bari, B; Kulisa, M; Mornex, F | 1 |
| Beuzeboc, P; Culine, S; Deplanque, G; Droz, JP; Fargeot, P; Ferlay, C; Fléchon, A; Gravis, G; Joly, F; Oudard, S; Perol, D; Pouessel, D; Priou, F; Zanetta, S | 1 |
| Bascoul-Mollevi, C; Beyer, J; De Giorgi, U; Einhorn, L; Fléchon, A; Germà-Lluch, JR; Kollmannsberger, C; Kramar, A; Lorch, A; Lotz, JP; Margolin, K; Massard, C; Necchi, A; Powles, T | 1 |
| Giesen, E; Kerst, JM; Mager, A; Rodenhuis, S; van Tinteren, H | 1 |
| Al-Barrak, J; Gilks, CB; Hoskins, P; Lau, H; Santos, JL; Swenerton, KD; Tinker, A | 1 |
| Fujii, S; Kaneko, H; Matsui, Y; Miura, Y; Nakamura, C; Sugino, N; Tsudo, M; Wakasa, T; Watanabe, M | 1 |
| Azoff, J; Borchert, M; Buranahirun, C; Dhall, G; Finlay, J; Ji, L; Khatua, S; O'Neil, S; Panigrahy, A; Patel, S; Sposto, R | 1 |
| Adiguzel, I; Fang, L; Faoro, L; Huang, JE; Karlin, DA; Scappaticci, FA; Socinski, MA; Spigel, DR; Townley, PM; Waterhouse, DM | 1 |
| Anderlini, P; Fanale, M; Fayad, L; Horowitz, S; Ji, Y; Kwak, LW; Liboon, MJ; Nunez, C; Popat, U; Pro, B; Samaniego, F; Younes, A | 1 |
| Grossniklaus, HE; Herwig, MC; Hubbard, GB; Wells, JR | 1 |
| Abrams, RA; Basu, S; Batus, M; Bonomi, P; Faber, LP; Fidler, MJ; Gielda, BT; Liptay, M; Marsh, JC; Warren, WH; Zusag, TW | 1 |
| Bartels, U; Bouffet, E; Dirks, P; Fried, I; Hawkins, C; Huang, A; Scheinemann, K; Tabori, U; Tsangaris, E | 1 |
| Chen, DF; Feng, QF; Liang, J; Ou, GF; Wang, LH; Xiao, ZF; Zhang, HX; Zhang, XR; Zhou, ZM; Zhu, H | 1 |
| Castillo, L; Chantada, GL; Diez, B; Dufort, G; Koop, K; Palma, J; Richard, L; Sampor, C; Sasso, DF | 1 |
| Cox, NJ; Dolan, ME; Gamazon, ER; Huang, RS | 1 |
| Assens, M; Federspiel, B; Hansen, CP; Hasselby, JP; Jepsen, I; Kjaer, A; Knigge, U; Langer, SW; Olsen, IH | 1 |
| Anchisi, S; Bieri, S; Elhfidh, M; Khanfir, K; Matzinger, O; Mirimanoff, RO; Ozsahin, M; Zouhair, A | 1 |
| Benesch, M; Deinlein, F; Faldum, A; Fleischhack, G; Gerber, NU; Kortmann, RD; Krauss, J; Kuehl, J; Pietsch, T; Rutkowski, S; von Bueren, AO; von Hoff, K; Warmuth-Metz, M; Zwiener, I | 1 |
| Jeremić, B; Miličić, B; Milisavljevic, S | 4 |
| Amin, NP; Camidge, DR; Gaspar, LE; Kavanagh, B; Miften, M; Raben, D; Rochford, N; Thornton, D | 1 |
| Iwaba, A; Kato, T; Nagaoka, A; Naito, S; Sakurai, T; Tomita, Y; Tsukigi, M; Yamagishi, A; Yamakawa, M | 1 |
| Bay, JO; Blay, JY; Bonichon, F; Bui-Nguyen, B; Chevreau, C; Coindre, JM; Cupissol, D; Italiano, A; Jimenez, M; Lotz, JP; Mathoulin-Pélissier, S; Penel, N; Ray-Coquard, I; Thyss, A | 1 |
| Abdel-Hady Hemida, R; Abdel-Hady, el-S; El-Shamey, M; Gamal, A | 1 |
| Kawase, T; Takahashi, S; Yoshida, K | 1 |
| Fujii, M; Ito, M; Momota, H; Motomura, K; Natsume, A; Wakabayashi, T | 1 |
| Blagden, S; Gabra, H; Graham, J; Sharma, R | 1 |
| Akiyama, S; Gamoh, M; Narasaka, T; Niitani, T; Ohto, T | 1 |
| Boos, J; Hempel, G; Kersting, G; Lippert, J; Willmann, S; Würthwein, G | 1 |
| Boström, J; Glas, M; Herrlinger, U; Kim, Y; Mack, F; Rieger, J; Schäfer, N; Scheffler, B; Simon, M; Steinbach, JP; Stuplich, M; Thanendrarajan, S; Tichy, J | 1 |
| Leahey, A; Meadows, AT; Shields, CL; Turaka, K | 1 |
| Bahlis, NJ; Carlson, L; Duan, Q; Duggan, P; Hasegawa, W; Russell, JA; Stewart, DA; Voralia, M | 1 |
| Albers, P; Beyer, J; Lorch, A; Winter, C | 1 |
| Allen, PJ; Brady, MS; Busam, KJ; Chou, JF; Coit, DG; Fields, RC; Kraus, DH; Panageas, KS; Pulitzer, MP | 1 |
| Baez, F; Barnoya, M; Bonilla, M; Fu, L; Luna-Fineman, S; Rodríguez-Galindo, C | 1 |
| Federico, M; Gentile, M; Gobbi, P; Hohaus, S; Iannitto, E; La Sala, A; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Montanini, A; Morabito, F; Scalone, R; Stelitano, C; Voso, MT | 1 |
| Ballanti, S; Dammacco, F; Di Ianni, M; Falzetti, F; Iodice, G; Martelli, MF; Minelli, O; Reale, A; Ria, R; Serio, G; Vacca, A | 2 |
| Boudova, L; Briere, J; Bron, D; Chevalier, C; Cogliatti, S; Cuccuini, W; Gaulard, P; Gisselbrecht, C; Hirchaud, E; Houlgatte, R; Jack, A; Mounier, N; Rosenwald, A; Schmitz, N; Soulier, J; Sundstrom, C; Thieblemont, C; Trougouboff, P; Voelker, HU; Ysebaert, L | 1 |
| Chen, CP; Jablons, DM; Jahan, TM; Weinberg, VK; Yom, SS | 1 |
| Benson, W; George, B; Hertzberg, MS | 1 |
| Chen, YH; Dosoretz, AP; Fisher, DC; Fox, AM; Freedman, AS; LaCasce, AS; Mauch, PM; Ng, AK; Silver, B | 1 |
| Barbera, S; Barletta, E; Ceribelli, A; De Maio, E; Di Maio, M; Favaretto, A; Filipazzi, V; Gallo, C; Gamucci, T; Gridelli, C; Iaffaioli, RV; Isa, L; Maione, P; Morabito, A; Perrone, F; Piccirillo, MC; Rocco, G; Rossi, A; Signoriello, S; Vecchione, A | 1 |
| Sorscher, SM | 1 |
| Furuya, T; Ikeda, T; Inoue, M; Kaneda, H; Koshinaga, T; Maebayashi, T; Masuko, T; Mugishima, H; Ohashi, K; Sugito, K; Yagasaki, H | 1 |
| Eagle, RC; Kaliki, S; Leahey, A; Shah, SU; Shields, CL; Shields, JA | 1 |
| Abdel Rahman, H; El Debawy, E; Ezzat, S; Mostafa, NE; Moussa, EA; Rayan, Ael R; Yones, A; Zekri, WZ | 1 |
| Munoz, J; Sanchez, BE; Wang, D | 1 |
| Ikenoue, M; Iwakiri, T; Kodama, Y; Marutsuka, K; Miyata, S; Moriguchi, S; Ryu, S; Sawa, D; Takeshima, H; Uchinokura, S; Uehara, H; Yamada, N; Yamashita, S; Yokogami, K | 1 |
| Asha, HS; Chacko, RT; Eapen, A; Fleming, JJ; Hepzibah, J; Kapoor, N; Ramakrishna, B; Somasundaram, N; Thomas, N | 1 |
| Charoentum, C; Chewaskulyong, B; Permsuwan, U; Ruengorn, C; Thongprasert, S | 1 |
| Raveesunthornkiet, M; Ruangtrakool, R; Sanpaki, K; Thorner, PS; Treetipsatit, J | 1 |
| Damasco, VC; Dire, DJ | 1 |
| Ciuleanu, T; Guba, SC; Hong, S; Hozak, RR; Karaseva, NA; Lorigan, P; Mullaney, BP; Myrand, SP; Ohannesian, D; Powell, E; Reck, M; Scagliotti, GV; Smit, EF; Socinski, MA; Szczesna, A; Thatcher, N; von Pawel, J | 1 |
| Jin, S; Shao, N; Zhu, W | 1 |
| Avci, Z; Gursel, O; Kurekci, E; Malbora, B; Olgac, A; Ozbek, N | 1 |
| Cho, YJ; Duk Lee, J; Go, SI; Hwang, YS; Jeong, YY; Kim, DC; Kim, HC; Ko, GH; Lee, GW; Lee, JH; Lee, JS; Oh, S; Yang, JW | 1 |
| Beyer, J; Bokemeyer, C; Hartmann, JT; Kleinhans, A; Kollmannsberger, CK; Kramar, A; Lorch, A; Rick, O | 1 |
| Baek, HJ; Kim, HS; Lim, DH; Park, ES; Park, HJ; Park, KD; Sung, KW; Won, SC | 1 |
| Aaberg, TM; Chevez-Barrios, P; Chintagumpala, M; Gao, W; Gombos, DS; Grossniklaus, HE; Hwang, CK; Paysse, E; Verner-Cole, E | 1 |
| Berger, MS; Blakely, J; Chiappori, AA; Chu, QS; Moezi, MM; Ross, HJ; Salgia, R; Schnyder, J; Schreeder, MT; Stephenson, JJ; Subramaniam, DS | 1 |
| Belda-Iniesta, C; Cejas, P; De Castro Carpeño, J; Feliu, J; López, R; Moreno, V; Nistal, M; Sereno, M | 1 |
| Brown, NJ; Jitlal, M; Lee, SM; Tin, AW; Woll, PJ; Young, RJ | 1 |
| Horváth, A; Horváth, E; Popşor, S | 1 |
| Bi, N; Cao, J; Li, J; Li, W; Liang, J; Lv, J; Ou, G; Ren, H; Wang, L; Wu, S; Zhang, X; Zhou, Z | 1 |
| Adachi, M; Aida, N; Hata, M; Inoue, T; Ito, S; Kigasawa, H; Niwa, T; Odagiri, K; Ogino, I; Omura, M | 1 |
| Beard, CJ; Buyyounouski, MK; Efstathiou, JA; Wilder, RB | 1 |
| Berlin, J; Black, J; E Engel, M; Fagan, EL; Shoemaker, AH; Slone, JS | 1 |
| Iyoda, A; Jiang, SX; Kageyama, T; Masuda, N; Matsumoto, T; Nagashio, R; Ryuge, S; Saegusa, M; Sato, Y; Satoh, Y | 1 |
| Behrens, C; Correa, AM; Erasmus, JJ; Kalhor, N; Kim, ES; Lee, JJ; Pataer, A; Raso, MG; Roth, JA; Stewart, DJ; Swisher, SG; Vaporciyan, AA; Wistuba, II | 1 |
| Tsukasaki, K | 1 |
| Guirado Torrecillas, L; Hernández Contreras, ME; Rosa Salazar, V | 1 |
| Atchaneeyasakul, LO; Buaboonnam, J; Chiewvit, P; Sanpakit, K; Trinavarat, A | 1 |
| Bianciotto, CG; Iturralde, JC; Kaliki, S; Rojanaporn, D; Say, EA; Shields, CL | 1 |
| Bergeron, C; Bouvet, N; Ellershaw, C; Jenney, ME; Kelsey, A; Martelli, H; Merks, JH; Oberlin, O; Rey, A; Sanchez de Toledo, J; Scopinaro, M; Spooner, D; Stevens, MC | 1 |
| Barriger, RB; Bradley, JD; De Petris, L; Kim, TH; Marks, LB; Moreno, M; Palma, DA; Ramella, S; Rengan, R; Rodrigues, G; Senan, S; Stitt, L; Tsujino, K | 1 |
| Guo, C; Li, H; Liu, C; Ma, C; Shi, Y; Song, X; Wang, Q; Wang, X; Zhang, L; Zhang, X; Zhu, F | 1 |
| Harilal, A; Krishnakumar, S; Maheswari, UK; Mitra, M; Mohanty, C; Sahoo, SK | 1 |
| Dong, XJ; Li, LY; Wang, MZ; Xia, Y; Zhang, L; Zhang, XT; Zhao, J; Zhong, W | 1 |
| Eijk, PP; Groenendijk, MR; Paul, MA; Postmus, PE; Smit, EF; Thunnissen, E; van de Wiel, MA; Ylstra, B | 1 |
| Han, TJ; Heo, DS; Kim, HJ; Kim, YW; Lee, SH; Wu, HG | 1 |
| Bisogno, G; Carli, M; Casanova, M; Dall'Igna, P; De Ioris, MA; De Leonardis, F; De Salvo, GL; Ferrari, A; Manzitti, C; Meazza, C | 1 |
| Matsunaga, M; Miwa, K; Noguchi, T; Sasaki, Y | 1 |
| Furuya, K; Goto, T; Kato, M; Kita, T; Kudoh, K; Miyamoto, M; Sasaki, N; Takano, M; Watanabe, A; Yoshikawa, T | 1 |
| Ktenidis, K; Papanikolaou, A; Pervana, S; Tsolakidis, D | 1 |
| Abonour, R; Brames, MJ; Einhorn, LH; Siddiqui, BK; Suleiman, Y | 1 |
| Basu, EM; Cheung, NK; Kramer, K; Kushner, BH; Modak, S; Roberts, SS | 2 |
| Kim, HO; Kim, HS; Kim, NK; Lyu, CJ; Suh, CO | 1 |
| Cullen, M | 1 |
| Almarzouki, H; Bababeygy, SR; Berry, JL; Jubran, R; Kim, JW; Lee, TC; Murphree, AL; Wong, K | 1 |
| Faegh, A; Ghassemi, F; Karkhaneh, R; Rahmanikhah, E; Roohipoor, R | 1 |
| Guba, SC; Liepa, AM; Lorigan, P; Peterson, P; Reck, M; Smit, EF; Socinski, MA; Szutowicz-Zielinska, E; Thatcher, N; Winfree, KB | 1 |
| Ahmed, AB; Bruserud, O; Hatfield, KJ; Kittang, AO; Reikvam, H; Sjo, M; Tvedt, TH | 1 |
| Harigae, H; Hirokawa, M; Ishida, Y; Ishizawa, K; Ito, J; Kameoka, Y; Kato, Y; Murai, K; Noji, H; Sasaki, O; Sawada, K; Shichishima, T; Tajima, K; Takahashi, N | 1 |
| Ando, M; Gemma, A; Hino, M; Kobayashi, K; Kosaihira, S; Minegishi, Y; Miyanaga, A; Mizutani, H; Nomura, K; Noro, R; Okano, T; Seike, M; Yoshimura, A | 1 |
| Carmichael, C; Ferrell, B; Frankel, P; Hsu, J; Margolin, K; Pal, SK; Saikia, J; Stein, CA; Sun, V; Twardowski, P; Yamzon, J | 1 |
| Di Maio, M; Martelli, O; Rossi, A | 1 |
| Beyer, J; Droz, JP; Fizazi, K; Hartmann, JT; Kramar, A; Lorch, A; Massard, C; Pico, JL; Rosti, G | 1 |
| Bakhshi, S; Radhakrishnan, V; Sharma, S; Vishnubhatla, S | 1 |
| Godoy, HE; Lele, SB; Odunsi, K; Olawaiye, AB; Rauh-Hain, JA; Shahzad, MM | 1 |
| Chen, W; He, Y; Peng, J; Song, W; Zhang, S | 1 |
| Ansari, RH; Atkins, JN; Bogart, JA; Green, MR; Hodgson, LD; Kelley, MJ; Pang, H; Vokes, EE | 1 |
| Bootsma, G; Borger, J; De Ruysscher, D; Dingemans, AM; Geraedts, W; Lambin, P; Lunde, R; Pitz, C; Reymen, B; van Baardwijk, A; Van Loon, J; Wanders, R | 1 |
| Benesch, M; Deinlein, F; Faldum, A; Friedrich, C; Gerber, NU; Kortmann, RD; Kuehl, J; Kwiecien, R; Ottensmeier, H; Pietsch, T; Rutkowski, S; von Bueren, AO; von Hoff, K; Warmuth-Metz, M | 1 |
| Fukayama, M; Kurokawa, M; Nakamura, F; Takazawa, Y; Uni, M; Yoshimi, A | 1 |
| Fujii, T; Fujiwara, M; Jinno, S; Kobayashi, D; Kodera, Y; Nomoto, S; Ohashi, N; Shimokata, T; Takeda, S; Tanaka, C; Yamada, S | 1 |
| Demura, Y; Kimura, H; Morikawa, M; Okazawa, H; Tsuchida, T; Umeda, Y | 1 |
| Joung, YS; Kim, JH; Koo, HH; Lee, SH; Lim, DH; Shin, HJ; Son, MH; Suh, YL; Sung, KW; Yoo, KH | 1 |
| Jaehde, U; Kloft, C; Lindauer, A; Nock, V | 1 |
| Jaehde, U; Kloft, C; Minichmayr, I; Nock, V | 1 |
| Hangaishi, A; Imai, Y; Kobayashi, T; Kurokawa, M; Morikawa, T; Nakamura, F; Ota, S; Shinohara, A; Takazawa, Y; Yamamoto, G | 1 |
| Dickie, G; Finnigan, R; Hruby, G; Keller, J; Poulsen, M; Rischin, D; Tripcony, L; Wratten, C | 1 |
| Boyd, TE; Budde, LE; Chen, TL; Frayo, SL; Gooley, TA; Gopal, AK; Kammerer, BE; Knudsen, NL; Oliveira, GR; Pagel, JM; Press, OW; Roden, JE; Shustov, AR; Warr, TA; Zhang, MM | 1 |
| Mendonça-Torres, MC; Roberts, SS | 1 |
| Akamatsu, H; Endo, M; Kenmotsu, H; Murakami, H; Naito, T; Nakajima, T; Nakamura, Y; Ono, A; Shukuya, T; Takahashi, T; Tsuya, A; Wakuda, K; Yamamoto, N | 1 |
| Arai, E; Futamura, N; Hirata, A; Ishiguro, N; Kozawa, E; Miyahara, R; Nishida, Y; Tsukushi, S; Tsurudome, I; Urakawa, H | 1 |
| Alapetite, C; Calaminus, G; Frappaz, D; Garrè, ML; Kortmann, R; Nicholson, JC; Patte, C; Ricardi, U; Saran, F; Worch, J | 1 |
| Dauphin, G; de Araujo, PC; Demarche, M; Forget, P; Leroy, P; Rausin, L | 1 |
| Goto, K; Niho, S; Ohe, Y; Ohmatsu, H; Umemura, S; Yoh, K; Yoshida, T | 1 |
| Bakhshi, S; Chawla, B; Hada, M; Kashyap, S | 1 |
| Berdel, WE; Demant, A; Evers, G; Kessler, T; Köhler, G; Krug, U; Kuhlmann, M; Mesters, R; Mikesch, JH; Mohr, M; Müller-Tidow, C; Pohlen, M; Schliemann, C; Schmidt, E; Thoennissen, GB; Thoennissen, NH; Wessling, J | 1 |
| Kuwano, H; Murakawa, T; Murayama, T; Nagayama, K; Nakajima, J; Sano, A; Tsuchiya, T; Yoshida, Y | 1 |
| Aslan, D; Cetin, M; Eroglu, C; Eser, B; Kaynar, L; Keklik, M; Kurnaz, F; Mentes, S; Orhan, O; Sahin, C; Sivgin, S; Soyuer, S; Unal, A; Yildiz, OG | 1 |
| Jiang, SY; Karam, I; Khaira, M; Lee, CW; Schellenberg, D | 1 |
| Abonyi-Tóth, Z; Katona, L; Kovács, G; Moldvay, J; Rokszin, G | 1 |
| Hasegawa, Y; Kataoka, K; Kimura, T; Kondo, M; Kondoh, Y; Nishiyama, O; Taniguchi, H; Watanabe, N | 1 |
| Chi, YH; Du, F; Jiang, WC; Song, Y; Sun, YK; Wang, JW; Yang, L; Zhou, AP | 1 |
| Czuczman, MS; Edvardsen, K; Fayad, L; Fecteau, D; Fennessy, M; Henkel, K; Jewell, RC; Joyce, R; Kharfan-Dabaja, MA; Liao, Q; Lisby, S; Lossos, IS; Matasar, MJ; Moskowitz, CH; Rodriguez, MA; Shea, TC; Singh, RP; Spitzer, G | 1 |
| Brasch, F; Gehl, HB; Görner, M; Hirnle, P; Scholtz, LU; Sudhoff, H; Wegehenkel, K | 1 |
| Khunnarong, J; Manusirivithaya, S; Pataradool, K; Pitakkarnkul, S; Prutthiphongsit, W; Srijaipracharoen, S; Tangjitgamol, S; Thavaramara, T | 1 |
| Angarita, FA; Meek, E; Rodríguez, JL; Sánchez, JO; Tawil, M; Torregrosa, L | 1 |
| Baek, HJ; Han, JW; Im, HJ; Kang, HJ; Koh, KN; Lee, SH; Park, HJ; Park, KD; Sung, KW | 1 |
| Duque, M; Gupta, A; Saif, MW | 1 |
| Antonelli, M; Biassoni, V; Gandola, L; Giangaspero, F; Massimino, M; Modena, P; Pecori, E; Poggi, G; Schiavello, E; Spreafico, F; Vajna De Pava, M | 1 |
| Bornfeld, N; Eggert, A; Jurklies, C; Künkele, A; Lohmann, D; Schulte, JH; Wieland, R | 1 |
| Choi, MK; Hoon Lim, D; Kang, ES; Kim, DW; Kim, SJ; Kim, WS; Ko, YH; Park, JH; Pyo, DH; Seok, H | 1 |
| Lee, DW; Lee, HN; Lee, JW; Lee, KH; Park, JS; Park, ST | 1 |
| Gisselbrecht, C | 1 |
| Beiske, K; Brock, P; Casale, F; Castel, V; Cullinane, C; Erminio, G; Gambini, C; Garaventa, A; Haupt, R; Holmes, K; Kohler, JA; Marquez, C; Munzer, C; Navarro, S; Parodi, S; Peuchmaur, M; Rubie, H; Valteau-Couanet, D | 1 |
| Buiga, R; Irimie, A; Kontogeorgos, G; Piciu, A; Piciu, D | 1 |
| Athanasopoulos, A; Daladimos, T; Kosmas, C; Papachrysanthou, T; Tsavaris, N; Vlachoyiannopoulos, PG | 1 |
| Liu, H; Shan, Y; Tian, YT; Wang, CF; Xie, YB; Xu, Q; Yuan, XH; Zhang, JW; Zhao, DB; Zhou, ZX | 1 |
| Ishigaki, T; Kobayashi, M; Kobayashi, S; Ohno, N; Sato, K; Tojo, A; Uchimaru, K; Watanabe, N; Yuji, K | 1 |
| Collins, G; Eyre, T; Hildyard, C; Sheikh, S | 1 |
| Fetterly, GJ; Fong, MK; Iyer, RV; McDougald, LJ | 1 |
| Alavi, A; Bradley, JD; Cho, KH; DeNittis, A; Duan, F; Gorelick, JJ; Johnson, DW; Kim, SK; Komaki, R; Macapinlac, H; Machtay, M; Munden, R; Neumann, DR; Reddin, JS; Sherwin, N; Siegel, BA; Snyder, BS; Videtic, G; Wilf, LH | 1 |
| Curtin, J; Downey, A; Edwards, S; Kwa, M; Muggia, F; Reich, E; Wallach, R | 1 |
| Jamil, K; Naidu Madireddy, UR; Natukula, K; Pingali, UR; Suresh Attili, VS | 1 |
| Bokemeyer, C; Budach, W; de Zwart, P; Eckert, F; Hartmann, JT; Horger, M; Kluba, T; Königsrainer, A; von Weyhern, CH | 1 |
| All-Ericsson, C; Bartuma, K; Holm, S; Kosek, S; Pal, N | 1 |
| Argiris, A; Gooding, WE; McLaughlin, B; Schmitz, JC; Siegfried, JM; Socinski, MA; Tarhini, AA; Zahoor, H | 1 |
| Arakawa, Y; Fujimoto, K; Kikuchi, T; Kunieda, T; Miyamoto, S; Mizowaki, T; Murata, D; Takagi, Y; Takahashi, JC | 1 |
| Fukuoka, K; Matsutani, M; Nishikawa, R; Sasaki, A; Suzuki, T; Wakiya, K; Yanagisawa, T | 1 |
| Bastide, C; Bruyère, F; Deville, JL; Flechon, A; Guy, L; Karsenty, G | 1 |
| Abramson, DH; Brodie, SE; Francis, JH; Jonna, G; Liu, CY; Marr, BP | 1 |
| Imai, H; Izumi, H; Komatsu, N; Noguchi, M; Ota, Y; Sekiguchi, Y; Shimada, A; Sugimoto, KJ; Wakabayashi, M; Yamaguchi, N | 1 |
| Bulanov, A; Fedyanin, M; Garin, A; Mosyakova, Y; Pokataev, I; Polockii, B; Tjulandin, S; Tryakin, A; Zakharova, T | 1 |
| Brouwers, EE; Huitema, AD; Kuck, EM; Rozemeijer, R; van Gorp, F; van Rens, MT | 1 |
| Fukuoka, M; Horai, T; Katakami, N; Nakagawa, K; Ohmatsu, H; Okamoto, H; Saijo, N; Sekine, I; Shibuya, M; Yokoyama, A | 1 |
| Balleisen, L; Basara, N; Behre, G; Casper, J; Christopeit, M; Ganser, A; Hinke, A; Hinke, R; Kahl, C; Koenigsmann, M; Metzner, B; Mohren, M; Niederwieser, D; Reichle, A; Sayer, HG; Stadler, M; Theurich, S; Uharek, L | 1 |
| Kalpana, N; Narendran, V; Shah, PK | 1 |
| Boutros, PC; Feigen, M; Harris, S; John, T; Lambin, P; Liew, MS; Mitchell, P; Sia, J; Starmans, MH; Tafreshi, A; White, S; Zimet, A | 1 |
| Chohnabayashi, N; Ishikawa, G; Jinta, T; Kitamura, A; Mochizuki, S; Nishimura, N; Suzuki, K; Tomishima, Y; Yamano, Y | 1 |
| Caprario, LC; Kent, DM; Strauss, GM | 1 |
| Joung, YS; Kim, JH; Koo, HH; Lee, NH; Lee, SH; Lim, DH; Shin, HJ; Suh, YL; Sung, KW; Yoo, KH | 1 |
| Bover, I; Domine, M; Font, A; Galán, A; Gómez Codina, J; González Billalabeitia, E; Gúrpide, A; Isla, D; Lecumberri, R; López Vivanco, G; Rocha, E; Rosell, R; Vicente, V | 1 |
| Chihara, D; Chou, T; Hasegawa, Y; Henzan, H; Izutsu, K; Kaneko, H; Kato, K; Kondo, E; Mizuta, S; Sakai, R; Sakamaki, H; Sugahara, H; Suzuki, R; Suzumiya, J; Yokoyama, K | 1 |
| Pantongrag-Brown, L; Pittayanon, R; Rerknimitr, R; Wisedopas, N | 1 |
| Diehn, M; Hanlon, AL; Harris, JP; Le, QT; Loo, BW; Murphy, JD | 1 |
| Arver, S; Cavallin-Ståhl, E; Cohn-Cedermark, G; Eberhard, J; Giwercman, A; Isaksson, S; Lundberg Giwercman, Y; Ståhl, O | 1 |
| Furuse, H; Ishii, Y; Kai, F; Nagata, M; Otsuka, A; Ozono, S; Sugiyama, T; Suzuki, T; Takayama, T; Yajima, T | 1 |
| Honavar, SG; Khanna, R; Manjandavida, FP; Reddy, VA | 1 |
| Daugaard, G; Feldt-Rasmussen, B; Gundgaard, MG; Lauritsen, J; Mortensen, MS; Oturai, PS | 1 |
| Brock, P; Burchill, SA; Corrias, MV; Dallorso, S; Gregory, WM; Ladenstein, R; Laureys, G; Luksch, R; Papadakis, V; Pearson, AD; Swerts, K; Tchirkov, A; Valteau-Couanet, D; Vicha, A; Viprey, VF | 1 |
| Chen, X; Dai, H; Qian, Z; Wang, Y; Xu, X; Zhao, Y | 1 |
| Bozinov, O; Branscheidt, M; Frontzek, K; Rushing, EJ; Valavanis, A; Wegener, S; Weller, M | 1 |
| Maggs, FG | 1 |
| Kotwall, CA; Powell, JL; Shiro, BC | 1 |
| Beaven, AW; Bejot, C; Bhattacharyya, P; Carini, C; Chow, KF; Donato, ML; Feldman, T; Gadaleta, G; Goy, A; Kdiry, S; Mato, AR; Pecora, AL; Protomastro, EA; Rowley, SD; Smith, J; Stives, S; Timberg, M; Valentinetti, M; Yang, X; Yannotti, KM | 1 |
| Arce-Lara, C; Kelley, MJ; Santana-Davila, R; Szabo, A; Whittle, J; Williams, CD | 1 |
| Bastos, DA; Feldman, DR | 1 |
| Buil-Bruna, N; López-Picazo, JM; Martín-Algarra, S; Moreno-Jiménez, M; Ribba, B; Trocóniz, IF | 1 |
| Carvalho, MA; Carvalho, RS; Chammas, R; Fernandes, VC; Monteiro, AN; Nepomuceno, TC; Rodrigues, DC; Suarez-Kurtz, G; Woods, NT | 1 |
| Batus, M; Bonomi, P; Dandekar, VK; Fidler, MJ; Kiel, K; Sher, DJ; Young, J | 1 |
| Behfar, M; Beiki, D; Eftekhari, M; Fallahi, B; Fard-Esfahani, A; Ghavamzadeh, A; Hamidieh, AA; Hosseini, AS; Paragomi, P; Shamshiri, A | 1 |
| Karangelis, D; Nikolaidis, N; Roubelakis, A; Weeden, DF | 1 |
| Bay, JO; Biron, P; Brindel, I; Bui, BN; Caty, A; de Revel, T; Delva, R; Dubot, C; Fizazi, K; Fléchon, A; Gaulet, M; Geoffrois, L; Gligorov, J; Gravis, G; Horn, E; Lotz, JP; Micléa, JM; Provent, S; Roubaud, G; Selle, F; Soares, DG; Temby, I; Wittnebel, S | 1 |
| Bai, L; Greenwood, M; Kerridge, I; Ma, CK; Reid, C; Ward, C; Wong, K; Xia, W | 1 |
| Demir, AH; Emir, S; Karakuş, E; Özcan, F; Özyörük, D; Senayli, A; Tiryaki, T | 1 |
| Boku, N; Furuse, J; Ishido, K; Kasuga, A; Machida, N; Morizane, C; Nishina, T; Okusaka, T; Sudo, K; Takahashi, H; Tobimatsu, K; Yamaguchi, T | 1 |
| Albert, I; Ao-Baslock, A; Berger, MS; Blakely, LJ; Kazarnowicz, A; Kovacs, P; Langer, CJ; Moezi, MM; Pajkos, G; Pathak, AK; Ross, HJ; Schnyder, J; Schreeder, MT; Somfay, A; Zatloukal, P | 1 |
| Cafferty, FH; Cullen, MH; Gabe, R; Huddart, RA; Pollock, P; Shamash, J; Stenning, SP; White, JD | 1 |
| Bailly, C; Bal-Mahieu, C; Boulet, E; Guilbaud, N; Kruczynski, A; Lansiaux, A; Lartigau, E; Leblond, P; Meignan, S; Pillon, A; Sarrazin, T | 1 |
| Aieta, M; Bosso, D; Buonerba, C; Cobelli, OD; De Placido, S; Di Lorenzo, G; Federico, P; Ferro, M; Imbimbo, C; Izzo, M; Longo, N; Perri, F; Policastro, T; Puglia, L; Vittoria Scarpati, GD | 1 |
| Kadowaki, M; Kohno, K; Kondo, S; Kubota, A; Okamura, S; Takase, K; Takeshita, M; Tanimoto, K; Yamasaki, S | 1 |
| Bacakoglu, F; Cok, G; Erdinc, M; Goker, E; Goksel, O; Goksel, T; Karakus, H; Uslu, R | 1 |
| Asamura, H; Fujiwara, Y; Horinouchi, H; Kanda, S; Kitazono, S; Mizugaki, H; Nokihara, H; Tamura, T; Tanaka, A; Tsuta, K; Yagishita, S; Yamamoto, N | 1 |
| Choi, YB; Koo, HH; Lee, NH; Lee, SH; Lim, DH; Shin, HJ; Son, MH; Sung, KW; Yoo, KH | 1 |
| DoRosario, A; Kleffel, S; Larson, AR; Lee, N; Lezcano, C; Murphy, GF; Schatton, T; Wang, LC; Zhan, Q | 1 |
| Beumer, J; Chen, A; Chen, Z; Christner, SM; Deng, X; Doho, GH; Khuri, FR; Kim, S; Kowalski, J; Li, C; Owonikoko, TK; Ramalingam, SS; Rossi, MR; Sica, GL; Strychor, S; Sun, SY; Switchenko, JM; Yue, P; Zhang, G | 1 |
| Ak, G; Akcay, M; Bayman, E; Etiz, D | 1 |
| Akhurst, T; Cullinane, C; Eu, P; Hicks, RJ; Lewin, J; Mileshkin, L; Rao, A; Waldeck, K; Watkins, DN | 1 |
| Lonial, K; Noyes, AM; Siegel, RD | 1 |
| Li, T; Mao, GJ; Sun, H; Sun, LL; Zhang, Y | 1 |
| Adachi, S; Endo, I; Ichikawa, Y; Ishikawa, T; Kida, K; Narui, K; Sasaki, T; Satake, T; Shimada, K; Shimizu, D; Sugae, S; Tanabe, M; Yamada, A | 1 |
| Allen-Rhoades, W; Kim, E; Krance, R; Louis, CU; Mazloom, A; Nuchtern, J; Paulino, AC; Russell, H | 1 |
| Benson, C; Blay, JY; Dirksen, U; Gelderblom, H; Judson, I; Juergens, H; Placzke, J; Rasper, M; Rutkowski, P; van den Berg, H; van Maldegem, AM | 1 |
| Liu, F; Liu, Y; Wang, KL; Zhang, X | 1 |
| Fukushima, T | 1 |
| Eba, J; Misumi, Y; Nakamura, K; Ohe, Y; Okamoto, H; Shibata, T; Shimokawa, T; Yamamoto, N | 1 |
| Barone, C; Bengala, C; Biasoni, D; Carlo-Stella, C; Catanzaro, M; Di Nicola, M; Farè, E; Giannatempo, P; Gianni, AM; Lo Vullo, S; Magni, M; Mariani, L; Matteucci, P; Necchi, A; Nicolai, N; Piva, L; Pizzocaro, G; Raggi, D; Salvioni, R; Schiavetto, I; Siena, S; Stagni, S; Torelli, T | 1 |
| Adiguzel, R; Andreana, PR; Arslan, Z; Ates, M; Bemis, T; Bercovitch, LG; Bögli, S; Boucherez, J; Boudouf, S; Briat, JF; Brown, BM; Busemann, A; Buters, J; Byers, JS; Cairo, MS; Carrier, F; Chalmers, JJ; Chang, E; Chen, J; Chen, Y; Christenson, MK; Cielecka-Piontek, J; Cole, PA; Cooper, BS; Davis, PH; De Silva, RA; Decato, S; DeFries, RS; Demir, V; Denic, A; Deserno, M; Dickey, AM; Diss, E; Eberlein, B; Eyerich, S; Faluvegi, G; Farlow, MR; Fletcher, JW; Francetic, T; Furlan, L; Garbacki, P; Gartung, A; Garvin, JH; Gates, L; Gaymard, F; Ghetti, B; Gibson, MP; Griffin, RG; Hamed, M; Hammad, LA; Hammond, GB; Han, J; Hann, R; Hao, N; Harrison, LA; Heidecke, CD; Hutchins, GD; Inlow, M; Irmer, H; Jani, P; Jara-Cavieres, A; Jawadi, H; Jiang, Q; Jiang, Y; Kameda, T; Keeler, EG; Kim, H; Kim, R; Kim, S; Kinney, PL; Krause, A; Kumar, V; Kwok, Y; Lam, T; Lanni, F; Le May, M; Lee, A; Lee, JF; Lee, MJ; Leontyev, IV; Li, Q; Li, X; Liu, J; Liu, NK; Lominadze, D; Lösche, M; Lu, QB; Lu, Y; Lu, Z; Mach, H; Madsen, E; Marletta, M; Marlier, ME; McDonald, BC; McKay, IS; Mckenzie, CL; Mecozzi, S; Menges, P; Meyers, D; Michaelis, VK; Montooth, KL; Moore, LR; Morgan, JK; Morris, E; Movahed, M; Nalabothula, N; Narayanan, S; Nguyen, D; Nho, K; Oken, B; Ong, TC; Osborne, LS; Paczkowska, M; Park, EK; Pennino, D; Peters, S; Potluri, LP; Qin, C; Radhakrishnan, K; Randerson, JT; Rantanen, J; Reyt, G; Ring, J; Risacher, SL; Rodriguez, M; Saykin, AJ; Schmidt-Weber, CB; Sengelaub, DR; Shatters, RG; Shen, L; Shen, V; Shindell, DT; Stuchebrukhov, AA; Swaminathan, S; Takahashi, K; Talaczyńska, A; Tallman, EF; Tan, C; Terry, SF; Trabbic, KR; Trease, AJ; Tretter, C; Uitto, J; Váradi, A; von Bernstorff, W; Voulgarakis, A; Wagenhofer, M; Wahbeh, H; Wang, EN; Wang, X; Wells, RJ; West, JD; Williams, PS; Wolff, JE; Wootla, B; Xu, B; Xu, XM; Yoder, KK; Zalewski, P; Zan, GH; Zborowski, M; Zhang, HH; Zhang, W; Zhao, J; Zoecklein, L | 1 |
| Acab, A; Chailangkarn, T; Dietrich, A; Fernandez, TV; Griesi-Oliveira, K; Gu, X; Gupta, AR; Haddad, G; Ji, W; Lifton, RP; Marchetto, MC; Ming, GL; Muotri, AR; Murdoch, JD; Nicol, X; Nunez, Y; Passos-Bueno, MR; Pradhan, D; Sanders, SJ; Song, H; Spitzer, N; State, MW; Sunaga, DY; Vadasz, E; Walker, MF | 1 |
| Chang, J; Du, Z; Li, D; Lin, D; Shen, H; Tan, W; Wei, L; Wu, C; Wu, T; Xu, B; Yu, D; Yuan, P | 1 |
| Arce-Lara, C; Devisetty, K; Gore, EM; Kelley, MJ; Moran, A; Santana-Davila, R; Sparapani, R; Szabo, A; Whittle, J; Williams, CD | 1 |
| Beck, JF; Ebinger, M; Feuchtinger, T; Furtwängler, R; Greil, J; Handgretinger, R; Illhardt, T; Klingebiel, T; Lang, P; Schlegel, PG; Schwarze, CP | 1 |
| Bakhshi, S; Meel, R; Pushker, N; Vishnubhatla, S | 1 |
| Abonour, R; Einhorn, LH; Matei, D; Reddy Ammakkanavar, N | 1 |
| Krishnakumar, S; Sreenivasan, S | 1 |
| Anurathapan, U; Choeyprasert, W; Chuansumrit, A; Hongeng, S; Nartthanarung, A; Pakakasama, S; Sirachainan, N; Songdej, D | 1 |
| Chan, WH; Ibrahim, ZA; Narihan, MZ; Ong, EJ; Wong, SL | 1 |
| Bornfeld, N; Eggert, A; Holdt, M; Künkele, A; Lohmann, D; Schulte, JH; Temming, P; Wilm, J | 1 |
| Johnston, WT; Kagame, K; Ndamira, A; Newton, R; Picton, SV; Revill, P; Simmons, IG; Twinamasiko, A; Waddell, KM | 1 |
| Carrasco, R; Cruz, O; de Torres, C; Guillen, A; Lavarino, C; Mañé, S; Mora, J; Parareda, A; Rios, J; Salvador, H; Suñol, M; Vancells, M | 1 |
| Kadalayil, L; KhoshZaban, M; Kuku, S; Ledermann, J; Loddo, M; McCormack, M; Proctor, I | 1 |
| Gautschi, M; Häberle, J; Hahn, D; Hu, L; Laemmle, A; Leibundgut, K; Nuoffer, JM; Rüfenacht, V | 1 |
| Baudin, E; Caplin, ME; Ferolla, P; Filosso, P; Garcia-Yuste, M; Lim, E; Oberg, K; Pelosi, G; Perren, A; Rossi, RE; Travis, WD | 1 |
| Du, XL; Li, HQ; Lu, CH; Pan, CX; Sheng, XG; Wang, C; Yin, YJ | 1 |
| Advani, R; Ansell, SM; Bartlett, NL; Belada, D; Coiffier, B; Drachman, JG; Fayad, L; Forero-Torres, A; Kuliczkowski, K; Ng, E; Stuart, R | 1 |
| Chen, P; Chen, Z; Guo, S; Hu, C; Huang, C; Li, B; Li, L; Li, W; Liao, M; Lu, S; Luo, Y; Song, X; Wu, G; Xu, L; Yu, Y; Zhang, L; Zhang, Y; Zhou, C | 1 |
| Brown, RJ; Dhall, G; Finlay, JL; Gardner, SL; Ginn, KF; Khatua, S; Yankelevich, M; Yildiz, VO; Zaky, W | 1 |
| Fox, SY; Gerecitano, J; Grewal, R; Hamlin, PA; Horwitz, S; Kobos, R; Kumar, A; Matasar, M; McCall, SJ; Moskowitz, AJ; Moskowitz, CH; Noy, A; Palomba, ML; Perales, MA; Portlock, CS; Sauter, C; Schöder, H; Shukla, N; Steinherz, P; Straus, D; Trippett, T; Yahalom, J; Younes, A; Zelenetz, A | 1 |
| Costa, DB; Desai, NV; Folch, E; Gangadharan, SP; Huberman, MS; Karp, RS; Kent, MS; Le, X; Majid, A; Rangachari, D; VanderLaan, PA | 1 |
| Elder, JE; Mathew, AA; McKenzie, JD; Sachdev, N; Staffieri, SE | 1 |
| Baggstrom, M; Bogart, J; Crawford, J; Graziano, SL; Gu, L; Masters, GA; Miller, AA; Otterson, GA; Pang, HH; Ready, NE; Thomas, SP; Vokes, EE | 1 |
| Akinaga, S; Fujiwara, H; Imada, K; Ishida, T; Ishitsuka, K; Jo, T; Miyamoto, T; Moriuchi, Y; Nosaka, K; Saburi, Y; Suzushima, H; Taira, N; Takemoto, S; Tobinai, K; Tomonaga, M; Ueda, R; Uike, N; Uozumi, K; Utsunomiya, A; Yamamoto, K; Yoshida, S | 1 |
| Chang, CY; Chen, KH; Hou, JY; Liang, DC; Liu, HC; Sheu, JC; Yeh, TC | 1 |
| Brisse, HJ; Canale, S; Elie, C; Galmiche-Rolland, L; Irtan, S; Le Cossec, C; Michon, J; Minard-Colin, V; Sarnacki, S; Schleiermacher, G; Valteau-Couanet, D | 1 |
| Advani, RH; Gascoyne, R; Habermann, TM; Hong, F; Horning, SJ; Kahl, BS; Li, H; Quon, A; Ranheim, EA; Swinnen, LJ | 1 |
| Adachi, S; Fujino, H; Heike, T; Hiramatsu, H; Hori, T; Kato, I; Saida, S; Umeda, K; Watanabe, K; Yamada, T | 1 |
| De Leyn, P; De Ruysscher, D; Eberhardt, WE; Felip, E; Hoffmann, H; Le Péchoux, C; Peters, S; Stahel, R; Weder, W; Westeel, V | 1 |
| Abujamra, AL; Almeida, MT; Benites, E; Boldrini, E; Brunetto, AL; Castillo, LA; Costa, C; Gadelha, A; Gregianin, LJ; Kirst, D; Macedo, CD; Morais, V; Nakasato, A; Pereira, WV; Petrilli, AS; Pizza, M; Rodriguez-Galindo, C; Watanabe, FM | 1 |
| Clerico, D; DiDomenico, C; Leahey, A | 1 |
| Bouffet, E; Coluccia, D; Hawkins, C; Kamaly-Asl, I; Kulkarni, AV; Lafay-Cousin, L; Ramaswamy, V; Remke, M; Rutka, JT; Schneider, C; Tabori, U; Taylor, MD | 1 |
| Belderbos, J; De Ruysscher, D; Deasy, JO; Din, S; Dingemans, AM; Houben, R; Lambin, P; Oberije, C; Rimner, A; Uyterlinde, W; van de Heuvel, M | 1 |
| Aleieldin, A; Alfaar, AS; ElZomor, H; Fawzi, M; Kamel, A; Nour, R; Taha, H; Zaghloul, MS | 1 |
| Min, J; Wang, Q; Xu, Z; Yang, M; Zhang, AQ | 1 |
| Berthold, F; Peinemann, F; Tushabe, DA; van Dalen, EC | 1 |
| Abesada-Terk, G; Alemany, C; Brown, RH; Cartwright, TH; Faig, D; Fulp, WJ; Jacobsen, PB; Kim, GP; Lee, JH; Levine, RM; Malafa, M; Markham, MJ; Schreiber, F; Sharp, PV; Tanvetyanon, T | 1 |
| Harada, M; Inoue, A; Ishida, T; Kinoshita, I; Maemondo, M; Mori, Y; Morikawa, N; Nakagawa, T; Nukiwa, T; Oizumi, S; Saito, R; Sugawara, S; Suzuki, T; Taima, K; Watanabe, H | 1 |
| Datsenko, PV; Panshin, GA | 1 |
| Artal, A; Barneto, I; De Castro, J; Esteban, E; Gascó, P; Gasent, JM; Montalar, J; Muñoz-Langa, J; Sanchez, A; Vidal, S | 1 |
| Cohen, BH; Curran, JG; Dunkel, IJ; Finlay, JL; Gajjar, A; Geyer, JR; Hilden, J; Holmes, E; Ingles, SA; Miller, DC; Packer, RJ; Pollack, IF; Zhou, T | 1 |
| Bertozzi, AI; De Carli, E; Delion, M; Doz, F; Grill, J; Kalifa, C; Leblond, P; Rakotonjanahary, J; Rialland, X | 1 |
| Ahn, HS; Hong, CR; Ju, HY; Kang, HJ; Kim, H; Kim, HS; Kim, MS; Lee, JW; Park, JD; Park, KD; Park, SH; Shin, HY | 1 |
| Allen, JC; Bouffet, E; Buxton, AB; Chuba, PJ; Donahue, B; Fisher, PG; Goldman, S; Kretschmar, CS; Pollack, IF; Robertson, PL; Zhou, T | 1 |
| Al-Massarani, G; Alammar, M; Banat, I; Najjar, F | 1 |
| Asari, Y; Itoga, M; Kayaba, H; Morimoto, T; Nakamura, K; Okumura, K; Taima, K; Takanashi, S; Tanaka, H; Tanaka, Y | 1 |
| Gomez, D; Komaki, R; Lee, MS; Levy, LB; Liao, Z; Lu, C; Tang, C; Zhuang, Y | 1 |
| Bassett, R; Champlin, R; Gulbis, AM; Holmberg, L; Jones, RB; Kingham, A; Ledesma, C; Margolin, K; Nieto, Y; Pagliaro, L; Tannir, N; Tu, SM | 1 |
| Hoffmann, L; Khalil, AA; Knap, MM; Moeller, DS; Winther-Larsen, A | 1 |
| Kawaguchi, H; Kobayashi, M; Kurisu, K; Nosaka, R; Sugiyama, K; Takayasu, T; Yamasaki, F | 1 |
| Hanna, N; Jalal, SI; Mamdani, H | 1 |
| Pointdujour-Lim, R; Samara, WA; Say, EA; Shields, CL | 1 |
| Chang, GJ; Crane, CH; Das, P; Feig, BW; Krishnan, S; Minsky, BD; Rashid, A; Skibber, JM; Voong, KR; Wolff, RA; Yao, JC | 1 |
| Bauer, JJ; Biewald, E; Bornfeld, N; Grasemann, C; Hauffa, BP; Hauffa, PK; Sauerwein, W; Schündeln, MM; Temming, P | 1 |
| Burris, C; Hungerford, JL; Kingston, J; Pavlidou, E; Reddy, MA; Sagoo, MS; Scheimberg, I; Thaung, C | 1 |
| Gui, L; Han, XH; He, XH; Liu, P; Qin, Y; Shi, YK; Sun, Y; Yang, S; Yao, JR; Zhang, CG; Zhang, SX; Zhao, LY; Zhou, P; Zhou, SY | 1 |
| Koo, DH; Lee, HS; Lee, SS; Lee, YG; Lim, SY; Nam, H; Oh, S; Song, JU | 1 |
| Hansen, PB; Thomsen, RH; Zakarian, K | 1 |
| Altuntaş, F; Civriz Bozdağ, S; Durgun, G; Esbah, O; Kaya, A; Kayıkçı, Ö; Kocubaba, Ş; Şirinoğlu Demiriz, I; Tekgündüz, E; Tetik, A | 1 |
| Allendorf, DJ; Bordoni, RE; Dixon, PM; Grant, SC; Jerome, ML; Miley, DK; Reddy, VB; Robert, F; Saleh, MN; Singh, KP | 1 |
| Bakoyiannis, C; Bamias, A; Christodoulou, C; Dimopoulos, MA; Karavasilis, V; Koutsoukos, K; Makatsoris, T; Papandreou, CN; Pectasides, D; Tzannis, K | 1 |
| Aerts, I; Algret, N; Bertozzi, AI; Cassoux, N; Desjardins, L; Doz, F; Esteve, M; Hajage, D; Lévy-Gabriel, C; Lumbroso-Le Rouic, L; Savignoni, A | 1 |
| Golubeva, OV; Gorovtsova, OV; Gorshkov, IM; Krivovyaz, OS; Polyakov, VG; Ushakova, TL; Yarovoy, AA | 1 |
| Akarsu, Z; Duman, E; Gunduz, S; Inal, A; Kaya, V; Ozturk, D; Yildirim, M; Yildiz, M | 1 |
| Bourneau-Martin, D; Drablier, G; Lagarce, L; Lainé-Cessac, P; Le Louet, H; Leguay, Z; Pellier, I | 1 |
| Eisele, G; Roth, P; Tonder, M; Weller, M | 1 |
| Hur, GY; Kang, EJ; Kang, KH; Kim, JS; Lee, SY; Min, KH; Oh, SC; Seo, JH; Shim, JJ | 1 |
| Bartels, U; Bouffet, E; Hader, W; Hawkins, C; Lafay-Cousin, L; Laperriere, N; Laughlin, S; Lindzon, G; Nordal, R; Taylor, MD | 1 |
| Ball, DL; Bedő, J; Chabrot, M; Everitt, SJ; Hicks, RJ; Leimgruber, A; MacManus, M; Möller, A; Solomon, B; Wen, SW | 1 |
| Elborai, Y; Elhaddad, A; Hafez, H; Hammad, M; Hussein, H; Lehmann, L; Moussa, EA | 1 |
| Imai, H; Ishioka, C; Komine, K; Okita, A; Saijo, K; Shimodaira, H; Shirota, H; Takahashi, M; Takahashi, S | 1 |
| Bratta, M; Candeloro, G; D'Orazi, V; Fumagalli, LA; Pasta, V; Rea, S; Recchia, F; Rosselli, M | 1 |
| Avivi, I; Gibstein, L; Herishanu, Y; Joffe, E; Perry, C; Polliack, A; Sarid, N | 1 |
| Gilligan, T | 1 |
| Beddok, A; Faraldi, M; Ngatchou Taenga, ÉC; Rakotonavalona, A; Vanbocksteal, J | 1 |
| Hirai, M; Kobayashi, Y; Konishi, T; Miyagawa, T; Nokubi, M; Saito, K; Washino, S | 1 |
| Bogart, JA; Crawford, J; Gu, L; Pang, HH; Ready, NE; Salama, JK; Schild, SE; Vokes, EE; Wang, X | 1 |
| Aliustaoglu, M; Aydin, D; Ercelep, O; Gemici, C; Gumus, M; Isik, D; Korkmaz, T; Mayadagli, A; Mert, AG; Odabas, H; Ozcelik, M; Ozdemir, P; Seker, M; Surmeli, H; Yuksel, S | 1 |
| Chekerov, R; Ismaeel, F; Richter, R; Roots, I; Sehouli, J; Siepmann, T; Woopen, H | 1 |
| Aplenc, R; Bagatell, R; Desai, AV; Fisher, BT; Getz, K; Huang, V; Li, Y; Mante, A; Seif, AE | 1 |
| Aoyagi, H; Chubachi, S; Ikemura, S; Iwami, E; Matsuzaki, T; Nakajima, T; Terashima, T | 1 |
| Deng, W; Li, N; Luo, S; Shen, W; Wei, C | 1 |
| DoRosario, A; Elco, CP; Frank, MH; Garcia, SS; Kleffel, S; Lee, N; Lezcano, C; Mueller, H; Murphy, GF; Posch, C; Saab, KR; Schatton, T; Sobolewski, K; Thakuria, M; Wang, LC; Wang, YE; Wilson, BJ; Zhan, Q | 1 |
| Bacon, CL; Bracken-Clarke, D; Browne, PV; Conneally, E; Daly, PA; Flynn, C; Gardiner, N; Hayden, PJ; Kennedy, MJ; Lee, G; McCaffrey, J; Ni Chonghaile, M; O'Donnell, DM; O'Kane, G; Power, D; Vandenberghe, E | 1 |
| Janssen, S; Kaesmann, L; Rades, D; Schild, SE | 1 |
| Narendran, V; Pandian, AJ; Shah, PK; Sripriya, S | 1 |
| Miyahara, M; Ureshino, H | 1 |
| Berry, JL; Jubran, R; Kim, JW; Lee, TC; Moysidis, SN; Murphree, AL; Shih, G; Wong, K | 1 |
| Bhattacharjee, A; Chaturvedi, P; D'Cruz, A; Dhumal, S; Joshi, A; Kane, S; Noronha, V; Pai, P; Patil, VM; Prabhash, K; Sharma, V; Zanwar, S | 1 |
| Chawla, B; Gupta, V; Hada, M; Kashyap, S; Narasimhaiah, PC; Sen, S; Seth, R | 1 |
| Biner Uslu, I; Dikmen, A; Erdoğan, Y; Yilmaz Demirci, N; Yılmaz, A; Yilmaz, Ü | 1 |
| Arai, H; Honda, M; Kobayashi, Y; Ueda, N; Yoshida, K | 1 |
| Choi, YB; Koo, HH; Lee, JW; Lee, NH; Son, MH; Sung, KW; Yi, E; Yoo, KH | 1 |
| Kitahara, T; Shirase, T; Takeichi, Y; Tsuji, Y; Yamazoe, N; Yukawa, H | 1 |
| Berthold, F; Peinemann, F; van Dalen, EC | 1 |
| Buzzonetti, L; Cozza, R; De Ioris, MA; Natali, G; Romanzo, A; Valente, P | 1 |
| Chen, L; Chen, Y; Feng, X; Peng, L; Wang, J; Zhong, D | 1 |
| Carr, K; Forbes, JA; He, L; Highfield Nickols, H; Moots, P; Utz, A; Weaver, K | 1 |
| Ai, S; Chen, R; Ding, Y; Du, Y; Li, Q; Luo, X; Ma, W; Mao, Y; Yang, H; Ye, H | 1 |
| Bagatell, R; Bunin, NJ; Desai, AV; Grupp, SA; Heneghan, MB; Li, Y; Seif, AE | 1 |
| Hathaisanguan, S; Maneechawakajorn, J | 1 |
| Borovskaya, TG; Dygai, AM; Fomina, TI; Vychuzhanina, AV | 1 |
| Ishida, T; Ogura, M; Takahashi, T; Tsukasaki, K; Utsunomiya, A | 1 |
| Arriola, E; Cave, J; Cross, N; Danson, S; Galea, I; Geldart, T; Griffiths, R; Hamid, D; Maishman, T; Mulatero, C; Nolan, L; Ottensmeier, C; Potter, V; Stanton, L; Wheater, M; Woll, PJ | 1 |
| Appaji, L; Padma, M; Ramanathan, S; Suma, MN; Suma, TL | 1 |
| Ando, M; Ando, Y; Emi, N; Hayashi, T; Inaguma, Y; Ito, K; Okamoto, A; Okamoto, M; Tomono, A; Tsuge, M; Yamada, S | 1 |
| Craig, MD; Cumpston, A; D'Souza, A; Dhakal, B; Eastwood, D; Esselman, J; Fenske, TS; Hamadani, M; Hari, P; Kanate, AS; Pasquini, MC; Shillingburg, A; Veltri, LW; Watkins, K | 1 |
| Hatfield, LA; Huskamp, HA; Lamont, EB | 1 |
| Badoglio, M; Bregni, M; Crysandt, M; Giannatempo, P; Ifrah, N; Kanfer, E; Lanza, F; Laszlo, D; Lo Vullo, S; Mariani, L; Martino, M; Massard, C; Mercier, M; Michieli, M; Nagler, A; Necchi, A; Oechsle, K; Pedrazzoli, P; Raggi, D; Rosti, G; Schumacher, K; Secondino, S; Wahlin, A; Wuchter, P | 1 |
| Fujimoto, S; Imai, H; Kaira, K; Minato, K; Mori, K; Watase, N; Yamada, M | 1 |
| Azad, R; Chawla, B; Hasan, F; Pathy, S; Pattebahadur, R; Seth, R; Sharma, S; Upadhyaya, A | 1 |
| Abrari, A; Gupta, A; Kumar, A; Patir, R; Vaishya, S | 1 |
| Aerts, J; Akerley, W; Fairchild, J; Felip, E; Gold, K; Havel, L; Horn, L; Kim, SW; Kong Sanchez, T; Lorigan, P; Luft, A; Nakagawa, K; Pietanza, MC; Pieters, A; Reck, M; Spigel, D; Szczesna, A; Thomas, M; Wu, YL; Zielinski, C | 1 |
| Janssen, S; Käsmann, L; Rades, D | 1 |
| Bremnes, RM; Brydøy, M; Fosså, SD; Gundersen, POM; Haugnes, HS; Hjelle, LV; Oldenburg, J; Sprauten, M; Tandstad, T; Wilsgaard, T | 1 |
| Feng, T; Huang, Y; Li, HM; Lin, DX; Ma, F; Tan, W; Tan, WW; Xu, BH; Yang, J; Yu, DK; Yuan, P | 1 |
| Ju, Y; Liang, G; You, C; Zhang, S | 1 |
| Guarino, M; Hanna, N; Jayaram, N; Masters, GA; Misleh, J; Patel, JD; Sanborn, RE; Stephens, A; Wu, J | 1 |
| Hishiki, T; Hiyama, E; Hoshino, K; Ida, K; Iehara, T; Koh, K; Kurihara, S; Onitake, Y; Oue, T; Tanaka, Y; Ueda, Y; Watanabe, K; Yano, M | 1 |
| Dimitriadis, GK; Kosmas, C; Miltiadous, C; Roditis, P | 1 |
| Fujimoto, S; Imai, H; Kaira, K; Kazama, T; Minato, K; Mori, K; Watase, N; Yamada, M | 1 |
| Alvarez, MJ; Ambesi-Impiombato, A; Andrews, SJ; Califano, A; Dela Cruz, FS; Diolaiti, D; Forouhar, F; Glade Bender, JL; Kung, AL; Mansukhani, MM; Marks, LJ; Mitchell, CM; Modzelewski, B; Nagy, PL; Rainey, AR; Turk, AT; Yamashiro, DJ | 1 |
| Dray, M; Mweempwa, A; Tan, A | 1 |
| Baudin, E; Berdelou, A; Caramella, C; Hescot, S; Leboulleux, S; Lombes, M; Paci, A | 1 |
| Daly, M; Kelly, K; Tam, K | 1 |
| Azuma, E; Hirayama, M; Imai, H; Iwamoto, S; Komada, Y; Matsumine, A; Miura, Y; Nakatani, K; Toyoda, H; Yodoya, N | 1 |
| Beck-Popovic, M; Bergin, C; Gaillard, MC; Houghton, S; Mosimann, P; Munier, FL; Puccinelli, F; Stathopoulos, C | 1 |
| Chowdhury, T; Duncan, C; Fabian, ID; Johnson, KP; Onadim, Z; Reddy, MA; Sagoo, MS; Stacey, AW | 1 |
| Behera, M; Belani, CP; Curran, WJ; Ernani, V; Higgins, KA; Khuri, FR; Owonikoko, TK; Pakkala, S; Pillai, RN; Ramalingam, SS; Saba, NF; Shin, DM; Steuer, CE | 1 |
| Siddiqui, SN; Zafar, SN; Zaheer, N | 1 |
| Adamenko, O; Belfiori, G; Cardinali, L; Crippa, S; Doglioni, C; Falconi, M; Muffatti, F; Palucci, M; Partelli, S; Zamboni, G | 1 |
| Akiba, T; Amaki, J; Ando, T; Asano, N; Ejima, Y; Hasegawa, M; Hyo, R; Ii, N; Itami, J; Itasaka, S; Katayama, N; Kobayashi, Y; Kubota, N; Maeda, T; Miyazaki, K; Murayama, T; Oguchi, M; Saito, B; Saito, Y; Sekiguchi, N; Suzuki, R; Takizawa, J; Tomita, N; Ueda, K; Wada, H; Yamaguchi, M | 1 |
| Koo, HH; Lee, HJ; Lee, JW; Lim, DH; Shin, HJ; Suh, YL; Sung, KW; Yi, ES; Yoo, KH | 1 |
| Kaneko, T; Koike, K; Kurata, T; Motobayashi, M; Nakazawa, Y; Sano, K; Shigemura, T; Sumi, T; Suzuki, S; Watanabe, T | 1 |
| Asakura, T; Nin, M; Okada, T; Satoh, M; Tsujihata, M; Yumiba, S | 1 |
| Bi, N; Chen, D; Chen, M; Chen, W; Du, L; Feng, Q; He, J; Hui, Z; Jiang, W; Li, J; Liang, J; Liu, L; Lv, C; Lv, J; Shi, A; Shyr, Y; Wang, L; Wang, W; Wang, X; Wu, S; Xiao, Z; Xu, Y; Yin, W; Zhang, H; Zhang, T; Zhao, L; Zhou, Z | 1 |
| Butcher, B; Chong, G; Cull, G; Fay, K; Filshie, R; Gandhi, MK; Gill, D; Grigg, A; Hahn, U; Hertzberg, M; Hicks, RJ; Ho, SJ; Hofman, MS; Johnston, A; Kannourakis, G; Lewis, ID; Milliken, S; Renwick, W; Seymour, JF; Taper, J; Trotman, J; Warburton, P; Watson, AM; Wirth, A | 1 |
| Gress, TM; Rinke, A | 1 |
| Elner, VM; Harbour, JW; Mohney, BG; Musch, DC; Smith, AB; Smith, BD; Smith, SJ | 1 |
| Du, ZL; Feng, T; Huang, Y; Li, HM; Lin, DX; Ma, F; Tan, W; Tan, WW; Xu, BH; Yang, J; Yu, DK; Yuan, P | 1 |
| Aziz, HA; Berry, JL; Jubran, R; Kim, JW; Kogachi, K; McGovern, K; Murphree, AL; Zolfaghari, E | 1 |
| Flynt, A; Hamid, O; McCleod, M; Polzer, J; Roberson, S; Salgia, R; Spigel, DR; Stille, JR; Weaver, RW | 1 |
| Crosse, B; Cullen, M; Fife, KM; Hackshaw, A; Harden, S; Middleton, G; Muthukumar, D; Nash, S; Ngai, Y; Ottensmeier, CH; Schmid, P; Seckl, MJ; Taylor, P; Thompson, J | 1 |
| Bolm, L; Janssen, S; Käsmann, L; Rades, D | 1 |
| Chinea-Rodríguez, A; Gallego-Rivera, JI; Gorospe, L; Rioja-Martín, ME | 1 |
| Barbieri, F; Bertolini, F; Grizzi, G; Lococo, F; Mengoli, MC; Novello, S; Orsi, G; Rossi, G | 1 |
| Anwer, F; Chan, O; Hamdani, AA; Sokolova, A; Ullah, W | 1 |
| Endo, M; Fujiwara, T; Kawamura, T; Kenmotsu, H; Kobayashi, H; Kotake, M; Mamesaya, N; Mori, K; Murakami, H; Naito, T; Nakashima, K; Omae, K; Omori, S; Ono, A; Taira, T; Takahashi, T; Wakuda, K | 1 |
| Adbul-Karim, F; Link, N; Michener, CM; Radeva, M; Rose, PG | 1 |
| Aparicio, T; Baudin, E; Bonnet, I; Cadiot, G; Coriat, R; Dahan, L; Desauw, C; Guimbaud, R; Hentic, O; Le Malicot, K; Lecomte, T; Legoux, JL; Lepage, C; Lepère, C; Lombard-Bohas, C; Malka, D; Manfredi, S; Roquin, G; Scoazec, JY; Thirot-Bidault, A; Tougeron, D; Walter, T | 1 |
| Allinson, K; Candy, N; Carr, O; McMillen, J; Trivedi, R; Young, A | 1 |
| Clark, C; Gaze, MN; Mankad, K; Michalski, A; Seunarine, K; Szychot, E; Thust, S | 1 |
| Cho, EJ; Cho, HW; Koo, HH; Lee, JW; Lee, S; Lee, SK; Lim, DH; Ma, Y; Sung, KW; Yoo, KH | 1 |
| Dean, RK; Gill, D; Nat, A; Subedi, R | 1 |
| Besse, B; Dols, MC; Dubey, S; Glisson, B; Jain, R; Jiang, Y; Menon, H; Nackaerts, K; Orlov, S; Paz-Ares, L; Ramlau, R; Schupp, M; Tang, R; Zhang, Y; Zhu, M | 1 |
| Albany, C; Chovanec, M; Hahn, N; Taza, F | 1 |
| Barbera, MA; Biasco, G; Bondi, A; Brandi, G; Brighi, N; Campana, D; Corbelli, J; Pantaleo, MA; Paragona, M | 1 |
| Bechtold, M; Berry, JL; Jubran, R; Kim, JW; Reid, M; Shah, S; Zolfaghari, E | 1 |
| Chen, X; Wang, XX; Xue, LW; Yin, DD | 1 |
| Aggarwal, C; Berman, AT; Cohen, RB; Evans, TL; Langer, C; Levin, WP; Lin, L; Rengan, R; Rwigema, JM; Simone, CB; Verma, V | 1 |
| Han, D; Li, S; Ren, X; Shang, W; Sun, L; Wang, G; Xu, L | 1 |
| Delosh, R; Evans, D; Krushkal, J; Laudeman, J; Morris, J; Ogle, C; Parchment, R; Reinhart, R; Rubinstein, L; Selby, M; Silvers, T; Sonkin, D; Teicher, BA | 1 |
| Claret, L; Copeland, AR; Fanale, MA; Fayad, LE; Feng, L; Fowler, N; Hagemeister, FB; Hu, B; Nastoupil, LJ; Neelapu, S; Nieto, Y; Oki, Y; Rodriguez, MA; Romaguera, J; Samaniego, F; Turturro, F; Westin, JR; Younes, A | 1 |
| Horwitz, SM; Mehta-Shah, N; Ratner, L | 1 |
| Awataguchi, T; Hirakawa, H; Kadota, R; Kiba, T; Noguchi, N; Ota, N; Otomo, C; Saito, M; Saito, Y; Sakaguchi, M; Sato, M; Shoji, F; Suzuki, T; Takahashi, T; Watanabe, Y | 1 |
| Cadzin, BR; Fleisher, M; Fox, SY; Gavane, S; Gerecitano, J; Grewal, R; Hamlin, PA; Horwitz, SM; Kumar, A; Matasar, M; McCall, SJ; Moskowitz, AJ; Moskowitz, CH; Ni, A; Noy, A; Palomba, ML; Perales, MA; Portlock, CS; Sauter, C; Schöder, H; Straus, D; Thoren, KL; Yahalom, J; Younes, A; Zelenetz, AD | 1 |
| Ailawadhi, S; Dholaria, B; Patel, RJ; Roy, V; Sluzevich, JC | 1 |
| Chandra, A; Khetan, V; Krishnakumar, S; Natarajan, V; Sreelakshmi, KV | 1 |
| Eze, C; Manapov, F | 1 |
| Adachi, JI; Mishima, K; Miyake, Y; Nishikawa, R; Sasaki, A; Suzuki, T | 1 |
| Antoine Aymard, P; Belhous, K; Couloigner, V; Franchi, G; Galmiche, L; Kadlub, N; Minard-Colin, V; Moreau, A; Nevoux, J; Picard, A | 1 |
| Bi, N; Liang, J; Wang, L | 1 |
| Gallie, B; Lambourne, M; MacDonald, H; Matevski, D; Racher, H; Soliman, SE | 1 |
| Costa, JC; Grauslund, M; Melchior, LC; Santoni-Rugiu, E; Sørensen, JB; Urbanska, EM | 1 |
| Hope, AJ; Papp, S; Perez-Ordóñez, B; Wasserman, JK | 1 |
| Boddy, AV; Chatelut, E; Osborne, C; Paci, A; Veal, GJ; White-Koning, M | 1 |
| Gupta, SK; Kumar, A; Pant, G; Pooniya, V; Verma, N | 1 |
| Courtien, AI; Devlin, SM; Drullinsky, P; Gerecitano, J; Kumar, A; Matasar, MJ; McCall, SJ; Miller, ST; Moskowitz, CH; Noy, A; Palomba, ML; Portlock, CS; Sauter, CS; Schoder, H; Straus, DJ; Younes, A; Zelenetz, AD | 1 |
| Fukui, T; Igawa, S; Katagiri, M; Kubota, M; Kurahayashi, S; Mitsufuji, H; Naoki, K; Nishinarita, N; Okuma, Y; Ono, T; Ozawa, T; Sasaki, J; Shirasawa, M; Sone, H; Sugimoto, A; Sugita, K | 2 |
| Aoyama, T; Arai, H; Ikeda, T; Imataki, O; Ishide, K; Katsumata, N; Kume, T; Mori, M; Shiozaki, H | 1 |
| Allan, E; Ayan, A; Barney, CL; Bazan, JG; DiCostanzo, D; Grecula, J; Haglund, KE; Otterson, GA; Scoville, N; Williams, T; Xu-Welliver, M | 1 |
| Goel, M; Kanetkar, AV; Khobragade, KH; Ostwal, V; Patkar, S; Ramaswamy, A | 1 |
| Malik, K; Shields, CL; Welch, RJ | 1 |
| Moeller, M; Schuette, W; Siebolts, U; Wickenhauser, C | 1 |
| Amaki, J; Asano, N; Choi, I; Ejima, Y; Fukuhara, N; Katayama, N; Kim, SJ; Kim, WS; Ko, YH; Kobayashi, Y; Kubota, N; Maeda, T; Miyazaki, K; Oguchi, M; Saito, B; Shimada, K; Shimoda, E; Soejima, T; Suzuki, R; Terui, Y; Tsukamoto, N; Utsumi, T; Yamaguchi, M | 1 |
| Azuma, K; Hoshino, T; Imamura, Y; Ishii, H; Kinoshita, T; Matsuo, N; Naito, Y; Tokito, T; Yamada, K | 1 |
| Chihara, D; Fanale, MA; Fayad, LE; Feng, L; Fowler, N; Garg, N; Horowitz, SB; Hosing, C; Kamble, RT; Khouri, IF; Nastoupil, L; Nieto, Y; Oki, Y; Romaguera, JE; Ruben, CE; Samaniego, F; Stafford, MD; Strati, P; Wesson, ET | 1 |
| Fukuhara, S; Hatta, S; Ito, Y; Izutsu, K; Kim, SW; Maeshima, AM; Makita, S; Maruyama, D; Munakata, W; Suzuki, T; Watanabe, J; Yuda, S | 1 |
| Dandoy, CE; Davies, SM; Jodele, S; Lane, A; Myers, K; Teusink-Cross, A; Wallace, G; Weiss, B | 1 |
| Asanuma, H; Shima, H; Shimada, H; Yamada, Y | 1 |
| Honavar, SG; Mulay, K; Rao, R; Reddy, VAP | 1 |
| Fukushima, T; Hara, J; Hishiki, T; Ikeda, H; Kamijo, T; Kaneko, M; Kaneko, T; Kuroda, T; Matsumoto, K; Nakagawara, A; Nakazawa, A; Ohira, M; Shichino, H; Soejima, T; Tajiri, T; Takahashi, H; Takimoto, T; Teramukai, S; Yokota, I; Yoneda, A | 1 |
| Hamada, N; Nakanishi, Y; Okamoto, I; Otsubo, K | 1 |
| Alcalde-Ruiz, E; Catala-Mora, J; Chantada, GL; Croxatto, JO; Dabezies, AP; de Dávila, MTG; Dufort, G; Fandiño, AC; Kopp, K; López, JP; Ossandon, D; Parareda-Salles, A; Pérez, V; Ravindranath, Y; Reaman, G; Rey, G; Sampor, C; Suñol, M; Urbieta, M; Zelter, M | 1 |
| Ito, M; Ito, R; Kageyama, Y; Katayama, N; Kawakami, K; Masuya, M; Nagaharu, K; Yamaguchi, T | 1 |
| Anurathapan, U; Dhanachai, M; Hansasuta, A; Hongeng, S; Jinawath, A; Khongkhatithum, C; Mahachoklertwattana, P; Pakakasama, S; Sirachainan, N | 1 |
| Akyüz, C; Inam, O; Kiratli, H; Koç, İ; Varan, A | 1 |
| Pedraza, AM; Stephenson, AJ | 1 |
| Akiba, J; Azuma, K; Hoshino, T; Ishii, H; Masuda, K; Matsuo, N; Naito, Y; Sakazaki, Y; Tokito, T; Tsuneyoshi, S; Yamada, K; Zaizen, Y | 1 |
| Annala, M; Beltran, H; Chedgy, EC; Chi, KN; Donoghue, AJ; Fazli, L; Herberts, C; Hurtado-Coll, A; Konomura, S; Liew, J; Parimi, S; Ritch, E; Sboner, A; Sigouros, M; Struss, W; Vandekerkhove, G; Vergidis, J; Wyatt, AW | 1 |
| Aplenc, R; Bagatell, R; Desai, AV; Fisher, B; Getz, K; Huang, V; Li, Y; Seif, AE | 1 |
| Abdel-Rahman, O | 1 |
| Dührsen, U; Lamm, W; Liebregts, T; Turki, AT | 1 |
| Amemiya, K; Hirotsu, Y; Iijima, Y; Kakizaki, Y; Kobayashi, Y; Miyashita, Y; Mochizuki, H; Omata, M; Oyama, T; Tsutsui, T; Uchida, Y | 1 |
| Dómine Gómez, M; Fröhling, KP; Huber, RM; Kapp, K; Kollmeier, J; Mauri, C; Navarro, A; Ponce-Aix, S; Riera-Knorrenschild, J; Sadjadian, P; Schmidt, M; Thomas, M; Wiegert, E; Wittig, B; Wolf, M | 1 |
| Baker, KS; Carpenter, PA; El-Haddad, A; Elzembely, MM; Park, JR; Pinto, N; Riad, KF; Sayed, HA | 1 |
| Boddy, AV; Duong, JK; Errington, J; Ladenstein, R; Nath, CE; Shaw, PJ; Veal, GJ | 1 |
| Asprino, PF; Bastos, DA; Bezerra, ROF; Camargo, AA; Canedo, FSNA; de Melo, ALA; Gongora, ABL | 1 |
| Ding, B; Havel, L; Hochmair, MJ; Horn, L; Huemer, F; Johnson, ML; Kabbinavar, F; Krzakowski, M; Lam, S; Lin, W; Liu, J; Liu, SV; Lopez-Chavez, A; Losonczy, G; Mansfield, AS; Mok, T; Nishio, M; Reck, M; Sandler, A; Shames, DS; Szczęsna, A | 1 |
| Atrafi, F; Byers, LA; Calles, A; Camidge, DR; Chae, YK; Gabrail, NY; Garralda, E; Groen, HJM; He, L; Hoening, E; Hu, B; Komarnitsky, P; Lolkema, MP; Nuthalapati, S; Sangha, RS; Tian, T; Viteri, S | 1 |
| Anzai, M; Goto, N; Ishizuka, T; Kadowaki, M; Kodawara, T; Morikawa, M; Nakamura, T; Negoro, Y; Suehiro, Y; Tsukamoto, H; Umeda, Y; Watanabe, K; Yamashita, S; Yano, R; Yoshimura, M | 1 |
| Ben Mrad, M; Chauleur, C; de Laroche, G; Espenel, S; Garcia, MA; Guy, JB; Langrand-Escure, J; Magné, N; Moreno-Acosta, P; Rancoule, C; Trone, JC; Vallard, A | 1 |
| Altman, JK; Broun, ER; Carroll, MP; Karp, JE; Kaufmann, SH; Ketterling, RP; Lazarus, HM; Litzow, MR; Luger, SM; Paietta, EM; Pratz, KW; Rowe, JM; Rybka, WB; Tallman, MS; Tun, HW; Wang, XV; Zhang, Y | 1 |
| Dong, H; Fu, Y; Li, Q; Lu, X; Wang, M; Yang, G | 1 |
| Kasami, T; Kawamoto, K; Kiryu, M; Miyoshi, H; Ohshima, K; Sone, H; Suzuki, T; Takizawa, J | 1 |
| Adkins, ES; Cohn, SL; London, WB; Maris, JM; Mattei, P; Matthay, KK; Meany, HJ; Naranjo, A; Park, JR; Schmidt, ML; Shimada, H; Tenney, SC; Twist, CJ | 1 |
| Barriuso, J; Frizziero, M; Hubner, RA; Lamarca, A; McNamara, MG; Valle, JW | 1 |
| Dean, S; Herath, D; Kosmider, S; McCracken, J | 1 |
| Nazha, B; Owonikoko, TK | 1 |
| Damiani, E; Doyle, AP; Solorio, JA; Wallace, HM | 1 |
| Aboulafia, D; Ambinder, RF; Cesarman, E; Henry, D; Lee, J; Looney, D; Maldarelli, F; Mitsuyasu, R; Noy, A; Ramos, JC; Reid, EG; Sparano, J; Wachsman, W; Yahyaei, S | 1 |
| Aldrich, JD; Overman, MJ; Raghav, KPS; Varadhachary, GR; Wolff, RA | 1 |
| Feng, J; Lin, J; Ye, Q | 1 |
| Boudreaux, JP; Ramirez, RA; Thiagarajan, R; Thomas, KEH; Voros, BA; Woltering, EA | 1 |
| Sato, S; Tamai, Y; Tanaka, E | 1 |
| Arai, H; Honda, M; Kobayashi, Y; Yasuhara, Y; Yoshida, K | 1 |
| Albert, I; Barlesi, F; Bidoli, P; Cadranel, J; Chung, J; Drews, U; Fritsch, A; Govindan, R; Horn, L; Juhász, E; Kowalski, D; Novello, S; Reck, M; Robinet, G; Wagner, A | 1 |
| Bunn, PA; Pacheco, J | 1 |
| Barriuso, J; Fazio, N; Frizziero, M; Hubner, RA; Kordatou, Z; Lamarca, A; Manoharan, P; Mansoor, W; McNamara, MG; Nuttall, C; Spada, F; Valle, JW | 1 |
| Li, B; Song, Y; Zhang, Y; Zhao, D | 1 |
| Honavar, SG; Rao, R; Reddy, VP | 1 |
| Giroulet, F; Pomoni, A; Prior, J; Tabotta, F | 1 |
| Berkowitz, RS; Braga, A; Dos Santos Esteves, APV; Elias, KM; Filho, JR; Horowitz, NS; Mora, PAR; Sun, SY; Uberti, EH; Velarde, GC | 1 |
| Bai, L; Huang, J; Li, Q; Yang, Y; Zhang, N; Zhou, J; Zhou, K | 1 |
| Binninger, A; Dille, S; Elender, C; Hutzschenreuter, U; Jänicke, M; Marschner, N; Spring, L; Steffens, CC | 1 |
| Li, Z; Lu, S | 1 |
| Boulinguez, S; Evrard, SM; Godeau, M; Guinard, E; Lamant, L; Larrieu-Ciron, D; Meyer, N; Pages-Laurent, C; Riffaud, L; Severino-Freire, M; Sibaud, V; Tauber, M | 1 |
| Hirakawa, Y; Iwai, T; Kawaji, Y; Kobayashi, T; Kuriyama, K; Kuroda, J; Muramatsu, A; Nagata, H; Ohshiro, M; Uchiyama, H; Urata, Y | 1 |
| Aladjidi, N; Auperin, A; Couec, ML; Gandemer, V; Haouy, S; Jourdain, A; Lambliotte, A; Landman-Parker, J; Leblanc, T; Michon, J; Minard-Colin, V; Patte, C; Plat, G; Rigaud, C | 1 |
| Gawdi, A; Mubarak, M; Singal, AK | 1 |
| Auerbach, C; Cheron, R; Natarajan, E; Pashankar, F | 1 |
| Bahij, R; Halekoh, U; Hansen, O; Holmskov, K; Jeppesen, SS; Olsen, KE | 1 |
| Ayarza, M; Clark, SM; Hairston, A; Lentz, KL; Liu, B; Morgan, KP; Wind, LS | 1 |
| Aimono, E; Hongo, H; Kosaka, T; Mikami, S; Nishihara, H; Oya, M; Watanabe, K | 1 |
| Chen, Q; Dong, Y; Mo, X; Xia, J; Zhang, B; Zhang, J; Zhang, L; Zhang, S | 2 |
| Cheon, JE; Choi, JY; Choi, YH; Hong, CR; Hong, KT; Kang, HJ; Kim, IH; Kim, SK; Lee, YJ; Park, JD; Park, KD; Park, SH; Phi, JH; Shin, HY; Wang, KC | 1 |
| Cai, S; Cai, Y; Cheng, X; Dai, Z; Jia, H; Jiang, R; Luan, Y; Pu, H; Shi, T; Tang, J; Tu, D; Tu, R; Wang, H; Yang, H; Zang, R; Zhang, Y | 1 |
| Griswold, D; Nakamoto, K; Sanabria, J; Weaver, A | 1 |
| Adler, S; Aljumaily, R; Antal, JM; Beck, JT; Boccia, RV; Bulat, I; Chiu, VK; Csoszi, T; Domine Gomez, M; Dragnev, KH; Hamm, JT; Hanna, W; Hart, LL; Hoyer, RJ; Hussein, MA; Lai, AY; Lowczak, A; Maglakelidze, M; Malik, RK; Morris, SR; Nikolinakos, P; Owonikoko, TK; Richards, DA; Roberts, PJ; Rocha Lima, CM; Sawrycki, P; Schuster, SR; Sorrentino, JA; Weiss, JM; Yang, Z | 1 |
| Abrouk, N; Brown, B; Burbano, E; Caroen, S; Carter, CA; Coyle, A; Ferry, L; Larson, C; Oronsky, A; Oronsky, B; Quinn, M; Reid, TR; Scribner, CL; Thilagar, B; Varner, G | 1 |
| Alejos, A; Amador, G; Barnoya, M; Castellanos, ME; Chantada, G; Fu, L; Fuentes-Alabi, S; Girón, V; Goenz, MA; Luna-Fineman, S; Maldonado, C; Méndez, G; Morales, RA; Ortiz, R; Rodríguez-Galindo, C; Sanchez, G; Wilson, M | 1 |
| Albert, DM; Ali, MJ; Chévez-Barrios, P; Chintagumpala, M; Eagle, RC; Gao, Y; Honavar, SG; Khetan, V; Krailo, M; Leahey, AM; Matthay, K; Meadows, A; O'Brien, J; Piao, J; Vemuganti, G | 1 |
| Das, M; Diehn, M; Hellyer, JA; Hoang, NT; Jeong, Y; Neal, JW; Niu, X; Padda, SK; Ramchandran, K; Stehr, H; Wakelee, H | 1 |
| Armand, C; Benoite, M; Bernichon, E; Bouleftour, W; Chanal, E; Delorme, G; Fournel, P; Guillot, A; Lacroix, B; Langrand-Escure, J; Lardon, R; Levigne, F; Lorin, S; Perraud, Y; Rowinski, E; Tremeau, L; Vallard, A; Vassal, C | 1 |
| Adjei, AA; Aubry, MC; Bertino, E; Dakhil, SR; Dy, GK; Lee Hann, C; Mandrekar, SJ; Molina, JR; Nieva, JJ; Sachs, BA; Schenk, EL; Schild, SE; Tan, AD; Wadsworth, TW | 1 |
| Davis, ID; Grimison, P; Kalinowski, P; Martin, A; Maruff, P; Olver, IN; Schembri, A; Stockler, M; Toner, GC; Whitford, HS | 1 |
| Häberle, B; Maxwell, R; Schmid, I; Schweinitz, DV | 1 |
| Lu, L; Wang, Y; Yang, L; Zhang, L | 1 |
| Aye, J; Beierle, EA; Clay, MR; Coleman, A; Hoppmann, A; Mroczek-Musulman, E; Ranganathan, S; Tynes, C; Whelan, KF; Williams, AP; Williams, GR | 1 |
| Carlos, R; Díaz Molina, JP; Paes de Almeida, O; Sánchez-Romero, C | 1 |
| Boku, N; Daiko, H; Hirano, H; Honma, Y; Inaba, K; Itami, J; Ito, Y; Iwasa, S; Kanamori, J; Kato, K; Murakami, N; Nagashima, K; Oguma, J; Okita, N; Shoji, H; Takashima, A | 1 |
| Baker, J; Dexter, PR; He, J; Hui, SL; Jin, F; Kachroo, S; Shao, C; Zhang, Z | 1 |
| Biasoni, D; Bisogno, G; Boldrini, R; Conte, M; Crocoli, A; D'Angelo, P; Dall'Igna, P; De Pasquale, MD; Inserra, A; Miele, E; Siracusa, F; Spreafico, F; Terenziani, M | 1 |
| Cappellano, AM; Chen, MJ; de Carvalho, ÍT; de Rezende, ACP; Hamerschlak, N; Helito, JK; Sakuraba, RK; Silva, NS; Weltman, E | 1 |
| De Petris, L; Fang, F; Lewensohn, R; Pettersson, A; Tendler, S; Viktorsson, K; Zhan, Y | 1 |
| Andric, Z; Atagi, S; Califano, R; De Boer, R; Garassino, M; Horn, L; Kabbinavar, F; Karaseva, N; Każarnowicz, A; Lam, S; Lee, JS; Liu, SV; Mansfield, AS; Morris, S; Quach, C; Reck, M; Sánchez, A; Wen, X; Yu, W | 1 |
| Ancell, KK; Bezzerides, M; Khattab, MH; Kirschner, AN; Luo, G; Sherry, AD | 1 |
| Cafferty, FH; Hennig, I; Huddart, RA; Shamash, J; Stenning, SP; White, JD | 1 |
| Bai, H; Duan, J; Guo, R; Li, J; Sun, J; Wang, J; Wang, Z | 1 |
| Armstrong, SA; Liu, SV | 1 |
| Chorath, J; Gong, J; Guan, M; Hendifar, A; Kamrava, M; Klempner, SJ; Nassir, Y; Nissen, N; Placencio-Hickok, VR | 1 |
| Bas, Z; Dalvin, LA; Lally, SE; Leahey, A; Rao, R; Schwendeman, R; Shah, A; Shields, CL; Shields, JA; Tadepalli, S | 1 |
| Gunturu, KS; Ho, D; Raibagkar, P; Srinivasan, J | 1 |
| Kakuda, Y; Katagiri, H; Miyagi, M; Murata, H; Takahashi, M; Wang, Y; Wasa, J | 1 |
| Aquin, T; Banerji, S; Bucher, O; Dawe, DE; Green, S; Rittberg, R | 1 |
| Chen, L; Cui, L; Gao, M; He, K; He, M; Jia, Y; Li, J; Pan, Y; Shao, D; Shi, T; Yang, X; Yue, F; Zhang, M; Zhao, Y; Zheng, X | 1 |
| Bi, N; Chen, D; Chen, M; Feng, Q; He, J; Hui, Z; Jiang, W; Li, J; Liang, J; Liu, L; Lv, C; Lv, J; Shi, A; Wang, J; Wang, L; Wang, W; Wang, X; Wu, S; Xiao, Z; Xu, Y; Yin, W; Zhang, H; Zhang, T; Zhao, L; Zhou, Z | 1 |
| Balaji, S; Kim, U; Muthukkaruppan, V; Priya, CG; Santhi, R; Vanniarajan, A | 1 |
| Almutereen, M; Elborai, Y; Hafez, H; Lee, MA; Lehmann, L; Maher, OM | 1 |
| Cramer-van der Welle, CM; Groen, HJM; Schramel, FMNH; van de Garde, EMW; van Leeuwen, AS | 1 |
| Andrade, CF; Figueiró, F; Filippi-Chiela, E; Gonzalez, EA; Klamt, F; Nunes, V; Pilar, ES; Solari, JIG | 1 |
| Aparicio, J; Arranz, JA; Bastús, R; Castellano, D; Durán, I; García Del Muro, X; García-Sánchez, J; Germà, JR; Gironés, R; Gumà, J; Maroto, P; Meana, JA; Ochenduszko, S; Sagastibeltza, N; Terrasa, J | 1 |
| Cho, HW; Ju, HY; Kim, JH; Koo, HH; Lee, JW; Lim, DH; Shin, HJ; Suh, YL; Sung, KW; Yoo, KH | 1 |
| Arakawa, Y; Hiwatari, M; Hogetsu, K; Kato, S; Koh, K; Kubota, Y; Takita, J; Watanabe, K | 1 |
| Adachi, S; Hiramatsu, H; Horikoshi, Y; Kato, I; Kawaguchi, K; Ogura, T; Saida, S; Takachi, T; Takita, J; Umeda, K; Watanabe, K | 1 |
| Chintagumpala, M; Gombos, D; Huang, L; Jubran, RF; Krailo, M; Meadows, A; Murphree, AL; O'Brien, J; Piao, J; Shields, CL; Villablanca, JG | 1 |
| Bay, JO; Chatelut, E; Chevreau, C; Delmas, C; Delva, R; Filleron, T; Fléchon, A; Gravis, G; Gross-Goupil, M; Lafont, T; Lotz, JP; Marsili, S; Massart, C; Moeung, S; Thomas, F | 1 |
| Bas, Z; Dalvin, LA; Pacheco, R; Rao, R; Shields, CL; Tadepalli, S; Vaidya, S | 1 |
| Hirose, K; Kataoka, N; Kunimatsu, Y; Ogura, Y; Sato, I; Sugimoto, T; Tachibana, Y; Takeda, T; Tani, N | 1 |
| Gloude, N; Lauhan, CR; Schiff, D | 1 |
| Azuma, K; Hoshino, T; Ishii, H; Kawahara, A; Matsuo, N; Tokito, T | 1 |
| Bartolini, S; Brandes, AA; Franceschi, E; Mascarin, M; Minichillo, S; Mura, A; Tomasello, C; Tosoni, A | 1 |
| Abdel-Rahman, O; Karachiwala, H; Morris, D; Tilley, D | 1 |
| Aggarwal, C; Cella, D; Dahlberg, SE; Feliciano, JL; Lash, BW; Leach, JW; Leal, TA; Mohindra, NA; Owonikoko, TK; Ramalingam, SS; Srkalovic, G; Steffen McLouth, LE; Wade, JL; Wagner, LI; Zhao, F | 1 |
| Arrieta, O; Lara-Mejía, L; Zatarain-Barrón, ZL | 1 |
| Imai, Y; Shiseki, M; Tanaka, J; Tanaka, N; Yoshinaga, K | 1 |
| Frampton, JE | 1 |
| Fujiwara, K; Goto, K; Harada, T; Hayashi, T; Kaneda, H; Kenmotsu, H; Kimura, M; Kogure, Y; Koike, T; Matsui, R; Nishio, M; Nogami, N; Seto, T; Shimizu, S; Shimokawa, M; Suzuki, K; Takiguchi, T | 1 |
| Acar, R; Arpacı, F; Aykan, MB; Buyukturan, G; Erdem, G; Erturk, I; Esen, R; Karadurmus, N; Kızıloz, H; Urun, Y; Yildiz, B | 1 |
| Aerts, I; Bertozzi, AI; Cassoux, N; Coze, C; Desjardins, L; Doz, F; Dupont, A; Levy-Gabriel, C; Lumbroso-Le Rouic, L; Russo, I; Savignoni, A | 1 |
| Chen, CK; Hayashi, S; Ikari, K; Kusano, J; Ogai, A; Ozawa, Y; Yamamoto, R; Yoshida, R | 1 |
| Alpdogan, SO; Carabasi, M; Chapman, A; DiMeglio, M; Filicko-OHara, J; Flomenberg, N; Gaballa, S; Ghimire, S; Gong, J; Martinez-Outschoorn, U; Pan, J; Porcu, P; Pro, B; Ramirez, M; Rose, L; Wagner, JL; Weiss, M | 1 |
| Chan, JY; Farid, M; Lim, C; Lim, ST; Martin, P; Poon, E; Somasundaram, N; Tang, T; Tao, M; Toh, SQ; Yan, SX; Yunon, MJ | 1 |
| Chen, H; Horita, N; Takeshi, K | 1 |
| Baize, N; Chouaid, C; Monnet, I | 1 |
| Li, J; Liu, Z; Mi, M; Wang, Y; Zhang, C; Zhang, L | 1 |
| Cho, H; Koo, HH; Lee, JW; Lim, DH; Ma, Y; Shin, HJ; Suh, YL; Sung, KW; Yoo, KH | 1 |
| Aoudjhane, M; Cervera, P; Coppo, P; Corre, E; Duléry, R; Fabiani, B; Lemonnier, MP; Marjanovic, Z; Mohty, M; Van de Wyngaert, Z | 1 |
| Alatorre-Alexander, J; Califano, R; Cheng, Y; De Castro Carpeno, J; Deng, Y; Garassino, MC; Horn, L; Lam, S; Leal, T; Lee, JS; Liu, SV; Mansfield, AS; McCleland, M; Mok, T; Nishio, M; Orlandi, F; Phan, S; Reck, M; Reinmuth, N; Scherpereel, A | 1 |
| Bas, Z; Dalvin, LA; Leahey, AM; Rao, R; Shah, A; Shields, CL; Tadepalli, S | 1 |
| Chen, L; Gao, M; He, K; Li, J; Pan, Y; Shao, D; Shi, T; Yang, X; Zhang, F; Zhang, M; Zhao, J; Zhao, Y; Zheng, X | 1 |
| Kapoor, R; Rastogi, N; Sarma, S; Thakkar, D; Wadhwa, T; Yadav, SP | 1 |
| Chang, JS; Pan, M | 1 |
| Bay, JO; Chatelut, E; Chevreau, C; Ciccolini, J; Culine, S; Delva, R; Filleron, T; Fizazi, K; Flechon, A; Gallois, Y; Gravis, G; Gross-Goupil, M; Guitton, J; Lelièvre, B; Lotz, JP; Massard, C; Moeung, S; Mourey, L; Olivier, P; Paci, A; Thomas, F | 1 |
| Audino, AN; Saraf, A; Wedekind, MF; Willen, F | 1 |
| Bison, B; Friedrich, C; Gerber, NU; Gessi, M; Haberler, C; Juhnke, BO; Kool, M; Kortmann, RD; Kwiecien, R; Mynarek, M; Pfister, SM; Pietsch, T; Rutkowski, S; Schüller, U; Spix, C; Timmermann, B; von Bueren, AO; von Hoff, K; Warmuth-Metz, M | 1 |
| Bach, BA; Bentsion, D; Byers, LA; de Groot, P; Dunbar, M; Ellis, PM; Fujimoto, J; Gans, S; Gay, CM; Glasgow, J; Groen, HJM; He, L; Kang, K; Owonikoko, TK; Penkov, K; Sehgal, V; Sibille, A; Son, C | 1 |
| Baudin, E; Beaulaton, C; Blanchet, O; Cadiot, G; Chatelain, D; Do Cao, C; Ducreux, M; Durand, A; Faron, M; Gu, C; Hadoux, J; Hautefeuille, V; Hervieu, V; Hescot, S; Jannin, A; Kanaan, C; Laboureau, S; Leteurtre, E; Marchal, A; Petorin, C; Rousselet, MC; Scoazec, JY; Tauveron, I; Walter, T; Zakeyh, JJ | 1 |
| Dinçaslan, H; Gündüz, AK; Mirzayev, I; Özalp Ateş, FS | 1 |
| Burns, TF; Camidge, DR; Chen, C; Dowlati, A; Hann, CL; Koch, MM; Komarnitsky, P; Ludwig, C; Morgensztern, D; Nimeiri, H; Patel, M; Ward, PJ | 1 |
| Collins, GP; Cwynarski, K; Phillips, EH | 1 |
| Iida, S; Inagaki, H; Ishida, T; Ito, A; Iwasaki, H; Kusumoto, S; Masaki, A; Murase, T; Muto, R; Nakano, N; Sakamoto, Y; Takeshita, M; Tashiro, Y; Tokunaga, M; Ueda, R; Utsunomiya, A; Yonekura, K | 1 |
| Ahn, BC; Cho, BC; Hong, MH; Kim, HR; Lee, S; Lim, SM; Shim, HS | 1 |
| Fukushima, M; Otaki, T; Usui, Y | 1 |
| Antonini Cappellini, GC; Bria, E; Cappuzzo, F; Carpano, S; Carta, A; D'Argento, E; Fadda, GM; Gelibter, AJ; Giusti, R; Martelli, O; Metro, G; Minuti, G; Nelli, F; Ricciardi, S; Russano, M; Stefani, A | 1 |
| Abdel-Rahman, O; Koski, SL | 1 |
| Bansal, D; Jain, R; Kakkar, N; Menon, P; Radhika, S; Rao, KLN; Trehan, A | 1 |
| Al-Salama, ZT | 1 |
| Alexander, J; Coupland, SE; Jana, P; Kaliki, S; Kalirai, H; Kondapi, AK; Manukonda, R; Nair, RM; Narayana, RVL; Prabhu, V; Tomar, N; Vemuganti, GK | 1 |
| Bartels, U; Bhatia, A; Boyett, JM; Dhall, G; Embry, L; Fangusaro, J; Fouladi, M; Gajjar, A; Khatua, S; Leary, S; MacDonald, S; Murphy, ES; Onar-Thomas, A; Patel, SK; Shaw, D; Souweidane, M; Trask, CL; Wu, S | 1 |
| Barnett, S; Bérénos, IM; Carruthers, V; Huitema, ADR; Kong, J; Lalmohamed, A; Nijstad, AL; Parke, E; Tweddle, DA; Veal, GJ; Zwaan, CM | 1 |
| Hu, Z; Huang, L; Jiang, S; Jin, P; Wang, J; Zhen, H | 1 |
| Dayen, C; Debieuvre, D; Dixmier, A; Falchero, L; Gally, S; Greenwood, W; Pau, D; Sibley-Revelat, A | 1 |
| Ballenberger, M; Harshan, M; Indaram, M; Machnicki, S; Mina, B; Novoselac, AV; Singh, A; Vojnic, M | 1 |
| Chen, J; Gao, X; Hou, X; Huang, H; Li, S; Shi, Q; Zhao, Y | 1 |
| Al-Saadi, R; Brok, J; de Camargo, B; de Krijger, RR; Drost, J; Godzinski, J; Graf, N; Groenendijk, A; Jiang, Y; Mavinkurve-Groothuis, AMC; Morosi, C; Perotti, D; Pritchard-Jones, K; Ramírez-Villar, GL; Rübe, C; Schenk, JP; Spreafico, F; Vaidya, SJ; van den Heuvel-Eibrink, MM; van Tinteren, H; Verschuur, AC; Vujanic, GM | 1 |
| Endo, S; Fujiwara, Y; Higashida, M; Iwamoto, R; Katada, Y; Kinoshita, S; Kitagawa, S; Kubota, H; Mineta, S; Okada, T; Sanuki, F; Tanaka, H; Ueno, M; Ueno, T; Yoshimatsu, K | 1 |
| Andrini, E; Ardizzoni, A; Artioli, F; Barbieri, F; Bonetti, A; Brighenti, M; Cinieri, S; Colantonio, I; Ficorella, C; Follador, A; Frassoldati, A; Gelsomino, F; Genova, C; Lamberti, G; Mazzoni, F; Pasello, G; Riccardi, F; Rihawi, K; Tiseo, M; Tognetto, M | 1 |
| Chowdhury, T; Duncan, C; Karaa, EK; Reddy, MA; Sagoo, MS; Scheimberg, I; Sheriff, IHN | 1 |
| An, J; Huang, M; Huang, Y; Li, C; Li, L; Luo, S; Peng, Y; Wang, J; Wang, Z; Wu, L; Yang, H; Yang, X; Zhang, Y | 1 |
| Amaki, J; Ando, T; Asano, N; Choi, I; Ejima, Y; Fukuhara, N; Hasegawa, M; Kagami, Y; Kameoka, Y; Katayama, N; Kubota, N; Maeda, T; Maruyama, D; Masaki, Y; Matsuoka, H; Miyazaki, K; Murayama, T; Oguchi, M; Sakai, R; Sekiguchi, N; Shimada, K; Suzuki, R; Taguchi, S; Takizawa, J; Terui, Y; Tsukamoto, H; Tsukamoto, N; Uoshima, N; Utsumi, T; Wada, H; Yamaguchi, M | 1 |
| Kim, JO; Kim, KH; Park, JY; Park, SG; Seo, MD | 1 |
| Hamada, M; Ichikawa, D; Imaya, M; Kawashima, N; Kojima, S; Miwata, S; Muramatsu, H; Narita, A; Narita, K; Nishikawa, E; Nishio, N; Takahashi, Y; Wakamatsu, M; Yamamori, A; Yoshida, T | 1 |
| Gentille, C; Joshi, J; Pingali, SR; Randhawa, J; Sarfraz, H; Shah, S | 1 |
| Asher, R; Connolly, EA; Forgeson, G; Goh, J; Grimison, P; Hamad, N; Heller, GZ; Hill, S; Joshi, A; Kuchel, A; Lewin, J; Liow, E; McKenzie, J; Tan, A; Tan, H; Toner, G; Tran, B; Tung, ILY; Walpole, E; Wang, Y; Weickhardt, A; Wickham, A; Winstanley, MA; Wong, V | 1 |
| Hu, Z; Liao, J; Liu, C; Sun, S; Wang, H; Wang, J; Wu, X; Yu, H; Zhang, Y; Zhao, X | 1 |
| Choi, E; Heo, MH; Kim, H; Kim, JY; Park, KU | 1 |
| Chan, EHL; Chan, JYS; Chang, EWY; Chee, YL; de Mel, S; Diong, C; Farid, M; Goh, AZK; Goh, YT; Grigoropoulos, NF; Jeyasekharan, A; Khoo, LP; Lee, J; Lee, YS; Lim, C; Lim, ST; Liu, X; Nagarajan, C; Poon, E; Poon, M; Quek, R; Somasundaram, N; Tan, D; Tang, T; Tao, M; Tay, T; Yang, VSW | 1 |
| Agreda-Vásquez, GP; Avendano, O; Barreyro, P; Cubero, D; Enrico, A; Fogliatto, L; Machnicki, G; Mela-Osorio, MJ; Ovilla, R; Pavlovsky, M; San Sebastián, JA; Trufelli, D; Villanova, P | 1 |
| Castillo, JJ; Dittus, C; Miller, JA; Wehbie, R | 1 |
| Cao, L; Chen, G; Cheng, Y; Fan, Y; Fang, Y; Gong, Y; He, Z; Hu, C; Jiang, L; Li, X; Liu, Q; Liu, Y; Lu, K; Min, X; Shi, W; Wang, J; Wang, Q; Wu, J; Xu, F; Xu, X; Yang, R; Yao, W; Yao, Y; Yu, G; Zhang, B; Zhang, X; Zhao, J; Zhao, W; Zhou, C | 1 |
| Kuai, X; Liu, K; Liu, S; Tao, Z; Wang, G; Xia, S; Zhang, H; Zhu, H | 1 |
| Byers, L; Califano, R; Chafin, W; Cho, BC; Faivre-Finn, C; Jabbour, SK; Kato, T; Lai, WV; Rimner, A; Rudin, CM; Yu, J; Yu, L; Zhao, B | 1 |
| Jodłowska, A; Postek-Stefańska, L | 1 |
| Imai, H; Kagamu, H; Kaira, K; Kishikawa, T; Minato, K; Minemura, H; Mouri, A; Nagai, Y; Shiono, A; Takechi, H; Taniguchi, H; Tsuda, T; Umeda, Y; Wasamoto, S; Yamada, Y; Yamaguchi, O | 1 |
| Min, S; Zheng, Q; Zhou, Y | 1 |
| Imai, H; Kagamu, H; Kaira, K; Kanazawa, K; Kishikawa, T; Minato, K; Minemura, H; Mouri, A; Nagai, Y; Shiihara, J; Shiono, A; Taniguchi, H; Tsuda, T; Wasamoto, S; Yamada, Y; Yamaguchi, O | 1 |
| Bischoff, H; Cardona, A; De Boer, R; de Castro Junior, G; Dziadziuszko, R; Garassino, MC; Hochmair, M; Krzakowski, M; Lam, S; Liu, SV; Losonczy, G; Mansfield, A; Mok, TSK; Morris, S; Reck, M; Smolin, A; Sugawara, S | 1 |
| Koyama, N; Kumazawa, A; Shobatake, R; Takahashi, N | 1 |
| Bal, A; Gupta, N; Gupta, P; Khosla, D; Shastri, M; Singh, N; Srinivasan, R | 1 |
| Chmielewska, I; Grodkiewicz, M; Korbel, MA; Koziel, P; Milanowski, J | 1 |
| Dębczyński, M; Kuklińska, B; Mojsak, D; Mróz, RM | 1 |
| André, M; Berriolo-Riedinger, A; Borel, C; Brice, P; Edeline, V; Feugier, P; Gac, AC; Gastinne, T; Ghesquières, H; Guidez, S; Le Bras, F; Morschhauser, F; Nicolas-Virelizier, E; Quittet, P; Ribrag, V; Stamatoullas, A; Vander Borght, T | 1 |
| Mansoor, Q; Ng, J; Sadiq, M | 1 |
| Imai, H; Kaburagi, T; Kagamu, H; Kaira, K; Kanazawa, K; Kishikawa, T; Masubuchi, K; Minato, K; Minemura, H; Nagai, Y; Shiihara, J; Shiono, A; Takechi, H; Taniguchi, H; Tsuda, T; Umeda, Y; Wasamoto, S; Yamada, Y | 1 |
| Bonnabry, P; Fleury-Souverain, S; Guillarme, D; Maurin, J; Rudaz, S | 1 |
| Chen, L; Chen, Y; Deng, P; Dong, Y; Han, B; Kong, T; Liu, D; Qian, F; Yang, H; Zhang, B; Zhang, W; Zhang, Y | 1 |
| Arkania, E; Bai, Y; Chen, J; Cheng, Y; Dvorkin, M; Han, L; Ji, Y; Kang, W; Li, X; Makharadze, T; Melkadze, T; Min, X; Pan, Y; Pan, Z; Shi, J; Sun, H; Viguro, M; Wang, Q; Wang, X; Wen, G; Wu, L; Yang, J; Zhao, Y; Zhu, J | 1 |
| Alkassis, S; Austin, A; Azar, I; Chi, J; Chopra, A; Jang, H; Kim, S; Mamdani, H; Mehdi, S; Neu, K; Saha, BK; Yazdanpanah, O | 1 |
| Asao, T; Kobayashi, K; Morita, S; Tanaka, T; Watanabe, S | 1 |
| Ando, T; Hanai, K; Kamitani, R; Kashizaki, F; Mizuno, R; Sekido, Y; Tanaka, A | 1 |
| Anampa-Guzmán, A; Block, A; Darrall, A; DeMarco, J; Ghione, P; Groman, A; Hernandez-Ilizaliturri, FJ; Hutson, A; Johnson, M; Kader, A; Kostrewa, J; Lund, I; Mavis, C; McWhite, K; Mohr, A; Nichols, J; Przespolewski, E; Sait, SJ; Sundaram, S; Thomas, R; Torka, P; Wong, J | 1 |
| Azuma, K; Ishii, H; Kawashima, Y; Kurata, T; Okamoto, I; Okamoto, M; Shimose, T; Shingu, N; Yoshioka, H | 1 |
| Abonour, R; Abu Zaid, M; Adra, N; Chovanec, M; Einhorn, L | 1 |
| Beishuizen, A; Bhojwani, D; Burke, GAA; Burkhardt, B; Cairo, M; Curtis, M; Deshpande, S; Howes, A; Kabickova, E; Kang, HJ; Luisi, F; Minard-Colin, V; Norris, R; Nottage, K; Srinivasan, S; Sun, S; Tacyildiz, N; Tamegnon, M; Uyttebroeck, A; Vinti, L | 1 |
| Badira, CP; Banavali, S; Chinnaswamy, G; Kembhavi, S; Khanna, N; Laskar, S; Muckaden, MA; Prasad, M; Qureshi, S; Ramadwar, M; Ramanathan, S; Vora, T | 1 |
| Liu, K; Qin, Q; Zhu, H; Zhu, Y | 1 |
| Gon, Y; Iida, Y; Kenmotsu, H; Ko, R; Kobayashi, H; Kodama, H; Mamesaya, N; Murakami, H; Naito, T; Ono, A; Shimizu, T; Takahashi, T; Wakuda, K | 1 |
| Alva, E; Bukowinski, A; Cramer, SL; Daley, J; Escoto, H; Fair, D; Hartt, D; Kim, H; LeBlanc, Z; Merjaneh, N; Metts, J; Pressey, JG; Ray, A; Szabo, S; Todd, K; Watanbe, M | 1 |
| Huang, Z; Zhang, Y | 1 |
| Adamo, V; Cantale, O; Castorina, L; Chillari, F; Colarossi, C; Esposito, F; Franchina, T; Giuffrida, D; Puliafito, I; Ricciardi, GRR; Russo, A; Sciacca, D; Vitale, MP | 1 |
| Eom, JS; Jo, EJ; Kim, KU; Kim, MH; Kim, SH; Lee, K; Lee, MK; Mok, J; Park, HK | 1 |
| Gunarić, A; Karan Križanac, D; Kraljević, M; Šekerija Zovko, S; Tomić, K | 1 |
| Bando, Y; Fujisawa, M; Furukawa, J; Hara, T; Harada, K; Hirata, J; Jimbo, N; Nakano, Y; Okamura, Y; Terakawa, T; Ueki, H | 1 |
| Che, Y; Chen, J; Chen, Z; Cheng, X; Chu, R; Huang, C; Jiang, J; Kong, B; Li, J; Li, K; Li, L; Liu, P; Pan, X; Song, K; Song, L; Wang, J; Xue, Y; Yao, S; Zhang, X; Zhao, Y | 1 |
| Che, G; Chen, Y; Gou, H; Huang, Q; Jiang, L; Liao, H; Lu, Y; Zhang, Y; Zhou, N | 1 |
| Allen, PB; Bazzi, LA; Bryan, LJ; Casulo, C; Chmiel, JS; Dillehay, GL; Gordon, LI; Kane, KL; Karmali, R; Mehta, J; Palmer, BA; Pro, B; Savas, H; Smith, SE; Winter, JN | 1 |
| Kang, K; Lin, G; Lu, Y; Luo, R; Wang, H; Yao, Z | 1 |
| Ebinger, M; Fuchs, J; Heinz, AT; Klingebiel, T; Koscielniak, E; Kratz, CP; Ljungman, G; Münter, MW; Pajtler, KW; Rößler, J; Schönstein, A; Seitz, G; Sparber-Sauer, M; Stegmaier, S; Timmermann, B; Vokuhl, C; von Kalle, T | 1 |
| Alejos, A; Giron, V; Graff, Z; Luna-Fineman, S; Miller, K; Pixtun, D | 1 |
| Artaç, M; Bozcuk, H; Eser, İ; Mutlu, H | 1 |
| Benedetti, DJ; Kao, PC; Ma, C; Marcus, KJ; Mullen, EA; Wong, CI | 1 |
| Bai, B; Gao, Y; He, Y; Huang, C; Huang, H; Ping, L; Shi, L; Wang, X | 1 |
| Gu, X; Guan, Y; Hao, Y; Song, Z; Sun, Y; Wang, W; Xiang, J; Yao, Q; Zeng, X | 1 |
| Emi, M; Hamai, Y; Hirano, K; Hirohata, R; Ohsawa, M; Okada, M; Yamaguchi, S; Yoshikawa, T | 1 |
| Bullock, TN; Carducci, MA; Gentzler, RD; Hanley, M; Horton, B; Kim, K; Mock, J; Park, KS; Phelps, MA; Piekarz, R; Rhee, JC; Rudek, MA; Rudin, CM; Villaruz, LC | 1 |
| Bhosale, P; Chisholm, GB; Flores Legarreta, A; Frumovitz, M; Gonzales, NR; Jhingran, A; Ramalingam, P; Saab, R; Salvo, G | 1 |
| Burke, SM; Ghasemi, M; Goey, AKL; Hernandez-Ilizaliturri, FJ; Lin, LH; Mager, DE; Mavis, CK; Nichols, JR; Torka, P | 1 |
| Fan, XX; Li, ZH; Wang, L; Wang, XY; Weng, Y; Yan, L; Zhang, SL | 1 |
| Hara, Y; Hashimoto, H; Horita, N; Kaneko, A; Kaneko, T; Kobayashi, N; Kubo, S; Kudo, M; Matsumoto, H; Somekawa, K; Teranishi, S; Watanabe, K | 1 |
| Gao, Y; Gu, H; Hu, H; Huang, D; Li, F; Li, J; Liao, R; Wu, R; Zhang, W; Zhang, Y; Zhi, T | 1 |
182 review(s) available for etoposide and carboplatin
| Article | Year |
|---|---|
Carboplatin/etoposide in small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Hematopoietic Cell Growth Factors; Humans; Lung Neoplasms | 1992 |
Platinum/etoposide therapy in non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Humans; Lung Neoplasms; Neoplasm Staging | 1992 |
Towards improved cancer therapy using subcutaneously administered hemopoietic colony stimulating factors.
Topics: Antineoplastic Agents; Carboplatin; Clinical Trials as Topic; Combined Modality Therapy; Drug Evaluation; Etoposide; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Injections, Subcutaneous; Neutropenia | 1990 |
New agents in the treatment of acute myeloid leukemia.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Daunorubicin; Drug Evaluation; Etoposide; Humans; Idarubicin; Leukemia, Myeloid; Middle Aged; Mitoxantrone; Remission Induction; Tretinoin | 1991 |
Carboplatin in small cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Humans; Lung Neoplasms; Organoplatinum Compounds | 1990 |
[Chemotherapy in non-small cell bronchial carcinoma. 12 years' experience in an international cooperative group: EORTC Lung Cancer Working Party].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Screening Assays, Antitumor; Etoposide; Humans; Lung Neoplasms; Vindesine | 1990 |
New drugs and new delivery techniques.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Bleomycin; Brain Neoplasms; Carboplatin; Carmustine; Cisplatin; Etoposide; Humans; Infusions, Intra-Arterial; Interferons; Nitrosourea Compounds; Organoplatinum Compounds; Rats | 1985 |
Use of carboplatin in the treatment of testicular cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Evaluation; Etoposide; Humans; Male; Organoplatinum Compounds; Testicular Neoplasms | 1989 |
[Chemotherapy of small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Organoplatinum Compounds; Vincristine | 1988 |
Cisplatin and carboplatin in combination with etoposide as a treatment for non-small cell lung cancer: the experience of the EORTC Lung Cancer Working Party.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Etoposide; Humans; Lung Neoplasms; Organoplatinum Compounds | 1988 |
[Treatment strategy to obtain cure for recurrent advanced breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Carmustine; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Neoplasm Recurrence, Local; Thiotepa | 1994 |
The role of hematopoietic growth factors in support of ifosfamide/carboplatin/etoposide chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Drug Administration Schedule; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Interleukin-6; Lung Neoplasms; Neutropenia; Recombinant Proteins; Thrombocytopenia | 1995 |
Carboplatin/etoposide combination chemotherapy in the treatment of poor prognosis patients with small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Lung Neoplasms; Neoplasm Staging; Prognosis; Radiography; Survival Rate | 1995 |
[Mega-dose chemotherapy with peripheral blood stem cell transplantation (PBS-CT) for small cell lung cancer (SCLC)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lung Neoplasms; Male; Middle Aged | 1995 |
[Germ cell tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Remission Induction; Survival Rate; Testicular Neoplasms; Vinblastine | 1995 |
[High-dose chemotherapy (HDCT) with peripheral blood stem cell transplantation (PBSCT) in ovarian cancer patients with poor prognosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ovarian Neoplasms; Prognosis | 1995 |
[Myeloablative chemotherapy with autologous bone marrow and/or peripheral blood stem cell transplantation in children with high-risk solid tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Carboplatin; Child; Combined Modality Therapy; Cryopreservation; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Kidney Neoplasms; Neoplasms; Neuroblastoma; Rhabdomyosarcoma; Wilms Tumor | 1995 |
[High-dose chemotherapy with autologous bone marrow transplantation or peripheral blood stem cell transplantation--testicular cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Combined Modality Therapy; Dactinomycin; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Testicular Neoplasms; Vinblastine | 1995 |
The use of ifosfamide, carboplatin, and etoposide in children with solid tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Neoplasms; Neuroblastoma; Neutropenia; Sarcoma; Thrombocytopenia; Wilms Tumor | 1995 |
Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Clinical Trials as Topic; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Vincristine | 1995 |
A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Carboplatin; Chromosomes, Human, Pair 13; Chromosomes, Human, Pair 8; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Eosinophilia; Etoposide; Fatal Outcome; Female; Humans; Hydroxyurea; Hyperplasia; Ifosfamide; Leukemia, Myeloid; Lymph Nodes; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Syndrome; Translocation, Genetic; Vincristine | 1995 |
[A case of small cell lung cancer associated with fulminant hepatitis B].
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Hepatitis B; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged | 1994 |
The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Salvage Therapy; Teniposide; Vincristine | 1995 |
Acute myeloid leukaemia with t(9;11)(p22;q23) in a patient treated for adult T cell leukaemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; Cyclophosphamide; Etoposide; Humans; Karyotyping; Leukemia, Myeloid, Acute; Leukemia, T-Cell; Male; Neoplasms, Second Primary; Translocation, Genetic | 1994 |
Intensive combined-modality therapy in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Vincristine | 1994 |
Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistance.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Drug Resistance; Etoposide; Humans; Isotretinoin; Lung Neoplasms; Neoplasms, Second Primary; Neoplastic Stem Cells; Oncogenes; Phenotype; Tumor Cells, Cultured | 1994 |
High dose versus standard dose chemotherapy for the treatment of breast cancer. A review of current concepts.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Busulfan; Carboplatin; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Paclitaxel; Taxoids; Thiotepa | 1995 |
Hemolytic uremic syndrome after high dose chemotherapy with autologous stem cell support.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Hemolytic-Uremic Syndrome; Humans; Hypertension; Immunoglobulins, Intravenous; Male; Middle Aged; Plasma; Remission Induction; Renal Insufficiency; Retinal Vein Occlusion; Thiotepa; Thrombocytopenia; Transplantation, Autologous; Vincristine | 1995 |
[Maintenance of the dose-intensity of chemotherapy combining carboplatin, cyclophosphamide, etoposide in women with ovarian cancer aged 70 and over].
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ovarian Neoplasms; Retrospective Studies; Survival Rate; Treatment Outcome | 1996 |
Ifosfamide in the treatment of small cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Randomized Controlled Trials as Topic; Remission Induction; Survival Rate | 1996 |
Dose-intensive ifosfamide for the treatment of non-Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Salvage Therapy; Transplantation, Autologous | 1996 |
[Carboplatin and etoposide combination for the treatment of recurrent epithelial ovarian cancer].
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Salvage Therapy; Survival Rate; Treatment Outcome | 1996 |
[Clinical studies on combination of ifosfamide, carboplatin and etoposide (ICE) with whole body hyperthermia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Hyperthermia, Induced; Ifosfamide; Neoplasms; Treatment Outcome | 1996 |
The cost-effectiveness of four cisplatin-containing chemotherapy regimens in the treatment of stages III B and IV non-small cell lung cancer: an Italian perspective.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cost-Benefit Analysis; Deoxycytidine; Etoposide; Gemcitabine; Health Care Costs; Humans; Ifosfamide; Insurance, Health, Reimbursement; Italy; Lung Neoplasms; Mitomycin; Ribonucleotide Reductases; Vinblastine; Vinorelbine | 1996 |
Avascular necrosis following extensive chemotherapy and dexamethasone treatment in a patient with advanced ovarian cancer: case report and review of the literature.
Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Papillary; Dexamethasone; Etoposide; Female; Humans; Middle Aged; Neoplasm, Residual; Osteonecrosis; Ovarian Neoplasms; Paclitaxel | 1996 |
The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Lung Neoplasms; Neutropenia; Paclitaxel; Thrombocytopenia; Treatment Outcome | 1996 |
Treatment of advanced seminoma: an update.
Topics: Antineoplastic Agents; Bleomycin; Carboplatin; Cisplatin; Etoposide; Humans; Male; Neoplasm, Residual; Seminoma; Vinblastine | 1997 |
Dosage individualization of carboplatin and etoposide based on pharmacokinetic investigations.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Etoposide; Humans | 1997 |
Treatment in germ cell tumours: state of the art.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Etoposide; Follow-Up Studies; Germinoma; Humans; Lymph Node Excision; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Remission Induction; Seminoma; Survival Rate; Treatment Outcome; Urologic Neoplasms | 1997 |
Future trials in germ cell malignancy (GCM) of the testis.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Clinical Trials as Topic; Decision Making; Etoposide; Forecasting; Genetic Therapy; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Orchiectomy; Paclitaxel; Patient Participation; Quality of Life; Risk Factors; Safety; Salvage Therapy; Seminoma; Testicular Neoplasms | 1997 |
[A case report of choroid plexus carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Choroid Plexus Neoplasms; Combined Modality Therapy; Etoposide; Female; Humans; Infant; Prognosis | 1997 |
Future directions in the chemotherapy of ovarian cancer.
Topics: Administration, Oral; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Europe; Female; Forecasting; Gemcitabine; Humans; Injections, Intraperitoneal; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Time Factors; Topotecan; Vinblastine; Vinorelbine | 1997 |
Topotecan in combination chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Paclitaxel; Suramin; Topoisomerase I Inhibitors; Topotecan | 1997 |
UKCCSG's germ cell tumour (GCT) studies: improving outcome for children with malignant extracranial non-gonadal tumours--carboplatin, etoposide, and bleomycin are effective and less toxic than previous regimens. United Kingdom Children's Cancer Study Grou
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Child; Child, Preschool; Cisplatin; Etoposide; Female; Germinoma; Humans; Infant; Male; Prognosis; Recurrence; Survival Analysis; Treatment Outcome | 1998 |
The role of carboplatin in the treatment of small-cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Clinical Trials as Topic; Dose-Response Relationship, Drug; Etoposide; Humans; Lung Neoplasms; Paclitaxel | 1998 |
Ifosfamide and paclitaxel combinations for the treatment of advanced non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Paclitaxel; Platinum Compounds | 1998 |
Defining the role of novel high-dose chemotherapy regimens for the treatment of high-risk breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Clinical Trials as Topic; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Mitoxantrone; Neoplasm Staging; Paclitaxel; Taxoids; Thiotepa | 1998 |
[Small cell lung cancer associated with nephrotic syndrome: remission after chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Glomerulonephritis, IGA; Humans; Lung Neoplasms; Male; Middle Aged; Proteinuria; Remission Induction | 1998 |
[Chemotherapy of small cell bronchogenic carcinoma in a patient on hemodialysis for chronic renal failure. Apropos of a case].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Humans; Kidney Failure, Chronic; Lung Neoplasms; Male; Middle Aged; Renal Dialysis | 1998 |
[Irinotecan-containing combinations in solid tumors, except colonic carcinomas].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Diarrhea; Docetaxel; Enzyme Inhibitors; Etoposide; Female; Genital Neoplasms, Female; Humans; Irinotecan; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Neoplasm Proteins; Neoplasms; Neutropenia; Paclitaxel; Stomach Neoplasms; Taxoids; Topoisomerase I Inhibitors; Treatment Outcome | 1998 |
[A case of adult T cell leukemia (lymphoma type) involving the pancreas].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Etoposide; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Pancreatic Neoplasms; Prednisolone; Remission Induction; Vincristine | 1999 |
The evolving role of paclitaxel for patients with carcinoma of unknown primary site.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Etoposide; Humans; Neoplasms, Unknown Primary; Paclitaxel | 1999 |
Concurrent paclitaxel-containing regimens and thoracic radiation therapy for limited-disease small cell lung cancer.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Clinical Trials as Topic; Combined Modality Therapy; Etoposide; Humans; Lung Neoplasms; Paclitaxel | 1999 |
[Continuous radiosensitizing chemotherapy].
Topics: Antineoplastic Agents; Carboplatin; Carcinoma; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Etoposide; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Lung Neoplasms; Nutritional Support; Radiation-Sensitizing Agents; Rectal Neoplasms | 1999 |
Combined treatment of metastatic osteosarcoma of the spine.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Doxorubicin; Etoposide; Femoral Neoplasms; Humans; Male; Neoadjuvant Therapy; Osteosarcoma; Spinal Neoplasms; Tomography, X-Ray Computed | 1999 |
Ifosfamide in non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Etoposide; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Paclitaxel | 1999 |
Metastatic adult medulloblastoma showing prolonged response to chemotherapy.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Combined Modality Therapy; Etoposide; Humans; Male; Medulloblastoma; Middle Aged; Neoplasm Metastasis; Remission Induction; Time Factors; Vincristine | 1999 |
[Chemotherapy in combination with whole-body hyperthermia in advanced malignant pleural mesothelioma].
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Hyperthermia, Induced; Ifosfamide; Male; Mesothelioma; Middle Aged; Palliative Care; Pleural Effusion, Malignant; Pleural Neoplasms; Recurrence | 2000 |
[Recent topics in chemotherapy for elderly patients with lung cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Lung Neoplasms; Middle Aged | 2000 |
Pharmacokinetically guided administration of chemotherapeutic agents.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Busulfan; Carboplatin; Cisplatin; Etoposide; Fluorouracil; Humans; Topotecan | 2000 |
Chemoradiation in locally advanced non-small cell lung cancer.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Deoxycytidine; Docetaxel; Drug Administration Schedule; Etoposide; Forecasting; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Multicenter Studies as Topic; Paclitaxel; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Survival Rate; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 2001 |
Lung cancer: therapeutic options for stage IV and recurrent NSCLC.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Deoxycytidine; Docetaxel; Etoposide; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Survival Rate; Taxoids; Teniposide; Treatment Outcome; Vinblastine; Vinorelbine | 2001 |
Body surface area as a determinant of pharmacokinetics and drug dosing.
Topics: Adult; Animals; Anthropometry; Antineoplastic Agents; Area Under Curve; Body Surface Area; Carboplatin; Cardiac Output; Child; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Humans; Kidney; Liver; Medical Oncology; Neoplasms; Paclitaxel; Taxoids | 2001 |
Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literature review.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cohort Studies; Disease-Free Survival; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Recurrence; Salvage Therapy; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 2001 |
Paclitaxel-based three-drug combinations for the treatment of small cell lung cancer: a review of the Sarah Cannon Cancer Center experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Clinical Trials, Phase II as Topic; Etoposide; Humans; Lung Neoplasms; Paclitaxel; Topotecan | 2001 |
Paclitaxel and docetaxel in prostate cancer.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Chemotherapy, Adjuvant; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dexamethasone; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Enzyme Inhibitors; Estramustine; Etoposide; Genes, bcl-2; Humans; Hydrocortisone; Male; Microtubules; Mitosis; Mitoxantrone; Multicenter Studies as Topic; Neoplasm Proteins; Oligodeoxyribonucleotides, Antisense; Paclitaxel; Palliative Care; Prostatic Neoplasms; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Survival Analysis; Taxoids; Treatment Outcome; Tubulin | 2001 |
[Is still there an indication for high-dose chemotherapy with hematopoietic stem-cell support in the treatment of germ-cell tumors?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Randomized Controlled Trials as Topic; Salvage Therapy; Testicular Neoplasms | 2001 |
European perspectives on paclitaxel/platinum-based therapy for advanced non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Drug Evaluation, Preclinical; Etoposide; Europe; Humans; Lung Neoplasms; Paclitaxel; Radiation-Sensitizing Agents | 2001 |
[Combination chemotherapy with VP-16 in the treatment of lung cancer and malignant lymphoma].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Clinical Trials, Phase II as Topic; Cytarabine; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Lymphoma; Mesna; Methylprednisolone; Mitoxantrone | 2001 |
Treatment of advanced ovarian cancer.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Liposomes; Ovarian Neoplasms; Paclitaxel; Randomized Controlled Trials as Topic; Topotecan | 2001 |
Topoisomerase I inhibitors combination chemotherapy in non-small cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Docetaxel; Doxorubicin; Enzyme Inhibitors; Etoposide; Gemcitabine; Humans; Ifosfamide; Irinotecan; Lung Neoplasms; Paclitaxel; Taxoids; Topoisomerase I Inhibitors; Topotecan; Vinblastine; Vinorelbine | 2001 |
Carboplatin-etoposide combination in small cell lung cancer patients older than 70 years: a phase II trial.
Topics: Administration, Oral; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Neoplasm Staging; Neutropenia; Survival Rate; Treatment Outcome | 2002 |
The status of high-dose chemotherapy with hematopoietic stem cell transplantation in germ cell tumor patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Etoposide; Europe; Forecasting; Gastrointestinal Diseases; Germinoma; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Ifosfamide; Kidney Diseases; Male; Multicenter Studies as Topic; Neoplasms, Second Primary; Paclitaxel; Prognosis; Randomized Controlled Trials as Topic; Salvage Therapy; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2002 |
The role of gemcitabine-based doublets in the management of ovarian carcinoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carboplatin; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Ovarian Neoplasms; Paclitaxel; Topotecan; Vinblastine; Vinorelbine | 2002 |
Developmental chemotherapy in advanced ovarian cancer: incorporation of newer cytotoxic agents in a phase III randomized trial of the Gynecologic Oncology Group (GOG-0182).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Deoxycytidine; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Ovarian Neoplasms; Paclitaxel; Topotecan | 2002 |
Bilateral metachronous germinoma of the basal ganglia occurring long after total removal of a mature pineal teratoma: case report.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Basal Ganglia Diseases; Brain Neoplasms; Carboplatin; Child; Combined Modality Therapy; Etoposide; Germinoma; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Second Primary; Pineal Gland; Teratoma | 2002 |
Secondary thyroid carcinoma after treatment for clear cell carcinoma of the uterus: case report and review of the literature.
Topics: Adenocarcinoma, Clear Cell; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Lymphatic Metastasis; Mesna; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Thyroid Neoplasms; Thyroidectomy; Uterine Neoplasms; Vincristine | 2001 |
Platinum compounds in the treatment of advanced breast cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Mastectomy; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Preoperative Care; Severity of Illness Index; Treatment Outcome; Vinblastine; Vinorelbine | 2001 |
[New strategies in the management of retinoblastoma].
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Eye Enucleation; Eye, Artificial; Female; Fluorescein Angiography; Follow-Up Studies; Forecasting; Genetic Therapy; Humans; Hyperthermia, Induced; Infant; Infant, Newborn; Male; Neoadjuvant Therapy; Retinal Neoplasms; Retinoblastoma; Time Factors | 2002 |
Unique management of stage 4S neuroblastoma complicated by massive hepatomegaly: case report and review of the literature.
Topics: Abdominal Muscles; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Breast Feeding; Carboplatin; Combined Modality Therapy; Enteral Nutrition; Etoposide; Hemorrhage; Hepatomegaly; Humans; Infant; Laparotomy; Liver Neoplasms; Lung Diseases; Male; Neoplasm Staging; Neuroblastoma; Occlusive Dressings; Pancytopenia; Parenteral Nutrition, Total; Positive-Pressure Respiration; Postoperative Complications; Sepsis; Surgical Mesh; Vacuum | 2002 |
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Topics: Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma; Middle Aged; Prednisone; Prognosis; Randomized Controlled Trials as Topic; Recurrence; Vincristine | 2002 |
[Carboplatin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Docetaxel; Etoposide; Gemcitabine; Humans; Lung Neoplasms; Paclitaxel; Randomized Controlled Trials as Topic; Taxoids; Treatment Outcome | 2002 |
[Chemotherapy for elderly patients with lung cancer].
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Docetaxel; Doxorubicin; Etoposide; Gemcitabine; Humans; Lung Neoplasms; Paclitaxel; Taxoids; Vinblastine; Vincristine; Vinorelbine | 2002 |
Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Case Management; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Multiple Primary; Orchiectomy; Radiotherapy, Adjuvant; Remission Induction; Retroperitoneal Space; Retrospective Studies; Risk Factors; Salvage Therapy; Seminoma; Survival Rate; Testicular Neoplasms; Treatment Outcome; Vinblastine | 2002 |
Platinum drugs in the treatment of non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Etoposide; Humans; Lung Neoplasms; Paclitaxel | 2002 |
[A study of usefulness of chemotherapy in long-term survival choroid plexus carcinoma case of childhood].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Choroid Plexus Neoplasms; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Survivors; Treatment Outcome | 2002 |
[Combinations of platinum salts and gemcitabine in the treatment of non-small-cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Deoxycytidine; Docetaxel; Etoposide; Gastrointestinal Diseases; Gemcitabine; Hematologic Diseases; Humans; Lung Neoplasms; Neoadjuvant Therapy; Paclitaxel; Pneumonectomy; Randomized Controlled Trials as Topic; Remission Induction; Reproducibility of Results; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 2002 |
Desmoplastic small round cell tumour: a description of two cases and review of the literature.
Topics: Abdominal Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Humans; Liver Neoplasms; Male; Prognosis; Salvage Therapy | 2003 |
Chemotherapy for good-risk germ-cell tumors.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Drug Administration Schedule; Etoposide; Germinoma; Humans; Male; Risk Factors; Testicular Neoplasms | 2002 |
Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Etoposide; Germinoma; Humans; Male; Middle Aged; Prognosis; Remission Induction; Survival Rate; Testicular Neoplasms; Vincristine | 2003 |
Small cell carcinoma of the bladder: a case report and a literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Life Tables; Liver Neoplasms; Male; Middle Aged; Stevens-Johnson Syndrome; Survival Analysis; Urinary Bladder Neoplasms; Vincristine | 2003 |
Ifosfamide, carboplatin, etoposide (ICE)-based second-line chemotherapy for the management of relapsed and refractory aggressive non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Secondary Prevention; Stem Cell Transplantation | 2003 |
An advance in small-cell lung cancer treatment--more or less.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Greece; Humans; Lung Neoplasms; Multicenter Studies as Topic; Paclitaxel; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; United States; Vincristine | 2003 |
Primary central nervous system germ cell tumors.
Topics: Antineoplastic Agents; Bleomycin; Carboplatin; Central Nervous System Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dose Fractionation, Radiation; Emergency Medical Services; Etoposide; Germinoma; Humans; Life Style; Mastectomy, Segmental; Salvage Therapy; Stereotaxic Techniques; Vinblastine; Vincristine | 2003 |
Improving second-line therapy in aggressive non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Rituximab; Salvage Therapy; Survival Rate; Treatment Outcome | 2004 |
Analysis of treatment for small cell cancer of the bladder and report of three cases.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Biomarkers, Tumor; Bone Neoplasms; Carboplatin; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Deoxycytidine; Disease Progression; Etoposide; Gemcitabine; Humans; Life Tables; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasms, Second Primary; Prostatectomy; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Urinary Diversion | 2004 |
[Current strategy of chemotherapy for reflactory bone and soft tissue sarcomas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Carboplatin; Cisplatin; Clinical Trials, Phase II as Topic; Docetaxel; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Imatinib Mesylate; Lung Neoplasms; Piperazines; Prognosis; Pyrimidines; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Taxoids | 2004 |
Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Length of Stay; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Pancoast Syndrome; Pneumonectomy; Postoperative Complications; Radiotherapy Dosage; Radiotherapy, Conformal; Radiotherapy, High-Energy; Retrospective Studies; Salvage Therapy; Survival Analysis; Survival Rate; Treatment Outcome; Vinblastine; Vinorelbine | 2004 |
Recurrent ovarian cancer: how important is it to treat to disease progression?
Topics: Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Disease Progression; Docetaxel; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Ovarian Neoplasms; Paclitaxel; Recurrence; Risk; Taxoids; Time Factors; Topotecan | 2004 |
[Second-line chemotherapy for recurrent ovarian cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclophosphamide; Docetaxel; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Irinotecan; Ovarian Neoplasms; Paclitaxel; Platinum; Taxoids | 2005 |
[Genetic analysis and individualized therapy for diffuse glioma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinases; Drug Administration Schedule; Etoposide; Female; Genes, p53; Glioma; Humans; Male; Middle Aged; Oligodendroglioma; Proteasome Endopeptidase Complex; Proteins; Tumor Suppressor Proteins | 2005 |
[Orbital rhabdomyosarcoma: difficulties with European treatment protocol].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Clinical Protocols; Combined Modality Therapy; Cranial Irradiation; Dactinomycin; Disease-Free Survival; Epirubicin; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Life Tables; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Orbital Neoplasms; Radiation Injuries; Radiotherapy, Adjuvant; Reoperation; Rhabdomyosarcoma, Embryonal; Survival Analysis; Treatment Outcome; Vincristine | 2005 |
HIV-related lymphoma treated with maintenance thalidomide.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Axilla; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Immunotherapy; Lymphatic Irradiation; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Male; Prednisone; Randomized Controlled Trials as Topic; Remission Induction; Rituximab; Thalidomide; Vincristine | 2005 |
Favorable histology, MYCN-amplified 4S neonatal neuroblastoma.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gene Amplification; Genes, myc; Genes, Neoplasm; Hepatomegaly; Humans; Infant, Newborn; Isotretinoin; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Neuroblastoma; Prognosis; Remission Induction; Risk Factors | 2007 |
High dose chemotherapy in germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Patient Selection; Prognosis; Risk Factors; Salvage Therapy; Survival Rate; Treatment Outcome; Vinblastine | 2005 |
[Progress of the ATLL study: an overview].
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Cyclin-Dependent Kinase Inhibitor p16; Cyclophosphamide; Doxorubicin; Etoposide; Genes, p16; Genes, p53; Hematopoietic Stem Cell Transplantation; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemic Infiltration; Mutation; Nitrosourea Compounds; Prednisolone; Receptors, Cytokine; Vincristine; Vindesine | 2005 |
Chemoradiation paradigm for the treatment of lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Etoposide; Humans; Lung Neoplasms; Multicenter Studies as Topic; Paclitaxel; Randomized Controlled Trials as Topic | 2006 |
Treatment of stage I-III non-small-cell lung cancer in the elderly.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Humans; Lung Neoplasms; Neoadjuvant Therapy | 2006 |
Ovarian dysgerminoma and Apert syndrome.
Topics: Acrocephalosyndactylia; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosome Aberrations; Combined Modality Therapy; Dysgerminoma; Etoposide; Female; Humans; In Situ Hybridization, Fluorescence; Neoplasm Proteins; Neoplastic Syndromes, Hereditary; Nucleic Acid Hybridization; Ovarian Neoplasms; Ovariectomy; Point Mutation; Receptor, Fibroblast Growth Factor, Type 2; Remission Induction | 2008 |
Chemotherapy dose--response relationships in non-small cell lung cancer and implied resistance mechanisms.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Gemcitabine; Humans; Lung Neoplasms; Paclitaxel; Survival Rate; Vinblastine; Vinorelbine | 2007 |
[Lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Docetaxel; Drug Administration Schedule; Etoposide; Glutamates; Guanine; Humans; Irinotecan; Lung Neoplasms; Pemetrexed; Taxoids | 2007 |
[Management of localized germ-cell tumours of the testis].
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Clinical Protocols; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Etoposide; Follow-Up Studies; Humans; Lymph Node Excision; Male; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Practice Guidelines as Topic; Prognosis; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Seminoma; Testicular Neoplasms; Testis; Time; Time Factors | 2007 |
Pemetrexed in small-cell lung cancer: background and review of the ongoing GALES pivotal trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Etoposide; Glutamates; Guanine; Humans; Lung Neoplasms; Mesothelioma; Pemetrexed; Randomized Controlled Trials as Topic | 2007 |
Dysgerminoma in a child with ataxia-telangiectasia.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Ataxia Telangiectasia; Biomarkers, Tumor; Bleomycin; CA-125 Antigen; Carboplatin; Child; Chorionic Gonadotropin, beta Subunit, Human; Dysgerminoma; Etoposide; Female; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Immunoglobulins, Intravenous; Neoplasm Proteins; Ovarian Neoplasms; Ovariectomy; Respiration Disorders | 2007 |
[Chemotherapy in lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Etoposide; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Paclitaxel; Survival Rate | 2007 |
Wilms' tumour in adults: a case report and review of the literature.
Topics: Adult; Antineoplastic Agents; Carboplatin; Cyclophosphamide; Etoposide; Humans; Male; Nephrectomy; Positron-Emission Tomography; Wilms Tumor | 2007 |
[Treatment of localized nasal NK/T-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Glyoxal; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Peripheral Blood Stem Cell Transplantation; Prednimustine; Prednisolone; Prognosis; Radiotherapy; Vincristine | 2008 |
Development of testicular alpha-fetoprotein-secreting germ cell tumor 3 years after treatment of intracranial lesion identified as non-secreting germ cell tumor on the basis of clinical data--case report.
Topics: alpha-Fetoproteins; Carboplatin; Combined Modality Therapy; Cranial Irradiation; Disease-Free Survival; Etoposide; Follow-Up Studies; Hemianopsia; Humans; Magnetic Resonance Imaging; Male; Neoplasm Proteins; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Orchiectomy; Supratentorial Neoplasms; Testicular Neoplasms; Young Adult | 2008 |
Are RAS mutations predictive markers of resistance to standard chemotherapy?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase III as Topic; Clinical Trials, Phase IV as Topic; Colorectal Neoplasms; Combined Modality Therapy; Drug Resistance, Neoplasm; Drug Therapy; Etoposide; Genes, ras; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mutation; Predictive Value of Tests; Prognosis; Survival Analysis; Treatment Outcome | 2009 |
Contralateral testicular relapse after prophylactic radiation in a patient with primary testicular diffuse large B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Blood-Testis Barrier; Bone Marrow; Carboplatin; Central Nervous System Neoplasms; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Injections, Spinal; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Orchiectomy; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Salvage Therapy; Testicular Neoplasms; Transplantation Conditioning; Treatment Failure; Vincristine | 2009 |
Purely intramedullary spinal cord primitive neuroectodermal tumor: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Etoposide; Humans; Infant; Magnetic Resonance Imaging; Male; Methotrexate; Neuroectodermal Tumors, Primitive; Paraparesis; Prognosis; Spinal Cord Neoplasms; Thoracic Vertebrae | 2009 |
Management of good risk germ-cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Risk Factors; Testicular Neoplasms | 2009 |
High-dose chemotherapy in nonseminomatous germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Randomized Controlled Trials as Topic; Testicular Neoplasms; Treatment Outcome; Vindesine | 2009 |
[Management of diffuse large B-cell lymphoma in the rituximab era].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Prednisolone; Prognosis; Randomized Controlled Trials as Topic; Rituximab; Vincristine | 2009 |
Carboplatin and etoposide combined with radiotherapy for limited-stage small-cell esophageal carcinoma: three cases and review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Esophageal Neoplasms; Etoposide; Female; Humans; Male; Middle Aged; Radiation Injuries | 2010 |
A meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Small Cell; Cisplatin; Disease-Free Survival; Etoposide; Humans; Irinotecan; Lung Neoplasms; Randomized Controlled Trials as Topic | 2010 |
[Concurrent chemoradiotherapy for localized nasal NK/T-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Japan; Killer Cells, Natural; Korea; Lymphoma, T-Cell; Male; Nose Neoplasms; Prospective Studies; Radiotherapy Dosage; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Unusual case of small cell gastric carcinoma: case report and literature review.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma, Small Cell; Chromogranins; Diabetes Mellitus, Type 2; Endoscopy; Etoposide; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Prognosis; Stomach Neoplasms; Synaptophysin; Tretoquinol | 2011 |
Double high-dose chemotherapy and stem cell transplantation in adult Wilms' tumor.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Cyclophosphamide; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Melphalan; Paclitaxel; Radiography; Salvage Therapy; Topotecan; Transplantation, Autologous; Wilms Tumor; Young Adult | 2010 |
Primary diaphragmatic yolk sac tumor and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Diaphragm; Endodermal Sinus Tumor; Etoposide; Female; Humans; Infant | 2011 |
[Small cell neuroendocrine carcinoma of the bladder: A case report and review of the literature].
Topics: Acute Kidney Injury; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma in Situ; Carcinoma, Neuroendocrine; Carcinoma, Transitional Cell; Combined Modality Therapy; Emergencies; Etoposide; Humans; Lymphatic Irradiation; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Prognosis; Prostatic Hyperplasia; Topoisomerase I Inhibitors; Topotecan; Urinary Bladder Neoplasms | 2011 |
[High-dose chemotherapy and residual tumor resection in male germ cell tumors].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Prognosis; Salvage Therapy; Seminoma; Testicular Neoplasms; Young Adult | 2011 |
An updated meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Etoposide; Humans; Irinotecan; Lung Neoplasms; Prognosis; Randomized Controlled Trials as Topic; Small Cell Lung Carcinoma; Survival Rate | 2012 |
Radiotherapy treatment planning for testicular seminoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bleomycin; Carboplatin; Cisplatin; Etoposide; Evidence-Based Medicine; Humans; Lymphatic Diseases; Male; Neoplasm Staging; Radiography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Seminoma; Testicular Neoplasms | 2012 |
Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asia; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Decision Trees; Etoposide; Europe; Female; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; North America; Paclitaxel; Radiation Pneumonitis; Radiotherapy Dosage | 2013 |
Primary ovarian small cell carcinoma of pulmonary type with enlarged paraaortic lymph node masses: a case report and review of the literature.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Etoposide; Female; Humans; Lymphatic Metastasis; Middle Aged; Ovarian Neoplasms | 2012 |
Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Carboplatin; Child; Child, Preschool; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neuroblastoma; Retrospective Studies; Salvage Therapy; Soft Tissue Neoplasms; Young Adult | 2013 |
High-dose etoposide in allogeneic stem cell transplantation.
Topics: Adenine Nucleotides; Anthracyclines; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Busulfan; Carboplatin; Carmustine; Clinical Trials as Topic; Clofarabine; Cyclophosphamide; Dose Fractionation, Radiation; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Leukemia; Leukemia, Myeloid, Acute; Lomustine; Mucositis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy, Adjuvant; Severity of Illness Index; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2012 |
Current and future management of NK/T-cell lymphoma based on clinical trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Chemoradiotherapy; Clinical Trials as Topic; Dexamethasone; DNA, Viral; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Neoplasm Staging; Nose Neoplasms | 2012 |
Treatment of patients with small-cell lung cancer: from meta-analyses to clinical practice.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Lung Neoplasms; Meta-Analysis as Topic | 2013 |
Treatment of poorly differentiated neuroendocrine carcinoma of the pancreas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Etoposide; Humans; Paclitaxel; Pancreatic Neoplasms; Receptor, IGF Type 1; TOR Serine-Threonine Kinases; Treatment Outcome | 2013 |
[Clinical analysis of 17 cases of gastric small cell carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Etoposide; Female; Follow-Up Studies; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplastic Cells, Circulating; Retrospective Studies; Stomach Neoplasms; Survival Rate | 2013 |
[Chemotherapy in male external genital organs (testicular and penile cancer)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Cryopreservation; Etoposide; Fluorouracil; Humans; Ifosfamide; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Paclitaxel; Penile Neoplasms; Spermatozoa; Testicular Neoplasms; Vinblastine | 2013 |
Sustained complete remission of a limited-stage blastic plasmacytoid dendritic cell neoplasm followed by a simultaneous combination of low-dose DeVIC therapy and radiation therapy: a case report and review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carboplatin; Chemoradiotherapy, Adjuvant; Dendritic Cells; Dexamethasone; Etoposide; Humans; Ifosfamide; Immunohistochemistry; Male; Neoplasm Staging; Positron-Emission Tomography; Remission Induction; Skin Neoplasms; Time Factors; Treatment Outcome; Whole Body Imaging | 2013 |
The role of high-dose chemotherapy in the management of germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Ifosfamide; Neoplasms, Germ Cell and Embryonal; Prognosis; Salvage Therapy | 2014 |
Clinical study on carboplatin for treating pediatric patients with Wilms tumors.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Treatment Outcome; Wilms Tumor | 2014 |
[Treatment of adult T-cell leukemia-lymphoma].
Topics: Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Methotrexate; Nitrosourea Compounds; Prednisolone; Prednisone; Prognosis; Salvage Therapy; Vincristine; Vindesine; Zidovudine | 2014 |
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Carboplatin; Carcinoid Heart Disease; Carcinoid Tumor; Cisplatin; Dacarbazine; Etoposide; Europe; Humans; Lung Neoplasms; Pneumonectomy; Positron-Emission Tomography; Receptors, Somatostatin; Societies, Medical; Temozolomide; Tomography, X-Ray Computed; Ultrasonography | 2015 |
2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Disease Management; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Etoposide; Europe; Humans; Lung; Lung Neoplasms; Lymph Nodes; Mediastinum; Multimodal Imaging; Pneumonectomy; Positron-Emission Tomography; Radiotherapy, Adjuvant; Societies, Medical; Tomography, X-Ray Computed; Vinblastine; Vinorelbine | 2015 |
Rapid COJEC versus standard induction therapies for high-risk neuroblastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Etoposide; Humans; Induction Chemotherapy; Infant; Neuroblastoma; Randomized Controlled Trials as Topic; Vincristine | 2015 |
Locally Advanced Non-Small Cell Lung Cancer: Optimal Chemotherapeutic Agents and Duration.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Lung Neoplasms; Paclitaxel; Patient Selection; Precision Medicine; Radiotherapy, Adjuvant; Risk Factors | 2015 |
The influence of polypharmacy on grade III/IV toxicity, prior discontinuation of chemotherapy and overall survival in ovarian cancer.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Deoxycytidine; Disease-Free Survival; Etoposide; Female; Gemcitabine; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Polypharmacy; Randomized Controlled Trials as Topic; Survival Rate; Topotecan; Withholding Treatment; Young Adult | 2016 |
[Intravesical Recurrence of Small Cell Carcinoma of the Ureter: A Case Report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Humans; Male; Middle Aged; Nephrectomy; Recurrence; Ureteral Neoplasms; Urinary Bladder Neoplasms | 2016 |
Rapid COJEC Induction Therapy for High-risk Neuroblastoma Patients - Cochrane Review.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Male; Neoadjuvant Therapy; Neuroblastoma; Randomized Controlled Trials as Topic; Risk Assessment; Survival Rate; Vincristine; Young Adult | 2016 |
[First-line Chemotherapy for Extensive-disease Small Cell Lung Cancer:
A Network Meta-analysis].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Network Meta-Analysis; Randomized Controlled Trials as Topic; Small Cell Lung Carcinoma | 2016 |
Treatment of Locally Advanced Non-Small Cell Lung Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Etoposide; Humans; Lung Neoplasms; Paclitaxel; Radiotherapy Dosage | 2017 |
Comparison of Concurrent Use of Thoracic Radiation With Either Carboplatin-Paclitaxel or Cisplatin-Etoposide for Patients With Stage III Non-Small-Cell Lung Cancer: A Systematic Review.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Etoposide; Humans; Lung Neoplasms; Paclitaxel; Thorax | 2017 |
Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cell Proliferation; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Ki-67 Antigen; Mitotic Index; Neoadjuvant Therapy; Neoplasm Staging; Neuroendocrine Tumors; Pancreatectomy; Pancreatic Neoplasms; Prognosis | 2016 |
Neuroendocrine Cancer, Therapeutic Strategies in G3 Cancers.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Gastrointestinal Neoplasms; Humans; Irinotecan; Ki-67 Antigen; Neoplasm Grading; Neuroendocrine Tumors; Practice Guidelines as Topic; Prognosis; Treatment Outcome | 2017 |
Comparison of irinotecan/platinum versus etoposide/platinum chemotherapy for extensive-stage small cell lung cancer: A meta-analysis.
Topics: Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Diarrhea; Etoposide; Fatigue; Humans; Irinotecan; Leukopenia; Lung Neoplasms; Nausea; Neoplasm Staging; Neutropenia; Odds Ratio; Proportional Hazards Models; Small Cell Lung Carcinoma; Thrombocytopenia; Vomiting | 2017 |
Adult T-Cell Leukemia/Lymphoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leukemia-Lymphoma, Adult T-Cell; Prednisone; Vincristine; Vindesine | 2017 |
Craniospinal Germinomas in Patient with Down Syndrome Successfully Treated with Standard-Dose Chemotherapy and Craniospinal Irradiation: Case Report and Literature Review.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Craniospinal Irradiation; Down Syndrome; Etoposide; Germinoma; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Multiple Primary; Positron-Emission Tomography; Treatment Outcome | 2017 |
Anticancer drug treatment for advanced lung cancer with interstitial lung disease.
Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Disease Progression; Etoposide; Follow-Up Studies; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Paclitaxel; Platinum; Retrospective Studies; Risk Assessment; Risk Factors | 2018 |
Successful treatment of primary bone marrow Hodgkin lymphoma with brentuximab vedotin: a case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Brentuximab Vedotin; Carboplatin; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Immunoconjugates; Male; Vinblastine | 2018 |
Prognostic markers in clinical stage I seminoma and nonseminomatous germ cell tumours.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Lymph Node Excision; Lymph Nodes; Male; Neoplasm Invasiveness; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Prognosis; Radiotherapy, Adjuvant; Retroperitoneal Space; Seminoma; Testicular Neoplasms | 2018 |
Current Treatment Options in Gastroenteropancreatic Neuroendocrine Carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Intestinal Neoplasms; Irinotecan; Neuroendocrine Tumors; Pancreatic Neoplasms; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Stomach Neoplasms | 2019 |
[PRIMARY SMALL CELL NEUROENDOCRINE CARCINOMA OF THE URETER].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Combined Modality Therapy; Etoposide; Gastrectomy; Humans; Laparoscopy; Male; Neoplasms, Multiple Primary; Nephroureterectomy; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Ureteral Neoplasms; Urologic Surgical Procedures, Male | 2018 |
Advancements in Small-cell Lung Cancer: The Changing Landscape Following IMpower-133.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Pharmacological; Carboplatin; Clinical Protocols; Clinical Trials as Topic; Etoposide; Humans; Lung Neoplasms; Small Cell Lung Carcinoma; Survival Analysis; Treatment Outcome | 2019 |
Dashing Decades of Defeat: Long Anticipated Advances in the First-line Treatment of Extensive-Stage Small Cell Lung Cancer.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carboplatin; Clinical Trials, Phase III as Topic; Drug Therapy; Etoposide; Humans; Immunotherapy; Small Cell Lung Carcinoma | 2020 |
Worsening of anti-Hu paraneoplastic neurological syndrome related to anti-PD-1 treatment: Case report and review of literature.
Topics: Antibodies, Antinuclear; Antibodies, Neoplasm; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Autoantigens; Carboplatin; Carcinoma, Small Cell; Cerebellar Neoplasms; Combined Modality Therapy; Disease Progression; ELAV Proteins; Etoposide; Female; Humans; Lung Neoplasms; Middle Aged; Nivolumab; Paraneoplastic Syndromes, Nervous System; Programmed Cell Death 1 Receptor; Radiotherapy, Adjuvant; Treatment Outcome | 2020 |
Atezolizumab: A Review in Extensive-Stage SCLC.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carboplatin; Etoposide; Humans; Lung Neoplasms; Progression-Free Survival; Quality of Life; Small Cell Lung Carcinoma | 2020 |
Durable Response in Relapsed Adolescent Peripheral T-cell Lymphoma: A Case Report and Review of the Literature.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Autografts; Carboplatin; Etoposide; Humans; Ifosfamide; Lymphoma, T-Cell, Peripheral; Male; Recurrence; Stem Cell Transplantation | 2022 |
Durvalumab: A Review in Extensive-Stage SCLC.
Topics: Adult; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Humans; Lung Neoplasms; Small Cell Lung Carcinoma | 2021 |
Clinical pharmacology of cytotoxic drugs in neonates and infants: Providing evidence-based dosing guidance.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carboplatin; Etoposide; Humans; Infant; Infant, Newborn | 2022 |
A phase II, open-label, single-arm trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Clinical Trials, Phase II as Topic; Etoposide; Humans; Lung Neoplasms; Multicenter Studies as Topic; Research Design; Small Cell Lung Carcinoma | 2022 |
High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centres.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Retrospective Studies; Salvage Therapy; Testicular Neoplasms | 2022 |
A network meta-analysis for efficacies and toxicities of different concurrent chemoradiotherapy regimens in the treatment of locally advanced non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Docetaxel; Etoposide; Humans; Irinotecan; Lung Neoplasms; Network Meta-Analysis; Paclitaxel; Pemetrexed; Vinorelbine | 2022 |
Small Cell Lung Cancer in the Course of Idiopathic Pulmonary Fibrosis-Case Report and Literature Review.
Topics: Aged; Carboplatin; Etoposide; Humans; Idiopathic Pulmonary Fibrosis; Lung Neoplasms; Small Cell Lung Carcinoma | 2022 |
High-dose chemotherapy for relapsed testicular germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Retrospective Studies; Salvage Therapy; Testicular Neoplasms | 2023 |
Pathological complete response to neoadjuvant tislelizumab plus chemotherapy in stage IIIB small cell lung cancer: A case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Humans; Lung Neoplasms; Neoadjuvant Therapy; Small Cell Lung Carcinoma | 2023 |
Efficacy and toxicity profile of first-line treatment for extensive-stage small cell lung cancer: A Bayesian network meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Carboplatin; Cisplatin; Etoposide; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Network Meta-Analysis; Small Cell Lung Carcinoma | 2023 |
First-line immune-checkpoint inhibitor treatment in extensive-disease small-cell lung cancer: A classical and network meta-analysis.
Topics: Antineoplastic Agents, Immunological; B7-H1 Antigen; Carboplatin; Etoposide; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Network Meta-Analysis; Platinum; Programmed Cell Death 1 Receptor; Small Cell Lung Carcinoma | 2023 |
665 trial(s) available for etoposide and carboplatin
| Article | Year |
|---|---|
High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Drug Evaluation; Etoposide; Feasibility Studies; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Transplantation, Autologous; Treatment Outcome | 1992 |
Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell lung cancer in a randomised phase II study. The EORTC Lung Cancer Cooperative group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Random Allocation; Time Factors; Vincristine | 1992 |
Combination chemotherapy with carboplatin, etoposide, and vincristine as first-line treatment in small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Treatment Outcome; Vincristine | 1992 |
Platinum/etoposide therapy in non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Humans; Lung Neoplasms; Neoplasm Staging | 1992 |
Carboplatin plus oral etoposide in the management of unresectable non-small cell lung cancer. Preliminary results of a Vanderbilt trial.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Platelet Count | 1992 |
Intensive etoposide and carboplatin chemotherapy for advanced non-small-cell lung cancer. A phase II trial of the Cancer and Leukemia Group B.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Analysis | 1992 |
Second-line carboplatin-based chemotherapy for small cell lung cancer: the Groningen experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Clinical Trials, Phase II as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Pilot Projects; Remission Induction; Survival Rate; Vincristine | 1992 |
Phase II and III studies with carboplatin in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Remission Induction; Survival Rate; Vincristine | 1992 |
Carboplatin plus oral etoposide in the management of advanced, non-small cell lung cancer: preliminary results of a Vanderbilt trial.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Pilot Projects; Remission Induction; Survival Rate; Thrombocytopenia | 1992 |
Carboplatin and etoposide (CarE) combined with radiotherapy and vincristine, doxorubicin and cyclophosphamide (VAC) in limited small cell lung cancer. A phase II study.
Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Radiography; Time Factors; Treatment Outcome; Vincristine | 1992 |
Extensive small-cell lung cancer. A randomized comparison of two chemotherapy programs with early crossover in instances of failure. Association pour le Traitement des Tumeurs Intra-Thoraciques (ATTIT).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Vincristine | 1992 |
Cutaneous toxicity of high-dose carboplatin, etoposide and ifosfamide followed by autologous stem cell reinfusion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Drug Eruptions; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Kidney; Neoplasms, Germ Cell and Embryonal; Skin; Transplantation, Autologous | 1992 |
Carboplatin in small cell lung cancer: the Royal Marsden Hospital experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Combined Modality Therapy; Cranial Irradiation; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Mesothelioma; Middle Aged; Palliative Care; Pleural Neoplasms; Remission Induction; Survival Rate | 1992 |
Phase 2 trial of chronic low-dose oral etoposide as salvage therapy of platinum-refractory ovarian cancer.
Topics: Carboplatin; Cisplatin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Humans; Neutropenia; Ovarian Neoplasms | 1992 |
Etoposide and carboplatin in neuroblastoma: a French Society of Pediatric Oncology phase II study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Male; Neuroblastoma; Treatment Outcome | 1992 |
Phase I and II study of high-dose ifosfamide, carboplatin, and etoposide with autologous bone marrow rescue in lymphomas and solid tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Neoplasms; Survival Analysis; Transplantation, Autologous | 1992 |
A dose-escalation study of carboplatin/cyclophosphamide/etoposide along with autologous bone marrow or peripheral blood stem cell rescue.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Component Transfusion; Bone Marrow Transplantation; Candidiasis; Carboplatin; Clinical Trials, Phase I as Topic; Cyclophosphamide; Etoposide; Female; Humans; Infusions, Intravenous; Male; Neutropenia; Remission Induction; Stem Cells; Survival Rate; Thrombocytopenia | 1992 |
Escalating sequential high-dose carboplatin and etoposide with autologous marrow support in children with relapsed solid tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Central Nervous System Neoplasms; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Gastrointestinal Diseases; Hodgkin Disease; Humans; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Neuroblastoma; Neutropenia; Thrombocytopenia | 1992 |
Phase 2 trial of intraperitoneal carboplatin and etoposide as salvage treatment of advanced epithelial ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Etoposide; Female; Humans; Injections, Intraperitoneal; Middle Aged; Ovarian Neoplasms; Salvage Therapy; Survival Rate | 1992 |
Carboplatin combined with carmustine and etoposide in the treatment of glioblastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carmustine; Etoposide; Glioma; Humans; Middle Aged; Survival Analysis | 1992 |
Exploring the use of chronic low-dose oral etoposide in ovarian cancer: is there a role for this "new drug" in the management of platinum-refractory disease?
Topics: Administration, Oral; Carboplatin; Cisplatin; Drug Administration Schedule; Drug Resistance; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Ovarian Neoplasms | 1992 |
Etoposide plus carboplatin admixture. Phase I study of five- or seven-day continuous infusion.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusion Pumps, Implantable; Male; Middle Aged; Neoplasms | 1992 |
Phase II trial of carboplatin and etoposide activity in pretreated breast cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Drug Evaluation; Etoposide; Female; Humans; Middle Aged | 1992 |
High dose carboplatin/VP-16 plus ifosfamide with autologous bone marrow support in the treatment of refractory germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Kidney Diseases; Male; Neoplasms, Germ Cell and Embryonal; Transplantation, Autologous | 1991 |
High dose chemotherapy with carboplatin, VP 16 +/- ifosfamide in germ cell tumors: the Italian experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Italy; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Remission Induction; Reoperation | 1991 |
Effective new low toxicity chemotherapy with carboplatin, vinblastine and methotrexate for small cell lung cancer: a randomised trial against doxorubicin, cyclophosphamide and etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prognosis; Vinblastine | 1991 |
Determining carboplatin/etoposide dosage in extensive stage small-cell lung cancer (SCLC).
Topics: Aged; Carboplatin; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging | 1991 |
A phase I trial of high-dose carboplatin and etoposide with autologous marrow support for treatment of stage D neuroblastoma in first remission: use of marker genes to investigate the biology of marrow reconstitution and the mechanism of relapse.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Carboplatin; Child; Drug Evaluation; Drug Resistance; Etoposide; Genetic Markers; Genetic Vectors; Humans; Informed Consent; Kanamycin Kinase; Neomycin; Neoplasm Recurrence, Local; Neuroblastoma; Phosphotransferases; Recombinant Proteins; Research Design; Transduction, Genetic; Transplantation, Autologous | 1991 |
A phase I trial of high-dose carboplatin and etoposide with autologous marrow support for treatment of relapse/refractory neuroblastoma without apparent bone marrow involvement: use of marker genes to investigate the biology of marrow reconstitution and t
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Carboplatin; Child; Drug Evaluation; Drug Resistance; Etoposide; Genetic Markers; Genetic Vectors; Humans; Informed Consent; Kanamycin Kinase; Neomycin; Neoplasm Recurrence, Local; Neuroblastoma; Phosphotransferases; Recombinant Proteins; Research Design; Transduction, Genetic; Transplantation, Autologous | 1991 |
High dose chemotherapy with cisplatin, VP16 and carboplatin with stem cell support in patients with advanced ovarian cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Ovarian Neoplasms; Pancytopenia; Transplantation, Autologous | 1991 |
Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Child; Etoposide; Follow-Up Studies; Glomerular Filtration Rate; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Remission Induction; Sperm Count; Survival Rate; Testicular Neoplasms | 1991 |
New agents in the treatment of acute myeloid leukemia.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Daunorubicin; Drug Evaluation; Etoposide; Humans; Idarubicin; Leukemia, Myeloid; Middle Aged; Mitoxantrone; Remission Induction; Tretinoin | 1991 |
Carboplatin in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Rate; Vincristine | 1991 |
Single or double consolidation treatment according to remission status after initial therapy in metastatic neuroblastoma: first results of LMCE 3 study in 40 patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Carmustine; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; France; Humans; Infant; Life Tables; Male; Neuroblastoma; Remission Induction; Reoperation; Survival Analysis; Transplantation, Autologous; Vincristine | 1991 |
A single center experience with bone marrow transplantation for high risk neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Carmustine; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; France; Humans; Infant; Male; Neuroblastoma; Organoplatinum Compounds; Remission Induction; Reoperation; Survival Rate; Teniposide; Vincristine | 1991 |
[Phase III study: cisplatin combination therapy vs. carboplatin monotherapy in metastasizing seminoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Dysgerminoma; Etoposide; Genital Neoplasms, Male; Humans; Ifosfamide; Male | 1991 |
VP 16 carboplatinum in neuroblastoma: a SFOP phase II study. The Société Française d'Oncologie Pédiatrique.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Drug Evaluation; Etoposide; Female; Humans; Male; Neoplasm Staging; Neuroblastoma | 1991 |
A randomized trial of two platinum combinations in patients with advanced non-small cell lung cancer: a preliminary report. European Organization for the Research and Treatment of Cancer--Lung Cancer Working Party.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Randomized Controlled Trials as Topic; Survival Rate | 1990 |
A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Randomized Controlled Trials as Topic; Survival Analysis | 1990 |
[Chemotherapy in non-small cell bronchial carcinoma. 12 years' experience in an international cooperative group: EORTC Lung Cancer Working Party].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Screening Assays, Antitumor; Etoposide; Humans; Lung Neoplasms; Vindesine | 1990 |
[Clinical results of carboplatin in the treatment of malignant tumors. Clinical Cooperative Group of Carboplatin].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms | 1990 |
Carboplatin and etoposide in advanced lung cancer:--a phase I study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Creatinine; Drug Evaluation; Etoposide; Female; Glomerular Filtration Rate; Humans; Lung Neoplasms; Male; Middle Aged | 1990 |
Intracavitary chemotherapy.
Topics: Anthraquinones; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Catheters, Indwelling; Cisplatin; Clinical Trials as Topic; Cytarabine; Doxorubicin; Etoposide; Fluorouracil; Humans; Immunotherapy; Infusions, Parenteral; Melphalan; Methotrexate; Mitomycins; Mitoxantrone; Neoplasms; Organoplatinum Compounds | 1986 |
Carboplatin in association with etoposide and either adriamycin or epirubicin for untreated small cell lung cancer: a dose escalation study of carboplatin. UCL Clinical Oncology Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Staging; Organoplatinum Compounds | 1989 |
Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Clinical Trials as Topic; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Time Factors | 1987 |
[Carboplatin, VP-16 in epithelial ovarian cancer--initial experiences].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Combined Modality Therapy; Etoposide; Female; Humans; Organoplatinum Compounds; Ovarian Neoplasms | 1988 |
Maturation of mobilized peripheral blood progenitor cells: preclinical and phase I clinical studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cell Differentiation; Cell Division; Colony-Forming Units Assay; Cryopreservation; Culture Techniques; Cyclophosphamide; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Growth Substances; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Interleukin-3; Leukapheresis; Neoplasms; Neutropenia; Thiotepa | 1995 |
Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin.
Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Blood Transfusion, Autologous; Breast Neoplasms; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Epirubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasms; Predictive Value of Tests; Vincristine | 1994 |
High-dose ifosfamide/carboplatin/etoposide: maximum tolerable doses, toxicities, and hematopoietic recovery after autologous stem cell reinfusion.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Length of Stay; Male; Middle Aged; Neoplasms; Transplantation, Autologous; Treatment Outcome | 1994 |
Multicyclic, dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole blood.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion, Autologous; Carboplatin; Carcinoma, Small Cell; Cause of Death; Combined Modality Therapy; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leukapheresis; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Platelet Transfusion | 1995 |
Accelerated chemotherapy for poor prognosis germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Disease Progression; Drug Administration Schedule; Etoposide; Follow-Up Studies; Germinoma; Humans; Male; Pilot Projects; Prognosis; Survival Rate; Testicular Neoplasms; Vincristine | 1994 |
Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Middle Aged; Survival Analysis | 1995 |
Clinical value of fructose 1,6 bisphosphatase in monitoring renal proximal tubular injury.
Topics: Acetylglucosaminidase; Adolescent; Adult; Albuminuria; Alpha-Globulins; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Carboplatin; Cisplatin; Etoposide; Fructose-Bisphosphatase; Humans; Ifosfamide; Immunoglobulin G; Kidney Tubules, Proximal; Male; Middle Aged; Testicular Neoplasms | 1994 |
Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lenograstim; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Neutropenia; Neutrophils; Prognosis; Recombinant Proteins; Survival Rate; Vincristine | 1995 |
Oral etoposide and carboplatin. Effective therapy for elderly patients with small cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Female; Frail Elderly; Humans; Lung Neoplasms; Male; Middle Aged; Palliative Care; Remission Induction; Survival Rate | 1995 |
Delayed commencement of granulocyte colony-stimulating factor following autologous bone marrow transplantation accelerates neutrophil recovery and is cost-effective.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Mitoxantrone; Neoplasms; Neutrophils; Pilot Projects | 1994 |
Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexa
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Palliative Care; Prospective Studies; Quality of Life; Surveys and Questionnaires; Survival Rate; Teniposide; Vincristine | 1995 |
[Clinical study of recombinant human granulocyte colony-stimulating factor (RHG-CSF) on leucopenia induced by chemotherapy with CE regimen on lung cancer patients].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cross-Over Studies; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Recombinant Proteins | 1994 |
A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cohort Studies; Drug Tolerance; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Remission Induction; Thrombocytopenia | 1995 |
Human recombinant stem-cell factor induces melanocytic hyperplasia in susceptible patients.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cell Adhesion Molecules; Dendrites; Disease Susceptibility; Etoposide; Follow-Up Studies; Hematopoietic Cell Growth Factors; Humans; Hyperpigmentation; Hyperplasia; Injections, Subcutaneous; Lung Neoplasms; Melanins; Melanocytes; Recombinant Proteins; Stem Cell Factor | 1995 |
Etoposide phosphate or etoposide with cisplatin in the treatment of small cell lung cancer: randomized phase II trial.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Organophosphorus Compounds; Treatment Outcome | 1995 |
Continuous infusion etoposide/carboplatin for treatment of refractory acute leukemia.
Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Infusions, Intravenous; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Salvage Therapy | 1995 |
Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: preliminary results. Italian Neuroblastoma Cooperative Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Deferoxamine; Etoposide; Humans; Infant; Neoplasm Staging; Neuroblastoma; Risk Factors; Thiotepa | 1995 |
An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Bone Marrow; Carboplatin; Cell Survival; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Life Tables; Male; Middle Aged; Neoplasms; Proportional Hazards Models; Retrospective Studies; Thiotepa; Time Factors; Treatment Outcome | 1995 |
Single fraction prophylactic cranial irradiation for small cell carcinoma of the lung.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cognition; Combined Modality Therapy; Cranial Irradiation; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Memory; Psychomotor Performance; Radiotherapy Dosage; Remission Induction; Retrospective Studies; Survival Rate; Vincristine | 1995 |
Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Remission Induction; Survival Rate | 1995 |
Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancer.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Colony-Forming Units Assay; Drug Administration Schedule; Erythrocyte Transfusion; Erythropoietin; Etoposide; Female; Granulocytes; Hemoglobin A; Humans; Ifosfamide; Iron; Leukocyte Count; Lung Neoplasms; Macrophages; Male; Mesna; Middle Aged; Platelet Count; Platelet Transfusion; Recombinant Proteins; Vincristine | 1995 |
Phase I study of escalating doses of paclitaxel (Taxol) with fixed doses of ifosfamide, carboplatin, and etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Adenoid Cystic; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Remission Induction; Sarcoma | 1995 |
Ifosfamide/carboplatin/etoposide chemotherapy for metastatic breast cancer with or without autologous hematopoietic stem cell transplantation: evaluation of dose-response relationships.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Analysis | 1995 |
Ifosfamide/carboplatin/etoposide chemotherapy in patients with metastatic non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Survival Analysis | 1995 |
Ifosfamide/carboplatin/etoposide (ICE) for recurrent malignant solid tumors of childhood: a Pediatric Oncology Group Phase I/II study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasms; Recurrence | 1995 |
Pilot study of a high-dose carboplatin-based salvage strategy for relapsing or refractory germ cell cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Pilot Projects; Reoperation; Salvage Therapy; Thiotepa | 1995 |
[Neoadjuvant radiochemotherapy in locally advanced non-small cell bronchial carcinoma. Initial results of a prospective multicenter study].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Brain; Carboplatin; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prognosis; Prospective Studies; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Rate; Vindesine | 1995 |
Tandem autotransplantation for the treatment of metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Diarrhea; Disease-Free Survival; Etoposide; Feasibility Studies; Female; Humans; Middle Aged; Mouth Mucosa; Neoplasm Metastasis; Remission Induction; Stomatitis; Transplantation, Autologous | 1995 |
High-dose carboplatin and etoposide for salvage chemotherapy of germ cell tumours.
Topics: Adolescent; Adult; Blood Platelets; Bone Marrow; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Female; Germinoma; Humans; Leukocytes; Male; Middle Aged; Salvage Therapy; Treatment Outcome | 1995 |
Carboplatin/etoposide/radiation plus escalating doses of paclitaxel in stage III non-small cell lung cancer: a preliminary report.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Tolerance; Etoposide; Feasibility Studies; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Lung Neoplasms; Male; Neoplasm Staging; Paclitaxel; Pneumonectomy; Thorax | 1995 |
Phase II trial of carboplatin in combination with etoposide in locally advanced large cell carcinoma and adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged | 1995 |
Prospective multimodality treatment of SCLC--experience during the past 18 years.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Pneumonectomy; Postoperative Care; Prednisone; Procarbazine; Radiotherapy Dosage; Vincristine | 1995 |
Phase II study of carboplatin and etoposide as a first line regimen in patients with metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Disease-Free Survival; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis; Survival Rate; Treatment Outcome | 1994 |
Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Neutropenia; Remission Induction; Survival Rate; Thrombocytopenia; Vincristine | 1995 |
Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Non-Small-Cell Lung; Colony-Stimulating Factors; Ethylenes; Etoposide; Female; Humans; Interleukin-1; Interleukin-6; Lung Neoplasms; Male; Middle Aged; Neutropenia; Prospective Studies; Remission Induction; Thrombocytopenia | 1995 |
Recent advances in the therapy of Hodgkin's disease in elderly patients. The Piemonte Hodgkin's Disease Register (PHDR).
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Hodgkin Disease; Humans; Middle Aged; Prednisone; Registries; Retrospective Studies; Vincristine | 1993 |
Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Germinoma; Humans; Male; Survival Analysis; Vinblastine | 1993 |
Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Neutropenia; Remission Induction; Thrombocytopenia; Vincristine | 1995 |
Etoposide and carboplatin in extraocular retinoblastoma: a study by the Société Française d'Oncologie Pédiatrique.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Etoposide; Eye Neoplasms; Female; Follow-Up Studies; France; Humans; Infant; Male; Orbital Neoplasms; Remission Induction; Retinoblastoma | 1995 |
The subrenal capsule assay in selecting chemotherapy for ovarian cancer: a prospective randomized trial.
Topics: Aged; Altretamine; Animals; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Methotrexate; Mice; Mice, Inbred Strains; Middle Aged; Ovarian Neoplasms; Prospective Studies; Subrenal Capsule Assay; Tegafur | 1995 |
Carboplatin (CBDCA)-hexamethylmelamine (HMM)-oral etoposide (VP-16) first-line treatment of ovarian cancer patients with bulky disease: a phase II study.
Topics: Administration, Oral; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Ovarian Neoplasms | 1995 |
Phase I study and clinical pharmacological evaluation of daily oral etoposide combined with carboplatin in patients with lung cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged | 1995 |
Carboplatin and etoposide in extensive small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Treatment Outcome | 1994 |
High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Enterocolitis; Etoposide; Female; Germinoma; Humans; Ifosfamide; Kidney; Male; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Pregnancy; Prognosis; Remission Induction; Survival Rate; Testicular Neoplasms; Transplantation, Autologous; Trophoblastic Neoplasms; Uterine Neoplasms | 1995 |
Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy Dosage; Survival Rate; Time Factors | 1995 |
The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Salvage Therapy; Teniposide; Vincristine | 1995 |
A phase II trial of intraperitoneal high-dose carboplatin and etoposide with granulocyte macrophage-colony stimulating factor support in patients with ovarian carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carboplatin; Carcinoma; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Infusions, Parenteral; Ovarian Neoplasms; Survival Analysis; Thrombocytopenia; Treatment Outcome | 1995 |
Intraperitoneal adjuvant immunochemotherapy in operable gastric cancer with serosal involvement.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Immunotherapy; Injections, Intraperitoneal; Interferon alpha-2; Interferon-alpha; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Recombinant Proteins; Risk; Stomach Neoplasms; Survival Analysis | 1994 |
[Clinical study of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced leukopenia].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cross-Over Studies; Doxorubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Recombinant Proteins | 1994 |
Intensive dose ifosfamide, carboplatin, and etoposide followed by autologous stem cell rescue: results of a phase I/II study in breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Middle Aged; Neoplasm Staging; Nervous System Diseases; Remission Induction; Survival Rate; Treatment Outcome | 1993 |
High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Retroperitoneal Neoplasms; Survival Rate; Testicular Neoplasms; Transplantation, Autologous | 1994 |
[Recurrence and survival rate of advanced gastric cancer after preoperative EAP-II intra-arterial infusion therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Humans; Infusions, Intra-Arterial; Neoplasm Metastasis; Neoplasm Recurrence, Local; Preoperative Care; Stomach Neoplasms; Survival Rate | 1994 |
Altered etoposide pharmacokinetics and time to engraftment in pediatric patients undergoing autologous bone marrow transplantation.
Topics: Adolescent; Adult; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Child; Child, Preschool; Drug Interactions; Etoposide; Half-Life; Humans; Infant; Metabolic Clearance Rate; Neoplasms; Transplantation, Autologous | 1994 |
Phase I/II study of cyclophosphamide, carboplatin, and etoposide and autologous hematopoietic stem-cell transplantation with posttransplant interferon alfa-2b for patients with lymphoma and Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Interferon alpha-2; Interferon-alpha; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Recombinant Proteins; Recurrence; Safety; Survival Rate; Transplantation, Autologous | 1994 |
Phase II study of ifosfamide, carboplatin, and etoposide in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Remission Induction; Survival Analysis | 1994 |
Etoposide plus carboplatin or cisplatin in good-risk patients with germ cell tumors: a randomized comparison.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Etoposide; Germinoma; Humans; Male; Middle Aged; Neutropenia; Remission Induction; Seminoma; Survival Rate; Testicular Neoplasms | 1994 |
High-dose ifosfamide/carboplatin/etoposide with autologous hematopoietic stem cell support: safety and future directions.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Forecasting; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Neoplasms; Transplantation, Autologous; Treatment Outcome | 1994 |
[Phase I/II study of a combination regimen composed of cisplatin, carboplatin and etoposide against small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged | 1994 |
Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Etoposide; Female; Follow-Up Studies; Greece; Humans; Lung Neoplasms; Male; Middle Aged; Remission Induction; Survival Rate | 1994 |
A phase I trial of intraperitoneal carboplatin and etoposide with granulocyte macrophage colony stimulating factor support in patients with intraabdominal malignancies.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Infusions, Parenteral; Ovarian Neoplasms | 1994 |
Calvert's formula and high-dose carboplatin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Creatinine; DNA; DNA Adducts; Etoposide; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Neoplasms; Thiotepa | 1994 |
Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer Trials.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Remission Induction; Survival Analysis | 1994 |
Etoposide/vincristine-based chemotherapy with or without carboplatin in extensive-stage small cell lung cancer: a prospective randomized phase III trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Remission Induction; Survival Analysis; Vincristine | 1994 |
Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pneumonectomy; Radiotherapy Dosage; Radiotherapy, High-Energy; Remission Induction; Survival Rate; Thoracotomy | 1994 |
Carboplatin plus epirubicin plus VP-16, concurrent 'split course' radiotherapy and adjuvant surgery for limited small cell lung cancer. Gruppo Oncologico Centro-Sud-Isole (GOCSI).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Digestive System Diseases; Epirubicin; Etoposide; Humans; Kidney Diseases; Life Tables; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Survival Analysis | 1994 |
Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging | 1994 |
Phase I trial of continuous infusion carboplatin and etoposide in children with refractory acute leukemia: a Pediatric Oncology Group study.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Child; Child, Preschool; Diarrhea; Drug Administration Schedule; Etoposide; Female; Humans; Infections; Infusions, Intravenous; Leukemia; Male; Remission Induction; United States | 1994 |
Carboplatin and VP 16 in medulloblastoma: a phase II Study of the French Society of Pediatric Oncology (SFOP).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Male; Medulloblastoma; Treatment Outcome | 1994 |
Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor. A randomized trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Neutropenia; Thrombocytopenia | 1993 |
Urinary-derived monocyte-colony stimulating factor (P-100) following treatment with carboplatin and etoposide in small cell lung cancer (SCLC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Treatment Outcome | 1993 |
Ifosfamide, carboplatin, and etoposide: a new regimen with a broad spectrum of activity.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Hematopoiesis; Humans; Ifosfamide; Male; Middle Aged; Neoplasms; Treatment Outcome | 1994 |
Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in treatment of newly diagnosed pediatric solid tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasms; Treatment Outcome | 1994 |
Phase I-II trial of high dose Ara-C, carboplatinum, etoposide and steroids in patients with refractory or relapsed lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone Hemisuccinate; Middle Aged | 1994 |
Etoposide and carboplatin: a highly effective combination in relapsed or refractory Wilms' tumor--a phase II study by the French Society of Pediatric Oncology.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Hematologic Diseases; Humans; Infant; Kidney Neoplasms; Male; Neoplasm Staging; Remission Induction; Thrombocytopenia; Wilms Tumor | 1994 |
[Chemotherapy with oral etoposide, UFT and carboplatin in non-small cell lung cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1994 |
Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neutropenia | 1994 |
Two novel high-dose treatment regimens for metastatic breast cancer--ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicities.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Immunotherapy; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Stem Cell Transplantation; Survival Analysis; Thiotepa | 1993 |
High failure rate of carboplatin-etoposide combination in good risk non-seminomatous germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Neutropenia; Prospective Studies; Testicular Neoplasms; Thrombocytopenia; Treatment Outcome | 1993 |
Carboplatin, etoposide, and radiotherapy, followed by surgery, for the treatment of marginally resectable non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Thoracotomy | 1993 |
Carboplatin and etoposide in patients with advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Middle Aged; Stomach Neoplasms | 1993 |
Phase II trial of etoposide, carboplatin, and ifosfamide as salvage therapy in advanced ovarian carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Salvage Therapy; Treatment Outcome | 1993 |
CVM versus ACE in the treatment of small cell lung cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Infant, Newborn; Infections; Leukopenia; Lung Neoplasms; Male; Methotrexate; Middle Aged; Thrombocytopenia; Treatment Outcome; Vinblastine | 1993 |
Escalating high-dose carboplatin and autologous bone marrow transplantation in solid tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Germinoma; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Prospective Studies; Rhabdomyosarcoma; Transplantation, Autologous; Treatment Outcome | 1993 |
Cisplatin-etoposide and carboplatin-etoposide induction chemotherapy for good-risk patients with germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Follow-Up Studies; Germinoma; Humans; Male; Prognosis; Remission Induction; Survival Rate; Testicular Neoplasms | 1993 |
Etoposide and carboplatin as salvage and first-line therapy in ovarian cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Remission Induction; Salvage Therapy; Thrombocytopenia | 1993 |
Protracted oral etoposide in epithelial ovarian cancer: a phase II study in patients with relapsed or platinum-resistant disease.
Topics: Administration, Oral; Adult; Aged; Carboplatin; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Epithelium; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Prospective Studies | 1994 |
[A combination chemotherapy of mitoxantrone, etoposide, carboplatin, and prednisolone (MECP) in recurrent or refractory non-Hodgkin's lymphomas].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone; Remission Induction | 1994 |
Phase II evaluation of carboplatin and VP-16 for patients with metastatic breast cancer and only one prior chemotherapy regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Salvage Therapy; Thoracic Neoplasms; Treatment Outcome | 1993 |
Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: a phase II study of the EORTC Lung Cancer Cooperative Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Prognosis; Vincristine | 1993 |
Phase I/II trial of etoposide and carboplatin in extensive small-cell lung cancer. A report from the Cancer and Leukemia Group B.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Analysis | 1993 |
[Phase II study of a novel combination regimen composed of cisplatin, carboplatin and etoposide against unresectable non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged | 1993 |
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Germ Cell and Embryonal; Retroperitoneal Neoplasms; Survival Rate; Testicular Neoplasms | 1993 |
Hyperfractionated radiation therapy with and without concurrent chemotherapy for advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiotherapy Dosage | 1993 |
Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Remission Induction; Retroperitoneal Neoplasms; Testicular Neoplasms | 1993 |
High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Pancytopenia; Prognosis; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 1993 |
D-CECaT: a breakthrough for patients with neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Deferoxamine; Etoposide; Humans; Infant; Neoplasms, Germ Cell and Embryonal; Neuroblastoma; Thiotepa | 1993 |
A phase I and pharmacokinetic study of intraperitoneal carboplatin and etoposide.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Injections, Intraperitoneal; Kidney; Male; Middle Aged; Neoplasms; Neutropenia; Ovarian Neoplasms | 1993 |
A phase I trial of carboplatin and etoposide given as continuous infusions to adults with leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Carboplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1993 |
Phase II trial of carboplatin and etoposide in metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carboplatin; Etoposide; Female; Humans; Injections, Intravenous; Liver; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Remission Induction; Survival Rate | 1993 |
Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in children with relapsed solid tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infant; Least-Squares Analysis; Male; Neoplasms; Neutropenia; Thrombocytopenia; Treatment Outcome | 1993 |
Carboplatin and etoposide in advanced colorectal carcinoma. A phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Colorectal Neoplasms; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Staging | 1993 |
High-dose carboplatin, etoposide and cyclophosphamide with autologous bone marrow transplantation for the treatment of advanced malignancies: a phase I study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Kidney; Male; Middle Aged; Neoplasms; Transplantation, Autologous | 1995 |
Pre-treatment prognostic factors in patients with stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prognosis; Radiotherapy Dosage | 1995 |
Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Etoposide; Female; Humans; Male; Neoplasms, Germ Cell and Embryonal; Survival Analysis; Transplantation, Autologous | 1995 |
Dose intensification of carboplatin and etoposide as first-line combination chemotherapy in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cranial Irradiation; Etoposide; Humans; Lung Neoplasms; Middle Aged; Pilot Projects | 1995 |
Effect of interfraction interval in hyperfractionated radiotherapy with or without concurrent chemotherapy for stage III nonsmall cell lung cancer.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiotherapy Dosage; Survival Analysis | 1996 |
Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Blood-Brain Barrier; Brain Neoplasms; Carboplatin; Child; Etoposide; Female; Germinoma; Glioblastoma; Humans; Lymphoma; Male; Middle Aged; Neoplasm Metastasis; Neuroectodermal Tumors, Primitive; Oligodendroglioma; Tomography, X-Ray Computed | 1995 |
Dose escalation study of carboplatin with fixed-dose etoposide plus granulocyte-colony stimulating factor in patients with small cell lung carcinoma. A study of the Lung Cancer Study Group of West Japan.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Thrombocytopenia | 1996 |
Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cell Culture Techniques; Cells, Cultured; Combined Modality Therapy; Culture Media; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunomagnetic Separation; Leukapheresis; Lewis X Antigen; Melphalan; Middle Aged; Neutropenia; Tamoxifen; Thiotepa; Thrombocytopenia | 1996 |
Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Double-Blind Method; Doxorubicin; Etoposide; Female; Fluorouracil; Glutamine; Humans; Ifosfamide; Male; Neoplasms; Pilot Projects; Placebos; Sarcoma, Kaposi; Stomatitis; Vincristine | 1996 |
Phase I study of a carboplatin-cisplatin-etoposide combination chemotherapy in advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged | 1996 |
Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSF.
Topics: Adult; Bone Marrow; Breast Neoplasms; Busulfan; Carboplatin; Carmustine; Cyclophosphamide; Drug Administration Schedule; Drug Synergism; Etoposide; Female; Graft Survival; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Interleukin-3; Leukapheresis; Leukemia; Leukocyte Count; Lymphoma; Male; Middle Aged; Neutrophils; Prospective Studies; Thiotepa; Whole-Body Irradiation | 1996 |
Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Outpatients; Paclitaxel; Survival Analysis | 1996 |
-Intravenous or oral etoposide therapy of platinum refractory ovarian cancer with early recurrence. Results of a prospective randomized study-.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies; Survival Rate; Treatment Outcome | 1996 |
Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome | 1996 |
High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Germinoma; Humans; Male; Prognosis; Prospective Studies; Survival Analysis; Treatment Outcome | 1996 |
Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Carmustine; Cyclophosphamide; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged | 1995 |
A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow Transplantation; Carboplatin; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Middle Aged; Remission Induction; Survival Analysis; Treatment Outcome | 1996 |
Analysis of dose-response relationships in the setting of high-dose ifosfamide, carboplatin, and etoposide and autologous hematopoietic stem cell transplantation: implications for the treatment of patients with advanced breast cancer.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carboplatin; Carcinoma; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Retrospective Studies; Survival Rate; Transplantation, Autologous | 1996 |
[Carboplatin and etoposide combination for the treatment of recurrent epithelial ovarian cancer].
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Salvage Therapy; Survival Rate; Treatment Outcome | 1996 |
Analysis of thrombocytopenia due to carboplatin combined with etoposide in elderly patients with lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Etoposide; Evaluation Studies as Topic; Female; Humans; Lung Neoplasms; Male; Retrospective Studies; Thrombocytopenia | 1996 |
Response of pediatric malignant solid tumors following ifosfamide or ifosfamide/carboplatin/etoposide: a single hospital experience.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Etoposide; Female; Humans; Ifosfamide; Male; Mesna; Neoplasms | 1996 |
Intensified VICE regimen may improve SCLC survival.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Vincristine | 1996 |
Misoprostol prophylaxis for high-dose chemotherapy-induced mucositis: a randomized double-blind study.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Double-Blind Method; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Misoprostol; Mouth Mucosa; Neoplasms; Stomatitis | 1996 |
Pilot study of ambulatory infusional delivery of a multidrug regimen: ifosfamide, carboplatin and etoposide (ICE).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Thrombocytopenia | 1996 |
Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Neoplasms; Transplantation, Autologous | 1995 |
[Usefulness and problems of high dose chemotherapy using CBDCA, VP-16, and MCNU with peripheral blood stem cell transplantation in pediatric malignant brain tumors].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Medulloblastoma; Nitrosourea Compounds | 1996 |
Phase II study of recombinant human interleukin 3 administration following carboplatin and etoposide chemotherapy in small-cell lung cancer patients. SDZ ILE 964 (IL-3) Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Interleukin-3; Lung Neoplasms; Male; Middle Aged; Recombinant Proteins; Thrombocytopenia | 1996 |
Carboplatin pharmacokinetics in young children with brain tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Etoposide; Glomerular Filtration Rate; Hematologic Diseases; Humans; Prospective Studies; Reproducibility of Results; Statistics, Nonparametric | 1996 |
Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Confidence Intervals; Etoposide; Female; Hematologic Diseases; Humans; Kidney Diseases; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Survival Rate | 1996 |
Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Disease Progression; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Recombinant Proteins; Survival Rate | 1996 |
Phase I trial of intravenous carboplatin added to oral etoposide and oral cyclophosphamide for stage IV non-small cell lung cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged | 1996 |
Phase I/II study of carboplatin and oral etoposide with granulocyte-colony stimulating factor in advanced nonsmall cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged | 1995 |
Contemporary chemotherapy issues for children with brainstem gliomas.
Topics: Antineoplastic Agents; Brain Neoplasms; Brain Stem; Carboplatin; Carmustine; Dose-Response Relationship, Drug; Etoposide; Glioma; Humans; Neoplasm Recurrence, Local; Thiotepa; Vincristine | 1996 |
Partial substitution of cisplatin with carboplatin in combination with etoposide in advanced non-small cell lung cancer (NSCLC): a multicentric randomised phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Therapeutic Equivalency | 1996 |
Interferon alpha-2a and combined chemotherapy as first line treatment in SCLC patients: a randomized trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Drug Administration Schedule; Drug Synergism; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Interferon alpha-2; Interferon-alpha; Lung Neoplasms; Male; Middle Aged; Recombinant Proteins; Remission Induction | 1996 |
Phase I/II study of combination chemotherapy with cisplatin, carboplatin and etoposide in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged | 1996 |
[Clinical effect of intra-arterial carboplatin-combined chemotherapy for advanced uterine cervical cancer and increased tissue platinum levels with Lipo PGE1 administration before chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cervix Uteri; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Female; Humans; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Mitomycin; Platinum; Uterine Cervical Neoplasms; Vindesine | 1996 |
Dose-escalation study of oral etoposide and carboplatin in patients with advanced lung cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged | 1996 |
Sequential high-dose ICE chemotherapy with circulating progenitor cells (CPC) in small cell lung cancer: an EBMT study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Europe; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged | 1996 |
Early utilization of high-dose chemotherapy in germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Protocols; Etoposide; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Testicular Neoplasms | 1996 |
High-dose chemotherapy for germ cell tumors (GCT): Memorial Sloan Kettering Cancer Center.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Germinoma; Humans; Ifosfamide; Male; Transplantation, Autologous | 1996 |
The ICE regimen (ifosfamide, carboplatin, etoposide) for the treatment of germ-cell tumors and metastatic trophoblastic disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Pregnancy; Testicular Neoplasms; Trophoblastic Neoplasms; Uterine Neoplasms | 1996 |
Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: an EORTC Phase III trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Multivariate Analysis; Survival Analysis; Vincristine | 1996 |
A characteristic eruption associated with ifosfamide, carboplatin, and etoposide chemotherapy after pretreatment with recombinant interleukin-1 alpha.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Drug Eruptions; Etoposide; Female; Humans; Ifosfamide; Interleukin-1; Male; Middle Aged; Premedication; Prospective Studies | 1996 |
Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Germinoma; Humans; Infant; Male; Survival Rate | 1996 |
Phase I study of chemotherapy with carboplatin, epirubicin, and escalating dose of VP-16 with G-CSF support in extensive small cell lung cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cause of Death; Dose-Response Relationship, Drug; Drug Tolerance; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Sepsis; Thrombocytopenia | 1996 |
Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cause of Death; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Prognosis; Survival Analysis; Vinblastine; Vinorelbine | 1996 |
Salvage chemotherapy for relapsed or refractory non-Hodgkin's lymphoma with a combination of ACES (high-dose Ara C, carboplatin, etoposide and steroids) therapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Survival Analysis | 1996 |
Long-term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Retroperitoneal Neoplasms; Salvage Therapy; Survivors; Testicular Neoplasms | 1997 |
Phase I/II trial of carboplatin dose escalation in combination chemotherapy with etoposide, bleomycin and GM-CSF support for poor prognosis nonseminomatous germ cell tumors patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Etoposide; Germinoma; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Neutropenia; Prognosis | 1996 |
Etoposide phosphate infusion with therapeutic drug monitoring in combination with carboplatin dosed by area under the curve: a cancer research campaign phase I/II committee study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Small Cell; Drug Monitoring; Etoposide; Feasibility Studies; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Organophosphorus Compounds; Prodrugs | 1996 |
Paclitaxel, carboplatin, and oral etoposide in the treatment of small cell lung cancer.
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Paclitaxel; Survival Rate; Treatment Outcome | 1996 |
The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Lung Neoplasms; Neutropenia; Paclitaxel; Thrombocytopenia; Treatment Outcome | 1996 |
[Treatment of broncho-pulmonary cancer using carboplatin/etoposide: survival analysis].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Survival Analysis | 1996 |
Phase I trial of etoposide, carboplatin, and GM-CSF in extensive small-cell lung cancer: a Cancer and Leukemia Group B study (CALGB 8832).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Remission Induction; Survival Analysis | 1997 |
A phase II study of carboplatin-cisplatin-etoposide combination chemotherapy in advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged | 1997 |
A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Drug Administration Schedule; Etoposide; Germinoma; Humans; Male; Middle Aged; Prognosis; Risk Factors; Testicular Neoplasms | 1996 |
Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease Progression; Etoposide; Female; Glioblastoma; Glioma; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Supratentorial Neoplasms; Survival Rate; Tomography, X-Ray Computed | 1996 |
[Phase II study of combination chemotherapy with cisplatin, carboplatin and etoposide (CPVP) in unresectable non-small cell lung cancer: analysis of survival time and prognostic factors].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Survival Analysis | 1997 |
Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiotherapy Dosage; Survival Analysis | 1997 |
Response of previously untreated metastatic rhabdomyosarcoma to combination chemotherapy with carboplatin, epirubicin and vincristine.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Male; Rhabdomyosarcoma; Treatment Outcome; Vincristine | 1996 |
Ifosfamide, carboplatin and etoposide (ICE) combined with 41.8 degrees C whole body hyperthermia in patients with refractory sarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Pilot Projects; Sarcoma | 1996 |
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carcinoma, Small Cell; Cardiovascular Diseases; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Etoposide; Feasibility Studies; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pneumonectomy; Remission Induction; Survival Analysis; Transplantation Conditioning; Treatment Outcome | 1997 |
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Neoplasms; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Life Tables; Lung Neoplasms; Male; Middle Aged; Palliative Care; Pneumonectomy; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Treatment Outcome | 1997 |
Etoposide, intermediate-dose cytarabine and carboplatin (VAC): a combination therapy for the blastic phase of chronic myelogenous leukemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Cytarabine; Etoposide; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Remission Induction | 1997 |
High-dose carboplatin, etoposide and melphalan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: non-haematological, haematological toxicities and role of growth factor administration.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Erythropoietin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Hematopoietic System; Humans; Length of Stay; Melphalan; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Recombinant Proteins; Survival Rate | 1997 |
Treatment of recurrent malignant supratentorial gliomas with the association of carboplatin and etoposide: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Supratentorial Neoplasms; Treatment Outcome | 1997 |
Activity of standard-dose carboplatin, cyclophosphamide, and etoposide in patients with metastatic breast cancer with previous exposure to anthracyclines.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Cyclophosphamide; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Retreatment; Survival Rate | 1997 |
Randomized trial of filgrastim vs. sequential filgrastim and molgramostim after dose-intensified carboplatin, cyclophosphamide, and etoposide: a phase I pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukocyte Count; Male; Middle Aged; Neoplasms; Pilot Projects; Platelet Count; Recombinant Proteins; Survival Rate | 1997 |
Phase I trial of subcutaneous interleukin-1 alpha in children with malignant solid tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Bone Marrow; Bone Marrow Diseases; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Granulocytes; Humans; Ifosfamide; Infant; Injections, Subcutaneous; Interleukin-1; Male; Neoplasms; Recombinant Proteins | 1997 |
Optimization of chemotherapy administration for clinical 41.8 degrees C whole body hyperthermia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Body Temperature; Breast Neoplasms; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Cross-Over Studies; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Hyperthermia, Induced; Ifosfamide; Lung Neoplasms; Male; Neutropenia; Platelet Count; Sarcoma | 1997 |
Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Disease-Free Survival; Etoposide; Germinoma; Humans; Male; Prognosis; Remission Induction; Testicular Neoplasms | 1997 |
A novel high-dose chemotherapy protocol with autologous hematopoietic rescue in patients with metastatic breast cancer or recurrent non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Cyclophosphamide; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Recurrence; Thiotepa; Transplantation, Autologous | 1997 |
Carboplatin plus etoposide regimen in advanced breast cancer. A phase II study.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Drug Administration Schedule; Etoposide; Female; Humans; Injections, Intravenous; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Survival Rate; Treatment Outcome | 1997 |
Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide.
Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Etoposide; Female; Humans; Liver Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Survival Analysis | 1997 |
A phase II trial of radiochemotherapy with daily carboplatin, after induction chemotherapy (carboplatin and etoposide), in locally advanced nonsmall-cell lung cancer: final analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Remission Induction; Treatment Failure | 1997 |
Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Disease-Free Survival; Ependymoma; Etoposide; Female; Humans; Ifosfamide; Male; Pilot Projects; Prognosis; Vincristine | 1997 |
High-dose chemotherapy with carboplatin, cyclophosphamide and etoposide and autologous transplantation for multiple myeloma relapsing after a previous transplant.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Multiple Myeloma; Prognosis; Recurrence | 1997 |
[Efficacy of chemotherapy for clear cell adenocarcinoma of the ovary].
Topics: Adenocarcinoma, Clear Cell; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Ovarian Neoplasms; Remission Induction | 1997 |
Phase II study of high-dose cyclophosphamide, etoposide, and carboplatin (CEC) followed by autologous hematopoietic stem cell rescue in women with metastatic or high-risk non-metastatic breast cancer: multivariate analysis of factors affecting survival an
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Breast Neoplasms; Carboplatin; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Survival Rate; Transplantation, Autologous | 1997 |
[Neoadjuvant combined therapy in stage IIIA if non-small-cell bronchial cancer].
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Dimethoate; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vindesine | 1997 |
Prolonged administration of oral etoposide alone or with intravenous carboplatin in stage IV non-small cell lung cancer: a randomized trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Rate | 1997 |
Phase 1 trial of recombinant human interleukin-1 beta (rhIL-1 beta), carboplatin, and etoposide in patients with solid cancers: Southwest Oncology, Group Study 8940.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Interleukin-1; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Neutropenia; Recombinant Proteins; Thrombocytopenia | 1997 |
Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Survival Analysis | 1997 |
Chemoradiotherapy for poor-risk stage III non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Radiotherapy Dosage; Survival Analysis | 1997 |
Postoperative bronchopulmonary complications in stage III lung cancer patients treated with preoperative paclitaxel-containing chemotherapy and concurrent radiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Lung Diseases; Lung Neoplasms; Male; Neoplasm Staging; Paclitaxel; Pneumonectomy; Postoperative Complications; Radiotherapy; Radiotherapy Dosage | 1997 |
A phase II study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Neoplasm Staging; Paclitaxel; Pilot Projects | 1997 |
A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Cranial Irradiation; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Radiotherapy Dosage | 1997 |
Paclitaxel, carboplatin, and oral etoposide: a phase II trial in limited-stage small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel | 1997 |
[Chemotherapy versus chemoradiotherapy in patients with limited small cell lung carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Rate; Vincristine | 1997 |
Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cause of Death; Cisplatin; Clinical Trials, Phase II as Topic; Cochlea; Digestive System Neoplasms; Drug Administration Schedule; Drug Synergism; Esophageal Neoplasms; Etoposide; Evaluation Studies as Topic; Female; Humans; Kidney; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Remission Induction; Sepsis; Stomach Neoplasms; Thrombocytopenia; Vomiting | 1997 |
Paclitaxel in salvage therapy for germ cell tumors.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Blood Cells; Carboplatin; Cisplatin; Cohort Studies; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Testicular Neoplasms; Treatment Outcome | 1997 |
Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I/II study.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Dose Fractionation, Radiation; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Male; Pons; Radiotherapy, Adjuvant; Treatment Outcome | 1998 |
Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Survival Analysis; Thrombocytopenia | 1997 |
Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Eye Diseases; Eye Enucleation; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Neoplasm Seeding; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Vincristine; Vitreous Body | 1997 |
Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplantation; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Germinoma; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Multiple Organ Failure; Renal Dialysis; Retroperitoneal Neoplasms; Salvage Therapy; Survival Analysis; Testicular Neoplasms; Treatment Outcome | 1997 |
High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study.
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Remission Induction; Salvage Therapy; Transplantation, Autologous | 1997 |
Propantheline protects the oral mucosa after high-dose ifosfamide, carboplatin, etoposide and autologous stem cell transplantation.
Topics: Adult; Anti-Ulcer Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cholinergic Antagonists; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Propantheline; Stomatitis; Transplantation Conditioning; Transplantation, Autologous | 1997 |
One-hour paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of carcinoma of unknown primary site.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Etoposide; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Survival Rate; Treatment Outcome | 1997 |
Absence of thoracic radiation myelitis after hyperfractionated radiation therapy with and without concurrent chemotherapy for Stage III nonsmall-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Dose Fractionation, Radiation; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Myelitis | 1998 |
Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Double-Blind Method; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Survival Rate; Vincristine | 1998 |
UKCCSG's germ cell tumour (GCT) studies: improving outcome for children with malignant extracranial non-gonadal tumours--carboplatin, etoposide, and bleomycin are effective and less toxic than previous regimens. United Kingdom Children's Cancer Study Grou
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Child; Child, Preschool; Cisplatin; Etoposide; Female; Germinoma; Humans; Infant; Male; Prognosis; Recurrence; Survival Analysis; Treatment Outcome | 1998 |
Carboplatin, etoposide, and accelerated hyperfractionated radiotherapy for elderly patients with limited small cell lung carcinoma: a phase II study.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Radiotherapy Dosage; Survival Analysis | 1998 |
A phase II study of carboplatin and prolonged administration of oral etoposide in patients with small-cell lung cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival Rate; Thrombocytopenia | 1997 |
Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Analysis; Transplantation, Autologous | 1998 |
Paclitaxel, carboplatin, and extended-schedule oral etoposide for small-cell lung cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Treatment Outcome | 1998 |
A phase II trial of carboplatin and etoposide for relapsed or metastatic carcinoma of the cervix.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Confidence Intervals; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Prospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 1998 |
High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children's Cancer Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Brain Stem; Carboplatin; Carmustine; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Etoposide; Female; Humans; Male; Pons; Survival Rate; Thiotepa | 1998 |
Osteosarcoma of the extremities with synchronous lung metastases: long-term results in 44 patients treated with neoadjuvant chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Extremities; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis | 1998 |
Long-term results of autologous marrow transplantation for relapsed or refractory male or female germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Ovarian Neoplasms; Recurrence; Retrospective Studies; Testicular Neoplasms; Transplantation, Autologous | 1998 |
Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Kinetics; Leukocyte Count; Melphalan; Middle Aged; Multiple Myeloma; Prospective Studies | 1998 |
Phase II trial of combination chemotherapy with cisplatin, carboplatin and etoposide in stage IIIB and IV small-cell lung cancer. Fukuoka Lung Cancer Study Group.
Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Survival Rate; Treatment Outcome; Vomiting | 1998 |
Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Hypoxia; Disease-Free Survival; Dose-Response Relationship, Drug; Etanidazole; Etoposide; Expectorants; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infusions, Intravenous; Male; Mesna; Middle Aged; Neoplasms; Recurrence; Survival Rate | 1998 |
Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Infant, Newborn; Male; Neuroblastoma; Prognosis; Treatment Outcome; Vincristine | 1998 |
A multicentre phase II study of carboplatin and prolonged oral etoposide in the treatment of cancer of unknown primary site (CUPS).
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Unknown Primary | 1998 |
Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Carboplatin; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Infant; Male; Myeloablative Agonists; Neoplasm Recurrence, Local; Survival Analysis; Thiotepa; Transplantation, Autologous; Treatment Outcome | 1998 |
Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Lung Neoplasms; Male | 1998 |
Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Risk Factors; Survival Analysis | 1998 |
Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemical and Drug Induced Liver Injury; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Deafness; Disease Progression; Disease-Free Survival; Etoposide; Follow-Up Studies; Glioma; Hearing Loss; Hematologic Diseases; Humans; Ifosfamide; Infections; Life Tables; Lomustine; Medulloblastoma; Methotrexate; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Vincristine | 1998 |
Remission induction therapy of untreated acute myeloid leukemia using a non-cytarabine-containing regimen of idarubicin, etoposide, and carboplatin.
Topics: Acute Disease; Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Drug Tolerance; Etoposide; Female; Humans; Idarubicin; Intestinal Mucosa; Leukemia, Myeloid; Male; Middle Aged; Pilot Projects; Remission Induction; Survival Rate; Treatment Outcome; Xylose | 1998 |
A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: a report of the Children's Cancer G
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Transfusion; Carboplatin; Child; Child, Preschool; Cytokines; Drug Tolerance; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Ifosfamide; Infant; Interleukin-3; Length of Stay; Neoplasm Recurrence, Local; Neoplasms; Recombinant Fusion Proteins | 1998 |
Radiotherapy with/without cisplatin following chemotherapy in limited small-cell lung cancer.
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lung Neoplasms | 1998 |
Phase I trial of recombinant interleukin 3 before and after carboplatin/etoposide chemotherapy in patients with solid tumors: a southwest oncology group study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Etoposide; Female; Humans; Interleukin-3; Male; Middle Aged; Neoplasms; Neutrophils; Platelet Count; Platelet Transfusion; Recombinant Proteins; Thrombocytopenia | 1995 |
[A clinical evaluation of combination therapy with radiation, MCNU, carboplatin and IFN-beta or with radiation, MCNU, carboplatin, etoposide and IFN-beta for malignant gliomas].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Interferon-beta; Male; Middle Aged; Nitrosourea Compounds; Prognosis; Survival Rate | 1998 |
Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial. Joint Lung Cancer Study Group.
Topics: Activities of Daily Living; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cognition; Disease Progression; Emotions; Etoposide; Female; Hematologic Diseases; Humans; Interpersonal Relations; Lung Neoplasms; Male; Middle Aged; Quality of Life; Survival Analysis; Treatment Outcome | 1998 |
Phase II study with ifosfamide, carboplatin, etoposide (ICE regimen) at intermediate dosage for advanced non small cell lung cancer (NSCLC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Survival Analysis; Treatment Outcome | 1998 |
Toxicity and efficacy of ifosfamide, carboplatin and etoposide (modified ICE) as a salvage chemotherapy in Japanese patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Ifosfamide; Japan; Lymphoma, Non-Hodgkin; Male; Middle Aged; Remission Induction; Salvage Therapy; Survival Rate; Time Factors | 1998 |
Carboplatin-oral etoposide personalized dosing in elderly non-small cell lung cancer patients. Gruppo Oncologico Cooperativo Sud-Italia.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Humans; Lung Neoplasms; Male; Quality of Life; Surveys and Questionnaires; Survival Analysis; Treatment Outcome | 1998 |
High-dose chemotherapy for salvage treatment of germ cell tumors: Charité, Virchow Klinikum, Berlin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Mediastinal Neoplasms; Survival Rate; Treatment Outcome | 1998 |
Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary results.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Hyperthermia, Induced; Infant; Infant, Newborn; Laser Therapy; Male; Retinal Neoplasms; Retinoblastoma; Treatment Outcome | 1998 |
[CBDCA, etoposide and epirubicin high-dose combination chemotherapy supported by peripheral blood stem cell transplantation (PBSCT) in metastatic breast cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local | 1999 |
Feasibility of high-dose chemotherapy and autologous peripheral blood stem cell transplantation in children with high grade osteosarcoma.
Topics: Adolescent; Antineoplastic Agents; Carboplatin; Child; Dose-Response Relationship, Drug; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Osteosarcoma; Survival Rate; Transplantation, Autologous; Treatment Outcome | 1998 |
Phase II study of carboplatin and etoposide as salvage treatment for patients with metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Etoposide; Female; Humans; Middle Aged; Salvage Therapy; Survival Analysis | 1999 |
Weekly alternating non-cross-resistant chemotherapy for small cell lung cancer with a good prognosis: a study of the Hellenic Cooperative Oncology Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cranial Irradiation; Drug Administration Schedule; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prognosis; Survival Analysis | 1999 |
[Preventive effect of prostaglandin E1 on cisplatin-induced nephrotoxicity].
Topics: Aged; Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Female; Humans; Kidney; Kidney Diseases; Lung Neoplasms; Male; Middle Aged | 1999 |
Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Disease Progression; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Risk Assessment; Survival Analysis | 1999 |
Interstitial chemotherapy plus systemic chemotherapy for glioblastoma patients: improved survival in sequential studies.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carmustine; Catheters, Indwelling; Cisplatin; Combined Modality Therapy; Etoposide; Glioblastoma; Humans; Postoperative Care; Survival Analysis | 1999 |
Double-blind randomized study on the myeloprotective effect of melatonin in combination with carboplatin and etoposide in advanced lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cross-Over Studies; Cytoprotection; Double-Blind Method; Etoposide; Female; Hematologic Tests; Humans; Leukopoiesis; Lung Neoplasms; Male; Melatonin; Middle Aged; Protective Agents; Treatment Outcome | 1999 |
Induction of gamma-glutamylcysteine synthetase gene expression by platinum drugs in peripheral mononuclear cells of lung cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Blotting, Northern; Camptothecin; Carboplatin; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression; Glutamate-Cysteine Ligase; Humans; Irinotecan; Leukocytes, Mononuclear; Lung Neoplasms; Male; Middle Aged; Molecular Sequence Data; Polymerase Chain Reaction; RNA, Messenger; Statistics, Nonparametric; Tumor Cells, Cultured | 1999 |
Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: a phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Etoposide; Feasibility Studies; Female; Humans; Male; Middle Aged; Radiotherapy Dosage; Radiotherapy, High-Energy; Survival Analysis | 1999 |
Short-term chemotherapy and palliative radiotherapy for elderly patients with stage IV non-small cell lung cancer: a phase II study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Survival Rate; Treatment Outcome | 1999 |
Carboplatin and etoposide for recurrent malignant glioma following surgical and radiotherapy failure: A clinical study conducted at the Northern Israel Oncology Center.
Topics: Adolescent; Adult; Antineoplastic Agents; Brain Neoplasms; Carboplatin; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Treatment Failure; Treatment Outcome | 1999 |
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasms, Second Primary | 1999 |
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 107 patients with non-small-cell lung cancer: a mature follow-up report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Epirubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Survival Rate | 1999 |
Pilot study of the combination of melphalan, carboplatin and etoposide as a conditioning regimen for relapsed lymphoma patients.
Topics: Adolescent; Adult; Antineoplastic Agents; Carboplatin; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Melphalan; Middle Aged; Pilot Projects; Recurrence; Transplantation Conditioning | 1999 |
Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Filgrastim; Genes, Immunoglobulin; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunoglobulin Heavy Chains; Life Tables; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm, Residual; Polymerase Chain Reaction; Prospective Studies; Recombinant Proteins; Thiotepa; Treatment Outcome | 1999 |
Role of chemotherapy in the treatment of infantile fibrosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fibrosarcoma; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Mesna; Soft Tissue Neoplasms; Vincristine | 1999 |
Prolonged oral versus high-dose intravenous etoposide in combination with carboplatin for stage IV non-small-cell lung cancer (NSCLC): a randomized trial.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Survival Rate; Treatment Outcome | 1999 |
Phase II study of area under the plasma-concentration-versus-time curve-based carboplatin plus standard-dose intravenous etoposide in elderly patients with small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lung Neoplasms; Male; Multivariate Analysis; Survival Rate; Time Factors | 1999 |
Chemotherapy for unresectable and recurrent intramedullary glial tumours in children. Brain Tumours Subcommittee of the French Society of Paediatric Oncology (SFOP).
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Etoposide; Follow-Up Studies; Glioma; Humans; Infant; Neoplasm Recurrence, Local; Procarbazine; Spinal Cord Neoplasms; Vincristine | 1999 |
[Significance and effects of intraperitoneal cisplatin administration for ovarian cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Infusion Pumps, Implantable; Infusions, Parenteral; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Ovariectomy; Survival Analysis | 1999 |
[Combined modality therapy for malignant lymphoma of the primary central nervous system: a preliminary report of a new chemotherapeutic regimen with "PEACE"].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Procarbazine; Treatment Outcome | 1999 |
Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: prolonged intrathoracic tumor control and high central nervous system relapse rate. Groupe d'Oncologie-Pneumologie Clini
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Epirubicin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Nervous System Neoplasms; Neutropenia; Recurrence; Survival Rate; Thoracic Neoplasms; Thrombocytopenia; Treatment Outcome | 1999 |
Clinical outcome of high-dose chemotherapy combined with peripheral blood stem cell transplantation for male germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carboplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Testicular Neoplasms; Time Factors; Treatment Outcome | 1999 |
Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Movement; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Leukocytes, Mononuclear; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Stem Cells | 1999 |
[Combined alternating radiochemotherapy in stage III (TNM) (limited disease) small cell bronchial carcinoma: a phase II study with carboplatin/etoposide/vincristine and alternating radiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Combined Modality Therapy; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Survival Analysis; Vincristine | 1999 |
Ifosfamide, carboplatin and etoposide (ICE) in metastatic and refractory breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Metastasis; Safety; Salvage Therapy | 1999 |
Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Vincristine | 2000 |
Mini-ICE regimen as mobilization therapy for chronic myelogenous leukaemia patients at diagnosis.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Component Removal; Carboplatin; Cytogenetic Analysis; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Leukocytes, Mononuclear; Male; Middle Aged; Neutrophils; Philadelphia Chromosome; Platelet Count; Time Factors; Transplantation, Autologous | 1999 |
[High-dose chemotherapy with peripheral blood stem cell autotransplantation for patients with poor-risk testicular germ cell tumors--pilot study of the Japan Blood Cell Transplantation Study Group].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Pilot Projects; Survival Rate; Testicular Neoplasms; Transplantation, Autologous | 1999 |
A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remission.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Feasibility Studies; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Recurrence; Remission Induction; Salvage Therapy; Seminoma; Survival Analysis; Testicular Neoplasms | 1999 |
A phase I dose escalation study of multicyclic, dose-intensive chemotherapy with peripheral blood stem cell support for small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infusions, Intravenous; Injections, Subcutaneous; Leukapheresis; Lung Neoplasms; Male; Middle Aged; Radiotherapy; Recombinant Proteins; Transplantation, Autologous; Treatment Outcome | 2000 |
Epic as an effective, low toxicity salvage therapy for patients with poor risk lymphoma prior to beam high dose chemotherapy and peripheral blood progenitor cell transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Salvage Therapy; Transplantation, Autologous; Treatment Outcome | 1999 |
A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carboplatin; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Liver Neoplasms; Middle Aged; Mitoxantrone; Platelet Count; Soft Tissue Neoplasms; Survival Rate; Tamoxifen; Thiotepa; Transplantation, Autologous | 2000 |
Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Drug Administration Schedule; Etoposide; Female; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leukapheresis; Male; Middle Aged; Paclitaxel; Prospective Studies; Salvage Therapy; Survival Analysis | 2000 |
A phase II study of concurrent accelerated hyperfractionated radiotherapy and carboplatin/oral etoposide for elderly patients with stage III non-small-cell lung cancer.
Topics: Administration, Oral; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Neoplasm Staging; Sex Factors; Survival Analysis | 1999 |
[Chemotherapy in combination with whole-body hyperthermia in advanced malignant pleural mesothelioma].
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Hyperthermia, Induced; Ifosfamide; Male; Mesothelioma; Middle Aged; Palliative Care; Pleural Effusion, Malignant; Pleural Neoplasms; Recurrence | 2000 |
Randomised phase II study of cisplatin-etoposide versus infusional carboplatin in advanced non-small-cell lung cancer and mesothelioma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Confidence Intervals; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Survival Rate; Treatment Outcome | 2000 |
RPLND or primary chemotherapy in clinical stage IIA/B nonseminomatous germ cell tumors? Results of a prospective multicenter trial including quality of life assessment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Etoposide; Germinoma; Humans; Lymph Node Excision; Male; Neoplasm Staging; Quality of Life; Retroperitoneal Space; Testicular Neoplasms | 2000 |
Phase I trial of carboplatin, paclitaxel, etoposide, and cyclophosphamide with granulocyte colony stimulating factor as first-line therapy for patients with advanced epithelial ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Taxoids; Thrombocytopenia; Treatment Outcome | 2000 |
Interferon-alpha and 13-cis-retinoic acid as maintenance therapy after high-dose combination chemotherapy with growth factor support for small cell lung cancer--a feasibility study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Finland; Humans; Ifosfamide; Injections, Subcutaneous; Interferon-alpha; Isotretinoin; Lung Neoplasms; Male; Middle Aged | 2000 |
[Effectiveness of carboplatin and etoposide selective intra-arterial chemotherapy for progressive soft-tissue sarcoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intra-Arterial; Middle Aged; Sarcoma; Soft Tissue Neoplasms | 2000 |
Phase II study of ifosfamide, carboplatin, etoposide and GM-CSF in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Survival Rate | 2000 |
High-dose chemotherapy with peripheral blood stem cell transplantation for advanced testicular cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Testicular Neoplasms | 2000 |
First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Disease Progression; Etoposide; Eye Enucleation; Female; Humans; Male; Retinal Neoplasms; Retinoblastoma; Treatment Outcome | 2000 |
Phase I study of paclitaxel, carboplatin, and increasing days of prolonged oral etoposide in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Thrombocytopenia | 2000 |
Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients. A single-center study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Etoposide; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Middle Aged; Risk Factors; Treatment Outcome | 2000 |
High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Choriocarcinoma; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Retrospective Studies; Salvage Therapy; Seminoma; Testicular Neoplasms; Treatment Outcome | 2000 |
[Effectiveness of DeVIC chemotherapy for recurrent primary central nervous system lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Treatment Outcome | 2000 |
High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Feasibility Studies; Female; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Humans; Life Tables; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Mitoxantrone; Remission Induction; Salvage Therapy; Survival Analysis; Survival Rate; Treatment Outcome | 2000 |
A phase I study of prolonged ambulatory infusion carboplatin with oral etoposide showing activity in prostate cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Drug Therapy, Combination; Etoposide; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Pain; Prostatic Neoplasms; Treatment Outcome | 2000 |
The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity.
Topics: Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Child; Child, Preschool; Chorionic Gonadotropin; Combined Modality Therapy; Etoposide; Female; Germinoma; Humans; Infant; Infant, Newborn; Male; Ovarian Neoplasms; Prognosis; Survival Analysis; Testicular Neoplasms | 2000 |
A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Follow-Up Studies; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Neutropenia; Seminoma; Survival Analysis; Testicular Neoplasms; Thrombocytopenia; Time Factors; Treatment Outcome | 2000 |
A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclosporine; Dipyridamole; Etoposide; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Neoplasms; Prochlorperazine; Treatment Outcome; Vasodilator Agents | 2000 |
A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer.
Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival Analysis; Thrombocytopenia | 2001 |
Should high-dose chemotherapy be used to consolidate second or third line treatment in relapsing germ cell tumours?
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Taxoids | 2000 |
Use of hematopoietic progenitors in whole blood to support dose-dense chemotherapy: a randomized phase II trial in small-cell lung cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Platelet Count; Quality of Life | 2001 |
A randomized Phase II trial in patients with carcinoma of an unknown primary site.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Etoposide; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Treatment Outcome | 2001 |
Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infant; Leukocyte Count; Male; Neoplasms; Neutropenia; Neutrophils; Prospective Studies; Racial Groups; Recombinant Proteins; Recurrence; Survival Rate; Time Factors; United States | 2001 |
A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a h
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Ifosfamide; Infant; Infusions, Intravenous; Interleukin-6; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Recombinant Proteins | 2001 |
Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Ependymoma; Etoposide; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Procarbazine; Prognosis; Treatment Outcome; Vincristine | 2001 |
Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: a randomized trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiotherapy; Survival Rate | 2001 |
Mitoxantrone, etoposide, carboplatinum and ara-C combination therapy (MECA) in refractory and relapsed acute leukemia.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Middle Aged; Mitoxantrone; Recurrence; Risk Factors; Salvage Therapy; Treatment Outcome | 2000 |
Carboplatin AUC8 in combination with etoposide and bleomycin in the treatment of intermediate and poor-risk metastatic germ cell tumours: a phase II study.
Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bleomycin; Carboplatin; Etoposide; Female; Germinoma; Humans; Leukocyte Count; Male; Neoplasm Metastasis; Retrospective Studies | 2001 |
A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Nitrosourea Compounds; Prednisone; Survival Rate; Time Factors; Vincristine; Vindesine | 2001 |
Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Etoposide; Female; Follow-Up Studies; Glioblastoma; Humans; Male; Middle Aged; Radiotherapy; Survival Rate; Time Factors | 2001 |
Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literature review.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cohort Studies; Disease-Free Survival; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Recurrence; Salvage Therapy; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 2001 |
High-dose chemotherapy as a consolidation approach in advanced ovarian cancer: long-term results.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Longitudinal Studies; Melphalan; Middle Aged; Ovarian Neoplasms; Survival Rate; Treatment Outcome | 2001 |
Preclinical and clinical aspects on the use of amifostine as chemoprotector in neuroblastoma patients.
Topics: Adolescent; Amifostine; Animals; Antineoplastic Agents; Bone Marrow Diseases; Carboplatin; Cell Division; Child; Child, Preschool; Cisplatin; Cross-Over Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Etoposide; Humans; Ifosfamide; Mercaptoethylamines; Mice; Mice, Nude; Neuroblastoma; Neutropenia; Prodrugs; Safety; Thrombocytopenia; Treatment Failure; Tumor Cells, Cultured; Vincristine; Vomiting; Xenograft Model Antitumor Assays | 2001 |
OPEC/OJEC for stage 4 neuroblastoma in children over 1 year of age.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Diseases; Bone Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Cyclophosphamide; Diphosphonates; Disease-Free Survival; Etoposide; Female; Gastrointestinal Diseases; Humans; Incidence; Infant; Iodine Radioisotopes; Kidney Diseases; Male; Neoplasm Staging; Nervous System Diseases; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Survival Analysis; Survival Rate; Technetium Compounds; Treatment Outcome; Vincristine | 2001 |
Carboplatin calculated with Chatelut's formula plus etoposide for elderly patients with small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Neutropenia; Severity of Illness Index; Thrombocytopenia; Treatment Outcome | 2001 |
Gemcitabine/carboplatin versus cisplatin/etoposide for patients with poor-prognosis small cell lung cancer: a phase III randomized trial with quality-of-life evaluation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Quality of Life; Survival Analysis | 2001 |
Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Combined Modality Therapy; Etoposide; Feasibility Studies; Female; Fever; Follow-Up Studies; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Quality of Life; Radiodermatitis; Radiotherapy Dosage; Skin Neoplasms | 2001 |
Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: a phase II study.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Organophosphorus Compounds; Survival Analysis; Treatment Outcome | 2001 |
Phase I trial of a twice-daily regimen of amifostine with ifosfamide, carboplatin, and etoposide chemotherapy in children with refractory carcinoma.
Topics: Adolescent; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Mercaptoethylamines; Neoplasms; Treatment Failure | 2001 |
Bioequivalence investigation of high-dose etoposide and etoposide phosphate in lymphoma patients.
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cross-Over Studies; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Lymphoma; Middle Aged; Organophosphorus Compounds; Prodrugs; Therapeutic Equivalency | 2001 |
High-dose carboplatin with etoposide in patients with recurrent thymoma: the Indiana University experience.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Neoplasm Recurrence, Local; Thymoma; Thymus Neoplasms; Treatment Outcome | 2001 |
Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG).
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Disease Progression; Dose Fractionation, Radiation; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival Analysis; Thrombocytopenia; Treatment Outcome | 2001 |
Carboplatin-etoposide combination in small cell lung cancer patients older than 70 years: a phase II trial.
Topics: Administration, Oral; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Neoplasm Staging; Neutropenia; Survival Rate; Treatment Outcome | 2002 |
Commentary on "carboplatin-etoposide association in small cell lung cancer patients older than 70 years: a phase II trial".
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Humans; Lung Neoplasms; Neoplasm Staging; Survival Rate; Treatment Outcome | 2002 |
Efficacy of carboplatin with an MEP (mitoxantrone, etoposide and prednisone) regimen for relapsed and CHOP-resistant diffuse large B-cell lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Staging; Prednisone; Recurrence; Survival Rate; Time Factors; Vincristine | 2002 |
A phase II study of etoposide, doxorubicin, and carboplatin in the treatment of advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Etoposide; Female; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Stomach Neoplasms; Survival Analysis | 2002 |
Randomized cross-over clinical trial to study potential pharmacokinetic interactions between cisplatin or carboplatin and etoposide.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; Carboplatin; Cisplatin; Confidence Intervals; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Etoposide; Humans; Microsomes, Liver; Middle Aged; Rats | 2002 |
Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Eye Neoplasms; Humans; Infant; Neoplasm Recurrence, Local; Neoplasm Seeding; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Risk Factors; Treatment Outcome; Vincristine; Vitreous Body | 2002 |
Intra-arterial carboplatin and intravenous etoposide for the treatment of recurrent and progressive non-GBM gliomas.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Etoposide; Female; Glioma; Humans; Injections, Intra-Arterial; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Treatment Outcome | 2002 |
Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Feasibility Studies; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Neuroblastoma; Pilot Projects; Radiopharmaceuticals; Transplantation, Autologous | 2002 |
High-dose chemotherapy in the treatment of relapsed osteosarcoma: an Italian sarcoma group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Male; Neoplasm Recurrence, Local; Osteosarcoma; Remission Induction; Survival Analysis; Transplantation, Autologous | 2002 |
Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Eye Enucleation; Female; Humans; Hyperthermia, Induced; Infant; Male; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Treatment Failure; Treatment Outcome; Vincristine | 2002 |
Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms' tumor: a Children's Cancer Group report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Ifosfamide; Infant; Infusions, Intravenous; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Treatment Outcome; Wilms Tumor | 2002 |
Intensive chemotherapy with whole blood stem-cell support and concurrent chest radiotherapy in small cell lung cancer: a phase I/II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chi-Square Distribution; Combined Modality Therapy; Disease Progression; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Prospective Studies; Radiotherapy Dosage; Survival Analysis; Treatment Outcome | 2002 |
[Combination chemotherapy with carboplatin and etoposide for elderly patients aged 76 years or older with small cell lung cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Survival Rate | 2002 |
Toxicity of high-dose carboplatin: ultrafiltered and not total plasma pharmacokinetics is of clinical relevance.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Germinoma; Half-Life; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Thiotepa; Time Factors; Ultrafiltration | 2002 |
Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer Group.
Topics: Adolescent; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Glioma; Humans; Male; Neoadjuvant Therapy; Survival Rate; Vincristine | 2002 |
Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Etoposide; Female; Fluorouracil; Hepatoblastoma; Humans; Infant; Infant, Newborn; Liver Neoplasms; Male; Neoplasm Metastasis; Survival Rate; Vincristine | 2002 |
A phase II randomised trial comparing the cisplatin-etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Confidence Intervals; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Probability; Prognosis; Reference Values; Risk Assessment; Salvage Therapy; Survival Analysis; Treatment Outcome | 2002 |
Prospective study of carboplatin-based chemotherapy for pediatric germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Child; Etoposide; Female; Germinoma; Humans; Male; Neutropenia; Ovarian Neoplasms; Prospective Studies; Survival Analysis; Testicular Neoplasms; Treatment Outcome | 2002 |
Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Humans; Infant; Male; Medulloblastoma; Methotrexate; Neoplasms, Germ Cell and Embryonal; Prognosis; Treatment Outcome | 2002 |
A prospective study of P-IMVP-16/CBDCA: a novel salvage chemotherapy for patients with aggressive non-Hodgkin's lymphoma who had previously received CHOP therapy as first-line chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Neoplasm Staging; Prednisone; Prospective Studies; Salvage Therapy; Survival Rate; Time Factors; Treatment Failure; Vincristine | 2002 |
Early tandem high-dose ifosfamide, carboplatin, etoposide therapy with stem cell rescue for small-cell lung cancer: brief report on the results of a phase-I/II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Hematopoietic Stem Cells; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Survival Rate | 2002 |
The LMCE5 unselected cohort of 25 children consecutively diagnosed with untreated stage 4 neuroblastoma over 1 year at diagnosis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Cohort Studies; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Infant; Male; Melphalan; Neuroblastoma; Peripheral Blood Stem Cell Transplantation; Treatment Outcome | 2002 |
[Comparison of paclitaxel and carboplatin versus ifosfamide, etoposide, and carboplatin regimen for treatment of patients with advanced non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Survival Rate; Treatment Outcome | 2002 |
Chemoreduction for unilateral retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Female; Humans; Hyperthermia, Induced; Infant; Male; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Vincristine; Visual Acuity | 2002 |
Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Etoposide; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Survival Rate | 2002 |
Long-term survival in SCLC after treatment with paclitaxel, carboplatin and etoposide--a phase II study.
Topics: Adult; Aged; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Survival Analysis; Time Factors; Treatment Outcome | 2003 |
Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer.
Topics: Adult; Aged; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Survival Rate; Time Factors; Treatment Outcome | 2003 |
Outpatient intensive chemotherapy for small cell lung cancer: five years experience of modified 'ICE' ifosfamide carboplatin and etoposide.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Outpatients; Prognosis; Survival | 2002 |
[Influence of combined therapy of guben yiliu III, moxibustion and chemotherapy on immune function and blood coagulation mechanism in patients with mid-late stage malignant tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Drugs, Chinese Herbal; Etoposide; Female; Fluorouracil; Humans; Lung Neoplasms; Lymphocyte Count; Male; Mitomycin; Moxibustion; Phytotherapy; Stomach Neoplasms; T-Lymphocyte Subsets | 2002 |
Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesothelioma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Infusions, Intravenous; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Sepsis; Treatment Outcome | 2003 |
Pretreatment clinical prognostic factors in patients with stage IV non-small cell lung cancer (NSCLC) treated with chemotherapy.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Etoposide; Female; Humans; Karnofsky Performance Status; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors; Survival Analysis; Time Factors; Treatment Outcome | 2003 |
Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Predictive Value of Tests; Prognosis; Recurrence; Risk Factors; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2003 |
Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Male; Medulloblastoma; Neoadjuvant Therapy; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; United Kingdom; Vincristine | 2003 |
A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Hyperthermia, Induced; Ifosfamide; Lenograstim; Male; Middle Aged; Recombinant Proteins; Sarcoma; Survival Analysis; Treatment Outcome | 2003 |
An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Dose Fractionation, Radiation; Etoposide; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Radiotherapy, Adjuvant; Time Factors; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation | 2003 |
Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone-refractory prostate carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease Progression; Estramustine; Etoposide; Humans; Male; Middle Aged; Paclitaxel; Prostate-Specific Antigen; Prostatic Neoplasms; Rats; Survival Rate; Treatment Outcome | 2003 |
Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancer.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Patient Selection; Prognosis; Proportional Hazards Models; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 2003 |
Paclitaxel, carboplatin, and oral etoposide in advanced gastric adenocarcinoma: association with severe myelotoxicity.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Etoposide; Female; Humans; Male; Middle Aged; Neutropenia; Paclitaxel; Stomach Neoplasms; Treatment Failure | 2003 |
Preirradiation ifosfamide, carboplatin and etoposide (ICE) for the treatment of high-grade astrocytomas in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Prospective Studies; Radiotherapy; Survival Rate | 2003 |
High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study--TROG 96:07.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Combined Modality Therapy; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Radiation Oncology; Risk Factors; Skin Neoplasms; Societies, Medical; Survival Rate | 2003 |
Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Treatment Outcome | 2004 |
Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Neutropenia; Remission Induction; Rituximab; Salvage Therapy; Survival Analysis; Transplantation, Autologous | 2004 |
Outcome of pediatric recurrent and refractory malignant solid tumors following ifosfamide/carboplatin/etoposide (ICE): A phase II study in a pediatric oncology centre in Brazil.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brazil; Carboplatin; Child; Child, Preschool; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neoplasms; Remission Induction; Survival Rate; Treatment Outcome | 2004 |
Results of a prospective study for the treatment of retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Humans; Idarubicin; Infant; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Optic Nerve Neoplasms; Prospective Studies; Retinoblastoma; Risk Factors; Scleral Diseases; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Male; Medulloblastoma; Proportional Hazards Models; Survival Rate; Treatment Outcome; Vincristine | 2004 |
[Prognostic and predictive factors of patients with cancer of unknown origin treated with a paclitaxel-based chemotherapy].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Predictive Value of Tests; Prognosis; Survival Rate | 2004 |
Combined modality treatment for locally advanced non-small cell lung cancer: preoperative chemoradiation does not result in a poorer quality of life.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Dyspnea; Etoposide; Female; Health Status; Humans; Lung Neoplasms; Male; Middle Aged; Pain; Quality of Life; Vindesine | 2004 |
Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Oligonucleotides, Antisense; Proto-Oncogene Proteins c-bcl-2; Survival Rate; Thionucleotides; United States | 2004 |
Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Drug Resistance, Neoplasm; Etoposide; Germinoma; Humans; Infusions, Intravenous; Male; Middle Aged; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Salvage Therapy; Survival Analysis; Testicular Neoplasms; Treatment Outcome | 2004 |
[Evaluation of the therapeutic benefit of 41.8 degrees C whole body hyperthermia plus ifosfamide, carboplatin and etoposide (ICE) for patients with malignant pleural mesothelioma using the Modified Brunner-Score (MBS)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Hyperthermia, Induced; Ifosfamide; Mesothelioma; Pleural Neoplasms; Survival; Survivors | 2004 |
Five-year results of cyclic semi-high dose neoadjuvant chemotherapy supported by autologous peripheral blood stem-cell transplantation in patients with advanced ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Etoposide; Feasibility Studies; Female; Gynecologic Surgical Procedures; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Ovarian Neoplasms; Peripheral Blood Stem Cell Transplantation; Pilot Projects; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2004 |
Practical approach to management of retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Humans; Infant; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Vincristine | 2004 |
Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Etoposide; Female; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Neoplasms, Unknown Primary; Treatment Outcome | 2004 |
[Concurrent radiotherapy combined with carboplatin and etoposide in limited stage small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiotherapy, High-Energy; Survival Rate | 2004 |
Ifosfamide/carboplatin/etoposide (ICE) as front-line, topotecan/cyclophosphamide as second-line and oral temozolomide as third-line treatment for advanced neuroblastoma over one year of age.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neuroblastoma; Palliative Care; Temozolomide; Topotecan; Treatment Outcome | 2004 |
Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Metastasis; Seminoma; Testicular Neoplasms; Treatment Outcome | 2004 |
ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma--the Nordic Lymphoma Group experience.
Topics: Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease Progression; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Leukapheresis; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Peripheral Blood Stem Cell Transplantation; Recurrence; Scandinavian and Nordic Countries; Treatment Outcome | 2004 |
Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma.
Topics: Adult; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Female; Glioma; Humans; In Situ Hybridization; Male; Survival Analysis | 2004 |
Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Female; Humans; Hyperthermia, Induced; Infant; Male; Neoplasm Recurrence, Local; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Risk Factors; Vincristine | 2004 |
Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Hyperthermia, Induced; Ifosfamide; Leukopenia; Male; Middle Aged; Neoplasm Staging; Patient Selection; Salvage Therapy; Sarcoma; Survival Rate; Thrombocytopenia; Treatment Outcome | 2004 |
Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Colony-Stimulating Factors; Etoposide; Female; Humans; Ifosfamide; Male; Multivariate Analysis; Proportional Hazards Models; Recurrence; Rhabdomyosarcoma; Sarcoma; Survival Rate | 2005 |
Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a Minnie Pearl Cancer Research Network phase II trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Gemcitabine; Humans; Irinotecan; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Treatment Outcome | 2004 |
Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Dysgerminoma; Etoposide; Female; Humans; Neoplasm Staging; Ovarian Neoplasms | 2004 |
Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infant; Interleukin-11; Lymphoma; Male; Neoplasms; Platelet Count; Recombinant Proteins; Thrombocytopenia | 2005 |
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Stem Cell Transplantation; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 2005 |
Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Dactinomycin; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Rhabdomyosarcoma; Teniposide; Treatment Outcome; Vincristine | 2005 |
Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Cyclophosphamide; Etoposide; Follow-Up Studies; Humans; Infant; Intelligence; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Neuropsychological Tests; Postoperative Care; Proportional Hazards Models; Remission Induction; Survival Analysis; Vincristine | 2005 |
Paclitaxel, carboplatin, and oral etoposide as initial treatment for advanced ovarian carcinoma: a Minnie Pearl Cancer Research Network phase II trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Female; Humans; Infusions, Intravenous; Middle Aged; Ovarian Neoplasms; Paclitaxel | 2005 |
High-dose etoposide, thiotepa, and dose-adjusted carboplatin (TVCa) with autologous hematopoietic stem cell rescue as treatment of relapsed or refractory germ cell cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Etoposide; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Survival Analysis; Thiotepa; Transplantation, Autologous | 2005 |
A phase I clinical, pharmacologic, and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children's Oncology Gro
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Ifosfamide; Male; Megakaryocytes; Neoplasms; Recombinant Proteins; Thrombopoietin | 2005 |
[An early phase II clinical study of YM 294 (rhlL-11) in patients with solid tumors and malignant lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Edema; Etoposide; Female; Fever; Humans; Interleukin-11; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Platelet Count; Recombinant Proteins; Thrombocytopenia | 2005 |
Randomized phase III trial comparing cisplatin-etoposide to carboplatin-paclitaxel in advanced or metastatic non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Quality of Life | 2005 |
Randomized phase III trial of dose-dense chemotherapy supported by whole-blood hematopoietic progenitors in better-prognosis small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Ifosfamide; Incidence; Lung Neoplasms; Male; Middle Aged; Neutropenia; Prognosis; Recombinant Proteins; Severity of Illness Index; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2005 |
High-dose chemotherapy and autologous stem cell rescue for metastatic breast cancer: superior survival for tandem compared with single transplants.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carboplatin; Cohort Studies; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Middle Aged; Mitoxantrone; Organ Specificity; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Survival Analysis; Thiotepa; Transplantation, Autologous; Treatment Outcome | 2005 |
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Salvage Therapy; Treatment Outcome; Vinblastine | 2005 |
Phase II study of prolonged ambulatory infusion carboplatin and oral etoposide for patients progressing through hormonal therapy for prostate cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Etoposide; Follow-Up Studies; Humans; Infusion Pumps; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Time Factors; Treatment Outcome | 2005 |
Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis radiation therapy.
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Dementia, Vascular; Etoposide; Humans; Infant; Magnetic Resonance Imaging; Medulloblastoma; Methotrexate | 2005 |
Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Epidemiologic Methods; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prognosis; Radiotherapy Dosage; Skin Neoplasms | 2006 |
Identification of clinical prognostic factors in patients with unknown primary tumors treated with a platinum-based combination.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Doxorubicin; Etoposide; Female; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasms, Unknown Primary; Patient Selection; Prognosis; Prospective Studies; Survival Analysis; Treatment Outcome | 2005 |
A phase I and pharmacokinetic study of the selective, non-peptidic inhibitor of matrix metalloproteinase BAY 12-9566 in combination with etoposide and carboplatin.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biphenyl Compounds; Carboplatin; Cohort Studies; Colonic Neoplasms; Enzyme Inhibitors; Etoposide; Female; Humans; Male; Matrix Metalloproteinase Inhibitors; Melanoma; Middle Aged; Neoplasms; Neoplasms, Unknown Primary; Neutropenia; Organic Chemicals; Phenylbutyrates; Thrombocytopenia; Thymoma; Treatment Outcome; Vomiting | 2005 |
A phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Etoposide; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Taxoids; Treatment Outcome | 2006 |
A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Survival; Topotecan; Treatment Outcome | 2005 |
A novel intensive induction therapy for high-risk neuroblastoma utilizing sequential peripheral blood stem cell collection and infusion as hematopoietic support.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Infant; Linear Models; Male; Neuroblastoma; Peripheral Blood Stem Cell Transplantation; Pilot Projects; Remission Induction; Survival Analysis | 2006 |
Double-cycle, high-dose ifosfamide, carboplatin, and etoposide followed by peripheral blood stem-cell transplantation for small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Diarrhea; Etoposide; Female; Humans; Ifosfamide; Kidney; Leukocyte Count; Lung Neoplasms; Male; Radiotherapy Dosage; Stem Cell Transplantation; Survival Analysis; Treatment Outcome | 2005 |
Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive-stage small cell lung cancer: a Minnie Pearl Cancer Research Network randomized, prospective phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organophosphorus Compounds; Paclitaxel; Topotecan | 2005 |
Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Disease Progression; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Prognosis; Risk Assessment; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Vincristine | 2005 |
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Prognosis; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2005 |
Ifosfamide, carboplatin, and etoposide with midcycle vincristine versus standard chemotherapy in patients with small-cell lung cancer and good performance status: clinical and quality-of-life results of the British Medical Research Council multicenter ran
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Quality of Life; Statistics, Nonparametric; Survival Analysis; United Kingdom; Vincristine | 2005 |
Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.
Topics: Abdominal Neoplasms; Adolescent; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Ifosfamide; Infant; Male; N-Myc Proto-Oncogene Protein; Neoplasm Staging; Neuroblastoma; Neutropenia; Nuclear Proteins; Oncogene Proteins; Ploidies; Prognosis; Risk Factors; Treatment Outcome | 2005 |
Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel | 2006 |
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Agents; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Neuroblastoma; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2006 |
A randomized phase II trial of irinotecan plus carboplatin versus etoposide plus carboplatin treatment in patients with extended disease small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged | 2006 |
Efficacy and prognostic implications of administering adjuvant chemotherapy to patients with endometrial cancer that is confined to the uterus.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Endometrial Neoplasms; Epirubicin; Etoposide; Female; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Treatment Outcome; Uterus | 2007 |
A phase I trial of carboplatin and etoposide for elderly (>or=75 year-old) patients with small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Small Cell; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Eruptions; Etoposide; Female; Gastrointestinal Tract; Humans; Injections, Intravenous; Liver Function Tests; Lung Neoplasms; Male; Nausea; Neutropenia; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vomiting | 2006 |
Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Prognosis; Radiation Injuries; Survival Analysis; Treatment Outcome | 2006 |
High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experie
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Survival Rate; Vincristine | 2006 |
Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Disease-Free Survival; Etoposide; Female; Glioma; Humans; Loss of Heterozygosity; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome | 2006 |
Randomised phase III study of R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by high-dose therapy and a second randomisation to maintenance treatment with rituximab or not: an update of the CORAL study.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cisplatin; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Remission Induction; Rituximab; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2006 |
Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Prognosis; Prospective Studies; Quality of Life; Survival Rate; Vincristine | 2006 |
Influence of low-energy laser in the prevention of oral mucositis in children with cancer receiving chemotherapy.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Child; Child, Preschool; Cohort Studies; Etoposide; Female; Humans; Ifosfamide; Irinotecan; Low-Level Light Therapy; Male; Methotrexate; Mouth Mucosa; Neoplasms; Nutritional Status; Oral Hygiene; Severity of Illness Index; Stomatitis; Treatment Outcome | 2007 |
Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Prospective Studies; Survival Analysis; Treatment Outcome | 2006 |
[Immunoregulation and short-term therapeutic effects of super-selective intra-arterial chemotherapy combined with traditional Chinese drugs on gastric cancer patients].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Synergism; Drug Therapy, Combination; Drugs, Chinese Herbal; Epirubicin; Etoposide; Female; Humans; Injections, Intra-Arterial; Interferon-gamma; Interleukin-2; Male; Middle Aged; Phytotherapy; Stomach Neoplasms; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2006 |
Phase I/II trial of multicycle high-dose chemotherapy with peripheral blood stem cell support for treatment of advanced ovarian cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Melphalan; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Treatment Outcome | 2006 |
Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Damage, Chronic; Brain Stem; Carboplatin; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Etoposide; Humans; Infant; Infratentorial Neoplasms; Leucovorin; Mesna; Methotrexate; Neuroectodermal Tumors, Primitive; Peripheral Blood Stem Cell Transplantation; Remission Induction; Thiotepa; Transplantation, Autologous; Vincristine | 2008 |
Phase I and pharmacologic study of sequential topotecan-carboplatin-etoposide in patients with extensive stage small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Enzyme Inhibitors; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Topotecan; Treatment Outcome | 2006 |
Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Etoposide; Feasibility Studies; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Patient Selection; Prognosis; Radiotherapy, Adjuvant; Risk Factors; Survival Analysis; Treatment Outcome | 2006 |
A phase I study of dose-dense topotecan given upfront to standard therapy in patients with small cell lung cancer.
Topics: Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Karnofsky Performance Status; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Radiotherapy, Adjuvant; Remission Induction; Survival Rate; Topotecan; Treatment Outcome | 2006 |
[Five-year outcome of a new combination chemotherapy with CEA/ABVD for advanced Hodgkin's disease with poor prognosis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Survival Analysis; Treatment Outcome; Vinblastine | 2006 |
Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Stem Cell Transplantation; Treatment Outcome | 2007 |
Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Testicular Neoplasms; Time Factors | 2007 |
Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Breast Neoplasms; Carboplatin; Cyclophosphamide; Etoposide; Female; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Lymphoma; Male; Methotrexate; Middle Aged; Osmosis; Ovarian Neoplasms; Prospective Studies; Survival Rate | 2007 |
Pilot study of ifosfamide/carboplatin/etoposide (ICE) for peripheral blood stem cell mobilization in patients with high-risk or relapsed medulloblastoma.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Infant; Male; Medulloblastoma; Peripheral Blood Stem Cell Transplantation; Salvage Therapy | 2007 |
Chemoreduction for intraocular retinoblastoma in Malaysia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cryotherapy; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Infant; Laser Therapy; Malaysia; Male; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Vincristine | 2007 |
Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carboplatin; Cisplatin; Disease Progression; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Prognosis; Survival Analysis; Treatment Outcome | 2007 |
Influence of interfraction interval on local tumor control in patients with limited-disease small-cell lung cancer treated with radiochemotherapy.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy; Retrospective Studies | 2007 |
Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Salvage Therapy; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Transplantation, Autologous | 2006 |
Standard versus dose-intensified chemotherapy with sequential reinfusion of hematopoietic progenitor cells in small cell lung cancer patients with favorable prognosis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Disease Progression; Erythrocyte Transfusion; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Platelet Transfusion; Prognosis; Recombinant Proteins; Survival Rate | 2007 |
Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Infant, Newborn; Kidney Neoplasms; Male; Neoplasm Staging; Recurrence; Wilms Tumor | 2008 |
Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Treatment Outcome | 2007 |
Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Disease-Free Survival; Etoposide; Germany; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Testicular Neoplasms | 2007 |
Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and I
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Male; Mesna; Methotrexate; Neuroectodermal Tumors, Primitive; Supratentorial Neoplasms; Survival Rate; Vincristine | 2008 |
Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blindness; Carboplatin; Child, Preschool; Combined Modality Therapy; Cryotherapy; Disease Progression; Etoposide; Eye Enucleation; Humans; Hyperthermia, Induced; Infant; Infant, Newborn; Laser Therapy; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Visual Acuity | 2008 |
Phase III study of cyclophosphamide, doxorubicin, and etoposide compared with carboplatin and paclitaxel in patients with extensive disease small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cause of Death; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Survival Analysis | 2007 |
Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: a p
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Chemotherapy, Cancer, Regional Perfusion; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Portal Vein; Prospective Studies; Severity of Illness Index; Tablets, Enteric-Coated; Tegafur; Time Factors; Treatment Outcome; Uracil; Venous Thrombosis | 2007 |
Phase II trial of thalidomide with chemotherapy and as maintenance therapy for patients with poor prognosis small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Disease Progression; Etoposide; Female; Humans; Lung Neoplasms; Male; Prognosis; Survival Rate; Thalidomide; Treatment Outcome | 2008 |
VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Nitrosourea Compounds; Prednisone; Survival Rate; Vincristine | 2007 |
Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens.
Topics: Aged; Algorithms; Androgens; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Confidence Intervals; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Estramustine; Etoposide; Humans; Ketoconazole; Logistic Models; Male; Middle Aged; Paclitaxel; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Research Design; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 2007 |
Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Etoposide; Female; Humans; Infant; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Survival Analysis; Treatment Outcome | 2008 |
Conservative treatments of intraocular retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Child, Preschool; Cryotherapy; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Infant; Iodine Radioisotopes; Male; Neoadjuvant Therapy; Prospective Studies; Radiotherapy, High-Energy; Retinal Neoplasms; Retinoblastoma; Treatment Outcome | 2008 |
A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carboplatin; Carmustine; Cytarabine; Double-Blind Method; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Polyethylene Glycols; Recombinant Proteins; Transplantation, Autologous | 2008 |
Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Disease-Free Survival; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Odds Ratio; Thionucleotides; Treatment Outcome | 2008 |
Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Melphalan; Sarcoma; Soft Tissue Neoplasms; Thiotepa; Treatment Outcome; Vincristine | 2008 |
A pilot study of addition of amifostine to melphalan, carboplatin, etoposide, and cyclophosphamide with autologous hematopoietic stem cell transplantation in pediatric solid tumors-A pediatric blood and marrow transplant consortium study.
Topics: Adolescent; Adult; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Etoposide; Feasibility Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Hypocalcemia; Kidney Neoplasms; Melphalan; Neoplasms; Neuroblastoma; Pilot Projects; Recurrence; Risk Factors; Sarcoma; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Wilms Tumor | 2008 |
A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Hematologic Diseases; Humans; Ifosfamide; Incidence; Lung Neoplasms; Male; Middle Aged; Odds Ratio; Prognosis; Research Design; Survival Analysis; Treatment Outcome | 2008 |
Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Chromatography, High Pressure Liquid; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Mesna; Metabolic Clearance Rate; Middle Aged; Prognosis; Proportional Hazards Models; Small Cell Lung Carcinoma | 2008 |
A phase I study of bortezomib, etoposide and carboplatin in patients with advanced solid tumors refractory to standard therapy.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Boronic Acids; Bortezomib; Carboplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neoplasms; Neutropenia; Pyrazines; Thrombocytopenia | 2009 |
Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Docetaxel; ErbB Receptors; Erlotinib Hydrochloride; Etoposide; Female; Gene Amplification; Humans; In Situ Hybridization, Fluorescence; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Protein Kinase Inhibitors; Quinazolines; Remission Induction; Survival Rate; Taxoids | 2008 |
Phase II trial of combined modality therapy with concurrent topotecan plus radiotherapy followed by consolidation chemotherapy for unresectable stage III and selected stage IV non-small-lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Docetaxel; Etoposide; Female; Follow-Up Studies; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Taxoids; Topotecan | 2009 |
Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer: a randomized phase III trial.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Prognosis; Survival Analysis | 2008 |
Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cause of Death; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Hospitalization; Humans; Lung Neoplasms; Male; Middle Aged; Quality of Life; Small Cell Lung Carcinoma; Treatment Outcome | 2009 |
A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Topics: Adolescent; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Ifosfamide; Leukemia, B-Cell; Lymphoma, B-Cell; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Treatment Outcome; Young Adult | 2009 |
Long-term survival following chemoradiation for inoperable non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Radiotherapy, Adjuvant; Survival Rate | 2008 |
A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Radiotherapy; Rhabdoid Tumor; Teratoma; Thiotepa; Tomography, X-Ray Computed | 2009 |
Treatment of relapsed or refractory aggressive non-hodgkin lymphoma with two ifosfamide-based regimens, IMVP and ICE.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Treatment Outcome | 2008 |
ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine | 2009 |
A phase II study of carboplatin, etoposide, and exisulind in patients with extensive small cell lung cancer: CALGB 30104.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Small Cell Lung Carcinoma; Sulindac; Survival Rate; Treatment Outcome | 2009 |
Multicenter randomized open-label phase III study comparing efficacy, safety, and tolerability of conventional carboplatin plus etoposide versus dose-intensified carboplatin plus etoposide plus lenograstim in small-cell lung cancer in "extensive disease"
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Therapy, Combination; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lenograstim; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Prognosis; Prospective Studies; Quality of Life; Recombinant Proteins; Safety; Small Cell Lung Carcinoma; Survival Rate; Treatment Outcome; Young Adult | 2009 |
A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Central Nervous System Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Vincristine; Young Adult | 2009 |
Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Feasibility Studies; Female; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Remission Induction; Salvage Therapy; Survival Analysis; Thrombocytopenia; Transplantation, Autologous; Young Adult | 2009 |
Venous thromboembolism in recurrent ovarian cancer-patients: A systematic evaluation of the North-Eastern German Society of Gynaecologic Oncology Ovarian Cancer Study Group (NOGGO).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cohort Studies; Deoxycytidine; Disease-Free Survival; Etoposide; Female; Gemcitabine; Germany; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prognosis; Retrospective Studies; Survival Rate; Topotecan; Venous Thromboembolism | 2009 |
Carboplatin-based primary chemotherapy for infants and young children with CNS tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Infant; Survival Analysis; Time Factors; Treatment Outcome | 2009 |
Phase II study of ifosfamide, carboplatin, and etoposide in patients with a first recurrence of glioblastoma multiforme.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Disease Progression; Etoposide; Female; Glioblastoma; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Quality of Life; Time Factors; Treatment Outcome; Young Adult | 2010 |
Atypical choroid plexus papilloma: clinical experience in the CPT-SIOP-2000 study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Choroid Plexus Neoplasms; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Gadolinium; Humans; Infant; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Papilloma, Choroid Plexus; Registries; Vincristine; Young Adult | 2009 |
Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infusions, Intravenous; Male; Metabolic Clearance Rate; Neuroblastoma; Neutropenia; Remission Induction; Thrombocytopenia; Treatment Outcome | 2010 |
Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Fatigue; Female; Glutamates; Guanine; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Pemetrexed; Small Cell Lung Carcinoma; Treatment Outcome | 2009 |
A phase II prospective study of sequential myeloablative chemotherapy with hematopoietic stem cell rescue for the treatment of selected high risk and recurrent central nervous system tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kaplan-Meier Estimate; Male; Melphalan; Thiotepa; Transplantation Conditioning | 2010 |
Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Combined Modality Therapy; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Immunohistochemistry; Japan; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Nose Neoplasms; Probability; Proportional Hazards Models; Radiotherapy Dosage; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Risk Assessment; Sex Factors; Survival Analysis; Treatment Outcome; Young Adult | 2009 |
A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Melphalan; Middle Aged; Protein Kinases; Recurrence; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2009 |
Peripheral blood stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage neuroblastoma: a report from the Childrens Oncology Group.
Topics: Antineoplastic Agents; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Infant; Kaplan-Meier Estimate; Male; Maximum Tolerated Dose; Neuroblastoma; Peripheral Blood Stem Cell Transplantation; Vincristine | 2010 |
Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Infant; Male; Neoplasms, Germ Cell and Embryonal; Treatment Outcome; Young Adult | 2010 |
High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Epidemiologic Methods; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiotherapy, Adjuvant; Recurrence; Salvage Therapy; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2010 |
Sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small cell lung cancer: our experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiotherapy, Conformal; Survival Rate | 2009 |
High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Male; Medulloblastoma; Neoplasm Recurrence, Local; Quality of Life; Radiotherapy; Salvage Therapy; Thiotepa; Young Adult | 2010 |
TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Retreatment; Salvage Therapy | 2010 |
Triplet combination of carboplatin, irinotecan, and etoposide in the first-line treatment of extensive small-cell lung cancer: a single-institution phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Small Cell Lung Carcinoma; Treatment Outcome | 2010 |
High dose chemotherapy as salvage treatment for unresectable late relapse germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Etoposide; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Salvage Therapy; Survival Rate; Testicular Neoplasms; Treatment Outcome | 2010 |
Developmental pharmacokinetics of etoposide in 67 children: lack of dexamethasone effect.
Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Body Weight; Carboplatin; Child; Child, Preschool; Cytochrome P-450 CYP3A; Dexamethasone; Drug Interactions; Etoposide; Humans; Infant; Models, Biological; Neoplasms; Nonlinear Dynamics; Ondansetron; Polymorphism, Single Nucleotide | 2011 |
[Pre-treatment and treatment-induced neuron-specific enolase in patients with small-cell lung cancer: an open prospective study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Disease-Free Survival; Etoposide; Humans; Lung Neoplasms; Neoplasm Proteins; Phosphopyruvate Hydratase; Prospective Studies; Remission Induction; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2010 |
[Treatment of relapsed osteosarcoma. Role of chemotherapy using ifosamide and carboplatin].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Doxorubicin; Etoposide; Female; Follow-Up Studies; Histiocytoma, Malignant Fibrous; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Osteosarcoma; Treatment Outcome; Young Adult | 2010 |
A phase I trial of sorafenib combined with cisplatin/etoposide or carboplatin/pemetrexed in refractory solid tumor patients.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Niacinamide; Pemetrexed; Phenylurea Compounds; Pyridines; Sorafenib; Treatment Outcome | 2011 |
Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Australia; Carboplatin; Chemotherapy, Adjuvant; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Europe; Female; Humans; Ifosfamide; Israel; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; New York City; Proportional Hazards Models; Recurrence; Risk Assessment; Risk Factors; Rituximab; Salvage Therapy; Stem Cell Transplantation; Time Factors; Transplantation, Autologous; Treatment Outcome; Young Adult | 2010 |
The NK-1 receptor-antagonist aprepitant in high-dose chemotherapy (high-dose melphalan and high-dose T-ICE: paclitaxel, ifosfamide, carboplatin, etoposide): efficacy and safety of a triple antiemetic combination.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carboplatin; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Etoposide; Female; Granisetron; Humans; Ifosfamide; Male; Melphalan; Middle Aged; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Paclitaxel; Treatment Outcome; Vomiting; Young Adult | 2011 |
Duration: escalation study of oral etoposide with carboplatin in patients with varied solid tumors.
Topics: Administration, Oral; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Etoposide; Female; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Neoplasms; Neutropenia; Salvage Therapy; Thrombocytopenia | 2010 |
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Infant; Intention to Treat Analysis; Neoplasm Staging; Neuroblastoma; Prospective Studies; Survival Analysis; Treatment Outcome | 2010 |
Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group.
Topics: Adult; Aged; Aged, 80 and over; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Proportional Hazards Models; Radiotherapy Dosage; Relative Biological Effectiveness; Retrospective Studies; Survival Analysis; Treatment Failure; Vinblastine | 2012 |
A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposide-carboplatin as first-line therapy for extensive-disease small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Disease-Free Survival; Etoposide; Female; Germany; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Small Cell Lung Carcinoma | 2011 |
Addition of darbepoetin alfa to dose-dense chemotherapy: results from a randomized phase II trial in small-cell lung cancer patients receiving carboplatin plus etoposide.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Carboplatin; Darbepoetin alfa; Disease-Free Survival; Erythropoietin; Etoposide; Female; Hematinics; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Quality of Life; Small Cell Lung Carcinoma | 2011 |
Weekly cisplatin therapy compared with triweekly combination chemotherapy as concurrent adjuvant chemoradiation therapy after radical hysterectomy for cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Hysterectomy; Kaplan-Meier Estimate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Paclitaxel; Proportional Hazards Models; Radiotherapy, Adjuvant; Survival Rate; Uterine Cervical Neoplasms | 2011 |
Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Differentiation; Chromogranin A; Disease-Free Survival; Etoposide; Humans; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Neuroendocrine Cells; Orchiectomy; Prospective Studies; Prostatic Neoplasms | 2011 |
Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trial.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Cisplatin; Disease-Free Survival; Double-Blind Method; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Small Cell Lung Carcinoma | 2011 |
Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Carboplatin; Disease-Free Survival; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Pyrazines; Recurrence; Treatment Outcome; Young Adult | 2011 |
Feasibility and efficacy of repeated chemotherapy for progressive pediatric low-grade gliomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Glioma; Humans; Infant; Infant, Newborn; Lomustine; Male; Procarbazine; Retrospective Studies; Survival Rate; Thioguanine; Vinblastine; Vincristine | 2011 |
Successful treatment of metastatic retinoblastoma with high-dose chemotherapy and autologous stem cell rescue in South America.
Topics: Antineoplastic Agents; Carboplatin; Child, Preschool; Etoposide; Female; Humans; Infant; Male; Melphalan; Neoplasm Metastasis; Retinoblastoma; South America; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous | 2012 |
Concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (Stage III) non-small-cell lung cancer: single institution experience with 600 patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pneumonia; Retrospective Studies; Treatment Outcome | 2012 |
High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Consolidation Chemotherapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Mesna; Middle Aged; Peripheral Blood Stem Cell Transplantation; Sarcoma; Young Adult | 2012 |
Clinical prognostic factors in patients with locally advanced (stage III) nonsmall cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy: single-Institution Experience in 600 Patients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Prognosis; Proportional Hazards Models; Treatment Outcome | 2011 |
Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Blood Platelets; Carboplatin; Cisplatin; Combined Modality Therapy; Cystadenocarcinoma, Serous; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Granulosa Cell Tumor; Humans; Middle Aged; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Peripheral Nervous System Diseases; Salvage Therapy; Tamoxifen; Thrombocytopenia; Treatment Outcome | 2011 |
Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Eye Neoplasms; Female; Humans; Incidence; Infant; Infant, Newborn; Male; Neoplasms, Second Primary; Retinoblastoma; Retrospective Studies; Survival Rate; Vincristine | 2012 |
A prospective phase II study of RICE re-induction, then high-dose fludarabine and busulfan, followed by autologous or allogeneic blood stem cell transplantation for indolent b-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carboplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Male; Middle Aged; Prospective Studies; Quality of Life; Rituximab; Survival Rate; Transplantation Conditioning; Vidarabine | 2011 |
Retinoblastoma in Central America: report from the Central American Association of Pediatric Hematology Oncology (AHOPCA).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central America; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Eye Neoplasms; Female; Humans; Infant; Infant, Newborn; Male; Neoplasm Staging; Retinoblastoma; Survival Rate; Vincristine | 2012 |
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Gene Deletion; Genetic Predisposition to Disease; Genotype; Glutathione S-Transferase pi; Glutathione Transferase; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Proteins; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prednisone; Procarbazine; Prognosis; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2012 |
A pilot study on the use of outpatient fractionated ifosfamide, carboplatin and etoposide (ICE) and pegfilgrastim as a salvage and mobilizing regimen for relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pilot Projects; Polyethylene Glycols; Recombinant Proteins; Salvage Therapy; Young Adult | 2012 |
Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STEP trial.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Multivariate Analysis; Prognosis; Proportional Hazards Models; Quality of Life; Treatment Outcome; Vinblastine; Vinorelbine | 2012 |
Did salvage ICE chemotherapy improve the outcome in primary resistant/relapsing stage III/IV neuroblastoma?
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Neoplasm Recurrence, Local; Neuroblastoma; Salvage Therapy; Treatment Outcome | 2011 |
Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cost-Benefit Analysis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel | 2011 |
Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Disease-Free Survival; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Seminoma; Stem Cell Transplantation; Testicular Neoplasms | 2012 |
Tandem high-dose chemotherapy and autologous stem cell transplantation in young children with atypical teratoid/rhabdoid tumor of the central nervous system.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Infant; Male; Prospective Studies; Recurrence; Rhabdoid Tumor; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Thiotepa; Transplantation, Autologous | 2012 |
A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System; Drug Administration Schedule; Etoposide; Female; Humans; Indoles; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Small Cell Lung Carcinoma | 2012 |
Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neutropenia; Paclitaxel; Radiation Pneumonitis; Treatment Outcome | 2012 |
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Middle Aged; Survival Rate; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vinblastine; Young Adult | 2012 |
Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatr
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Male; Prognosis; Rhabdomyosarcoma; Sarcoma; Treatment Outcome; Vincristine | 2012 |
Regression patterns in treated retinoblastoma with chemotherapy plus focal adjuvant therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Female; Humans; Hyperthermia, Induced; Infant; Male; Retinal Neoplasms; Retinoblastoma; Vincristine | 2013 |
Safety and feasibility of high-dose ranimustine (MCNU), carboplatin, etoposide, and cyclophosphamide (MCVC) therapy followed by autologous stem cell transplantation for malignant lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nitrosourea Compounds; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous | 2012 |
Combination chemotherapy of alternating etoposide and carboplatin with weekly administration of irinotecan and cisplatin in extensive-stage small-cell lung cancer.
Topics: Adult; Aged; Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Diarrhea; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neutropenia; Severity of Illness Index; Small Cell Lung Carcinoma; Thrombocytopenia; Treatment Outcome | 2012 |
Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors.
Topics: Adult; alpha-Fetoproteins; Biomarkers, Tumor; Carboplatin; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Survival; Testicular Neoplasms; Treatment Outcome; Vinblastine | 2013 |
Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited-stage small-cell lung cancer, CALGB 30206.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chemoradiotherapy; Cisplatin; Confidence Intervals; Dehydration; Disease-Free Survival; Dose Fractionation, Radiation; Esophagitis; Etoposide; Female; Humans; Induction Chemotherapy; Irinotecan; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Small Cell Lung Carcinoma | 2013 |
Imaging the early response to chemotherapy in advanced lung cancer with diffusion-weighted magnetic resonance imaging compared to fluorine-18 fluorodeoxyglucose positron emission tomography and computed tomography.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Diffusion Magnetic Resonance Imaging; Early Detection of Cancer; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
The impact of preradiation residual disease volume on time to locoregional failure in cutaneous Merkel cell carcinoma--a TROG substudy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Chemoradiotherapy; Disease Progression; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lymph Nodes; Lymphatic Irradiation; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Pilot Projects; Proportional Hazards Models; Prospective Studies; Skin Neoplasms; Time Factors; Treatment Failure | 2013 |
A phase I study of pulse high-dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide (ICE) in patients with relapsed lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Synergism; Etoposide; Female; Humans; Hydroxamic Acids; Ifosfamide; Lymphoma; Male; Middle Aged; Rituximab; Vorinostat | 2013 |
Radiotherapy alone versus radiochemotherapy in patients with stage IIIA adenocarcinoma (ADC) of the lung.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Chemoradiotherapy; Disease Progression; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Prospective Studies; Radiotherapy; Time Factors | 2013 |
Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cytarabine; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Immunotherapy; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Grading; Recurrence; Survival Analysis; Treatment Failure; Young Adult | 2013 |
Treatment outcomes of paclitaxel for refractory or recurrent epithelial ovarian cancer patients in Thailand.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Serous; Deoxycytidine; Drug Resistance, Neoplasm; Endometrial Neoplasms; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Survival Rate | 2013 |
Evolving of therapeutic strategies for CNS-PNET.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Infant; Kaplan-Meier Estimate; Male; Methotrexate; Neuroectodermal Tumors, Primitive; Thiotepa; Vincristine | 2013 |
Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gene Amplification; Humans; Infant; Male; N-Myc Proto-Oncogene Protein; Neuroblastoma; Nuclear Proteins; Oncogene Proteins; Survival Analysis; Vincristine | 2013 |
Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Treatment Outcome | 2013 |
A non-comparative phase II study of dose intensive chemotherapy with doxorubicin and ifosfamide followed by high dose ICE consolidation with PBSCT in non-resectable, high grade, adult type soft tissue sarcomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasms; Young Adult | 2013 |
Phase I trial of carboplatin and etoposide in combination with panobinostat in patients with lung cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy-Induced Febrile Neutropenia; Early Termination of Clinical Trials; Etoposide; Humans; Hydroxamic Acids; Indoles; Lung Neoplasms; Middle Aged; Panobinostat | 2013 |
Prognostic factors and efficacy of different chemotherapeutic regimens in patients with mediastinal nonseminomatous germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Male; Mediastinal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Testicular Neoplasms; Vincristine; Young Adult | 2014 |
A randomized phase III study of single-agent amrubicin vs. carboplatin/etoposide in elderly patients with extensive-disease small-cell lung cancer.
Topics: Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Neoplasm Staging; Prognosis; Quality of Life; Small Cell Lung Carcinoma; Survival Rate | 2014 |
Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carboplatin; Disease Progression; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Prospective Studies; Recurrence; Risk Factors; Rituximab; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Young Adult | 2014 |
Intensive chemotherapy followed by reduced-dose radiotherapy for biopsy-proven CNS germinoma with elevated beta-human chorionic gonadotropin.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Child; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Etoposide; Female; Germinoma; Humans; Induction Chemotherapy; Male; Radiotherapy Dosage; Young Adult | 2014 |
Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: results from the ABEL study.
Topics: Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Lung Neoplasms; Male; Middle Aged; Small Cell Lung Carcinoma; Survival Analysis; Treatment Outcome | 2013 |
Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (RICER) in first-relapse/primary refractory diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Prognosis; Recurrence; Rituximab; Salvage Therapy; Thalidomide; Treatment Outcome | 2014 |
A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Thiotepa; Treatment Failure; Young Adult | 2014 |
Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Deoxycytidine; Disease-Free Survival; Etoposide; Female; Fluorouracil; Gastrointestinal Neoplasms; Gemcitabine; Humans; Irinotecan; Kaplan-Meier Estimate; Leucovorin; Male; Organoplatinum Compounds; Oxaliplatin; Prognosis; Proportional Hazards Models; Retrospective Studies; Treatment Outcome | 2014 |
Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Comorbidity; Etoposide; Female; Humans; Indoles; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pyrroles; Small Cell Lung Carcinoma; Treatment Outcome | 2014 |
A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Disease Progression; Disease-Free Survival; Etoposide; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Proportional Hazards Models; Testicular Neoplasms; Time Factors; Treatment Outcome; United Kingdom; Vincristine; Young Adult | 2015 |
Carboplatin plus etoposide in heavily pretreated castration-resistant prostate cancer patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Male; Neoplasm Grading; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Treatment Outcome | 2014 |
Timing of thoracic radiotherapy in limited stage small cell lung cancer: results of early versus late irradiation from a single institution in Turkey.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Cisplatin; Deoxycytidine; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy Dosage; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate; Time Factors | 2014 |
A Phase II/III study comparing carboplatin and irinotecan with carboplatin and etoposide for the treatment of elderly patients with extensive-disease small-cell lung cancer (JCOG1201).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Irinotecan; Japan; Lung Neoplasms; Male; Middle Aged; Patient Selection; Small Cell Lung Carcinoma; Survival Analysis; Treatment Outcome | 2015 |
High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Disease-Free Survival; Drug Combinations; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Young Adult | 2015 |
Randomized, controlled trial in groups C and D retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Disease-Free Survival; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Infant; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Tomography, X-Ray Computed; Vincristine | 2015 |
Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Extremities; Feasibility Studies; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Staging; Osteosarcoma; Prognosis; Retrospective Studies; Survival Rate | 2014 |
Do Cell-Cycle Phase-Specific Markers Predict Disease Grade, Stage, and Outcome in Cervical Carcinoma?
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Squamous Cell; Cell Cycle; Chemoradiotherapy; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Prognosis; Survival Rate; Uterine Cervical Neoplasms; Young Adult | 2015 |
Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: a randomized, double-blind, placeb
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cough; Cyclophosphamide; Double-Blind Method; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Remission Induction; Rituximab; Salvage Therapy; Thrombocytopenia; Treatment Outcome; Vincristine | 2015 |
A multicenter, open-label, randomized phase II controlled study of rh-endostatin (Endostar) in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease Progression; Disease-Free Survival; Endostatins; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Small Cell Lung Carcinoma; Young Adult | 2015 |
PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Carboplatin; Chemotherapy, Adjuvant; Etoposide; Feasibility Studies; Female; Hodgkin Disease; Humans; Ifosfamide; Immunoconjugates; Male; Middle Aged; Neoadjuvant Therapy; New York City; Positron-Emission Tomography; Recurrence; Salvage Therapy; Stem Cell Transplantation; Time Factors; Treatment Outcome; Young Adult | 2015 |
Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance).
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Disease Progression; Disease-Free Survival; Double-Blind Method; Etoposide; Female; Humans; Indoles; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Pyrroles; Small Cell Lung Carcinoma; Sunitinib; Treatment Outcome | 2015 |
Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Nitrosourea Compounds; Prednisolone; Treatment Outcome; Vincristine; Vindesine | 2015 |
Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404).
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prospective Studies; Rituximab; Vincristine; Young Adult | 2015 |
Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brazil; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Induction Chemotherapy; Infant; Infant, Newborn; Kaplan-Meier Estimate; Male; Proportional Hazards Models; Sarcoma, Ewing; Soft Tissue Neoplasms; Treatment Outcome; Vincristine | 2015 |
Randomized phase II trial comparing amrubicin with re-challenge of platinum doublet in patients with sensitive-relapsed small-cell lung cancer: North Japan Lung Cancer Study Group trial 0702.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Irinotecan; Japan; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Retreatment; Small Cell Lung Carcinoma; Survival Rate | 2015 |
Pilot Study of Intensive Chemotherapy With Peripheral Hematopoietic Cell Support for Children Less Than 3 Years of Age With Malignant Brain Tumors, the CCG-99703 Phase I/II Study. A Report From the Children's Oncology Group.
Topics: Antineoplastic Agents; Brain Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Combined Modality Therapy; Consolidation Chemotherapy; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Infant; Male; Pilot Projects; Thiotepa; Treatment Outcome; Vincristine | 2015 |
Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infant; Male; Neoadjuvant Therapy; Neoplasms, Germ Cell and Embryonal; Second-Look Surgery; Thiotepa; Treatment Outcome | 2015 |
Pediatric Survivors of Retinoblastoma Are at Risk for Altered Bone Metabolism After Chemotherapy Treatment Early in Life.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Fractures, Bone; Humans; Male; Retinoblastoma; Risk Factors; Survivors; Vincristine; Vitamin D Deficiency | 2015 |
Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Biomarkers, Tumor; Brain Diseases, Metabolic; Camptothecin; Carboplatin; Carcinoma, Small Cell; Disease-Free Survival; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Administration Schedule; Endonucleases; Etoposide; Fatigue; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Irinotecan; Kaplan-Meier Estimate; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Mitosis; Multiple Organ Failure; Pneumonia; Treatment Outcome; Weight Loss | 2015 |
Conservative treatment of retinoblastoma: a prospective phase II randomized trial of neoadjuvant chemotherapy followed by local treatments and chemothermotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Hyperthermia, Induced; Infant; Male; Neoadjuvant Therapy; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Vincristine | 2016 |
Spleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-Radiotherapy.
Topics: Aged; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiography; Spleen | 2015 |
Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cranial Irradiation; Disease-Free Survival; Etoposide; Female; Humans; Indoles; Lung Neoplasms; Maintenance Chemotherapy; Male; Middle Aged; Placebos; Pyrroles; Retrospective Studies; Small Cell Lung Carcinoma; Sunitinib | 2016 |
Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Biomarkers, Tumor; Carboplatin; Etoposide; Female; Humans; Ipilimumab; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Small Cell Lung Carcinoma; Treatment Outcome | 2016 |
Multimodal Therapy for Stage III Retinoblastoma (International Retinoblastoma Staging System): A Prospective Comparative Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Eye Enucleation; Female; Humans; Idarubicin; Infant; Male; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Survival Analysis; Vincristine | 2016 |
Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Diarrhea; Etoposide; Female; Humans; Ipilimumab; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Small Cell Lung Carcinoma; Treatment Outcome | 2016 |
A randomized, double-blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive-stage small cell lung cancer: Hoosier Cancer Research Network LUN06-113.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Disease Progression; Double-Blind Method; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Piperidines; Quinazolines; Small Cell Lung Carcinoma | 2017 |
Ongoing Clinical Trials in Testicular Cancer: The TIGER Trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Humans; Ifosfamide; Internationality; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prevalence; Risk Factors; Salvage Therapy; Survival Analysis | 2016 |
Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Proportional Hazards Models | 2017 |
Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Podophyllotoxin; Positron-Emission Tomography; Prednisone; Retreatment; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2017 |
A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive-disease small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Peptides, Cyclic; Proportional Hazards Models; Small Cell Lung Carcinoma; Survival Analysis; Treatment Outcome | 2017 |
Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Disease-Free Survival; Double-Blind Method; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Pravastatin; Response Evaluation Criteria in Solid Tumors; Small Cell Lung Carcinoma; Survival Rate | 2017 |
Incorporation of high-dose
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Induction Chemotherapy; Infant; Melphalan; Neuroblastoma; Stem Cell Transplantation; Thiotepa; Transplantation, Autologous; Young Adult | 2017 |
A Randomized, Placebo-Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Disease-Free Survival; Double-Blind Method; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Small Cell Lung Carcinoma; Survival Rate; Treatment Outcome | 2017 |
Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Histone Deacetylase Inhibitors; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Panobinostat; Survival Rate; Thrombocytopenia; Treatment Outcome; Young Adult | 2018 |
A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL.
Topics: Adenine; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Piperidines; Pyrazoles; Pyrimidines; Remission Induction; Rituximab | 2018 |
A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Resistance; Etoposide; Humans; Ifosfamide; Lymphoma, T-Cell, Peripheral; Recurrence; Retreatment; Treatment Outcome | 2018 |
High-dose Carboplatin/Etoposide/Melphalan increases risk of thrombotic microangiopathy and organ injury after autologous stem cell transplantation in patients with neuroblastoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Neuroblastoma; Retrospective Studies; Survival Rate; Thrombotic Microangiopathies; Transplantation, Autologous | 2018 |
Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Child; Child, Preschool; Comparative Genomic Hybridization; Etoposide; Female; Humans; Induction Chemotherapy; Infant; Japan; Male; Melphalan; Neuroblastoma; Prospective Studies; Survival Rate; Treatment Outcome | 2018 |
Impact of baseline characteristics on extensive-stage SCLC patients treated with etoposide/carboplatin: A secondary analysis of a phase III study.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Patient Selection; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Risk Assessment; Small Cell Lung Carcinoma; Survival Rate; Treatment Outcome | 2018 |
Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cohort Studies; Etoposide; Follow-Up Studies; Humans; Immunosuppressive Agents; Immunotherapy; International Agencies; Leflunomide; Lung Neoplasms; Maintenance Chemotherapy; Prognosis; Small Cell Lung Carcinoma; Survival Rate; Toll-Like Receptor 9 | 2018 |
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Double-Blind Method; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Progression-Free Survival; Small Cell Lung Carcinoma | 2018 |
A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carboplatin; Etoposide; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Neoplasms; Small Cell Lung Carcinoma; Treatment Outcome | 2019 |
A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Disease-Free Survival; Etoposide; Female; Flavonoids; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Diseases; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Piperidines; Recurrence; Remission Induction; Salvage Therapy; Sirolimus; Topotecan; Tumor Lysis Syndrome | 2019 |
Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Filgrastim; Gene Amplification; Hepatomegaly; Humans; Infant; Infant, Newborn; Loss of Heterozygosity; Male; N-Myc Proto-Oncogene Protein; Neoplasm Staging; Neuroblastoma; Risk Factors; Survival Rate | 2019 |
Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; APOBEC-3G Deaminase; Bortezomib; Carboplatin; Etoposide; Female; HIV; HIV Infections; Humans; Ifosfamide; Leukocytes, Mononuclear; Lymphoma; Male; Middle Aged; Oncolytic Virotherapy; Recurrence; Rituximab; Viral Load | 2018 |
The effects of carboplatin and etoposide on advanced small cell lung cancer and serum tumor markers in correlation with long-term survival rate.
Topics: Adult; Aged; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoembryonic Antigen; Endostatins; Etoposide; Female; Humans; Keratin-19; Lung Neoplasms; Male; Middle Aged; Recombinant Proteins; Small Cell Lung Carcinoma; Survival Rate | 2018 |
Phase II Study of Roniciclib in Combination with Cisplatin/Etoposide or Carboplatin/Etoposide as First-Line Therapy in Patients with Extensive-Disease Small Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Progression-Free Survival; Pyrimidines; Small Cell Lung Carcinoma; Sulfoxides | 2019 |
Cost-effectiveness analysis of atezolizumab plus chemotherapy in the first-line treatment of extensive-stage small-cell lung cancer.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cost of Illness; Cost-Benefit Analysis; Double-Blind Method; Etoposide; Health Care Costs; Humans; Lung Neoplasms; Neoplasm Staging; Placebos; Quality-Adjusted Life Years; Small Cell Lung Carcinoma; Survival Analysis | 2019 |
Outcome of relapse in children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia: A report from the French LMB study.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carboplatin; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; France; Humans; Ifosfamide; Infant; Leukemia; Lymphoma, Large B-Cell, Diffuse; Male; Prospective Studies; Recurrence; Rituximab; Survival Rate | 2019 |
Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Chemotherapy, Adjuvant; Cisplatin; Cytoreduction Surgical Procedures; Docetaxel; Etoposide; Female; Humans; Infusions, Intravenous; Infusions, Parenteral; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Progression-Free Survival; Proportional Hazards Models; Survival Rate; Treatment Outcome; Young Adult | 2019 |
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cisplatin; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Double-Blind Method; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Myeloid Cells; Paclitaxel; Prognosis; Pyrimidines; Pyrroles; Small Cell Lung Carcinoma; Survival Rate; Tissue Distribution | 2019 |
REPLATINUM Phase III randomized study: RRx-001 + platinum doublet versus platinum doublet in third-line small cell lung cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Azetidines; Carboplatin; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitro Compounds; Small Cell Lung Carcinoma; Treatment Outcome; Young Adult | 2019 |
A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Tre
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Double-Blind Method; Etoposide; Humans; Lung Neoplasms; Picornaviridae; Platinum | 2020 |
Treatment patterns and survival outcomes for small-cell lung cancer patients - a Swedish single center cohort study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Irinotecan; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate; Sweden; Treatment Outcome | 2020 |
Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lung Neoplasms; Patient Reported Outcome Measures; Quality of Life | 2020 |
Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II tria
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Etoposide; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Survival Rate; Vincristine; Young Adult | 2020 |
Induction Chemotherapy Reduces Radiation Therapy Dose and Volume in the Treatment of Intracranial Germinoma: Results of the SMC-G13 Trial.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Chorionic Gonadotropin, beta Subunit, Human; Cranial Irradiation; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Germinoma; Humans; Induction Chemotherapy; Male; Neutropenia; Pilot Projects; Progression-Free Survival; Prospective Studies; Proton Therapy; Radiotherapy Dosage; Radiotherapy, Conformal; Young Adult | 2020 |
Pharmacokinetic and Pharmacogenetic Study of Etoposide in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Monitoring; Etoposide; Female; Genotype; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Pharmacogenetics; Pharmacogenomic Testing; Young Adult | 2020 |
Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carboplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Medication Adherence; Middle Aged; Patient Reported Outcome Measures; Peripheral Nervous System Diseases; Small Cell Lung Carcinoma | 2020 |
Fractionated ifosfamide, carboplatin, and etoposide with rituximab as a safe and effective treatment for relapsed/refractory diffuse large B cell lymphoma with severe comorbidities.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Comorbidity; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Rituximab; Survival Rate | 2020 |
Prospective phase II study of children affected by bilateral intraocular retinoblastoma with macular involvement of both eyes or in the only preserved eye. Macular tumor control, eye preservation rate, and visual outcome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Macular Degeneration; Male; Non-Randomized Controlled Trials as Topic; Prognosis; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Vincristine; Visual Acuity | 2021 |
Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bendamustine Hydrochloride; Carboplatin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy | 2021 |
Phase I study of selinexor in combination with dexamethasone, ifosfamide, carboplatin, etoposide chemotherapy in patients with relapsed or refractory peripheral T-cell or natural-killer/T-cell lymphoma
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dexamethasone; Etoposide; Humans; Hydrazines; Ifosfamide; Lymphoma, T-Cell; Neoplasm Recurrence, Local; Triazoles | 2021 |
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133).
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carboplatin; Disease Progression; Double-Blind Method; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Small Cell Lung Carcinoma; Survival Analysis | 2021 |
Multicentric phase II trial of TI-CE high-dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Salvage Therapy; Survival Rate; Treatment Outcome; Young Adult | 2021 |
Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carboplatin; Double-Blind Method; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Small Cell Lung Carcinoma; Treatment Outcome | 2021 |
A Phase 1 Study Evaluating Rovalpituzumab Tesirine in Frontline Treatment of Patients With Extensive-Stage SCLC.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepinones; Carboplatin; Etoposide; Humans; Immunoconjugates; Lung Neoplasms; Small Cell Lung Carcinoma | 2021 |
Phase II trial of response-based radiation therapy for patients with localized germinoma: a Children's Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Etoposide; Germinoma; Humans; Pineal Gland; Prospective Studies; Young Adult | 2022 |
Carboplatin versus cisplatin in combination with etoposide in the first-line treatment of small cell lung cancer: a pooled analysis.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Progression-Free Survival; Small Cell Lung Carcinoma; Survival Rate; Treatment Outcome | 2021 |
A phase II, open-label, single-arm trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Clinical Trials, Phase II as Topic; Etoposide; Humans; Lung Neoplasms; Multicenter Studies as Topic; Research Design; Small Cell Lung Carcinoma | 2022 |
A phase II study of anlotinib combined with etoposide and platinum-based regimens in the first-line treatment of extensive-stage small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; China; Etoposide; Humans; Indoles; Lung Neoplasms; Platinum; Prospective Studies; Quinolines; Small Cell Lung Carcinoma | 2022 |
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Double-Blind Method; Etoposide; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Small Cell Lung Carcinoma | 2022 |
Rationale and Design of the Phase 3 KEYLYNK-013 Study of Pembrolizumab With Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Limited-Stage Small-Cell Lung Cancer.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Clinical Trials, Phase III as Topic; Etoposide; Humans; Lung Neoplasms; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Phthalazines; Piperazines; Randomized Controlled Trials as Topic; Small Cell Lung Carcinoma | 2022 |
Brief Report: Exploratory Analysis of Maintenance Therapy in Patients With Extensive-Stage SCLC Treated First Line With Atezolizumab Plus Carboplatin and Etoposide.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lung Neoplasms; Small Cell Lung Carcinoma | 2022 |
Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Carboplatin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Immunoconjugates; Lymphoma; Neoplasm Recurrence, Local; Treatment Outcome | 2022 |
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Double-Blind Method; Etoposide; Female; Humans; Immune Checkpoint Inhibitors; Ligands; Lung Neoplasms; Male; Middle Aged; Programmed Cell Death 1 Receptor; Small Cell Lung Carcinoma | 2022 |
A phase II study of carboplatin and etoposide plus durvalumab for previously untreated extensive-stage small-cell lung cancer (ES-SCLC) patients with a poor performance status (PS): NEJ045A study protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials, Phase II as Topic; Etoposide; Humans; Lung Neoplasms; Multicenter Studies as Topic; Small Cell Lung Carcinoma | 2022 |
Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCL.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Prospective Studies; Rituximab | 2023 |
Phase II study of durvalumab (MEDI 4736) plus carboplatin and etoposide in elderly patients with extensive stage small cell lung cancer: Study protocol of turtle study (LOGIK 2003).
Topics: Aged; Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials, Phase II as Topic; Etoposide; Humans; Lung Neoplasms; Multicenter Studies as Topic; Prospective Studies; Small Cell Lung Carcinoma; Turtles | 2023 |
Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial.
Topics: Adolescent; Carboplatin; Child; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Rituximab; Young Adult | 2023 |
Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma: A Multi-institutional Phase 2 Investigator-Initiated Nonrandomized Clinical Trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ifosfamide; Male; Positron Emission Tomography Computed Tomography; Salvage Therapy | 2023 |
Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Carboplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Neutropenia; Small Cell Lung Carcinoma; Thrombocytopenia | 2023 |
Population Pharmacokinetics and Pharmacodynamics of Carfilzomib in Combination with Rituximab, Ifosfamide, Carboplatin, and Etoposide in Adult Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Leukocytes, Mononuclear; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Prospective Studies; Proteasome Endopeptidase Complex; Rituximab | 2023 |
1137 other study(ies) available for etoposide and carboplatin
| Article | Year |
|---|---|
Intracranial germ cell tumours: I. Experience with platinum based chemotherapy and implications for curative chemoradiotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Etoposide; Female; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Pinealoma; Vincristine | 1992 |
High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Chemotherapy, Adjuvant; Etoposide; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Remission Induction; Time Factors | 1992 |
Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy carboplatin, etoposide, and epirubicin.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Tomography, X-Ray Computed | 1992 |
Carboplatin-containing regimens for small cell lung cancer: implications for management in the elderly.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Clinical Protocols; Cyclophosphamide; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Remission Induction; Survival Rate; Vincristine | 1992 |
Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Humans; Ifosfamide; L-Lactate Dehydrogenase; Lung Neoplasms; Male; Mesna; Middle Aged; Phosphopyruvate Hydratase; Probability; Prospective Studies; Remission Induction; Survival Rate | 1992 |
Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy with carboplatin, etoposide and epirubicin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Epirubicin; Etoposide; Humans; Lung Neoplasms | 1992 |
Intracranial germ cell tumours: II. The application of a partial transmission block technique to reduce late morbidity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Combined Modality Therapy; Cranial Irradiation; Etoposide; Humans; Neoplasms, Germ Cell and Embryonal; Pinealoma; Radiotherapy Dosage; Vincristine | 1992 |
[Treatment of recurrent ovarian cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infusions, Parenteral; Lymph Node Excision; Neoplasm Recurrence, Local; Ovarian Neoplasms; Ovariectomy; Paclitaxel | 1992 |
The optimisation of carboplatin dose in carboplatin, etoposide and bleomycin combination chemotherapy for good prognosis metastatic nonseminomatous germ cell tumours of the testis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Teratoma; Testicular Neoplasms | 1992 |
[Recent advances in ovarian cancer chemotherapy].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Docetaxel; Doxorubicin; Etoposide; Female; Humans; Infusions, Parenteral; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Paclitaxel; Taxoids | 1992 |
Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Glomerular Filtration Rate; Humans; Ifosfamide; Leukopenia; Middle Aged; Ovarian Neoplasms; Remission Induction; Survival Rate; Thrombocytopenia | 1992 |
[A case of adenocarcinoma of lung cancer with multiple brain metastasis and lymphangitis carcinomatosa responding well to chemotherapy with carboplatin, etoposide and ifosfamide].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Lymphangitis; Male; Radiotherapy Dosage | 1992 |
Feasibility study of high-dose carboplatin and etoposide in the salvage treatment of testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Feasibility Studies; Humans; Male; Middle Aged; Remission Induction; Salvage Therapy; Testicular Neoplasms; Treatment Outcome | 1992 |
Deferoxamine, cyclophosphamide, etoposide, carboplatin, and thiotepa (D-CECaT): a new cytoreductive chelation-chemotherapy regimen in patients with advanced neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Chelation Therapy; Child; Child, Preschool; Cyclophosphamide; Deferoxamine; Etoposide; Humans; Infant; Neuroblastoma; Pilot Projects; Remission Induction; Thiotepa | 1992 |
Treatment of advanced neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Infant; Melphalan; Neuroblastoma; Survival Rate; Vincristine | 1992 |
Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Humans; Infant; Kidney; Melphalan; Neuroblastoma; Transplantation, Autologous; Vincristine | 1992 |
Pilot study of high-dose vincristine, etoposide, carboplatin and melphalan with autologous bone marrow rescue in advanced neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Gastrointestinal Diseases; Humans; Infant; Male; Melphalan; Neuroblastoma; Pilot Projects; Transplantation, Autologous; Vincristine | 1992 |
[Intraperitoneal chemotherapy using CBDCA for malignant gynecological tumors].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Carboplatin; Catheters, Indwelling; Drug Administration Schedule; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Infusion Pumps, Implantable; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Remission Induction | 1992 |
Pharmacokinetics of high-dose etoposide after short-term infusion.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Drug Interactions; Etoposide; Humans; Infusions, Intravenous; Mass Spectrometry; Middle Aged; Time Factors | 1992 |
The pharmacokinetics of high-dose carboplatin in pediatric patients with cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Male; Neoplasms | 1992 |
Limited small cell lung cancer: the effect of radiotherapy on local control following response to chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Australia; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Survival Analysis; Survival Rate; Vincristine | 1991 |
Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Rate; Vincristine | 1991 |
Intercalated radio-chemotherapy in small cell lung cancer: toxicity and implications for future regimens.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Pulmonary Fibrosis; Radiation Injuries; Radiotherapy Dosage | 1991 |
[Intra-arterial infusion chemotherapy for unresectable hepatocellular carcinoma using an implantable reservoir].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Mitomycin; Mitomycins | 1991 |
Salvage therapy with high-dose chemotherapy and autologous bone marrow support in the treatment of primary nonseminomatous mediastinal germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Transplantation, Autologous | 1991 |
[Complete remission of a highly malignant, progressive under therapy Wilm's tumor using the combination carboplatin and etoposide (VP 16)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Kidney Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Nephrectomy; Remission Induction; Wilms Tumor | 1991 |
Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Risk Factors; Survival Rate | 1990 |
Carboplatin dose optimization.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Drug Administration Schedule; Etoposide; Humans; Neutropenia; Organoplatinum Compounds; Thrombocytopenia | 1990 |
'JEB'--a carboplatin based regimen for malignant germ cell tumours in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Lung; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds | 1990 |
Carboplatin dose in combination chemotherapy for testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Drug Administration Schedule; Etoposide; Hematologic Diseases; Humans; Male; Platelet Count; Testicular Neoplasms | 1991 |
[Combination therapy of a new platinum complex, DWA2114R with various antitumor agents against mouse tumors in vivo].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fibrosarcoma; Fluorouracil; Leukemia P388; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Ovarian Neoplasms; Sarcoma, Experimental; Vindesine | 1992 |
Etoposide, folinic acid, and 5-fluorouracil in carboplatin-pretreated patients with advanced gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Fluorouracil; Humans; Leucovorin; Premedication; Remission Induction; Stomach Neoplasms; Time Factors | 1991 |
Discrete pigmentation after chemotherapy.
Topics: Adolescent; Carboplatin; Child; Cyclophosphamide; Etoposide; Humans; Male; Pigmentation Disorders | 1991 |
High-dose carboplatinum and VP-16 in treatment of metastatic adrenal carcinoma.
Topics: Adrenal Cortex Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cushing Syndrome; Diagnosis, Differential; Etoposide; Humans; Infant; Male; Neoplasm Metastasis; Radiography | 1991 |
Ambulatory high-dose 5-day continuous-infusion ifosfamide combination chemotherapy in advanced solid tumors: a feasibility study.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Drug Stability; Epirubicin; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Infusion Pumps, Implantable; Infusions, Intravenous; Male; Mesna; Middle Aged; Mitoxantrone; Neoplasms | 1991 |
High dose chemotherapy for ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Etoposide; Female; Humans; Ovarian Neoplasms | 1991 |
[Clinical study of drug accumulation in gastric cancer after preoperative intra-arterial EAP II injection therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Epirubicin; Etoposide; Female; Gastric Mucosa; Humans; Injections, Intra-Arterial; Lymph Nodes; Male; Preoperative Care; Stomach Neoplasms | 1991 |
High-dose chemotherapy with autologous bone marrow rescue: haematopoietic reconstitution by non-cryopreserved marrow.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Carmustine; Cyclophosphamide; Etoposide; Humans; Middle Aged; Neoplasms; Remission Induction; Tissue Preservation; Transplantation, Autologous | 1991 |
Is treatment intensification by adding etoposide and carboplatin to fractionated total body irradiation and melphalan acceptable in children with solid tumors with respect to toxicity?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Humans; Infant; Melphalan; Neoplasms | 1991 |
Carboplatin/etoposide as first-line chemotherapy in advanced ovarian carcinoma: a pilot study.
Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Leukopenia; Middle Aged; Ovarian Neoplasms; Pilot Projects; Thrombocytopenia; Vomiting | 1991 |
High-dose carboplatin with etoposide (JET regimen) in children with advanced neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Humans; Neoplasm Staging; Neuroblastoma | 1991 |
Cutaneous toxicity of autologous bone marrow transplantation in nonseminomatous germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dermatitis; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Testicular Neoplasms; Transplantation, Autologous | 1990 |
Dose-finding studies with carboplatin, ifosfamide, etoposide, and mesna in non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Organoplatinum Compounds; Survival Rate | 1990 |
Phase II studies with carboplatin in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Remission Induction; Survival Rate | 1990 |
Etoposide, carboplatin, cyclophosphamide and vincristine in previously untreated patients with small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Vincristine | 1990 |
Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Pilot Projects; Remission Induction; Survival Rate; Thrombocytopenia | 1990 |
[Chemotherapy of small cell bronchial cancer with a combination of carboplatin, vincristine and etoposide].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Vincristine | 1990 |
[Carboplatin-Vepeside in the treatment of non-small cell bronchial cancers. A phase II study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Drug Evaluation; Etoposide; Humans; Lung Neoplasms; Organoplatinum Compounds | 1990 |
High-dose carboplatin in combination with etoposide (JET regimen) for childhood brain tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bone Marrow Diseases; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Drug Evaluation; Etoposide; Glioblastoma; Hearing Loss, Sensorineural; Humans; Infant; Medulloblastoma; Remission Induction | 1990 |
Carboplatin in combination with etoposide in inoperable non-small-cell lung cancer (NSCLC).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Remission Induction; Survival Rate | 1990 |
Squamous cell carcinoma antigen and carcinoembryonic antigen levels as prognostic factors for the response of cervical carcinoma to chemotherapy.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoembryonic Antigen; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Neoplasm Metastasis; Organoplatinum Compounds; Prognosis; Recurrence; Serpins; Uterine Cervical Neoplasms | 1990 |
A pilot study of high-dose carboplatin and pulsed etoposide in the treatment of childhood solid tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Child; Child, Preschool; Drug Evaluation; Etoposide; Female; Gastrointestinal Diseases; Hearing Loss, Sensorineural; Humans; Infant; Male; Neoplasms; Pilot Projects | 1990 |
[Endodermal sinus tumor. Histological changes induced by chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Infant, Newborn; Liver Neoplasms; Male; Mesonephroma; Neoplasm Recurrence, Local; Sacrococcygeal Region; Teratoma; Time Factors | 1990 |
Modification of the 8 drugs in 1 day regimen: feasibility of substitution of other agents.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Etoposide; Female; Follow-Up Studies; Hematologic Diseases; Humans; Male; Monitoring, Physiologic; Remission Induction; Risk Factors | 1990 |
Chemotherapy of germ-cell ovarian tumours: first-line treatment with etoposide, bleomycin and cisplatin or carboplatin.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Child; Cisplatin; Etoposide; Female; Humans; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Ovarian Neoplasms | 1987 |
Carboplatin, etoposide, and bleomycin for treatment of stage IIC seminoma complicated by acute renal failure.
Topics: Acute Kidney Injury; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Dysgerminoma; Etoposide; Humans; Organoplatinum Compounds | 1987 |
Chemotherapy for thyroid cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Male; Middle Aged; Organoplatinum Compounds; Thyroid Neoplasms; Vincristine | 1987 |
Carboplatin and etoposide pharmacokinetics in patients with testicular teratoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Etoposide; Glomerular Filtration Rate; Humans; Male; Organoplatinum Compounds; Teratoma; Testicular Neoplasms | 1989 |
Growth and chemotherapy of a human germ-cell tumour line (GCT 27).
Topics: Animals; Antineoplastic Agents; Bleomycin; Carboplatin; Cisplatin; Etoposide; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Testicular Neoplasms; Transplantation, Heterologous; Vinblastine | 1989 |
Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Drug Evaluation; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Ovarian Neoplasms | 1989 |
Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Lung Neoplasms; Melphalan; Organoplatinum Compounds; Prognosis; Radiotherapy Dosage; Remission Induction; Vincristine | 1989 |
Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for 'limited' stage small cell carcinoma of the bronchus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Vincristine | 1989 |
A novel pharmacodynamically based approach to dose optimization of carboplatin when used in combination with etoposide.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Hematopoiesis; Humans; Kidney; Lung Neoplasms; Organoplatinum Compounds; Platelet Count | 1989 |
Tumoricidal interactions of hyperthermia with carboplatin, cisplatin and etoposide.
Topics: Antineoplastic Agents; Carboplatin; Cell Survival; Cisplatin; Combined Modality Therapy; Drug Synergism; Etoposide; Hot Temperature; Organoplatinum Compounds; Tumor Cells, Cultured | 1989 |
High dose chemotherapy including vepeside, cyclophosphamide and carboplatin with autologous bone marrow transplantation in one case of chemoresistant testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cyclophosphamide; Drug Resistance; Etoposide; Humans; Male; Organoplatinum Compounds; Testicular Neoplasms; Transplantation, Autologous | 1989 |
[The course of squamous cell carcinoma antigen and CEA as prognostic criteria for response to chemotherapy in cervix cancer].
Topics: Adenocarcinoma; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoembryonic Antigen; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Neoplasm Recurrence, Local; Organoplatinum Compounds; Prognosis; Serpins; Uterine Cervical Neoplasms | 1989 |
Clinical, analytical and pharmacokinetic aspects in cancer chemotherapy with platinum coordination compounds.
Topics: Adolescent; Antineoplastic Agents; Carboplatin; Child; Child, Preschool; Cisplatin; Etoposide; Humans; Infant; Neoplasms; Organoplatinum Compounds; Spectrum Analysis | 1989 |
Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Vincristine | 1987 |
Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds | 1987 |
Carboplatin (JM8), etoposide (VP16) and thoracic irradiation for small cell lung cancer (S.C.L.C.): an evaluation of lung toxicity.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Pneumonia; Pulmonary Fibrosis; Radiation Injuries | 1988 |
VP-16 and carboplatin in previously untreated patients with extensive small cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds | 1988 |
Carboplatin (JM8) as a single agent and in combination in the treatment of small cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Humans; Lung Neoplasms; Organoplatinum Compounds | 1985 |
Phase II studies of combinations of drugs with high dose carboplatin in neuroblastoma (800 mg/m2 to 1 g 250/m2): a report from the LMCE group.
Topics: Carboplatin; Carmustine; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Etoposide; Humans; Methoxyhydroxyphenylglycol; Neuroblastoma; Organoplatinum Compounds | 1988 |
Phase I study of a carboplatin-etoposide combination in advanced thoracic cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Neutropenia; Organoplatinum Compounds; Pancytopenia; Thrombocytopenia | 1988 |
Pharmacokinetic studies in lung cancer patients.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carboplatin; Carmustine; Cisplatin; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Naphthacenes; Organoplatinum Compounds | 1984 |
[Lhermitte's sign and cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Head; Humans; Lung Neoplasms; Male; Movement; Radiotherapy, Adjuvant | 1995 |
[Cerebral germ cell tumors in adults. A retrospective study of 19 cases].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Male; Middle Aged; Radiotherapy Dosage; Retrospective Studies; Teratoma; Vinblastine | 1995 |
Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Male; Middle Aged; Prognosis; Seminoma; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Vinblastine | 1994 |
Long-term survival associated with metastatic small cell carcinoma of the esophagus treated by chemotherapy, autologous bone marrow transplantation, and adjuvant radiation therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Esophageal Neoplasms; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Liver Neoplasms; Lymphatic Metastasis; Melphalan; Prognosis; Radiotherapy Dosage; Transplantation, Autologous; Vincristine | 1994 |
[Ultra high-dose chemotherapy with peripheral blood stem cell autotransplantation for refractory testicular cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Transfusion, Autologous; Carboplatin; Carcinoma, Embryonal; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Endodermal Sinus Tumor; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Seminoma; Testicular Neoplasms; Vinblastine | 1994 |
Metastatic adamantinoma of bone to lung. A case report of the natural history and the use of chemotherapy and radiation therapy.
Topics: Ameloblastoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Postoperative Care; Radiotherapy Dosage; Tibia | 1994 |
Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assay.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Dactinomycin; DNA; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Germinoma; Humans; Leukocytes; Male; Middle Aged; Ovarian Neoplasms; Platinum; Spectrophotometry, Atomic; Testicular Neoplasms; Vinblastine | 1994 |
Retroviral mediated transfer of the human multidrug resistance gene (MDR-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Clinical Protocols; Drug Resistance; Etoposide; Genetic Vectors; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Informed Consent; Interleukin-3; Interleukin-6; Mesna; Middle Aged; Neoplasm Metastasis; Paclitaxel; Pancytopenia; Recombinant Fusion Proteins; Recombinant Proteins; Retroviridae; Stem Cell Factor; Transplantation, Autologous; Vinblastine | 1994 |
Natural killer cell activity in long-term survivors of testicular cancer. Influence of cytostatic therapy and initial stage of disease.
Topics: Antibody-Dependent Cell Cytotoxicity; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Etoposide; Humans; Killer Cells, Natural; Male; Multivariate Analysis; Neoplasm Metastasis; Testicular Neoplasms | 1995 |
Osteosarcoma following radiation treatment for meningioma: report of a case and effective treatment with chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cisplatin; Dactinomycin; Etoposide; Female; Gonadotropin-Releasing Hormone; Humans; Ifosfamide; Lung Neoplasms; Meningeal Neoplasms; Meningioma; Methotrexate; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Osteosarcoma; Tamoxifen; Tomography, X-Ray Computed; Vincristine | 1994 |
Expression of adhesion molecules on CD34+ cells: CD34+ L-selectin+ cells predict a rapid platelet recovery after peripheral blood stem cell transplantation.
Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Marrow; Bone Marrow Cells; Carboplatin; Carmustine; Cell Adhesion Molecules; Cell Movement; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Fluorouracil; Gene Expression; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; L-Selectin; Leukocyte Count; Male; Melphalan; Middle Aged; Neoplasms; Neutrophils; Platelet Count; Podophyllotoxin; Receptors, Very Late Antigen; Thiotepa | 1995 |
High-dose chemotherapy and autologous peripheral stem cell transplantation in patients with relapsing malignant lymphomas--first experience in the Slovak Republic.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Lymphoma; Mitoxantrone; Salvage Therapy; Slovakia | 1995 |
[Successful treatment with combined chemotherapy (carboplatin, etoposide, adriamycin, bleomycin) and radiotherapy for recurrent intracranial malignant germ cell tumor: case report].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Germinoma; Humans; Neoplasm Recurrence, Local | 1995 |
Characterization of carboplatin-resistant sublines derived from human larynx carcinoma cells.
Topics: Antineoplastic Agents; Carboplatin; Cell Survival; Cisplatin; Clone Cells; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fluorouracil; Glutathione; Glutathione Transferase; Humans; Laryngeal Neoplasms; Mitomycin; Proto-Oncogenes; Tumor Cells, Cultured; Vinblastine; Vincristine | 1995 |
Chemotherapy for Merkel cell carcinoma with carboplatin and etoposide.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Disease-Free Survival; Etoposide; Humans; Male; Middle Aged; Remission Induction; Skin Neoplasms | 1995 |
[A case of ovarian malignant Sertoli-Leidig cell tumor treated with CBDCA, etoposide and epirubicin chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Lymphatic Metastasis; Middle Aged; Ovarian Neoplasms; Remission Induction; Sertoli-Leydig Cell Tumor | 1995 |
High-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Parenteral Nutrition, Total | 1995 |
Does chemotherapy have a role in low-grade astrocytoma management? A report of 13 cases.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Etoposide; Female; Follow-Up Studies; Humans; Infant; Magnetic Resonance Imaging; Male; Thrombocytopenia | 1995 |
Introduction to ifosfamide/carboplatin/etoposide chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide | 1995 |
Carboplatin and etoposide in metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Etoposide; Female; Humans | 1995 |
High-dose ifosfamide, carboplatin, and etoposide pharmacokinetics: correlation of plasma drug levels with renal toxicity.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Etoposide; Female; Humans; Ifosfamide; Kidney; Kidney Function Tests; Male; Middle Aged; Transplantation, Autologous | 1995 |
Ifosfamide, carboplatin and etoposide for good prognosis small cell lung cancer: are four courses inadequate? West of Scotland Lung Cancer Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Prognosis; Survival Analysis; Treatment Outcome | 1995 |
Combination chemotherapy with carboplatin and etoposide of brain metastases from cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Etoposide; Female; Humans; Male; Middle Aged | 1994 |
[A pilot study of CBDCA-ETOP-CDDP combination therapy in refractory uterine cervical cancer recurring with lymph node metastasis].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Female; Humans; Lymphatic Metastasis; Middle Aged; Pilot Projects; Uterine Neoplasms | 1995 |
Influence of systemic chemotherapy on anti-P-glycoprotein antibody-dependent cell-mediated cytotoxicity in patients with small cell lung cancer.
Topics: Antibodies, Monoclonal; Antibody-Dependent Cell Cytotoxicity; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Doxorubicin; Drug Resistance, Multiple; Etoposide; Humans; Interleukin-2; Lung Neoplasms; Macrophage Colony-Stimulating Factor; Tumor Cells, Cultured | 1995 |
Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Leukemia, Myeloid, Acute; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Remission Induction; Salvage Therapy; Testicular Neoplasms; Vinblastine | 1993 |
Granulocyte colony-stimulating factor (CSF), macrophage-CSF, granulocyte-macrophage CSF, interleukin-3, and interleukin-6 levels in sera from children undergoing blood stem cell autografts.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Cytarabine; Daunorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-3; Interleukin-6; Leukemia, Myeloid, Acute; Leukocyte Count; Lymphoma, Non-Hodgkin; Macrophage Colony-Stimulating Factor; Male; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stem Cell Transplantation; Time Factors; Transplantation, Autologous | 1993 |
Malignant germ cell tumours in two siblings.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Child; Choriocarcinoma; Dysgerminoma; Etoposide; Female; Humans; Neoplasms, Germ Cell and Embryonal; Nuclear Family; Ovarian Neoplasms | 1993 |
A limited sampling method for estimation of the etoposide area under the curve.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Models, Biological; Regression Analysis | 1993 |
Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Carboplatin; Carcinoma; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged | 1993 |
[Treatment with ACVP-16 for relapsed and refractory non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Recurrence; Remission Induction; Vincristine | 1993 |
A comparison of two GM-CSF schedules to counteract the granulo-monocytopenia of carboplatin-etoposide chemotherapy.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukocyte Count; Male; Middle Aged; Platelet Count; Time Factors | 1995 |
Is carboplatin and oral etoposide an effective and feasible regimen in patients with small cell lung cancer?
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Radiotherapy, Adjuvant; Thrombocytopenia | 1995 |
[A case of primary HCG-producing intracranial germinoma effectively treated by high-dose chemotherapy and autologous bone marrow transplantation].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Carboplatin; Choriocarcinoma; Chorionic Gonadotropin; Combined Modality Therapy; Etoposide; Female; Germinoma; Humans; Neoplasms, Multiple Primary; Transplantation, Autologous | 1995 |
Establishment and characterization of acquired resistance to platinum anticancer drugs in human ovarian carcinoma cells.
Topics: Camptothecin; Carboplatin; Cisplatin; Cystadenocarcinoma, Serous; Drug Resistance; Drug Resistance, Multiple; Etoposide; Female; Glutathione; Glutathione Transferase; Humans; Ovarian Neoplasms; Tumor Cells, Cultured | 1995 |
[Carboplatin-VP16 combination in non small cell lung cancers in the aged patient. A study of the French group in pneumology (GFPC)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; France; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging | 1995 |
Surgical treatment of small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Rate; Vincristine | 1995 |
[Intensive and high-dose chemotherapy with peripheral blood stem cell transfusion for pediatric malignant brain tumor].
Topics: Age of Onset; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Ependymoma; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Medulloblastoma; Nitrosourea Compounds; Pinealoma | 1995 |
Successful liver treatment of a juvenile granulosa cell tumor in a 4-year-old child by regional deep hyperthermia, systemic chemotherapy, and irradiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child, Preschool; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Granulosa Cell Tumor; Humans; Hyperthermia, Induced; Ifosfamide; Liver Neoplasms; Ovarian Neoplasms; Ovariectomy; Ovary; Remission Induction; Temperature; Transaminases | 1995 |
Collection and transplantation of peripheral blood stem cells in very small children weighting 20 kg or less.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Blood Preservation; Body Weight; Bone Marrow Diseases; Carboplatin; Catheterization, Central Venous; Catheters, Indwelling; Child, Preschool; Cisplatin; Colony-Forming Units Assay; Combined Modality Therapy; Contraindications; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia; Male; Neoplasms; Platelet Transfusion; Retrospective Studies; Safety | 1995 |
[Response rate of small cell lung cancer treated with CE-CAP alternating chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged | 1994 |
Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Australia; Carboplatin; Carcinoma, Merkel Cell; Chemotherapy, Adjuvant; Etoposide; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Radiotherapy Dosage; Radiotherapy, Adjuvant; Retrospective Studies; Skin Neoplasms; Survival Rate; Time Factors | 1995 |
Therapy for small cell lung cancer using carboplatin, ifosfamide, etoposide (without dose reduction), mid-cycle vincristine with thoracic and cranial irradiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Treatment Outcome; Vincristine | 1994 |
Current sample handling methods for measurement of platinum-DNA adducts in leucocytes in man lead to discrepant results in DNA adduct levels and DNA repair.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Specimen Collection; Carboplatin; Cisplatin; DNA Adducts; DNA Repair; DNA, Neoplasm; Etoposide; Humans; Kinetics; Leukocytes; Neoplasms; Platinum | 1995 |
[Therapeutic effect of carboplatin and etoposide combinative therapy on 123 lung cancer cases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Etoposide; Humans; Leukopenia; Lung Neoplasms; Middle Aged; T-Lymphocyte Subsets | 1994 |
Therapeutic dilemma of disseminated CNS germinoma and the potential of increased platinum-based chemotherapy delivery with osmotic blood-brain barrier disruption.
Topics: Adolescent; Adult; Blood-Brain Barrier; Brain; Brain Neoplasms; Carboplatin; Cisplatin; Etoposide; Female; Germinoma; Hearing Loss, High-Frequency; Humans; Magnetic Resonance Imaging; Male; Mannitol; Platinum; Treatment Outcome | 1994 |
Refining therapeutic strategies for patients with resistant Wilm's tumor.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Kidney Neoplasms; Male; Medical Records; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome; Wilms Tumor | 1994 |
Combination chemotherapy for primitive neuroectodermal and other malignant brain tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Humans; Infant; Male; Neuroectodermal Tumors, Primitive; Vincristine | 1994 |
Experience with implanted subcutaneous ports for intraperitoneal chemotherapy in ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Catheters, Indwelling; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Parenteral; Middle Aged; Mitoxantrone; Ovarian Neoplasms; Postoperative Complications; Reoperation; Retrospective Studies | 1994 |
Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Colonic Neoplasms; Cyclophosphamide; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Ifosfamide; Leukemia P388; Mammary Neoplasms, Animal; Melanoma, Experimental; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mitomycin; Sarcoma, Experimental; Vinblastine | 1994 |
Multifocal osteonecrosis following chemotherapy and short-term corticosteroid therapy in a patient with small-cell bronchogenic carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Carboplatin; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Dexamethasone; Etoposide; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Osteonecrosis; Radionuclide Imaging | 1994 |
Carboplatin, etoposide, and ifosfamide as second-line treatment for ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Ovarian Neoplasms; Remission Induction; Survival Rate | 1994 |
Failure of granulocyte-macrophage colony-stimulating factor to reduce febrile neutropenia in children with recurrent solid tumors treated with ifosfamide, carboplatin, and etoposide chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Fever; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neutropenia | 1994 |
[Salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma with a combination of dexamethasone, etoposide, ifosfamide and carboplatin].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dexamethasone; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Remission Induction; Salvage Therapy | 1994 |
Consolidative thoracic radiotherapy and prophylactic cranial irradiation in limited disease small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Lomustine; Lung Neoplasms; Methotrexate; Remission Induction; Survival Analysis; Thorax; Treatment Outcome; Vincristine | 1993 |
Teniposide for meningeal carcinomatosis of small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Immunologic Factors; Injections, Spinal; Interferon-gamma; Lung Neoplasms; Meningeal Neoplasms; Middle Aged; Morphine; Teniposide; Vincristine | 1993 |
Carboplatin and etoposide in acute myeloid leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged | 1994 |
Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Cohort Studies; Combined Modality Therapy; Cytokines; Etoposide; Feasibility Studies; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Prognosis; Recurrence; Remission Induction; Sarcoma, Ewing; Survival Analysis; Whole-Body Irradiation | 1993 |
Carboplatin, epirubicin, and VP-16 chemotherapy in the treatment of small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Remission Induction; Survival Rate | 1994 |
Recurrent renal salt wasting in a child treated with carboplatin and etoposide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Brain Neoplasms; Carboplatin; Child, Preschool; Esthesioneuroblastoma, Olfactory; Etoposide; Humans; Hyponatremia; Kidney Tubules, Proximal; Male; Recurrence; Sodium | 1994 |
Carboplatin and oral etoposide in the treatment of patients with advanced breast cancer refractory to anthracyclines.
Topics: Administration, Oral; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Drug Resistance; Etoposide; Female; Humans; Middle Aged; Survival Analysis; Treatment Outcome | 1993 |
Antitumor activity of platinum analogs against human lung cancer cell lines and tumor specimens.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Doxorubicin; Drug Resistance; Etoposide; Humans; Lung Neoplasms; Organoplatinum Compounds; Tumor Cells, Cultured | 1993 |
[Effects of cisplatin, carboplatin, etoposide and human hepatocyte growth factor on the colony formation of four human liver cancer cell lines].
Topics: Carboplatin; Carcinoma, Hepatocellular; Cisplatin; Drug Synergism; Etoposide; Hepatoblastoma; Hepatocyte Growth Factor; Humans; Liver Neoplasms; Neoplastic Stem Cells; Recombinant Proteins; Tumor Cells, Cultured | 1993 |
[Neoadjuvant chemotherapy effective for small cell lung cancer in a nephrectomized patient].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Renal Cell; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Male; Neoplasms, Second Primary; Nephrectomy | 1993 |
Regional lymphatic drug exposure following intraperitoneal administration of 5-fluorouracil, carboplatin, and etoposide.
Topics: Animals; Ascitic Fluid; Carboplatin; Etoposide; Fluorouracil; Half-Life; Injections, Intraperitoneal; Lymph; Lymph Nodes; Peritoneum; Permeability; Swine | 1993 |
[Combination chemotherapy with carboplatin and etoposide against lung adenocarcinoma in a patient undergoing hemodialysis: a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Kidney Failure, Chronic; Lung Neoplasms; Male; Middle Aged; Renal Dialysis | 1993 |
[Treatment of unresectable non-small cell lung cancer (NSCLC) with carboplatin and chronic daily administration of oral etoposide].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged | 1994 |
High-dose carboplatin, etoposide and ifosfamide and autologous stem cell rescue in the treatment of non-Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Transplantation, Autologous | 1993 |
Intraperitoneal carboplatin and etoposide for persistent epithelial ovarian cancer: analysis of results by prior sensitivity to platinum-based regimens.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cohort Studies; Creatinine; Cyclophosphamide; Epithelium; Etoposide; Female; Follow-Up Studies; Humans; Infusions, Parenteral; Kidney; Middle Aged; Neutropenia; Ovarian Neoplasms; Peritoneal Neoplasms; Treatment Outcome | 1993 |
Management of small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Neoplasm Staging; Paraneoplastic Syndromes; Survival Rate | 1993 |
Prediction of long-term response after high-dose chemotherapy with autologous bone marrow transplantation in the salvage treatment of non-seminomatous germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Neoplasms, Germ Cell and Embryonal; Prognosis; Salvage Therapy; Transplantation, Autologous | 1993 |
An unusual case of haematuria.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Hematuria; Humans; Ifosfamide; Male; Mesna; Quadriplegia; Urinary Bladder Neoplasms | 1993 |
[A combination chemotherapy of carboplatin and etoposide for malignant fibrous histiocytoma with marked effect on the metastatic lung region].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Etoposide; Female; Histiocytoma, Benign Fibrous; Humans; Lung Neoplasms; Soft Tissue Neoplasms | 1993 |
Cisplatin-resistant metastatic hepatoblastoma: complete response to carboplatin, etoposide, and liver transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Cisplatin; Combined Modality Therapy; Drug Resistance; Etoposide; Female; Humans; Infant; Liver Neoplasms; Liver Transplantation; Lung Neoplasms; Remission Induction | 1993 |
High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot study.
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms; Pilot Projects; Prognosis; Prospective Studies; Salvage Therapy; Thrombocytopenia | 1993 |
Endometrioid carcinoma of the ovary. Retrospective study.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Endometriosis; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Retrospective Studies; Survival Rate; Tamoxifen | 1993 |
Optimal treatment for advanced seminoma?
Topics: Carboplatin; Cisplatin; Dysgerminoma; Etoposide; Humans; Remission Induction; Salvage Therapy | 1993 |
Surgical treatment of small cell carcinoma of the lung: advantage of preoperative chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisone; Preoperative Care; Prognosis; Retrospective Studies; Vincristine | 1995 |
Hematopoietic reconstitution with autologous stem cells.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide | 1996 |
[An advanced invasive thymoma that responded remarkably to neoadjuvant chemotherapy with carboplatin, adriamycin, and etoposide].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Male; Neoplasm Invasiveness; Remission Induction; Thymoma; Thymus Neoplasms | 1995 |
[A case of superior vena cava syndrome treated with combination radiation and CRE (CBDCA and VP-16) therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Etoposide; Humans; Lung Neoplasms; Male; Radiotherapy Dosage; Superior Vena Cava Syndrome | 1996 |
Factors influencing prognosis after dose-intensive therapy for recurrent or refractory Hodgkin's disease. Results of sequential trials: a case for treating patients with resistant disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Carmustine; Clinical Trials as Topic; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Mitoxantrone; Prognosis; Recurrence; Survival Rate; Thiotepa; Treatment Outcome; Vinblastine | 1995 |
Chemotherapy for progressive pilocytic astrocytomas in the chiasmo-hypothalamic regions.
Topics: Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Etoposide; Female; Humans; Hypothalamus; Infant; Magnetic Resonance Imaging; Male; Nimustine; Nitrosourea Compounds; Optic Chiasm | 1995 |
High-dose cyclophosphamide, carboplatin, and etoposide with autologous stem cell rescue in patients with breast cancer.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Creatinine; Cyclophosphamide; Diarrhea; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Nausea; Neutropenia; Remission Induction; Transplantation, Autologous; Treatment Outcome; Vomiting | 1996 |
Visual function after laser hyperthermia and chemotherapy for macular retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Etoposide; Eye Neoplasms; Female; Humans; Hyperthermia, Induced; Infant; Lasers; Macula Lutea; Retinoblastoma; Vincristine; Visual Acuity | 1996 |
Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Kidney; Kidney Failure, Chronic; Male; Peritoneal Dialysis; Renal Dialysis; Treatment Outcome; Wilms Tumor | 1996 |
Metastatic neuroblastoma in children older than one year: prognostic significance of the initial metaiodobenzylguanidine scan and proposal for a scoring system.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Male; Neoplasm Metastasis; Neuroblastoma; Predictive Value of Tests; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Tomography, Emission-Computed | 1996 |
Carboplatin and cisplatin in medulloblastoma at diagnosis: "comparable efficacy?".
Topics: Antineoplastic Agents; Carboplatin; Child; Etoposide; Humans; Medulloblastoma; Treatment Outcome | 1996 |
Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Humans; Lung Neoplasms | 1995 |
High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Pregnancy; Prognosis; Testicular Neoplasms; Trophoblastic Neoplasms; Uterine Neoplasms | 1995 |
Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Immunohistochemistry; Keratins; Middle Aged; Polymerase Chain Reaction; Prognosis; Recurrence; Retrospective Studies; Sensitivity and Specificity | 1996 |
Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Etoposide; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leukopenia; Male; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Pilot Projects; Remission Induction; Sarcoma; Thrombocytopenia | 1996 |
Evaluation of cytosine arabinoside, carboplatin and etoposide chemotherapy in the treatment of relapsing and refractory non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Drug Evaluation; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Remission Induction; Time Factors | 1996 |
[Therapy-related AML(M2) with t(8;21) that developed three years after chemotherapy for hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Doxorubicin; Epirubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Liver Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Translocation, Genetic | 1996 |
[Usefulness of neoadjuvant brachytherapy in the treatment of pineoblastoma: a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Etoposide; Female; Humans; Pineal Gland; Pinealoma | 1996 |
[Effects of carboplatin combination with etoposide against leukemia/lymphoma cell lines].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Humans; Leukemia; Lymphoma; Tumor Cells, Cultured | 1996 |
Etoposide, epirubicin and carboplatin in hormone-refractory prostate cancer.
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Castration; Drug Resistance; Epirubicin; Etoposide; Humans; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Survival Rate | 1996 |
Vasospastic angina after chemotherapy by with carboplatin and etoposide in a patient with lung cancer.
Topics: Aged; Angina Pectoris; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Coronary Vasospasm; Etoposide; Humans; Lung Neoplasms; Male | 1996 |
[Introduction and prospect of peripheral blood stem cell transplantation].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung Neoplasms; Male; Middle Aged | 1995 |
[Chemohyperthermic peritoneal perfusion and high-dose chemotherapy followed by peripheral blood stem cell transplantation in advanced colon cancer--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Colonic Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Hyperthermia, Induced; Liver Neoplasms; Lung Neoplasms; Middle Aged; Mitomycin; Perfusion; Peritoneum | 1996 |
Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Mesna; Middle Aged; Ovarian Neoplasms; Pilot Projects; Retroperitoneal Neoplasms; Testicular Neoplasms | 1996 |
High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Etoposide; Germinoma; Humans; Ifosfamide; Male; Multicenter Studies as Topic; Multivariate Analysis; Prognosis; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate | 1996 |
High-dose chemotherapy and ASCR of patients with relapsed or refractory germ cell tumors: long-term follow-up.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Time Factors; Transplantation, Autologous | 1996 |
Chemoreduction in the initial management of intraocular retinoblastoma.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Eye Neoplasms; Female; Fundus Oculi; Humans; Infant; Male; Pilot Projects; Prospective Studies; Radiotherapy, Adjuvant; Remission Induction; Retinoblastoma; Vincristine | 1996 |
Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Glaucoma, Neovascular; Humans; Infant; Male; Neoplasm Recurrence, Local; Retinoblastoma; Survival Rate; Vincristine; Visual Acuity | 1996 |
Chemotherapy plus local treatment in the management of intraocular retinoblastoma.
Topics: Animals; Anterior Chamber; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Combined Modality Therapy; Cryotherapy; DNA Adducts; DNA, Neoplasm; Etoposide; Eye Enucleation; Eye Neoplasms; Humans; Hyperthermia, Induced; Iodine Radioisotopes; Laser Coagulation; Melanoma; Rabbits; Retinoblastoma; Vincristine | 1996 |
Bilateral macular retinoblastoma managed by chemoreduction and chemothermotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cryotherapy; Etoposide; Eye Neoplasms; Female; Fundus Oculi; Humans; Hyperthermia, Induced; Infant, Newborn; Macula Lutea; Retinoblastoma; Vincristine | 1996 |
Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor--results of a pilot study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cranial Fossa, Posterior; Cranial Irradiation; Disease-Free Survival; Etoposide; Female; Hearing Loss; Humans; Ifosfamide; Infant; Magnetic Resonance Imaging; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Pilot Projects; Radiotherapy, Adjuvant; Remission Induction; Skull Base Neoplasms | 1996 |
BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Carboplatin; Cell Cycle; Cell Line; Cell Survival; Etoposide; Female; Humans; Hydroxyurea; Immunoblotting; Kinetics; Mice; Ovarian Neoplasms; Paclitaxel; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Transfection; Tumor Suppressor Protein p53; Vincristine | 1996 |
"MECCA": a developmental, dose-intensive, non-cross-resistant platinum-based chemotherapy for advanced ovarian cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Mitomycin; Neoplasm Staging; Ovarian Neoplasms | 1996 |
Comparison of carboplatin/etoposide/vincristine with cisplatin/etoposide as combination chemotherapy for small cell lung cancer.
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Small Cell; Drug Therapy, Combination; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Vincristine | 1995 |
Mobilized peripheral blood progenitor cells (PBPC) in support of tandem cycles of high-dose chemotherapy (HDC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplantation; Carboplatin; Cyclophosphamide; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Male; Melphalan; Middle Aged; Mitoxantrone; Neoplasms; Patient Acceptance of Health Care; Remission Induction; Salvage Therapy; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 1996 |
[A patient with lung metastasis of medulloblastoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Combined Modality Therapy; Cranial Irradiation; Etoposide; Humans; Lung Neoplasms; Male; Medulloblastoma; Spinal Cord Neoplasms | 1996 |
Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study.
Topics: Adenocarcinoma; Adult; Aged; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genes, ras; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mutation; Prospective Studies; Survival Analysis | 1997 |
Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy.
Topics: Antineoplastic Agents; Carboplatin; Child, Preschool; Cryotherapy; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Fundus Oculi; Humans; Hypothermia, Induced; Infant; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Remission Induction; Retinoblastoma | 1996 |
Modification of the antitumor activity of chemotherapeutic drugs by the hypoxic cytotoxic agent tirapazamine.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Interactions; Etoposide; Fluorouracil; Mice; Mice, Inbred C3H; Paclitaxel; Radiation-Sensitizing Agents; Tirapazamine; Triazines | 1997 |
Pharmacokinetics of carboplatin and etoposide in a haemodialysis patient with Merkel-cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Etoposide; Female; Humans; Kidney Failure, Chronic; Renal Dialysis; Time Factors | 1997 |
Antitumor effect of CPT-11, a camptothecin derivative, on human testicular tumor xenografts in nude mice.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Humans; Irinotecan; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Teratocarcinoma; Testicular Neoplasms; Topoisomerase I Inhibitors; Transplantation, Heterologous; Vinblastine | 1997 |
Carboplatin in the combination chemotherapy of non-seminomatous germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Etoposide; Female; Germinoma; Humans; Male; Ovarian Neoplasms; Randomized Controlled Trials as Topic; Testicular Neoplasms | 1996 |
Clinical efficacy of perceived 'CNS friendly' chemoradiotherapy for primary intracranial germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Combined Modality Therapy; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Radiotherapy Dosage; Radiotherapy, High-Energy; Remission Induction; Vincristine | 1997 |
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Cause of Death; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gene Amplification; Genes, myc; Genetic Markers; Humans; Infant; Infant, Newborn; Male; Neuroblastoma; Postoperative Complications; Prognosis; Prospective Studies; Survival Rate; Treatment Outcome; Vincristine | 1997 |
Residual mass following chemotherapy of seminoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Fibrosis; Humans; Life Tables; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Retrospective Studies; Salvage Therapy; Seminoma; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Vinblastine | 1997 |
[Etoposide-induced pneumonitis].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Etoposide; Humans; Lung Neoplasms; Male; Pneumonia | 1997 |
Long-term toxicity and neuropathology associated with the sequencing of cranial irradiation and enhanced chemotherapy delivery.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Dose-Response Relationship, Radiation; Drug Administration Schedule; Etoposide; Mannitol; Methotrexate; Radiation Injuries, Experimental; Radiotherapy, Adjuvant; Rats; Treatment Outcome | 1997 |
Salvage intraperitoneal therapy of advanced epithelial ovarian cancer: impact of retroperitoneal nodal disease.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Carcinoma; Cisplatin; Combined Modality Therapy; Cytarabine; Etoposide; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Laparotomy; Lymphatic Metastasis; Middle Aged; Mitoxantrone; Neoplasm Staging; Ovarian Neoplasms; Retroperitoneal Space; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome | 1997 |
Circulating immature cell counts on the harvest day predict the yields of CD34+ cells collected after granulocyte colony-stimulating factor plus chemotherapy-induced mobilization of peripheral blood stem cell.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Cytarabine; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukapheresis; Leukocyte Count; Male; Middle Aged; Neoplasms | 1997 |
Concurrent carboplatin, etoposide and thoracic radiation for poor-risk stage III non-small-cell lung carcinoma: a pilot study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Esophagitis; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Pilot Projects | 1997 |
[Two cases of adenosquamous cell carcinoma of advanced cervical cancer treated by carboplatin-based chemotherapy with peripheral blood stem cell autotransplant].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Uterine Cervical Neoplasms | 1997 |
High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Germinoma; Humans; Male; Mediastinal Neoplasms; Retroperitoneal Neoplasms; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 1997 |
[Small cell lung cancer with acute monocytic leukemia after combined chemotherapy including etoposide].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Female; Humans; Leukemia, Monocytic, Acute; Lung Neoplasms; Middle Aged; Neoplasms, Second Primary | 1997 |
Markedly improved survival in malignant sacro-coccygeal teratomas--16 years, experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cause of Death; Chemotherapy, Adjuvant; Child, Preschool; Cisplatin; Coccyx; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Sacrum; Spinal Neoplasms; Survival Rate; Teratoma | 1997 |
[Successful high-dose chemotherapy combined with autologous bone marrow transplantation in a case of refractory follicular lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Carboplatin; Cyclophosphamide; Etoposide; Humans; Lymphoma, Follicular; Male; Nitrosourea Compounds; Transplantation, Autologous; Treatment Outcome | 1997 |
Central neurocytoma: a clinical study of response to chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Male; Neurocytoma | 1997 |
Metastatic prolactinoma: effect of octreotide, cabergoline, carboplatin and etoposide; immunocytochemical analysis of proto-oncogene expression.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cabergoline; Carboplatin; Ergolines; Etoposide; Female; Gene Expression; Humans; Immunohistochemistry; Indium Radioisotopes; Magnetic Resonance Imaging; Middle Aged; Octreotide; Pituitary Neoplasms; Prolactinoma; Proto-Oncogene Mas; Proto-Oncogenes; Somatostatin; Treatment Failure | 1997 |
Enhancement of warfarin response in a patient receiving etoposide and carboplatin chemotherapy.
Topics: Aged; Anticoagulants; Antineoplastic Agents; Atrial Fibrillation; Carboplatin; Drug Interactions; Etoposide; Germinoma; Humans; Male; Mediastinal Neoplasms; Testicular Neoplasms; Warfarin | 1997 |
Limited-stage small cell lung cancer: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bronchoscopy; Carboplatin; Carcinoma, Small Cell; Etoposide; Humans; Lung Neoplasms; Male; Neoplasm Staging; Radiotherapy, Adjuvant | 1997 |
Allogeneic transplantation after a conditioning regimen with ifosfamide, carboplatin and etoposide (ICE).
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carboplatin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Middle Aged; Transplantation Conditioning | 1997 |
Nephrotoxicity of high-dose ifosfamide/carboplatin/etoposide in adults undergoing autologous stem cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Carboplatin; Creatinine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Kidney; Magnesium; Male; Middle Aged; Neoplasms; Potassium; Retrospective Studies | 1997 |
[High-dose chemotherapy with autologous stem cell rescue in patients with recurrent and high-risk pediatric brain tumors].
Topics: Age Factors; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Busulfan; Carboplatin; Child; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Risk Factors; Time Factors | 1997 |
High-dose chemotherapy with autologous peripheral blood stem cell transplantation for metastatic gastric leiomyosarcoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leiomyosarcoma; Stomach Neoplasms | 1997 |
Radiation therapy for relapsed CNS germinoma after primary chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carboplatin; Child, Preschool; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Germinoma; Humans; Male; Neoplasm Recurrence, Local; Retrospective Studies | 1998 |
High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Medulloblastoma; Neoplasm Recurrence, Local; Survival Analysis; Thiotepa; Transplantation, Autologous | 1998 |
Treatment of retinoblastoma vitreous base seeding.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Combined Modality Therapy; Etoposide; Female; Humans; Infant; Iridium Radioisotopes; Male; Neoplasm Seeding; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome; Vincristine; Vitreous Body | 1998 |
[High-dose chemotherapy and reinfusion of hematopoietic stem cells in advanced germ cells tumors with poor prognosis--the position in 1996].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Germinoma; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Neoplasm Staging; Practice Guidelines as Topic; Prognosis; Recurrence; Transplantation, Autologous | 1997 |
[Pilot study of relapsed osteosarcoma and brain tumor with ifosfamide, carboplatin and etoposide (ICE therapy)].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Child; Drug Administration Schedule; Etoposide; Female; Fever; Humans; Ifosfamide; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neutropenia; Osteosarcoma; Pilot Projects; Thrombocytopenia | 1998 |
The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Carboplatin; Cell Separation; Cisplatin; Colorectal Neoplasms; Cyclophosphamide; DNA Repair; DNA, Neoplasm; Doxorubicin; Enzyme Inhibitors; Etoposide; Humans; Melphalan; Paclitaxel; Tamoxifen; Thioguanine; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1998 |
Drug resistance in human neuroblastoma cell lines correlates with clinical therapy.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Humans; Melphalan; Neuroblastoma; Tumor Cells, Cultured | 1997 |
Treatment for advanced testicular cancer with high-dose chemotherapy and autologous blood stem cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Dose-Response Relationship, Drug; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 1998 |
Carboplatin and etoposide for recurrent malignant glioma: one department's experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Etoposide; Female; Glioma; Humans; Male; Middle Aged | 1998 |
Treatment of children with relapsed soft tissue sarcoma: report of the German CESS/CWS REZ 91 trial.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Germany; Humans; Hyperthermia, Induced; Ifosfamide; Male; Neuroectodermal Tumors; Prospective Studies; Recurrence; Rhabdomyosarcoma; Sarcoma; Survival Analysis; Treatment Outcome | 1998 |
Predicting chemotherapeutic response to small-cell lung cancer of platinum compounds by thallium-201 single-photon emission computerized tomography.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Ouabain; Prognosis; Radiography; Sodium-Potassium-Exchanging ATPase; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tumor Cells, Cultured | 1998 |
High-dose cyclophosphamide, etoposide and carboplatin with autologous bone marrow support for metastatic breast cancer: long-term results.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Cyclophosphamide; Etoposide; Humans; Middle Aged; Neoplasm Metastasis; Survival Rate; Transplantation, Autologous | 1998 |
High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kidney Diseases; Male; Neutropenia; Retinal Neoplasms; Retinoblastoma | 1997 |
Management of chemotherapy-related anaemia with low-dose recombinant human erythropoietin in patients with small cell lung cancer.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Erythropoietin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Recombinant Proteins; Retrospective Studies | 1997 |
Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs.
Topics: Animals; Antineoplastic Agents; Bleomycin; Carboplatin; Cell Line; Cell Survival; Cisplatin; Cricetinae; Cricetulus; Daunorubicin; Doxorubicin; Drug Screening Assays, Antitumor; Electroporation; Etoposide; Lung; Paclitaxel | 1998 |
Glucocorticoid pretreatment reduces the cytotoxic effects of a variety of DNA-damaging agents on rat tibial growth-plate chondrocytes in vitro.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Carboplatin; Cell Division; Chondrocytes; Cisplatin; Dactinomycin; Dexamethasone; Drug Interactions; Etoposide; Female; Male; Prednisolone; Rats; Tibia | 1998 |
[Invasive thymoma successfully treated with high-dose chemotherapy followed by peripheral blood stem cell transplantation(PBSCT)].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Neoplasm Invasiveness; Radiotherapy Dosage; Thymoma; Thymus Neoplasms; Vincristine | 1998 |
[Endoscopic findings of esophagitis in concurrent chemo-radiotherapy for lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Esophagitis; Esophagoscopy; Etoposide; Humans; Lung Neoplasms; Middle Aged; Mitomycin; Radiation Injuries; Radiotherapy; Vindesine | 1998 |
Chemotherapeutic agents used in the treatment of childhood malignancies have direct effects on growth plate chondrocyte proliferation.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carboplatin; Cell Cycle; Cell Division; Cells, Cultured; Chondrocytes; Cisplatin; Dactinomycin; Dexamethasone; Etoposide; Growth Plate; Male; Mercaptopurine; Methotrexate; Prednisolone; Rats; Rats, Sprague-Dawley; Thioguanine | 1998 |
Recurrence of SIADH after a high-dose regimen of thiotepa, carboplatin, and etoposide phosphate.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Inappropriate ADH Syndrome; Infant; Recurrence; Thiotepa | 1998 |
Effect of chemotherapy on carcinoma in situ of the testis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Biopsy, Needle; Bleomycin; Carboplatin; Carcinoma in Situ; Cisplatin; Disease-Free Survival; Etoposide; Humans; Male; Middle Aged; Orchiectomy; Prognosis; Retrospective Studies; Seminoma; Survival Rate; Testicular Neoplasms; Treatment Outcome; Vinblastine | 1998 |
Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Child; Cisplatin; Etoposide; Female; Germinoma; Humans; Middle Aged; Ovarian Neoplasms; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Vinblastine | 1998 |
Apoptotic effects of different drugs on cultured retinoblastoma Y79 cells.
Topics: Amsacrine; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Butyrates; Butyric Acid; Camptothecin; Carboplatin; Cisplatin; DNA Damage; Drug Screening Assays, Antitumor; Etoposide; Humans; Paclitaxel; Retinoblastoma; Suramin; Tumor Cells, Cultured | 1998 |
Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Epirubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Mesna; Prospective Studies; Recombinant Proteins; Vincristine | 1998 |
Intraocular concentrations of chemotherapeutic agents after systemic or local administration.
Topics: Absorption; Administration, Topical; Animals; Antineoplastic Agents; Aqueous Humor; Biological Availability; Carboplatin; Etoposide; Infusions, Intravenous; Injections; Macaca fascicularis; Ophthalmic Solutions; Orbit; Tissue Distribution; Vincristine; Vitreous Body | 1998 |
[High-dose chemotherapy with autologous peripheral blood stem cell transfusion in the treatment of advanced testis cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Organoplatinum Compounds; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 1998 |
[Clinical efficacy of concurrent carboplatin, etoposide, and definitive radiotherapy for stage III non-small-cell lung cancer: consideration as to therapeutic outcomes and morbidity].
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Morbidity; Retrospective Studies; Survival Rate; Treatment Outcome | 1998 |
High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kidney Neoplasms; Male; Melphalan; Neoplasm Recurrence, Local; Wilms Tumor | 1998 |
In vitro effect of amifostine on haematopoietic progenitors exposed to carboplatin and non-alkylating antineoplastic drugs: haematoprotection acts as a drug-specific progenitor rescue.
Topics: Amifostine; Antigens, CD34; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carboplatin; Cell Cycle; Cell Division; Cells, Cultured; Docetaxel; Doxorubicin; Etoposide; Hematopoietic Stem Cells; Humans; Leukocytes, Mononuclear; Paclitaxel; Taxoids; Time Factors | 1998 |
Neutropenic colitis as a complication of high-dose chemotherapy for refractory testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Choriocarcinoma; Colitis; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Neutropenia; Seminoma; Testicular Neoplasms | 1998 |
Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells.
Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Antineoplastic Agents; Carboplatin; Carrier Proteins; Cisplatin; Colorectal Neoplasms; Cyclophosphamide; DNA Adducts; DNA Damage; DNA Repair; DNA-Binding Proteins; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neoplasm; Endometrial Neoplasms; Etoposide; Female; Fluorouracil; Humans; Melphalan; Methylnitronitrosoguanidine; Mutagenesis; MutL Protein Homolog 1; MutS Homolog 2 Protein; Neoplasm Proteins; Nuclear Proteins; Paclitaxel; Proto-Oncogene Proteins; Thioguanine; Tumor Cells, Cultured | 1997 |
Decreased delivery and acute toxicity of cranial irradiation and chemotherapy given with osmotic blood-brain barrier disruption in a rodent model: the issue of sequence.
Topics: Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain; Carboplatin; Combined Modality Therapy; Etoposide; Female; Infusions, Intra-Arterial; Methotrexate; Radiotherapy; Random Allocation; Rats; Rats, Long-Evans; Tritium | 1995 |
Vasopressin modulation of peritoneal, lymphatic, and plasma drug exposure following intraperitoneal administration.
Topics: Animals; Antineoplastic Agents; Carboplatin; Etoposide; Fluorouracil; Injections, Intraperitoneal; Lymph; Peritoneum; Swine; Vasopressins | 1996 |
Etoposide-carboplatin association as 'emergency' up-front chemotherapy in a case of life-threatening adult medulloblastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Emergencies; Etoposide; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma | 1998 |
Hyaluronidase additional to standard chemotherapy improves outcome for children with malignant brain tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Etoposide; Female; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome | 1998 |
Use of adjuvant ICE chemotherapy in the treatment of anaplastic ependymomas.
Topics: Aging; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Ependymoma; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Survival Analysis | 1998 |
Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma.
Topics: alpha-Fetoproteins; Animals; Antineoplastic Agents; Carboplatin; Cell Division; Child, Preschool; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Hepatoblastoma; Humans; Ifosfamide; Infant; Liver Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous | 1998 |
Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Cisplatin; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Gene Amplification; Genes, myc; Humans; Kinetics; Neuroblastoma; Phenotype; Polymerase Chain Reaction; Time Factors; Tumor Cells, Cultured | 1998 |
[A case of neutropenic enterocolitis in high dose chemotherapy with peripheral blood stem cell transplantation for relapsed testicular tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Enterocolitis; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neutropenia; Seminoma; Testicular Neoplasms | 1998 |
[Successful treatment with high dose chemotherapy following peripheral blood stem cell transplantation for relapsed Burkitt's lymphoma with central nervous system involvement].
Topics: Adult; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carboplatin; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Transplantation, Autologous | 1998 |
The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Child, Preschool; Cryosurgery; Drug Administration Schedule; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Infant; Laser Coagulation; Male; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Vincristine | 1998 |
New retinoblastoma tumors in children undergoing systemic chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Cryotherapy; Etoposide; Female; Fundus Oculi; Humans; Hyperthermia, Induced; Infant; Male; Neoplasms, Second Primary; Retinal Neoplasms; Retinoblastoma; Vincristine | 1998 |
Survival of patients with medulloblastoma treated with carboplatin and etoposide before and after radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Humans; Infant; Medulloblastoma; Remission Induction | 1998 |
Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; New Zealand; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 1998 |
High-dose chemotherapy in germ cell tumours: a large single centre experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Prospective Studies; Retroperitoneal Neoplasms; Retrospective Studies; Salvage Therapy; Seminoma; Testicular Neoplasms; Treatment Outcome | 1998 |
Severe ocular and orbital toxicity after intracarotid etoposide phosphate and carboplatin therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carotid Artery, Internal; Etoposide; Eye Diseases; Glioblastoma; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Orbital Diseases; Organophosphorus Compounds; Tomography, X-Ray Computed | 1999 |
Bcl-2 overexpression results in reciprocal downregulation of Bcl-X(L) and sensitizes human testicular germ cell tumours to chemotherapy-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; bcl-X Protein; Carboplatin; Down-Regulation; Etoposide; Germinoma; Humans; Male; Proto-Oncogene Proteins c-bcl-2; Subcellular Fractions; Testicular Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1999 |
Monitoring of chemotherapy-induced proteinuria using capillary zone electrophoresis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Buffers; Calibration; Carboplatin; Electrophoresis, Capillary; Electrophoresis, Polyacrylamide Gel; Etoposide; Germinoma; Humans; Ifosfamide; Male; Proteinuria; Quality Control; Reproducibility of Results; Testicular Neoplasms; Transferrin | 1999 |
Hypersensitivity to carboplatin in children.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Drug Hypersensitivity; Etoposide; Humans; Infant; Infusions, Intravenous | 1999 |
CD4/CD8 double-positive adult T cell leukemia with preceding cytomegaloviral gastroenterocolitis.
Topics: Adult; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; CD4 Antigens; CD8 Antigens; Cyclophosphamide; Cytomegalovirus Infections; Doxorubicin; Enterocolitis; Etoposide; Gastritis; Hepatomegaly; Human T-lymphotropic virus 1; Humans; Immunocompromised Host; Immunophenotyping; Leukemia-Lymphoma, Adult T-Cell; Male; Neoplastic Stem Cells; Nitrosourea Compounds; Prednisolone; T-Lymphocyte Subsets; Vincristine; Vindesine | 1999 |
Hepatic artery administration of paclitaxel.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cimetidine; Combined Modality Therapy; Dexamethasone; Diphenhydramine; Etoposide; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Premedication | 1999 |
Schedule-dependent and -independent antitumor activity of paclitaxel-based combination chemotherapy against M-109 murine lung carcinoma in vivo.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Injections, Intravenous; Lung Neoplasms; Male; Methotrexate; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Nitrosourea Compounds; Paclitaxel; Vinblastine | 1998 |
Failure of high-dose chemotherapy with peripheral blood stem cell support for refractory placental site trophoblastic tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Hysterectomy; Ovarian Neoplasms; Ovariectomy; Pregnancy; Transplantation, Autologous; Trophoblastic Tumor, Placental Site; Uterine Neoplasms | 1999 |
Treatment outcome of patients with brain metastases from malignant germ cell tumors.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Germinoma; Humans; Male; Middle Aged; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Treatment Outcome | 1999 |
Effect of intracarotid infusion of etoposide: modification of the permeability of the blood-brain barrier and the blood-tumor barrier in rat brain tumor model.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Capillary Permeability; Carboplatin; Carotid Arteries; Etoposide; Glioma; Injections, Intra-Arterial; Male; Neoplasm Transplantation; Permeability; Rats; Rats, Wistar; Tumor Cells, Cultured | 1999 |
In vitro interactions of a new derivative of spicamycin, KRN5500, and other anticancer drugs using a three-dimensional model.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cell Division; Cisplatin; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Humans; Lung Neoplasms; Models, Biological; Models, Statistical; Purine Nucleosides; Tumor Cells, Cultured | 1999 |
The presentation and management of post-partum choriocarcinoma.
Topics: Adult; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Postpartum Hemorrhage; Postpartum Period; Pregnancy; Retrospective Studies; Uterine Neoplasms; Vincristine | 1999 |
Pharmacokinetics of etoposide and carboplatin in cerebrospinal fluid and plasma during hyperosmotic disruption of the blood brain barrier and intraarterial combination chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Carboplatin; Etoposide; Glioma; Half-Life; Humans; Middle Aged; Osmosis | 1999 |
[High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Retroperitoneal Neoplasms; Retrospective Studies; Seminoma; Testicular Neoplasms; Vinblastine | 1999 |
Severe muscle weakness due to hypokalemia as a manifestation of small-cell carcinoma.
Topics: ACTH Syndrome, Ectopic; Antineoplastic Agents; Carboplatin; Carcinoma, Small Cell; Etoposide; Humans; Hypokalemia; Lung Neoplasms; Male; Middle Aged; Muscle Weakness | 1999 |
Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Carboplatin; Cell Survival; DNA Primers; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Genes, erbB-2; Humans; Isoenzymes; Models, Biological; Neoplasm Proteins; Neoplasm Staging; Ovarian Neoplasms; Polymerase Chain Reaction; Receptor, ErbB-2; RNA, Messenger; Survival Analysis; Time Factors; Transcription, Genetic; Tumor Cells, Cultured | 1999 |
Neuron-specific enolase, thymidine kinase, and tissue polypeptide-specific antigen in diagnosis and response to chemotherapy of small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Immunoradiometric Assay; Lung Neoplasms; Male; Middle Aged; Phosphopyruvate Hydratase; Prospective Studies; Thymidine Kinase; Tissue Polypeptide Antigen; Treatment Outcome | 1999 |
Cancer-associated retinopathy during treatment for small-cell lung carcinoma.
Topics: Adrenal Cortex Hormones; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Calcium-Binding Proteins; Carboplatin; Carcinoma, Small Cell; Etoposide; Eye Proteins; Female; Hippocalcin; Humans; Immunosuppressive Agents; Lipoproteins; Lung Neoplasms; Nerve Tissue Proteins; Paraneoplastic Syndromes; Recoverin; Retinal Diseases; Vision, Low; Visual Acuity | 1999 |
Dose-intensive chemotherapy for breast cancer with brain metastases: a case series.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Carboplatin; Carmustine; Cisplatin; Cyclophosphamide; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Neoplasm Metastasis; Remission Induction; Survival Analysis; Thiotepa | 1999 |
[Two-step ultra high-dose chemotherapy with peripheral blood stem cell autotransplantation for refractory testicular cancer: a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Embryonal; Combined Modality Therapy; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lung Neoplasms; Male; Remission Induction; Testicular Neoplasms; Transplantation, Autologous | 1999 |
Safety and efficacy of a continuous infusion, patient controlled anti-emetic pump to facilitate outpatient administration of high-dose chemotherapy.
Topics: Adult; Ambulatory Care; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Dexamethasone; Diphenhydramine; Etoposide; Evaluation Studies as Topic; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Infusion Pumps; Infusions, Intravenous; Lorazepam; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Nausea; Patient Acceptance of Health Care; Prospective Studies; Safety; Self Care; Thiotepa; Vomiting | 1999 |
[Atypical paraneoplastic myasthenic syndrome: Lambert-Eaton syndrome or myasthenia?].
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Combined Modality Therapy; Diagnosis, Differential; Etoposide; Female; Humans; Lambert-Eaton Myasthenic Syndrome; Lung; Lung Neoplasms; Middle Aged; Myasthenia Gravis; Paraneoplastic Syndromes; Radiotherapy Dosage; Tomography, X-Ray Computed | 1999 |
Aggressive form of pleural epithelioid haemangioendothelioma: complete response after chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Etoposide; Female; Hemangioendothelioma, Epithelioid; Humans; Middle Aged; Pleural Neoplasms; Remission Induction; Severity of Illness Index; Tomography, X-Ray Computed | 1999 |
High-dose chemotherapy as primary treatment for poor-risk germ-cell tumors: the Memorial Sloan-Kettering experience (1988-1999).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cancer Care Facilities; Carboplatin; Cisplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Etoposide; Germinoma; Humans; Male; New York City; Retrospective Studies; Salvage Therapy; Survival Rate; Testicular Neoplasms; Transplantation, Autologous; Vinblastine | 1999 |
High-dose salvage chemotherapy. Germ-cell tumor treatment results in Germany.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Clinical Trials as Topic; Combined Modality Therapy; Etoposide; Germany; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Male; Prognosis; Recurrence; Salvage Therapy; Survival Rate; Testicular Neoplasms; Thiotepa | 1999 |
[Clinical study of high-dose chemotherapy with peripheral blood stem cell transplantation for poor-risk germ cell tumor].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Survival Rate; Testicular Neoplasms; Transplantation, Autologous | 1999 |
[Chemically-induced paraneoplastic hyperleukocytic lung].
Topics: Acute Disease; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biopsy; Bronchoscopy; Carboplatin; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Etoposide; Humans; Leukemoid Reaction; Leukocyte Count; Leukostasis; Lung; Lung Diseases; Lung Neoplasms; Male; Paraneoplastic Syndromes; Radiography, Thoracic; Respiratory Insufficiency | 1999 |
In vivo antitumor activity and induction of insulin-like growth factor-1-resistant apoptosis by SC-alphaalphadelta9.
Topics: Aminobutyrates; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Carboplatin; Cell Cycle Proteins; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Down-Regulation; Drug Interactions; Etoposide; Inhibitory Concentration 50; Insulin-Like Growth Factor I; Interleukin-3; Mice; Oxazoles; Receptor, IGF Type 1; Time Factors; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2000 |
Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity.
Topics: Animals; Antidotes; Auditory Threshold; Carboplatin; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Ear, Middle; Etoposide; Female; Guinea Pigs; Humans; Lung Neoplasms; Male; Rats; Rats, Long-Evans; Rats, Nude; Thiosulfates; Tumor Cells, Cultured | 2000 |
[A long-term survivor of extensive-stage small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Remission Induction; Survivors; Vindesine | 2000 |
Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting type I protein kinase A.
Topics: Antineoplastic Agents; Breast; Breast Neoplasms; Carboplatin; Cell Division; Cell Line; Cell Line, Transformed; Cell Survival; Cisplatin; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; Docetaxel; Doxorubicin; Epithelial Cells; Etoposide; Female; Genes, erbB-2; Humans; Oligodeoxyribonucleotides, Antisense; Paclitaxel; Receptor, ErbB-2; Taxoids; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Topotecan; Tumor Cells, Cultured | 2000 |
Mini-ICE regimen allows mobilization of peripheral blood progenitor cells in a patient with chronic myelogenous leukemia failing the ICE protocol.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Idarubicin; Ifosfamide; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male | 2000 |
Results of treatment after relapse from high-dose chemotherapy in germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Germinoma; Humans; Male; Middle Aged; Retrospective Studies; Salvage Therapy; Survival Analysis | 2000 |
Enhancing effect of electric stimulation on cytotoxicity of anticancer agents against rat and human glioma cells.
Topics: Animals; Antineoplastic Agents; Bleomycin; Carboplatin; Cell Division; Electric Stimulation; Etoposide; Glioma; Humans; Nimustine; Rats; Tumor Cells, Cultured; Vincristine | 2000 |
Patterns of practice survey for nonsmall cell lung carcinoma in the U.S.
Topics: Analysis of Variance; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Chi-Square Distribution; Cisplatin; Clinical Protocols; Decision Making; Diagnostic Imaging; Etoposide; Humans; Lung Neoplasms; Medical Oncology; Neoplasm Staging; Paclitaxel; Practice Patterns, Physicians'; Radiation Oncology; Radiotherapy, Adjuvant; United States | 2000 |
Metastatic medulloblastoma in 10-year-old girl treated successfully with chemotherapy without radiotherapy.
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Medulloblastoma | 1999 |
Nephrotoxicity of ifosfamide, carboplatin and etoposide (ICE) alone or combined with extracorporeal or radiant-heat-induced whole-body hyperthermia.
Topics: Adolescent; Adult; Aged; Albuminuria; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials, Phase II as Topic; Creatinine; Etoposide; Female; Glomerular Filtration Rate; Glycoproteins; Humans; Hyperthermia, Induced; Ifosfamide; Immunoglobulin G; Kidney; Male; Membrane Glycoproteins; Middle Aged; Sarcoma; Trypsin Inhibitor, Kunitz Soybean | 2000 |
Pediatric choroid plexus neoplasms.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child, Preschool; Choroid Plexus Neoplasms; Cyclophosphamide; Etoposide; Female; Humans; Infant; Male; Meningeal Neoplasms; Papilloma, Choroid Plexus; Radiotherapy, Adjuvant; Retrospective Studies; Vincristine | 1999 |
Complications of systemic chemotherapy as treatment of retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclosporine; Cytarabine; Etoposide; Female; Fever; Humans; Infant; Male; Methotrexate; Neutropenia; Organophosphorus Compounds; Retinal Neoplasms; Retinoblastoma; Thrombocytopenia; Vincristine | 2000 |
[VP-16 and VM-26 plus platinum drugs combined with radiotherapy in the treatment of small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cobalt Radioisotopes; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Teniposide | 1998 |
Management of patients with cancer of unknown primary site.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carboplatin; Carcinoma; Etoposide; Evaluation Studies as Topic; Female; Humans; Male; Neoplasms, Unknown Primary; Paclitaxel; Prognosis; Survival Rate; Taxoids | 2000 |
High-dose chemotherapy and stem cell transplantation for patients with stage IV breast cancer without clinically evident disease: correlation of CD34+ selection to clinical outcome.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cell Separation; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Mitoxantrone; Survival Analysis; Thiotepa; Treatment Outcome | 2000 |
High-dose chemotherapy and autologous haematopoietic support in poor risk non-seminomatous germ-cell tumours: an effective first-line therapy with minimal toxicity.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Risk Factors; Survival Analysis; Treatment Outcome | 2000 |
High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Cystadenocarcinoma; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Laparotomy; Melphalan; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Reoperation; Retrospective Studies; Survival Rate; Time Factors; Transplantation, Autologous | 2000 |
Advanced stage of dysgerminoma in testicular feminisation: is radical surgery necessary?
Topics: Aged; Androgen-Insensitivity Syndrome; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Disorders of Sex Development; Drug Administration Schedule; Dysgerminoma; Etoposide; Female; Humans; Male; Ovarian Neoplasms | 2000 |
A case of adrenocortical carcinoma associated with recurrence after laparoscopic surgery.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Combined Modality Therapy; Diagnostic Errors; Dichlorodiphenyldichloroethane; Etoposide; Fatal Outcome; Female; Humans; Laparoscopy; Middle Aged; Neoplasm Seeding | 2000 |
High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: an intention-to-treat analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Middle Aged; Prognosis; Radiotherapy; Survival Rate; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2000 |
Spontaneous regression of a germinoma in the pineal body after placement of a ventriculoperitoneal shunt.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biopsy; Carboplatin; Combined Modality Therapy; Etoposide; Germinoma; Humans; Hydrocephalus; Magnetic Resonance Imaging; Male; Pinealoma; Radiotherapy; Remission, Spontaneous; Tomography, X-Ray Computed; Ventriculoperitoneal Shunt | 2000 |
Transient complete remission of metastasized Merkel cell carcinoma by high-dose polychemotherapy and autologous peripheral blood stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Combined Modality Therapy; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Remission Induction; Skin Neoplasms | 2000 |
Long-term survival following extra-neural metastasis from a pineoblastoma.
Topics: Acetabulum; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Femoral Neoplasms; Humans; Ifosfamide; Ilium; Pineal Gland; Pinealoma; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Skin Neoplasms; Thigh; Vincristine | 2000 |
DNA damage after chemotherapy correlates with tumor response and survival in small cell lung cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Carboplatin; Carcinoma, Small Cell; DNA Damage; DNA Primers; DNA, Neoplasm; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Polymerase Chain Reaction; Prognosis; Pseudogenes | 2000 |
Synergistic induction of apoptosis of neuroblastoma by fenretinide or CD437 in combination with chemotherapeutic drugs.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Fenretinide; Flow Cytometry; Free Radicals; Humans; Neuroblastoma; Retinoids; Time Factors; Tretinoin; Tumor Cells, Cultured | 2000 |
High-dose chemotherapy with autologous stem cell support in an adult with bone marrow relapse of medulloblastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Busulfan; Carboplatin; Cerebellar Neoplasms; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Medulloblastoma; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Thiotepa; Transplantation, Autologous | 2000 |
Carcinoma of unknown primary site.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials, Phase II as Topic; Etoposide; Fatigue; Female; Follow-Up Studies; Humans; Leukopenia; Male; Middle Aged; Nausea; Neoplasms, Unknown Primary; Paclitaxel; Survival Analysis; Thrombocytopenia; Time Factors; Treatment Outcome; Vomiting | 2000 |
[Intramedullary spread of a cerebral oligodendroglioma. Two case reports].
Topics: Abducens Nerve Diseases; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carmustine; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Etoposide; Fatal Outcome; Female; Frontal Lobe; Humans; Intracranial Hypertension; Magnetic Resonance Imaging; Middle Aged; Neoplasm Invasiveness; Oligodendroglioma; Paralysis; Prognosis; Radiography; Radiotherapy, Adjuvant; Spinal Cord Neoplasms | 2000 |
Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation.
Topics: Adult; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Kidney Diseases; Male; Testicular Neoplasms; Transplantation Conditioning | 2000 |
Malignant rhabdoid tumour of the uterine cervix.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Humans; Hysterectomy; Ifosfamide; Rhabdoid Tumor; Uterine Neoplasms | 2001 |
Preoperative chemotherapy for lung cancer does not increase surgical morbidity.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Pneumonectomy; Postoperative Care; Premedication; Reference Values; Retrospective Studies; Survival Rate; Treatment Outcome; Vinblastine; Vinorelbine | 2001 |
Recurrent disseminated retinoblastoma in a 7-year-old girl treated successfully by high-dose chemotherapy and CD34-selected autologous peripheral blood stem cell transplantation.
Topics: Antigens, CD34; Antineoplastic Agents; Bone Marrow Neoplasms; Bone Neoplasms; Carboplatin; Child; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Recurrence; Remission Induction; Retinoblastoma; Thiotepa; Transplantation, Autologous; Vincristine | 2001 |
Combined intraarterial carboplatin, intraarterial etoposide phosphate, and IV Cytoxan chemotherapy for progressive optic-hypothalamic gliomas in young children.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Cyclophosphamide; Etoposide; Female; Glioma; Humans; Hypothalamic Neoplasms; Infant; Infant, Newborn; Infusions, Intra-Arterial; Injections, Intravenous; Magnetic Resonance Imaging; Male; Treatment Outcome; Visual Pathways | 2001 |
Influence of interfraction interval on the efficacy and toxicity of hyperfractionated radiotherapy in combination with concurrent daily chemotherapy in stage III non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Dose Fractionation, Radiation; Etoposide; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Radiation Injuries; Radiotherapy; Randomized Controlled Trials as Topic; Time Factors | 2001 |
[Acute hepatitis B virus after chemotherapy for a case with germinoma].
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebral Ventricle Neoplasms; Combined Modality Therapy; Etoposide; Germinoma; Hepatitis B; Hepatitis B Antigens; Humans; Male | 2001 |
Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Société Française d'Oncologie Pédiatrique.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Gene Amplification; Genes, myc; Humans; Infant; Infant, Newborn; Life Tables; Male; Neoplasm Staging; Neuroblastoma; Postoperative Complications; Radiotherapy, Adjuvant; Remission Induction; Survival Analysis; Survival Rate; Treatment Outcome; Vincristine | 2001 |
Modulation of VP-16 cytotoxicity by carboplatin and 41.8 degrees C hyperthermia.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blotting, Western; Carboplatin; Cell Survival; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum Chaperone BiP; Etoposide; Fibrosarcoma; Hyperthermia, Induced; Mice; NAD; Time Factors; Tumor Cells, Cultured | 2001 |
Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines.
Topics: Antineoplastic Agents; Carboplatin; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Drug Resistance, Multiple; Etoposide; Gene Amplification; Humans; Melphalan; Mutation; Neuroblastoma; Nuclear Proteins; Oncogene Proteins, Viral; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Repressor Proteins; Transcriptional Activation; Transduction, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |
Shunt-related abdominal metastases in an infant with medulloblastoma: long-term remission by systemic chemotherapy and surgery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cerebellar Neoplasms; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Hydrocephalus; Hydroxyurea; Infant; Liver Neoplasms; Magnetic Resonance Imaging; Male; Medulloblastoma; Neoplasm Recurrence, Local; Pelvic Neoplasms; Peritoneal Neoplasms; Remission Induction; Ventriculoperitoneal Shunt | 2001 |
[A case of pseudomyxoma peritonei treated successfully with intraperitoneal administration of CBDCA and etoposide, followed by local delivery of dextran with CDDP during surgery].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cystadenoma, Mucinous; Dextrans; Etoposide; Female; Humans; Hysterectomy; Injections, Intraperitoneal; Intraoperative Care; Laparotomy; Ovarian Neoplasms; Ovariectomy; Peritoneal Neoplasms; Pseudomyxoma Peritonei | 2001 |
Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma).
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Male; Pinealoma; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Vincristine | 2001 |
Three conventional-drug combination (ifosfamide, carboplatin, etoposide--ICE regimen) in advanced non-small cell lung cancer (NSCLC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Survival Rate; Treatment Outcome | 2001 |
Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cell Division; Dose-Response Relationship, Drug; Etoposide; Glioblastoma; Humans; Male; Matrix Metalloproteinase 2; Mice; Mice, Nude; Neovascularization, Pathologic; Peptide Fragments; Recombinant Proteins; Xenograft Model Antitumor Assays | 2001 |
[Outpatient chemotherapy for advanced lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Docetaxel; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Survival Rate; Taxoids | 2001 |
Acute myeloblastic leukemia as a second malignancy in a patient with hereditary retinoblastoma.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Neoplasms, Second Primary; Retinal Neoplasms; Retinoblastoma | 2001 |
Prophylactic effect of interferon-alpha for exacerbation of hepatitis B after high-dose chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; DNA, Viral; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hepatitis B, Chronic; Humans; Interferon-alpha; Liver Function Tests; Lymphoma, B-Cell; Male; Nitrosourea Compounds; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Transplantation, Autologous; Vincristine; Viremia; Virus Activation | 2001 |
Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Ifosfamide; Immunologic Factors; Immunotherapy; Interferon-alpha; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Vincristine | 2001 |
The prevalence of avascular necrosis in patients treated with chemotherapy for testicular tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Etoposide; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Osteonecrosis; Prevalence; Surveys and Questionnaires; Testicular Neoplasms; Time Factors; United Kingdom; Vincristine | 2001 |
Efficient carboplatin single therapy in a mouse model of human testicular nonseminomatous germ cell tumor.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Blood Cell Count; Carboplatin; Etoposide; Germinoma; Male; Mice; Mice, SCID; Microscopy, Electron, Scanning; Testicular Neoplasms; Transplantation, Heterologous | 2002 |
Improvement of anti-Hu-associated paraneoplastic sensory neuropathy after chemoradiotherapy in a small cell lung cancer patient.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Carboplatin; Carcinoma, Small Cell; Etoposide; Humans; Lung Neoplasms; Male; Paraneoplastic Polyneuropathy; Treatment Outcome | 2001 |
Testicular germ cell tumor with rhabdomyosarcoma successfully treated by disease-adapted chemotherapy including high-dose chemotherapy: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Cell Differentiation; Cisplatin; Combined Modality Therapy; Diphosphonates; Epirubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Liver Neoplasms; Lumbar Vertebrae; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Multiple Primary; Orchiectomy; Pamidronate; Remission Induction; Rhabdomyosarcoma; Seizures; Seminoma; Spinal Neoplasms; Teratoma; Testicular Neoplasms; Transplantation, Autologous | 2001 |
Retinoblastoma treated with primary chemotherapy alone: the significance of tumour size, location, and age.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Regression Analysis; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine | 2002 |
Retreatment with dose-dense weekly cisplatin after previous cisplatin chemotherapy is not complicated by significant neuro-toxicity.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Cisplatin; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Nervous System Diseases; Ovarian Neoplasms; Prospective Studies; Regression Analysis; Retreatment; Salvage Therapy | 2002 |
Olfactory neuroblastoma with epithelial and endocrine differentiation transformed into ganglioneuroma after chemoradiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Transformation, Neoplastic; Combined Modality Therapy; Esthesioneuroblastoma, Olfactory; Etoposide; Fatal Outcome; Ganglioneuroma; Humans; Inappropriate ADH Syndrome; Male; Middle Aged; Nasal Cavity; Nose Neoplasms; Radiotherapy, Adjuvant | 2001 |
Improved survival of children with advanced neuroblastoma treated by intensified therapy including myeloablative chemotherapy with stem cell transplantation: a retrospective analysis from the Tohoku Neuroblastoma Study Group.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Infant; Japan; Melphalan; Myeloablative Agonists; Neuroblastoma; Retrospective Studies; Risk Factors; Survival Rate; Transplantation Conditioning; Treatment Outcome; Universities | 2001 |
Abdominal rhabdoid tumor presenting as fetal hydrops: a case report.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cesarean Section; Etoposide; Fatal Outcome; Fetal Diseases; Humans; Hydrops Fetalis; Infant, Newborn; Multiple Organ Failure; Rhabdoid Tumor; Ultrasonography, Prenatal | 2001 |
Brain metastases from fallopian tube carcinoma responsive to intra-arterial carboplatin and intravenous etoposide: a case report.
Topics: Adenocarcinoma, Papillary; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Brain Stem; Carboplatin; Carotid Arteries; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dacarbazine; Etoposide; Fallopian Tube Neoplasms; Fallopian Tubes; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Magnetic Resonance Imaging; Middle Aged; Paclitaxel; Physical Examination; Rupture, Spontaneous; Temozolomide; Temporal Lobe; Vertebral Artery | 2001 |
[Globalization of anti-cancer therapies].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Carboplatin; Cisplatin; Colorectal Neoplasms; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Neoplasms; Ovarian Neoplasms; Paclitaxel; Prostatic Neoplasms; Stomach Neoplasms | 2002 |
[Chemotherapy for small-cell lung cancer (SCLC) patients with renal failure].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Paraneoplastic Polyneuropathy; Renal Dialysis; Renal Insufficiency | 2002 |
Extragonadal seminoma after renal transplantation and immunosuppression; treatment in the presence of renal dysfunction: a case report and literature review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chromosome Aberrations; Chromosomes, Human, Pair 12; Diagnosis, Differential; Disease Progression; Etoposide; Fatal Outcome; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Paclitaxel; Pelvic Neoplasms; Seminoma | 2001 |
[An autopsy case of pulmonary and central nervous system metastatic osteosarcoma treated with thirty-six courses of chemotherapy over four years].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Cisplatin; Dacarbazine; Deoxycytidine; Docetaxel; Drug Administration Schedule; Etoposide; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Paclitaxel; Spinal Cord Neoplasms; Survivors; Taxoids; Vincristine; Vindesine | 2002 |
p53 Gene status in relation to ex vivo chemosensitivity of non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cyclophosphamide; DNA Mutational Analysis; DNA, Complementary; DNA, Neoplasm; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Genes, p53; Humans; Lung Neoplasms; Male; Middle Aged; Polymerase Chain Reaction; Prognosis; Tumor Cells, Cultured | 2002 |
Misleading leads: don't assume an alpha-fetoprotein secreting tumour is of germ cell or hepatic origin.
Topics: Abdomen; Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Diagnosis, Differential; Etoposide; Humans; Immunohistochemistry; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Pancreatic Neoplasms; Pancreaticoduodenectomy; Status Epilepticus | 2002 |
Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Eye Enucleation; Female; Humans; Hyperthermia, Induced; Infant; Male; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Vincristine | 2002 |
Influence of phenytoin on the disposition of irinotecan: a case report.
Topics: Adolescent; Anticonvulsants; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Brain Neoplasms; Camptothecin; Carboplatin; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dexamethasone; Disease Progression; Drug Interactions; Enzyme Induction; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Irinotecan; Male; Melphalan; Mixed Function Oxygenases; Neoplasm Recurrence, Local; Ondansetron; Phenobarbital; Phenytoin; Pineal Gland; Pinealoma; Prodrugs; Salvage Therapy; Seizures | 2002 |
Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescue.
Topics: Acyclovir; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carboplatin; Central Nervous System Neoplasms; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Epstein-Barr Virus Infections; Etoposide; Eye Enucleation; Eye Neoplasms; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Lymphoma, Large B-Cell, Diffuse; Male; Meningeal Neoplasms; Methylprednisolone; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Optic Nerve Neoplasms; Radiotherapy, Adjuvant; Retinoblastoma; Rituximab; Thiotepa; Vincristine | 2002 |
High-dose chemotherapy with peripheral blood stem cell transplantation for advanced testicular cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Teratoma; Testicular Neoplasms | 2002 |
Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Prognosis; Randomized Controlled Trials as Topic; Risk; Treatment Outcome | 2002 |
Does hypopituitarism due to neurohypophyseal germinoma recover after chemotherapy?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Craniotomy; Deamino Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Etoposide; Female; Germinoma; Humans; Hypopituitarism; Pituitary Gland, Anterior; Pituitary Neoplasms; Renal Agents | 1999 |
High-dose chemotherapy and autologous peripheral blood stem-cell transfusion after conventional chemotherapy for patients with high-risk Ewing's tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Sarcoma, Ewing; Survival Rate; Treatment Outcome | 2002 |
Impact of maintenance chemotherapy on disease-free survival in patients with stage Ic and II epithelial ovarian cancer.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cystadenocarcinoma, Papillary; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Japan; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Retrospective Studies | 2002 |
[Outpatient chemotherapy for small cell lung cancer in our hospital].
Topics: Aged; Aged, 80 and over; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Treatment Outcome | 2002 |
Lethal ischemic stroke after cisplatin-based chemotherapy for testicular carcinoma and cannabis inhalation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cannabis; Carboplatin; Drug Interactions; Etoposide; Fatal Outcome; Humans; Male; Neoplasms, Germ Cell and Embryonal; Stroke; Testicular Neoplasms | 2002 |
Cumulative prior dose of cisplatin as a cause of the nephrotoxicity of high-dose chemotherapy followed by autologous stem-cell transplantation.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Infections; Kidney Diseases; Male; Middle Aged; Prospective Studies; Stem Cell Transplantation; Transplantation, Autologous | 2002 |
Possible benefits of high-dose chemotherapy and autologous stem cell transplantation for adults with recurrent medulloblastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Medulloblastoma; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Thiotepa; Transplantation, Autologous; Treatment Outcome | 2002 |
[Localization of primary small cell carcinoma with liver metastasis: a rare combination of colonic adenocarcinoma and undifferentiated small cell carcinoma].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Colectomy; Colon; Colonic Neoplasms; Docetaxel; Doxorubicin; Etoposide; Female; Humans; Immunohistochemistry; Liver; Liver Neoplasms; Neoplasms, Multiple Primary; Neoplasms, Unknown Primary; Paclitaxel; Taxoids; Time Factors; Vincristine | 2002 |
Effectiveness of preoperative chemotherapy using carboplatin (CBDCA) and surgery against an esophageal small cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; Etoposide; Follow-Up Studies; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Preoperative Care; Tomography, X-Ray Computed; Treatment Outcome | 2002 |
[Salvage thermochemotherapy in advanced refractory malignant tumors in children].
Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Hyperthermia, Induced; Interleukin-2; Male; Melphalan; Monitoring, Immunologic; Neoplasms; Neuroleptanalgesia; Salvage Therapy; Time Factors; Vincristine | 2002 |
Multidisciplinary therapy including high-dose chemotherapy followed by peripheral blood stem cell transplantation for invasive thymoma.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Thymoma; Thymus Neoplasms; Vincristine | 2002 |
High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Germany; Hematologic Diseases; Humans; Ifosfamide; Infant; Kidney Diseases; Kidney Neoplasms; Life Tables; Lung Neoplasms; Male; Melphalan; Peripheral Blood Stem Cell Transplantation; Prognosis; Stomatitis; Survival Analysis; Thiotepa; Transplantation, Autologous; Wilms Tumor | 2002 |
Successful treatment of advanced peripheral T-cell lymphoma with an angiocentric growth pattern complicated with hemophagocytic syndrome by high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Ifosfamide; Lymphoma, T-Cell, Peripheral; Middle Aged; Peripheral Blood Stem Cell Transplantation; Remission Induction; Transplantation, Autologous | 2002 |
Thermochemotherapy in hereditary retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Infant; Infant, Newborn; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Risk Factors; Treatment Outcome; Vincristine | 2003 |
[New data presented at ASCO 2002 concerning small cell bronchial cancer].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Carboplatin; Carcinoma, Small Cell; Cisplatin; Deoxycytidine; Etoposide; Gemcitabine; Humans; Imatinib Mesylate; Lung Neoplasms; Piperazines; Prognosis; Pyrimidines; Quinolones; Smoking; Smoking Prevention; Survival Analysis; Treatment Outcome | 2002 |
[Radio-chemotherapy combination in locally advanced, inoperable, non-small cell bronchial cancers].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Humans; Lung Neoplasms; Mitomycin; Neoplasm Staging; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vinblastine; Vindesine; Vinorelbine | 2002 |
High-dose chemotherapy and autologous peripheral blood stem cell rescue in a patient with pleuropulmonary blastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung Neoplasms; Melphalan; Pulmonary Blastoma; Radiography; Transplantation, Autologous; Treatment Outcome | 2003 |
Preoperative chemotherapy is essential for conservative surgery of Askin tumors.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Chemotherapy, Adjuvant; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Pneumonectomy; Postoperative Care; Preoperative Care; Prognosis; Radiotherapy, Adjuvant; Sarcoma, Small Cell; Thoracic Neoplasms; Treatment Outcome; Vincristine | 2003 |
Intra-arterial carboplatin and intravenous etoposide for the treatment of metastatic brain tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Disease Progression; Etoposide; Female; Hematologic Diseases; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Middle Aged; Survival Rate; Time Factors; Treatment Outcome | 2003 |
Neoadjuvant chemotherapy for extensive unilateral retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Hydrophthalmos; Infant; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Neoplasm Invasiveness; Optic Nerve Neoplasms; Retinal Neoplasms; Retinoblastoma; Tomography, X-Ray Computed | 2003 |
In regard to hyperfractionation for non-small-cell lung cancer: fire, ready, aim!
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Dose Fractionation, Radiation; Etoposide; Humans; Lung Neoplasms; Multicenter Studies as Topic; Paclitaxel; Prospective Studies; Randomized Controlled Trials as Topic | 2003 |
Chemotherapy for elderly SCLC patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Clinical Trials as Topic; Etoposide; Humans; Lung Neoplasms; Treatment Outcome | 2003 |
Bleomycin and scuba diving: to dive or not to dive?
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Choriocarcinoma; Diving; Etoposide; Humans; Lung Diseases; Male; Orchiectomy; Testicular Neoplasms | 2003 |
Outpatient-based ifosfamide, carboplatin and etoposide (ICE) chemotherapy in transplant-eligible patients with non-Hodgkin's lymphoma and Hodgkin's disease.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Stem Cell Transplantation; Survival Rate | 2003 |
Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin's lymphoma.
Topics: Adult; Aged; Ambulatory Care; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Rituximab; Secondary Prevention; Stem Cell Transplantation | 2003 |
The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carboplatin; Cell Line, Transformed; DNA Repair; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Gene Deletion; Hypoxia-Inducible Factor 1, alpha Subunit; Iron Chelating Agents; Male; Mice; Mice, Nude; Neoplasms, Experimental; Topoisomerase I Inhibitors; Transcription Factors; Tumor Suppressor Protein p53 | 2003 |
Current status and future of relapsed primary central nervous system lymphoma (PCNSL).
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Organophosphorus Compounds; Radioimmunotherapy; Recurrence; Rituximab; Time Factors | 2003 |
Successful high-dose chemotherapy for widespread neuroaxis dissemination of an optico-hypothalamic juvenile pilocytic astrocytoma in an infant: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Hypothalamic Neoplasms; Infant; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Nitrosourea Compounds; Optic Nerve Neoplasms; Peripheral Blood Stem Cell Transplantation; Syndrome | 2003 |
Modified Ifosphamide/CarboPlatin/Etoposide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Neoplasm Staging; Patient Selection; Prognosis; Randomized Controlled Trials as Topic | 2003 |
Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blindness; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Cytarabine; Epirubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Nasal Cavity; Necrosis; Neoplasm Recurrence, Local; Nose Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Salvage Therapy; Spinal Cord Neoplasms; Survival Analysis | 2003 |
[Marked improvement of Lambert-Eaton myasthenic syndrome resulting from treatment for small cell lung carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Humans; Inappropriate ADH Syndrome; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Male | 2003 |
Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Female; Humans; Infant; Infant, Newborn; Male; Neoplasm Staging; Radiotherapy, High-Energy; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Survival Rate; Time Factors; Vincristine | 2003 |
Clinical result of prolonged primary chemotherapy in retinoblastoma patients.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Drug Administration Schedule; Etoposide; Eye Enucleation; Humans; Ifosfamide; Infant; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Ultrasonography; Vincristine | 2003 |
Treatment of stage 4s neuroblastoma--report of 10 years' experience of the French Society of Paediatric Oncology (SFOP).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Etoposide; Female; France; Genetic Markers; Humans; Infant; Infant, Newborn; Male; Neuroblastoma; Patient Care Planning; Prognosis; Retrospective Studies; Societies, Medical; Vincristine | 2003 |
Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Eye Enucleation; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Vincristine | 2003 |
Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chi-Square Distribution; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Peritoneum; Statistics, Nonparametric; Testicular Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Middle Aged; Paclitaxel; Radiotherapy Dosage; Survival Rate; Uterine Cervical Neoplasms | 2003 |
Transduction of green fluorescent protein increased oxidative stress and enhanced sensitivity to cytotoxic drugs in neuroblastoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; B7-1 Antigen; Buthionine Sulfoximine; Carboplatin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Glutathione; Green Fluorescent Proteins; Humans; Lentivirus; Luminescent Proteins; Melphalan; Mutation; Neuroblastoma; Oxidative Stress; Transduction, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2003 |
Kit expression in small cell carcinomas of the lung: effects of chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Lung Neoplasms; Male; Middle Aged; Proto-Oncogene Mas; Proto-Oncogene Proteins c-kit; Survival Rate | 2003 |
Topotecan as first-line therapy for small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Cisplatin; Etoposide; Forecasting; Humans; Lung Neoplasms; Paclitaxel; Platinum; Topotecan | 2003 |
Options for first- and second-line therapy in small cell lung cancer--a workshop discussion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Etoposide; Humans; Lung Neoplasms; Neoplasm Recurrence, Local | 2003 |
[The role of surgical therapy for esophageal microcytoma. Experience of there clinical cases and results analysis].
Topics: Aged; Anastomosis, Surgical; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Esophagoplasty; Esophagoscopy; Etoposide; Fatal Outcome; Female; Humans; Laparotomy; Lymph Node Excision; Male; Middle Aged; Mitomycin; Remission Induction; Stomach; Thoracotomy; Vinblastine; Vinorelbine | 2003 |
Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Infant; Infant, Newborn; Male; Neoplasm Recurrence, Local; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Risk Factors; Survival Rate; Vincristine | 2003 |
Pneumocystis carinii pneumonia: a late presentation following treatment for stage IV neuroblastoma.
Topics: Abdominal Neoplasms; Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Fatal Outcome; Female; Humans; Immunocompromised Host; Isotretinoin; Neoplasm Staging; Neuroblastoma; Opportunistic Infections; Pneumonia, Pneumocystis; Radiotherapy, Adjuvant; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine | 2003 |
Encouraging result of tamoxifen in a retinoblastoma patient with central nervous system metastasis.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Glucocorticoids; Humans; Meningeal Neoplasms; Methotrexate; Retinoblastoma; Skull Neoplasms; Tamoxifen; Vincristine | 2003 |
Salvage chemotherapy for refractory or relapsed post-transplant lymphoproliferative disorder in patients after solid organ transplantation with a combination of carboplatin and etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Feasibility Studies; Female; Humans; Lymphoproliferative Disorders; Male; Middle Aged; Organ Transplantation; Pilot Projects; Salvage Therapy; Treatment Outcome | 2003 |
Cytotoxic treatment of aggressive prostate tumors with or without neuroendocrine elements.
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Estramustine; Etoposide; Humans; Male; Middle Aged; Prostatic Neoplasms; Remission Induction | 2002 |
A young woman with clear cell adenocarcinoma of the uterine cervix.
Topics: Adenocarcinoma, Clear Cell; Adolescent; Age of Onset; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinogens; Diethylstilbestrol; Etoposide; Female; Humans; Hysterectomy; Japan; Lymph Node Excision; Mitomycin; Neoadjuvant Therapy; Netherlands; Prognosis; Uterine Cervical Neoplasms | 2003 |
Pharmacokinetic analysis of combination chemotherapy with carboplatin and etoposide in small-cell lung cancer patients undergoing hemodialysis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Kidney Failure, Chronic; Lung Neoplasms; Male; Middle Aged; Renal Dialysis | 2004 |
Cardiac lymphoma successfully treated with high dose chemotherapy followed by autologous haematopoietic stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Chest Pain; Combined Modality Therapy; Cough; Cyclophosphamide; Doxorubicin; Etoposide; Female; Heart Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Nitrosourea Compounds; Prednisolone; Procarbazine; Remission Induction; Transplantation, Autologous; Vincristine | 2003 |
[Alternating electric heart axis in a patient with small cell lung cancer].
Topics: Abdominal Pain; Antineoplastic Agents; Carboplatin; Carcinoma, Small Cell; Echocardiography; Electrocardiography; Etoposide; Heart Conduction System; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pericardial Effusion; Pericardiocentesis | 2004 |
Testicular function in patients with testicular cancer treated with bleomycin-etoposide-carboplatin (BEC(90)) combination chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Etoposide; Germinoma; Hormones; Humans; Male; Neoplasm Staging; Sperm Count; Testicular Neoplasms; Time Factors | 2004 |
Fertility after high-dose chemotherapy for testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Estradiol; Etoposide; Fertility; Follicle Stimulating Hormone; Humans; Ifosfamide; Infertility, Male; Luteinizing Hormone; Male; Oligospermia; Peripheral Blood Stem Cell Transplantation; Prolactin; Sperm Count; Sperm Motility; Spermatogenesis; Testicular Neoplasms; Testosterone | 2004 |
Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carboplatin; Carcinoma, Embryonal; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Etoposide; Germinoma; Humans; Lymph Node Excision; Male; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasm Staging; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Orchiectomy; Prognosis; Risk Factors; Seminoma; Teratoma; Testicular Neoplasms; Treatment Outcome | 2004 |
Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosomes, Human; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 3; Chromosomes, Human, Pair 8; Combined Modality Therapy; Dexamethasone; DNA-Binding Proteins; Etoposide; Genes, bcl-2; Genes, myc; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogenes; Radiotherapy, Adjuvant; Remission Induction; Transcription Factors; Translocation, Genetic | 2004 |
Quality of life evaluations in patients with ovarian cancer during chemotherapy treatment.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cohort Studies; Doxorubicin; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Prospective Studies; Quality of Life; Topotecan | 2004 |
[A difficult case of advanced testicular choriocarcinoma effectively treated by chemotherapy and resection of lung metastasis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Choriocarcinoma; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Peripheral Blood Stem Cell Transplantation; Pneumonectomy; Testicular Neoplasms | 2004 |
Failure to eradicate AIDS-associated primary effusion lymphoma with high-dose chemotherapy and autologous stem cell reinfusion: case report and literature review.
Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Carboplatin; CD4 Lymphocyte Count; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Immunophenotyping; Lymphoma, AIDS-Related; Male; Middle Aged; Pleural Effusion, Malignant; Prednisone; Salvage Therapy; Sarcoma, Kaposi; Skin Neoplasms; Stem Cell Transplantation; Transplantation, Autologous; Treatment Failure; Vincristine; Viral Load | 2004 |
Metastatic lung disease to the central nervous system: in vitro response to chemotherapeutic agents.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Carboplatin; Carcinoma, Squamous Cell; Central Nervous System Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Tumor Cells, Cultured | 2004 |
Second-line chemotherapy with the association of liposomal daunorubicin, carboplatin and etoposide in children with recurrent malignant brain tumors.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Daunorubicin; Etoposide; Female; Humans; Liposomes; Magnetic Resonance Imaging; Male; Survival Analysis; Treatment Outcome | 2004 |
Ototoxicity in patients with dose-intensive therapy for cisplatin-resistant germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Germinoma; Hearing Loss; Humans | 2004 |
[Refractory germ cell cancer of testis treated by salvage high-dose chemotherapy: report of three cases].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Germinoma; Humans; Ifosfamide; Male; Peripheral Blood Stem Cell Transplantation; Prognosis; Salvage Therapy; Testicular Neoplasms; Thiotepa; Transplantation, Autologous; Vinblastine | 2004 |
[Adult T-cell leukemia/lymphoma of bone with multiple pathological fractures].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Extremities; Fatal Outcome; Female; Fractures, Spontaneous; Humans; Hypercalcemia; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Nitrosourea Compounds; Osteolysis; Prednisolone; Vincristine; Vindesine | 2004 |
Arsenic trioxide-induced death of neuroblastoma cells involves activation of Bax and does not require p53.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; Blotting, Western; Calpain; Carboplatin; Caspase 3; Caspases; Cell Line, Tumor; Cytochromes c; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Mutation; Neuroblastoma; Oxides; Proto-Oncogene Proteins c-bcl-2; Time Factors; Tumor Suppressor Protein p53; Vincristine | 2004 |
[Cellular changes in non-small cell lung cancer after neoadjuvant therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Diagnosis, Differential; Etoposide; Humans; Ifosfamide; Lung Neoplasms | 2004 |
Secondary leukemias in refractory germ cell tumor patients undergoing autologous stem-cell transplantation using high-dose etoposide.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Carboplatin; Combined Modality Therapy; Etoposide; Germinoma; Humans; Incidence; Indiana; Leukemia; Male; Middle Aged; Prostatic Neoplasms; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous | 2004 |
Primary omental synovial sarcoma: a case with cytogenetic confirmation.
Topics: Adult; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Maternal Age; Mesna; Neoplasm Recurrence, Local; Omentum; Peritoneal Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy, High-Risk; Sarcoma, Synovial | 2004 |
Pineal parenchymal tumours: I. Pineocytoma: a tumour responsive to platinum-based chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Diagnosis, Differential; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Pineal Gland; Pinealoma; Spinal Neoplasms; Vincristine | 2004 |
Metastatic Merkel cell tumor to the prostate and bladder.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Combined Modality Therapy; Etoposide; Facial Neoplasms; Fatal Outcome; Humans; Kidney Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Male; Palliative Care; Prostatic Neoplasms; Radiotherapy, Adjuvant; Spinal Neoplasms; Transurethral Resection of Prostate; Urethral Obstruction; Urinary Bladder Neoplasms | 2004 |
Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial Hospital.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kidney Neoplasms; Male; Melphalan; Neoplasm Recurrence, Local; Survival Analysis; Thiotepa; Transplantation, Autologous; Treatment Outcome; Wilms Tumor | 2004 |
Stage III non-small-cell lung cancer treated with high-dose hyperfractionated radiation therapy and concurrent low-dose daily chemotherapy with or without weekend chemotherapy: retrospective analysis of 301 patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome | 2004 |
[Erdheim-Chester disease: a non-Langerhans cell histiocytosis. A clinical-case and review of the literature].
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Child; Diagnosis, Differential; Drug Therapy, Combination; Erdheim-Chester Disease; Etoposide; Female; Follow-Up Studies; Hormones; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Middle Aged; Phenotype; Prednisone; Radiography; Somatostatin; Time Factors; Treatment Outcome; Vinblastine | 2004 |
What is the best treatment for retinoblastoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Humans; Hyperthermia, Induced; Infant; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Vincristine | 2004 |
Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Eye Enucleation; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Neoplasm Seeding; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Risk Factors; Treatment Failure; Vincristine | 2004 |
[Tumor lysis syndrome after chemotherapy for colon small cell carcinoma].
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Etoposide; Female; Hearing Loss; Humans; Liver Neoplasms; Middle Aged; Postoperative Care; Tumor Lysis Syndrome | 2004 |
Spinal cord compression and lung metastasis of Wilms' tumor in a pregnant adolescent.
Topics: Abdominal Pain; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Dexamethasone; Etoposide; Female; Fetus; Humans; Ifosfamide; Infant, Newborn; Kidney Neoplasms; Lumbar Vertebrae; Lung Neoplasms; Neoplasm Recurrence, Local; Patient Dropouts; Polyradiculopathy; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Spinal Cord Compression; Vincristine; Wilms Tumor | 2004 |
[A case of cT0N2M0 small cell lung cancer with Lambert-Eaton myasthenic syndrome].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Calcium Channels; Carboplatin; Carcinoma, Small Cell; Electromyography; Etoposide; Humans; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Male | 2004 |
[CD56-positive peripheral T-cell lymphoma primarily presenting with tonsillar swelling].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; CD56 Antigen; Cyclophosphamide; Etoposide; Fatal Outcome; Female; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Humans; Ileal Neoplasms; Lymphoma, T-Cell; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Nitrosourea Compounds; Peripheral Blood Stem Cell Transplantation; Remission Induction; Tonsillar Neoplasms; Transplantation, Autologous | 2004 |
Experience with chemoreduction and focal therapy for intraocular retinoblastoma in a developing country.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Developing Countries; Etoposide; Eye Enucleation; Humans; Radiotherapy; Retinoblastoma; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 2005 |
[A case report of esophageal small cell carcinoma: a long-term survival by radio-chemotherapy with carboplatin and etoposide].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Etoposide; Humans; Male; Middle Aged; Radiotherapy, High-Energy; Remission Induction; Survivors | 2004 |
[A case of retroperitoneal neuroblastoma in an adult with extensive bone marrow metastasis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Carboplatin; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Male; Neuroblastoma; Paraplegia; Retroperitoneal Neoplasms; Skull Neoplasms; Vincristine | 2004 |
[Clinical pathway based on evidence-based medicine (EBM) for chemotherapy for lung cancer].
Topics: Acute Kidney Injury; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Critical Pathways; Etoposide; Evidence-Based Medicine; Female; Humans; Irinotecan; Leukopenia; Lung Neoplasms; Male; Middle Aged; Vomiting | 2004 |
Interfraction interval in patients with stage III non-small-cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy: final results in 536 patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Survival Analysis | 2004 |
Effective use of high-dose chemotherapy and autologous stem cell rescue for relapsed adult Wilms' tumor and a novel alteration in intron 1 of the WT1 gene.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose-Response Relationship, Drug; Etoposide; Genes, Wilms Tumor; Germ-Line Mutation; Humans; Kidney Neoplasms; Male; Melphalan; Middle Aged; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Wilms Tumor | 2004 |
Conservative therapy in intraocular retinoblastoma: response/recurrence rate.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cryotherapy; Etoposide; Humans; Laser Therapy; Middle Aged; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome | 2005 |
Long-term survival in high-grade axial osteosarcoma with bone and lung metastases treated with chemotherapy only.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lumbar Vertebrae; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Thoracic Vertebrae; Time Factors; Tomography, X-Ray Computed | 2005 |
Successful treatment of an unresectable choroid plexus carcinoma in a patient with Li-Fraumeni syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Child, Preschool; Choroid Plexus Neoplasms; Cyclophosphamide; Etoposide; Female; Humans; Li-Fraumeni Syndrome; Magnetic Resonance Imaging; Neoplasm Metastasis | 2005 |
Double-platinum chemotherapy combined with etoposide in metastatic brain tumor from small cell lung carcinoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antineoplastic Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Radiotherapy, Adjuvant; Treatment Outcome | 2005 |
The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy.
Topics: Antineoplastic Agents; Apoptosis; Carboplatin; Carcinoma, Small Cell; Cell Division; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Etoposide; Gene Expression Regulation, Neoplastic; Humans; In Situ Nick-End Labeling; Insulin-Like Growth Factor I; Lung Neoplasms; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles; Receptor, IGF Type 1; RNA, Messenger; Vascular Endothelial Growth Factor A | 2005 |
Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Eye Enucleation; Female; Humans; Hyperthermia, Induced; Infant; Male; Multivariate Analysis; Neoplasm Recurrence, Local; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Risk Assessment; Risk Factors; Vincristine | 2004 |
Life-threatening airway obstruction caused by mediastinal germinoma in a 9-year-old girl.
Topics: Airway Obstruction; Anesthesia, General; Antineoplastic Combined Chemotherapy Protocols; Asphyxia; Asthma; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Contraindications; Diagnostic Errors; Dyspnea; Emergencies; Epilepsy, Generalized; Etoposide; Female; Germinoma; Humans; Hypoxia; Mediastinal Neoplasms; Radiotherapy, Adjuvant; Remission Induction; Tomography, X-Ray Computed; Tracheal Stenosis | 2005 |
Extra nodal NK/T-cell lymphoma nasal type that responded to DeVIC combination chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Combined Modality Therapy; Dexamethasone; Disease Progression; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Immunohistochemistry; Killer Cells, Natural; Lymphoma, T-Cell, Peripheral; Neoplasm Invasiveness; Neoplasm Staging; Radiotherapy, Adjuvant; Skin Neoplasms | 2005 |
Efficacy of two different platinum- or anthracycline-containing chemotherapy regimens for the treatment of small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chi-Square Distribution; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Probability; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Survival Analysis; Treatment Outcome | 2005 |
[Chemoradiotherapy for neurohypophyseal immature teratoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Drug Administration Schedule; Etoposide; Female; Humans; Pituitary Neoplasms; Radiotherapy Dosage; Teratoma | 2005 |
Hypopharyngeal small cell carcinoma: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Hypopharyngeal Neoplasms; Photomicrography; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Relationship between histopathological features of chemotherapy treated retinoblastoma and P-glycoprotein expression.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brachytherapy; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Immunoenzyme Techniques; Infant; Male; Neoplasm Invasiveness; Retinal Neoplasms; Retinoblastoma; Vincristine | 2005 |
Front-line doublets in advanced non-small cell lung cancer: The golden age for second line chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Docetaxel; Etoposide; Female; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Paclitaxel; Pemetrexed; Survival Rate; Taxoids | 2005 |
Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Hyperthermia, Induced; Infant; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Vincristine | 2005 |
[Chemotherapy in extended small-cell lung cancer. Retrospective analysis of two different series of patients treated with carboplatin and etoposide or ciclophosphamide-epidoxorubicin and etoposide].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Retrospective Studies | 2005 |
[Combined chemotherapy and radiation therapy for intracranial germinomas. The Val-de-Grace hospital experience].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Disease-Free Survival; Etoposide; Germinoma; Humans; Male; Neoadjuvant Therapy; Radiotherapy Dosage; Radiotherapy, Adjuvant | 2005 |
Ramifications of severe organ dysfunction in newly diagnosed patients with small cell lung cancer: contemporary experience from a single institution.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Carboplatin; Carcinoma, Small Cell; Cisplatin; Creatinine; Cyclophosphamide; Decision Making; Etoposide; Female; Humans; Lung Neoplasms; Male; Medical Records; Middle Aged; Multiple Organ Failure; Neoplasm Staging; Paclitaxel; Platelet Count; Survival Rate; Treatment Outcome | 2005 |
Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Male; Medulloblastoma; Radiotherapy Dosage; Spinal Canal; Survival Rate | 2005 |
Reversible dilated cardiomyopathy and neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cardiomyopathy, Dilated; Etoposide; Female; Humans; Infant; Kidney Neoplasms; Neuroblastoma | 2005 |
Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer?
Topics: Aged; Androgen Antagonists; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Dexamethasone; Disease Progression; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Hormones; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Thrombocytopenia; Time Factors; Treatment Outcome | 2005 |
[Small cell carcinoma of the bladder: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystectomy; Drug Administration Schedule; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Urinary Bladder Neoplasms; Urinary Diversion | 2005 |
Bevacizumab plus high-dose ifosfamide, etoposide and carboplatin (HD-ICE) as third-line salvage chemotherapy induced an unexpected dramatic response in highly platinum refractory germ-cell cancer.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Humans; Ifosfamide; Neoplasms, Germ Cell and Embryonal; Salvage Therapy; Treatment Outcome | 2006 |
[Surgical treatment for locally advanced lung cancer; therapeutic response of induction chemotherapy and postoperative chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pneumonectomy; Postoperative Period; Survival Rate | 2005 |
Topotecan combination chemotherapy in two new rodent models of retinoblastoma.
Topics: Animals; Animals, Newborn; Antineoplastic Agents; Apoptosis; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Etoposide; Eye; Humans; Mice; Mice, Knockout; Rats; Retinal Neoplasms; Retinoblastoma; Time Factors; Topotecan; Vincristine; Xenograft Model Antitumor Assays | 2005 |
Recurrent retroperitoneal malignant nerve sheath tumor associated with neurofibromatosis type 1 responding to carboplatin and etoposide combined chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lung Neoplasms; Male; Nerve Sheath Neoplasms; Neurofibromatosis 1; Peripheral Nervous System Neoplasms; Retroperitoneal Neoplasms | 2005 |
[Yolk sac tumor of the anterior mediastinum and pulmonary metastases; report of a case].
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Endodermal Sinus Tumor; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lung Neoplasms; Mediastinal Neoplasms; Positron-Emission Tomography; Superior Vena Cava Syndrome | 2005 |
[Thymic cancer effectively treated by combination chemotherapy of carboplatin and etoposide with concurrent radiotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Thymectomy; Thymus Neoplasms | 2005 |
Long-term visual outcome following chemoreduction for retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Infant; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome; Vincristine; Visual Acuity | 2005 |
Restoration of foveal anatomy and function following chemoreduction for bilateral advanced retinoblastoma with total retinal detachment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cryotherapy; Etoposide; Female; Fovea Centralis; Humans; Hyperthermia, Induced; Infant; Retinal Detachment; Retinal Neoplasms; Retinoblastoma; Tomography, Optical Coherence; Vincristine; Visual Acuity | 2005 |
Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Stem Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Delivery Systems; Etoposide; Female; Glioma; Humans; Male; Methotrexate; Osmosis; Retrospective Studies; Treatment Outcome | 2006 |
Primary endodermal sinus tumor of the cerebellar hemisphere: a case report with review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Endodermal Sinus Tumor; Etoposide; Humans; Magnetic Resonance Imaging; Male; Neurosurgical Procedures | 2006 |
Successful treatment with voriconazole of Aspergillus brain abscess in a boy with medulloblastoma.
Topics: Administration, Oral; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus fumigatus; Brain Abscess; Carboplatin; Cerebral Ventricle Neoplasms; Child; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Cyclophosphamide; Diagnostic Errors; Etoposide; Humans; Immunocompromised Host; Infusions, Intravenous; Lomustine; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Neuroaspergillosis; Pyrimidines; Surgical Wound Infection; Triazoles; Vincristine; Voriconazole | 2007 |
Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Chi-Square Distribution; Child; Child, Preschool; Cyclophosphamide; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lomustine; Male; Methotrexate; Neuroectodermal Tumors, Primitive; Prospective Studies; Stem Cell Transplantation; Supratentorial Neoplasms; Survival Analysis; Thiotepa; Treatment Outcome; Vincristine | 2006 |
High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.
Topics: Adolescent; Adult; Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibody Formation; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin G; Immunosuppressive Agents; Immunotherapy; Infant; Male; Melphalan; Mice; Neuroblastoma; Retrospective Studies; Thiotepa; Topotecan; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine; Whole-Body Irradiation | 2007 |
Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Cognition Disorders; Cranial Irradiation; Cyclophosphamide; Developmental Disabilities; Disease-Free Survival; Ependymoma; Etoposide; Follow-Up Studies; Ganglioglioma; Glioma; Humans; Infant; Medulloblastoma; Mitotic Index; Neuroectodermal Tumors, Primitive; Oligodendroglioma; Peripheral Blood Stem Cell Transplantation; Quadriplegia; Retrospective Studies; Sensation Disorders; Spinal Cord Neoplasms; Thiotepa; Transplantation, Autologous; Treatment Outcome; Vincristine | 2007 |
Prevalence and rupture rate of cerebral aneurysms discovered during intra-arterial chemotherapy of brain tumors.
Topics: Adult; Aged; Aged, 80 and over; Aneurysm, Ruptured; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cause of Death; Cerebral Angiography; Cross-Sectional Studies; Etoposide; Female; Humans; Incidental Findings; Infusions, Intra-Arterial; Infusions, Intravenous; Intracranial Aneurysm; Male; Middle Aged; Retrospective Studies; Risk; Survival Rate | 2006 |
Shifting to outpatient management of acute myeloid leukemia: a prospective experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Feasibility Studies; Female; Humans; Inpatients; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Outpatients; Patient Discharge; Patient Readmission; Prospective Studies; Remission Induction; Survival Rate; Treatment Outcome | 2006 |
Cyclophosphamide, etoposide and carboplatine plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutrophils; Odds Ratio; Peripheral Blood Stem Cell Transplantation; Stem Cells; Time Factors; Transplantation, Autologous; Treatment Outcome | 2006 |
Bronchial infiltration with diffuse large B-cell lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Bronchial Neoplasms; Carboplatin; DNA Primers; Etoposide; Gene Rearrangement; Humans; Ifosfamide; Immunoglobulin Heavy Chains; Lymphoma, B-Cell; Male; Middle Aged; Rituximab; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Metastatic choriocarcinoma successfully treated with paclitaxel and carboplatin after interstitial lung disease induced by EMA-CO.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Liver Neoplasms; Lung Diseases, Interstitial; Lung Neoplasms; Methotrexate; Paclitaxel; Uterine Neoplasms; Vincristine | 2006 |
Role of chemotherapy resistance genes in outcome of neuroblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carboplatin; Cell Line, Tumor; Child; Child, Preschool; Chromosome Deletion; Chromosomes, Human, Pair 1; Cisplatin; Computer Systems; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Profiling; Genes, MDR; Genes, myc; Humans; Infant; Kaplan-Meier Estimate; Male; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; S Phase; Treatment Outcome; Vault Ribonucleoprotein Particles; Vincristine | 2007 |
Prognostic factors in pleuro-pulmonary blastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Staging; Pleural Neoplasms; Pneumonectomy; Prognosis; Pulmonary Blastoma; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Second-Look Surgery; Treatment Outcome; Vincristine | 2007 |
MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Camptothecin; Carboplatin; Drug Therapy, Combination; Etoposide; Female; Glioma; Humans; Irinotecan; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Vascular Endothelial Growth Factor A | 2006 |
Outpatient fractionated ifosfamide, carboplatin and etoposide as salvage therapy in relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2006 |
Successful chemotherapy for congenital malignant gliomas: a report of two cases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Etoposide; Ganglioglioma; Humans; Infant; Male; Nitrosourea Compounds | 2006 |
[Current data concerning neoadjuvant chemotherapy].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Ifosfamide; Lung; Lung Neoplasms; Mitomycin; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Radiotherapy Dosage; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Risk; Time Factors | 2006 |
False-positive restaging PET scans involving the spleen in two patients with aggressive non-Hodgkin lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Burkitt Lymphoma; Carboplatin; Cyclophosphamide; Dexamethasone; Disease Progression; Doxorubicin; Etoposide; False Positive Reactions; Humans; Ifosfamide; Laparoscopy; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Necrosis; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Remission Induction; Rituximab; Salvage Therapy; Spleen; Splenectomy; Tomography, X-Ray Computed; Unnecessary Procedures; Vincristine | 2006 |
Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brazil; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Infant; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome; Vincristine | 2006 |
Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Fistula; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Life Tables; Lung Neoplasms; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Pleural Diseases; Pneumonectomy; Pneumonia; Pneumonia, Aspiration; Postoperative Complications; Pulmonary Embolism; Radiotherapy Dosage; Radiotherapy, Conformal; Remission Induction; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Tract Fistula; Retrospective Studies; Survival Analysis; Treatment Outcome | 2006 |
[How to treat well differentiated endocrine carcinoma with a high proliferative index? A case of gastric endocrine carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neuroendocrine Tumors; Stomach Neoplasms | 2006 |
Treating stage I nonseminomatous germ cell tumours with a single cycle of chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Treatment Outcome | 2006 |
Retinoblastoma and deletion of the long arm of chromosome 13: an underestimated diagnosis?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosome Deletion; Chromosomes, Human, Pair 13; Chromosomes, Human, Pair 8; Combined Modality Therapy; Etoposide; Eye Enucleation; False Negative Reactions; Female; Genes, Retinoblastoma; Humans; Hyperthermia, Induced; In Situ Hybridization, Fluorescence; Infant; Neoplasms, Multiple Primary; Remission Induction; Retinal Neoplasms; Retinoblastoma; Skull; Translocation, Genetic; Vincristine | 2008 |
Successful chemotherapy and 90Y-DOTATOC in a patient with mediastinal highly aggressive neuroendocrine carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Disease Progression; Etoposide; Female; Humans; Mediastinal Neoplasms; Middle Aged; Neoplasms, Unknown Primary; Octreotide; Remission Induction; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Camptothecin; Carboplatin; Cell Line, Tumor; Cell Survival; Cyclophosphamide; Cytarabine; Depsipeptides; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; Histone Deacetylase Inhibitors; HL-60 Cells; Humans; Imatinib Mesylate; Irinotecan; K562 Cells; Leukemia; Lymphoma; Mercaptopurine; Piperazines; Pyrimidines; Time Factors | 2007 |
Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Ependymoma; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Methotrexate; Neoplasm Recurrence, Local; Thiotepa; Transplantation, Autologous; Treatment Outcome; Vincristine | 2007 |
Postoperative adjuvant treatment for pineal parenchymal tumour of intermediate differentiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Diplopia; Drug Therapy; Etoposide; Gait Disorders, Neurologic; Humans; Magnetic Resonance Imaging; Male; Memory Disorders; Middle Aged; Neurosurgical Procedures; Pineal Gland; Pinealoma; Radiation Dosage; Radiotherapy; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Resolution of iris neovascularization following chemoreduction of advanced retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Fluorescein Angiography; Glaucoma, Neovascular; Humans; Infant; Iris; Neovascularization, Pathologic; Retinal Neoplasms; Retinoblastoma; Vincristine | 2006 |
A novel pattern of transaminase elevation associated with autologous transplant for neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Liver Function Tests; Male; Neuroblastoma; Retrospective Studies; Risk Factors; Transaminases; Transplantation Conditioning; Transplantation, Autologous | 2006 |
[Lung cancer with bone metastasis].
Topics: Analgesics; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Diphosphonates; Docetaxel; Drug Administration Schedule; Etoposide; Fractures, Bone; Gefitinib; Humans; Irinotecan; Lung Neoplasms; Paclitaxel; Pain, Intractable; Prognosis; Quinazolines; Radiotherapy Dosage; Taxoids | 2006 |
High-dose chemotherapy plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed Hodgkin disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cryopreservation; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Recurrence; Retrospective Studies; Time Factors; Transplantation, Autologous | 2006 |
Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Child; Etoposide; Eye Diseases; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Salvage Therapy; Survival Analysis; Vincristine | 2006 |
Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Humans; Medulloblastoma; Postoperative Care; Prospective Studies; Risk Factors; Treatment Outcome | 2006 |
High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Glioma; Humans; Infant; Male; Neoplasm, Residual; Procarbazine; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 2006 |
Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Carboplatin; Cerebral Ventricle Neoplasms; Combined Modality Therapy; Consciousness Disorders; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dacarbazine; Deoxycytidine; Etoposide; Female; Gemcitabine; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Hypophysectomy; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Pituitary Neoplasms; Temozolomide; Thiotepa; Topotecan | 2008 |
The International Classification of Retinoblastoma predicts chemoreduction success.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Humans; Hyperthermia, Induced; Infant; International Classification of Diseases; Reproducibility of Results; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Vincristine | 2006 |
Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Germinoma; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Testicular Neoplasms | 2006 |
Growth hormone deficiency after localized ganglioneuroblastoma: A case report.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Body Height; Carboplatin; Etoposide; Ganglioneuroblastoma; Growth Hormone; Humans; Hypothalamus; Infant; Male; Pituitary Gland | 2006 |
[Effect of interleukin-2 on apoptosis and function of human lymphocytes in in-vitro cytostatics culture].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Interleukin-2; Leukocytes, Mononuclear; Male | 2005 |
The association of chemotherapy induced neutropenia on treatment outcomes in small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Fever; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Treatment Outcome | 2006 |
Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Intraoperative Complications; Laser Therapy; Male; Neoplasm Recurrence, Local; Postoperative Complications; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome; Vincristine; Visual Acuity | 2007 |
Carcinoma showing thymus-like element (CASTLE) of thyroid: combined modality treatment in 3 patients with locally advanced disease.
Topics: Adult; Antineoplastic Agents; Carboplatin; Carcinoma; Drug Therapy, Combination; Etoposide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Radiography; Radiotherapy, Adjuvant; Thymus Neoplasms; Thyroid Neoplasms; Thyroidectomy | 2007 |
Stage 4S neuroblastoma, a disseminated tumor with excellent outcome.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Age Factors; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hepatomegaly; Humans; Infant; Infant, Newborn; Liver Neoplasms; Male; Neoplasm Regression, Spontaneous; Neoplasm Staging; Neuroblastoma; Prognosis; Retrospective Studies; Saudi Arabia; Skin; Skin Neoplasms; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2006 |
Alveolar rhabdomyosarcoma of the clivus with intrasellar expansion: Case report.
Topics: Abducens Nerve Diseases; Adrenocorticotropic Hormone; Angiography; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain; Carboplatin; Child, Preschool; Etoposide; Human Growth Hormone; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Radiosurgery; Rhabdomyosarcoma; Sella Turcica; Spine | 2006 |
[Role of radiotherapy of lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose Fractionation, Radiation; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Remission Induction; Survival Analysis; Time Factors; Treatment Outcome | 2006 |
Successful neoadjuvant synchronous chemo- and radiotherapy for disseminated primary intracranial choriocarcinoma: case report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Etoposide; Humans; Male; Methotrexate; Neoadjuvant Therapy; Peripheral Blood Stem Cell Transplantation; Treatment Outcome | 2007 |
[A case of CD56 positive T-cell lymphoma originating from mediastinal lymph nodes].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; CD56 Antigen; Cyclophosphamide; Dexamethasone; Diagnosis, Differential; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymph Nodes; Lymphoma, T-Cell; Male; Mediastinal Neoplasms; Middle Aged; Pleural Effusion, Malignant; Prednisolone; Tuberculosis, Pleural; Vincristine | 2006 |
Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Infection Control; Kaplan-Meier Estimate; Melphalan; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Postoperative Care; Retrospective Studies; Risk; Salvage Therapy; Sarcoma, Ewing; Topotecan; Transplantation Conditioning; Transplantation, Autologous; Treatment Failure; Vincristine | 2007 |
A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Evoked Potentials, Auditory, Brain Stem; Hearing; Hearing Loss; Humans; Infant; Infant, Newborn; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Vincristine | 2008 |
Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Biphenyl Compounds; Carboplatin; Carcinoma, Small Cell; Cell Growth Processes; Cell Line, Tumor; Down-Regulation; Drug Synergism; Etoposide; Humans; Lung Neoplasms; Membrane Proteins; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Nitrophenols; Piperazines; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering; Sulfonamides; Transfection; Up-Regulation | 2007 |
Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I in a patient with metastasizing large-cell carcinoma of the lung.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Carboplatin; Carcinoma, Large Cell; Chromatography, Gel; Etoposide; Female; Human Growth Hormone; Humans; Hypoglycemia; Immunohistochemistry; In Situ Hybridization; Insulin; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Paraneoplastic Endocrine Syndromes; Reverse Transcriptase Polymerase Chain Reaction; RNA | 2007 |
[A case of recurrent Helicobacter cinaedi-associated bacteremia in a small cell lung cancer patient during chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Helicobacter Infections; Humans; Immunocompromised Host; Lung Neoplasms; Male; Middle Aged; Recurrence | 2007 |
Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biliary Atresia; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunocompromised Host; Immunosuppressive Agents; Liver Transplantation; Lymphoma, T-Cell, Peripheral; Lymphoproliferative Disorders; Melphalan; Mesna; Postoperative Complications; Prednisone; Radiotherapy, Adjuvant; Transplantation, Autologous; Vidarabine; Vincristine | 2008 |
The combined effects of multiple chemotherapeutic agents for malignant glioma cells.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cell Line, Tumor; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Synergism; Etoposide; Glioma; Humans; Models, Statistical; Nimustine; Vincristine | 2007 |
Secondary glioblastoma multiforme after treatment for primary choroid plexus carcinoma in childhood.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Choroid Plexus Neoplasms; Cisplatin; Combined Modality Therapy; Diagnosis, Differential; Etoposide; Fatal Outcome; Glioblastoma; Humans; Male; Neoplasms, Second Primary; Vincristine | 2007 |
Syndrome of inappropriate antidiuretic hormone secretion and ectopic ACTH production in small cell lung carcinoma.
Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Immunohistochemistry; Inappropriate ADH Syndrome; Lung Neoplasms; Middle Aged; Radiography; Remission Induction | 2007 |
[Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
Topics: Adult; Antineoplastic Agents; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cell Survival; Cells, Cultured; Cisplatin; Cyclophosphamide; Drug Screening Assays, Antitumor; Etoposide; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Uterine Cervical Neoplasms | 2007 |
Collagen gel matrix assay as an in vitro chemosensitivity test for malignant astrocytic tumors.
Topics: Adult; Aged; Antineoplastic Agents; Astrocytoma; Carboplatin; Central Nervous System Neoplasms; Cisplatin; Collagen; Disease Progression; Disease-Free Survival; Drug Screening Assays, Antitumor; Etoposide; Female; Fibrin Foam; Follow-Up Studies; Glioblastoma; Humans; Japan; Karnofsky Performance Status; Male; Middle Aged; Nimustine; Sensitivity and Specificity; Survival Analysis; Tissue Adhesives; Treatment Outcome; Tumor Burden; Tumor Cells, Cultured | 2007 |
Unexpected dementia following prophylactic cranial irradiation for small cell lung cancer: case report.
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Carcinoma, Small Cell; Central Nervous System Neoplasms; Combined Modality Therapy; Dementia; Etoposide; Female; Humans; Lung Neoplasms; Memory Disorders; Radiotherapy | 2007 |
Anthracycline-based adjuvant chemotherapy in early-stage uterine sarcomas: long-term results of a single institution experience.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Staging; Sarcoma; Survival Analysis; Treatment Outcome; Uterine Neoplasms | 2007 |
Salvage chemotherapy with high-dose carboplatin plus etoposide and autologous peripheral blood stem cell transplant in male pure choriocarcinoma: a retrospective analysis of 13 cases.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Choriocarcinoma, Non-gestational; Chorionic Gonadotropin; Disease-Free Survival; Etoposide; Hematologic Neoplasms; Humans; Male; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Salvage Therapy; Survival Rate; Testicular Neoplasms; Time Factors; Transplantation, Autologous; Ultrasonography | 2007 |
A case of mixed adult Wilms' tumour and angiosarcoma responsive to carboplatin, etoposide and vincristine (CEO).
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Fatal Outcome; Female; Hemangiosarcoma; Humans; Kidney Neoplasms; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platelet Count; Tomography, X-Ray Computed; Vincristine; Wilms Tumor | 2008 |
Malignant teratoid/rhabdoid tumour: long-term survival.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Infant; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Rhabdoid Tumor; Survivors; Teratoma; Treatment Outcome; Vincristine | 2007 |
Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2007 |
Developmental chemotherapy and management of recurrent ovarian cancer.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Deoxycytidine; Docetaxel; Doxorubicin; Drugs, Investigational; Enzyme Inhibitors; Etoposide; Female; Gemcitabine; Humans; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Randomized Controlled Trials as Topic; Recurrence; Research Design; Taxoids; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome | 2003 |
Uveitis masquerade syndromes: diffuse retinoblastoma in an older child.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Diagnosis, Differential; Etoposide; Eye Enucleation; Humans; Male; Retinal Neoplasms; Retinoblastoma; Syndrome; Tomography, X-Ray Computed; Ultrasonography; Uveitis; Vincristine | 2007 |
Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cryptogenic Organizing Pneumonia; Cyclophosphamide; Cyclosporine; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Methotrexate; Neoplasm Recurrence, Local; Palatal Neoplasms; Remission Induction; Salvage Therapy; Transplantation, Homologous; Vincristine | 2007 |
[Clinical characteristics of cancer of unknown primary (CUP)--a summary of 22 cases].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Prognosis; Survival Rate | 2007 |
[Nutritional pathway for autologous stem cell transplantation].
Topics: Antineoplastic Agents, Alkylating; Body Weight; Carboplatin; Critical Pathways; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Melphalan; Multiple Myeloma; Parenteral Nutrition, Total; Transplantation Conditioning; Transplantation, Autologous | 2007 |
[Successful treatment of a Lambert-Eaton myasthenic syndrome patient with 3,4-diaminopyridine].
Topics: 4-Aminopyridine; Amifampridine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Male; Middle Aged; Pyridostigmine Bromide; Treatment Outcome | 2007 |
Clinical and molecular parameters for risk stratification in Mexican children with medulloblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Etoposide; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Infant; Male; Medulloblastoma; Mexico; Probability; Receptor, ErbB-2; Risk; Risk Assessment; Survival Rate; Time Factors | 2007 |
Accelerated hyperfractionated radiotherapy and concomitant chemotherapy in small cell lung cancer limited-disease. Dose response, feasibility and outcome for patients treated in western Sweden, 1998-2004.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cause of Death; Combined Modality Therapy; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Survival Analysis; Sweden; Treatment Outcome | 2007 |
[Testicular cancer--is there an indication for adjuvant or neoadjuvant systemic therapy?].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Humans; Lymph Node Excision; Male; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Prognosis; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Testicular Neoplasms | 2007 |
The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Cell Line, Tumor; Cell Survival; Dipeptides; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Immunoenzyme Techniques; Male; Melphalan; Mice; Molecular Structure; Neovascularization, Pathologic; Neuroblastoma; Prodrugs; Rats; Rats, Nude; Tumor Cells, Cultured; Vincristine | 2007 |
Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Survival Rate | 2008 |
[Comparison of salvage chemotherapy regimen ACES with ESHAP for refractory or relapsed malignant lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cytarabine; Etoposide; Female; Humans; Lymphoma; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation | 2007 |
[Comparison of regimen-related toxicity between high-dose melphalan and ICE as a preparatory regimen for autologous stem cell transplantation].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Melphalan; Middle Aged; Multiple Myeloma; Stem Cell Transplantation; Transplantation, Autologous | 2007 |
Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child, Preschool; Cisplatin; Cyclophosphamide; Etoposide; Feasibility Studies; Ganglioglioma; Humans; Infant; Medulloblastoma; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Oligodendroglioma; Quality of Life; Retrospective Studies; Thiotepa; Treatment Outcome; Vincristine | 2008 |
Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma; Cisplatin; Etoposide; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Prognosis; Radiotherapy, Adjuvant; Survival Analysis; Vincristine | 2008 |
[Evaluation of second-line chemotherapies most often used in recurrent epithelial ovarian cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cisplatin; Disease-Free Survival; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Middle Aged; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Topotecan; Treatment Outcome | 2007 |
[Chemotherapy of advanced non small cell lung cancer: effect on survival and symptoms affecting quality of life].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Poland; Quality of Life; Retrospective Studies; Survival Analysis; Treatment Outcome; Vinblastine | 2007 |
[Primary neuroendocrine carcinoma of the liver. From carcinoid tumor to small-cell hepatic carcinoma: case reports and review of the literature].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoid Tumor; Carcinoma; Carcinoma, Neuroendocrine; Cell Differentiation; Etoposide; Female; Follow-Up Studies; Humans; Liver Neoplasms; Rectal Neoplasms; Risk Factors; Treatment Outcome | 2008 |
Costs associated with intravenous chemotherapy administration in patients with small cell lung cancer: a retrospective claims database analysis.
Topics: Administration, Oral; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; Etoposide; Female; Health Care Costs; Humans; Infusions, Intravenous; Insurance Claim Review; Irinotecan; Male; Middle Aged; Retrospective Studies; Topotecan; United States; Vincristine | 2008 |
Cutaneous plasmablastic lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; HIV Infections; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Skin Neoplasms; Vincristine | 2008 |
[A patient with small cell lung cancer who developed a drug eruption due to concomitant therapy with carboplatin and etoposide].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Eruptions; Etoposide; Humans; Lung Neoplasms; Male | 2008 |
Childhood papillary thyroid cancer as second malignancy after successful treatment of rhabdomyosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Combined Modality Therapy; Dactinomycin; DNA, Neoplasm; Epirubicin; Etoposide; Humans; Ifosfamide; Infant; Iodine Radioisotopes; Male; Neoplasms, Second Primary; Rhabdomyosarcoma, Embryonal; Spinal Neoplasms; Thoracic Vertebrae; Thyroid Neoplasms; Thyroidectomy; Vincristine | 2008 |
IVE (ifosfamide, epirubicin and etoposide) is a more effective stem cell mobilisation regimen than ICE (ifosphamide, carboplatin and etoposide) in the context of salvage therapy for lymphoma.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Evaluation; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2008 |
Caecal metastasis from a primary small-cell lung carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Stem Neoplasms; Carboplatin; Carcinoma, Small Cell; Cecal Neoplasms; Cecum; Colonoscopy; Combined Modality Therapy; Cranial Irradiation; Etoposide; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged | 2008 |
Diseases desperate grown.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Randomized Controlled Trials as Topic; Research Design; Sample Size; Treatment Outcome | 2008 |
[Erythropoietic protein supportive treatment in small cell lung cancer].
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Erythropoietin; Etoposide; Female; Hematinics; Hemoglobins; Humans; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 2008 |
Infectious complications from high-dose chemotherapy and autologous stem cell transplantation for metastatic germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infections; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Premedication; Retrospective Studies; Transplantation, Autologous | 2008 |
Dose enhancement effect of anticaner drugs associated with increased temperature in vitro.
Topics: Antineoplastic Agents; Carboplatin; Cell Proliferation; Cell Survival; Combined Modality Therapy; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Gemcitabine; HeLa Cells; Humans; Hyperthermia, Induced; Ifosfamide; Organoplatinum Compounds; Oxaliplatin; Taxoids; Temperature; Vinblastine; Vinorelbine | 2008 |
Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cohort Studies; Combined Modality Therapy; Cytarabine; Dexamethasone; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Immunotherapy; Lymphoma, Non-Hodgkin; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Salvage Therapy; Transplantation, Autologous; Treatment Outcome | 2008 |
Granulocytic sarcoma of Core-binding Factor (CBF) acute myeloid leukemia mimicking pancreatic cancer.
Topics: Aged; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; CA-19-9 Antigen; Carboplatin; Core Binding Factors; Diagnosis, Differential; Etoposide; Female; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Lipase; Magnetic Resonance Imaging; Pancreatic Neoplasms; Sarcoma, Myeloid | 2008 |
Primary small cell carcinoma of the breast.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Carboplatin; Carcinoma, Small Cell; Etoposide; Fatal Outcome; Female; Humans; Irinotecan; Liver Neoplasms; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Thoracic Wall | 2009 |
Late relapse of stage i seminoma following single-agent carboplatin.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Etoposide; Humans; Male; Middle Aged; Neoplasm Staging; Recurrence; Seminoma; Testicular Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Excision repair cross complementing-1 and topoisomerase IIalpha gene expression in small-cell lung cancer patients treated with platinum and etoposide: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Antineoplastic Agents; Biomarkers, Tumor; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; DNA Repair; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Endonucleases; Etoposide; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Isoenzymes; Italy; Lung Neoplasms; Male; Middle Aged; Platinum Compounds; Polymerase Chain Reaction; Prognosis; Retrospective Studies; Severity of Illness Index; Survival Rate | 2008 |
Acute renal toxicity of 2 conditioning regimens in patients undergoing autologous peripheral blood stem-cell transplantation. Total body irradiation-cyclophosphamide versus ifosfamide, carboplatin, etoposide.
Topics: Acute Kidney Injury; Adult; Carboplatin; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Immunosuppressive Agents; Kidney; Peripheral Blood Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Whole-Body Irradiation | 2008 |
Transformation of cutaneous gamma/delta T-cell lymphoma following 15 years of indolent behavior.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Transformation, Neoplastic; Clone Cells; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Lymphoma, T-Cell, Cutaneous; Middle Aged; Panniculitis; Prednisone; Receptors, Antigen, T-Cell, gamma-delta; Skin Neoplasms; T-Lymphocytes; Vincristine | 2008 |
Pelvic teratoma with extensive spinal involvement in a neonate: an important differential diagnosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Diagnosis, Differential; Etoposide; Female; Humans; Hypertension; Infant; Neoplasm, Residual; Neuroblastoma; Pelvic Neoplasms; Retroperitoneal Neoplasms; Spinal Cord Compression; Teratoma; Treatment Outcome | 2008 |
Risk factors for hepatic veno-occlusive disease: a retrospective unicentric study in 116 children autografted after a high-dose BU-thiotepa regimen.
Topics: Adolescent; Antineoplastic Agents; Brain Neoplasms; Busulfan; Carboplatin; Child; Child, Preschool; Clonazepam; Etoposide; Female; Hepatic Veno-Occlusive Disease; Humans; Infant; Male; Retrospective Studies; Risk Factors; Sarcoma; Seizures; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Young Adult | 2008 |
In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytes; Carboplatin; Cell Line, Tumor; Cisplatin; Dacarbazine; Drug Screening Assays, Antitumor; Etoposide; Female; Glioblastoma; Glioma; Hepatocytes; Humans; Lomustine; Male; Membrane Glycoproteins; Middle Aged; Procarbazine; Recombinant Fusion Proteins; Temozolomide; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; Vincristine | 2008 |
Recurrent melanotic neuroectodermal tumor of infancy: a proposal for treatment protocol with surgery and adjuvant chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 7; Comparative Genomic Hybridization; Etoposide; Humans; Ifosfamide; Infant; Loss of Heterozygosity; Male; Mandibular Neoplasms; Neoplasm Recurrence, Local; Neuroectodermal Tumor, Melanotic; Vincristine | 2008 |
ERCC1 expression as a prognostic marker in N2(+) nonsmall-cell lung cancer patients treated with platinum-based neoadjuvant concurrent chemoradiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; DNA-Binding Proteins; Docetaxel; Endonucleases; Etoposide; Female; Humans; Immunoenzyme Techniques; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Survival Rate; Taxoids; Treatment Outcome | 2008 |
Clinical manifestations and treatment of retinoblastoma in Korea.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Eye; Eye Enucleation; Female; Humans; Infant; Korea; Male; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome; Vincristine | 2008 |
The Werner's syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compounds.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; B-Lymphocytes; Camptothecin; Carboplatin; Cell Proliferation; Cell Survival; Cells, Cultured; Cisplatin; Daunorubicin; Enzyme Inhibitors; Etoposide; Exodeoxyribonucleases; Genotype; Humans; Platinum Compounds; Polymorphism, Single Nucleotide; RecQ Helicases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Topoisomerase Inhibitors; Werner Syndrome; Werner Syndrome Helicase | 2009 |
The success of primary chemotherapy for group D heritable retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Disease-Free Survival; Etoposide; Eye Enucleation; Female; Germ-Line Mutation; Humans; Infant; Male; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retinoblastoma Protein; Treatment Outcome; Vincristine | 2009 |
Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: a report from the Children's Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infant; Male; Neuroblastoma; Paclitaxel; Survival Rate; Topotecan; Transplantation Conditioning; Treatment Outcome; Vincristine; Young Adult | 2008 |
Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hungary; Hysterectomy; Methotrexate; Middle Aged; Pregnancy; Risk Factors; Vincristine; Young Adult | 2008 |
Small cell carcinoma of unknown primary presenting with disease confined to the central nervous system.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Central Nervous System Neoplasms; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Radiography; Radiotherapy Dosage | 2009 |
Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Prospective Studies; Radiotherapy Dosage; Radiotherapy, Conformal; ROC Curve; Small Cell Lung Carcinoma; Tumor Burden; Vinblastine; Vinorelbine | 2009 |
Pharmacokinetic analysis of carboplatin and etoposide in a small cell lung cancer patient undergoing hemodialysis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Diabetic Nephropathies; Disease-Free Survival; Etoposide; Humans; Kidney Failure, Chronic; Lung Neoplasms; Male; Renal Dialysis; Small Cell Lung Carcinoma | 2008 |
Trilateral retinoblastoma with pituitary-hypothalamic dysfunction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Etoposide; Fatal Outcome; Female; Gestational Age; Humans; Hypothalamic Diseases; Infant; Infusions, Parenteral; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Pituitary Neoplasms; Retinal Neoplasms; Retinoblastoma; Retinoblastoma Protein; Tomography, X-Ray Computed; Topotecan; Vincristine | 2008 |
Molecular profile of breast versus ovarian cancer cells in response to treatment with the anticancer drugs cisplatin, carboplatin, doxorubicin, etoposide and taxol.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carboplatin; Cell Line, Tumor; Cisplatin; Doxorubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Ovarian Neoplasms; Paclitaxel; RNA, Messenger | 2008 |
Long-term survival of a patient with small cell lung cancer after nine lines of chemotherapy and radiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Small Cell Lung Carcinoma; Topotecan; Treatment Outcome | 2008 |
Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children's Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bone Marrow Transplantation; Brain Neoplasms; Carboplatin; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Disease Progression; Etoposide; Female; Humans; Infant; Male; Myeloablative Agonists; Neoplasm Recurrence, Local; Prognosis; Salvage Therapy; Thiotepa; Transplantation, Autologous | 2008 |
[Case of cancer-associated retinopathy in which immediate treatment succeeded].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Fatal Outcome; Humans; Lung Neoplasms; Male; Methylprednisolone; Paraneoplastic Syndromes; Prednisolone; Pulse Therapy, Drug; Retinal Diseases; Treatment Outcome | 2008 |
Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers.
Topics: Adenocarcinoma; Adult; Aged; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cetuximab; Deoxycytidine; Disease Models, Animal; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Etoposide; Female; Gemcitabine; Gene Expression Profiling; Genes, ras; Humans; Immunoblotting; Lung Neoplasms; Male; Mice; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Middle Aged; Mutation; Oligonucleotide Array Sequence Analysis; Paclitaxel; Polymerase Chain Reaction; Prognosis; Protein Kinase Inhibitors; Quinazolines; Radiation-Sensitizing Agents; Small Cell Lung Carcinoma; Tumor Suppressor Protein p53; Vinblastine; Vinorelbine; Xenograft Model Antitumor Assays | 2008 |
Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with Wilms tumour.
Topics: Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Glomerular Filtration Rate; Humans; Ifosfamide; Infant; Kidney Neoplasms; Kidney Tubules; Linear Models; Male; Nephrectomy; Prospective Studies; Treatment Outcome; Vincristine; Wilms Tumor | 2009 |
High-dose chemotherapy followed by stem cell rescue for high-risk germ cell tumors: the Stanford experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal | 2009 |
No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Radiotherapy Dosage; Remission Induction; Salvage Therapy; Thiotepa; Vincristine; Young Adult | 2009 |
Possible contribution of aprepitant to ifosfamide-induced neurotoxicity.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carboplatin; Dexamethasone; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Male; Morpholines; Nausea; Nerve Sheath Neoplasms; Neurotoxicity Syndromes | 2008 |
Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma.
Topics: Adrenal Gland Neoplasms; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Fluorouracil; Focal Nodular Hyperplasia; Granulocyte Colony-Stimulating Factor; Hepatectomy; Hepatoblastoma; Humans; Ifosfamide; Immunoglobulin G; Incidental Findings; Liver Neoplasms; Male; Melphalan; Mesna; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neuroblastoma; Radiotherapy, Adjuvant; Tomography, X-Ray Computed; Vincristine | 2008 |
Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dose Fractionation, Radiation; Etoposide; Female; Humans; Male; Medulloblastoma; Methotrexate; Neoplasm Metastasis; Radiotherapy Dosage; Survival Rate; Treatment Outcome | 2009 |
Factors associated with severe acute esophagitis from hyperfractionated radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer.
Topics: Acute Disease; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Esophagitis; Etoposide; Female; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Small Cell Lung Carcinoma | 2009 |
Glassy cell carcinoma of the uterine cervix responsive to neoadjuvant intraarterial chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Hysterectomy; Infusions, Intra-Arterial; Neoadjuvant Therapy; Neoplasm Staging; Treatment Outcome; Uterine Cervical Neoplasms | 2008 |
Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2009 |
Re: 'A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small-cell lung cancer: a randomized trial'.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Research Design; Small Cell Lung Carcinoma; Treatment Outcome | 2009 |
Anti-Ma2 paraneoplastic encephalitis associated with testicular germ cell tumor treated by carboplatin, etoposide and bleomycin.
Topics: Adult; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Nerve Tissue Proteins; Orchiectomy; Paraneoplastic Syndromes, Nervous System; Testicular Neoplasms | 2008 |
Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Eye Enucleation; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Radiotherapy, High-Energy; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome; Vincristine; Visual Acuity | 2009 |
[Clinical analysis of 81 cases with primary small cell carcinoma of the esophagus].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Etoposide; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplastic Cells, Circulating; Proportional Hazards Models; Retrospective Studies; Survival Rate | 2008 |
Combining carboplatin and etoposide in docetaxel-pretreated patients with castration-resistant prostate cancer: a prospective study evaluating also neuroendocrine features.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Etoposide; Humans; Male; Middle Aged; Orchiectomy; Prognosis; Prospective Studies; Taxoids; Treatment Outcome | 2009 |
Long-term outcomes of surgery for malignant sacrococcygeal teratoma: 20-year experience of a regional UK centre.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Child, Preschool; Etoposide; Female; Follow-Up Studies; Humans; Infant; Male; Neoadjuvant Therapy; Sacrococcygeal Region; Spinal Neoplasms; Teratoma; Treatment Outcome; United Kingdom | 2009 |
Prognostic factors and treatment outcomes of retinoblastoma in pediatric patients: a single-institution study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Infant; Laser Coagulation; Male; Prognosis; Retinal Neoplasms; Retinoblastoma; Survival Rate; Thailand; Treatment Outcome; Vincristine | 2009 |
Treatment of PC3 prostate cancer cells with mitoxantrone, etoposide, doxorubicin and carboplatin induces distinct alterations in the expression of kallikreins 5 and 11.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Kallikreins; Male; Mitoxantrone; Necrosis; Prostatic Neoplasms; RNA, Messenger; Serine Endopeptidases; Time Factors | 2009 |
Self-reported experience of mucositis in cancer patients who underwent conditioning regimen and stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Mucositis; Multiple Myeloma; Neoplasms; Severity of Illness Index; Whole-Body Irradiation; Young Adult | 2009 |
Future research directions for the treatment of AML.
Topics: Antineoplastic Agents; Azacitidine; Biomedical Research; Carbazoles; Carboplatin; Cytarabine; Daunorubicin; Decitabine; Enzyme Inhibitors; Etoposide; Flavonoids; Furans; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Piperidines; Quinolones; Staurosporine; Topotecan; Tretinoin | 2008 |
Sudden dispersion of retinoblastoma shortly after initial chemotherapy treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Humans; Infant; Male; Neoplasm Seeding; Retinal Neoplasms; Retinoblastoma; Vincristine; Vitreous Body | 2009 |
Interferon-beta, MCNU, and conventional radiotherapy for pediatric patients with brainstem glioma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Carboplatin; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; DNA Methylation; Etoposide; Female; Glioma; Humans; Interferon-beta; Magnetic Resonance Imaging; Male; Nitrosourea Compounds; Retrospective Studies; Temozolomide; Treatment Outcome | 2009 |
Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infant; Kidney Neoplasms; Male; Melphalan; Prognosis; Rhabdoid Tumor; Survival Rate; Tomography, X-Ray Computed; Transplantation, Autologous; Treatment Outcome; Vincristine | 2009 |
Retinoblastoma regression patterns following chemoreduction and adjuvant therapy in 557 tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Calcinosis; Carboplatin; Child, Preschool; Cryotherapy; Etoposide; Female; Humans; Hyperthermia, Induced; Infant; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Vincristine | 2009 |
Primary cystic germinoma originating from the midbrain.
Topics: Adult; Antineoplastic Agents; Biopsy; Brain Stem Neoplasms; Carboplatin; Central Nervous System Cysts; Diplopia; Etoposide; Germinoma; Humans; Male; Mesencephalon; Radiotherapy; Treatment Outcome | 2009 |
Topotecan-carboplatin-etoposide combination as 1st line treatment in patients with small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease Progression; Dose-Response Relationship, Drug; Drug Tolerance; Etoposide; Female; Humans; Lung Neoplasms; Male; Small Cell Lung Carcinoma; Topotecan; Treatment Outcome | 2009 |
Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue.
Topics: Adolescent; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Etoposide; Female; Germinoma; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Survival Rate; Thiotepa; Treatment Outcome | 2009 |
Small cell carcinoma of the pancreas: role of EUS-FNA and subsequent effective chemotherapy using carboplatin and etoposide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy, Fine-Needle; Carboplatin; Carcinoma, Small Cell; Endosonography; Etoposide; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms; Tomography, X-Ray Computed; Ultrasonography, Interventional | 2009 |
Efficacy of temozolomide treatment in patients with high-grade glioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Etoposide; Female; Glioblastoma; Gliosarcoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Oligodendroglioma; Prognosis; Temozolomide; Treatment Outcome; Tumor Necrosis Factor-alpha | 2009 |
Management of pilomyxoid astrocytomas: our experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Prognosis | 2009 |
From upfront nephrectomy to preoperative chemotherapy and back: a single institution experience in the treatment of Wilms tumor.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Infant; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Neoplasm Staging; Nephrectomy; Preoperative Care; Retrospective Studies; Treatment Outcome; Vincristine; Wilms Tumor | 2009 |
Desmoplastic small round cell tumor in children: a new therapeutic approach.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Child; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 22; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Neoadjuvant Therapy; Oncogene Proteins, Fusion; Pelvic Neoplasms; Radiotherapy, Adjuvant; Sarcoma, Small Cell; Splenic Neoplasms; Translocation, Genetic; Transplantation, Autologous; Vincristine | 2009 |
Chemotherapy is of limited efficacy in the control of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma in Situ; Combined Modality Therapy; Etoposide; Humans; Male; Neoplasm Staging; Orchiectomy; Prognosis; Radiotherapy Dosage; Seminoma; Testicular Neoplasms; Treatment Outcome; Young Adult | 2009 |
Results of surgical treatment for patients with small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Preoperative Care; Prognosis; Small Cell Lung Carcinoma; Survival Rate; Vincristine | 2009 |
The stage of offspring of female rats after treatment with cytostatics of various groups.
Topics: Animals; Carboplatin; Cisplatin; Cytostatic Agents; Drug Administration Schedule; Epirubicin; Etoposide; Female; Male; Paclitaxel; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Time Factors | 2008 |
Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in adolescents.
Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carboplatin; Cisplatin; Cyclophosphamide; Double-Blind Method; Drug Interactions; Etoposide; Fever; Humans; Ifosfamide; Incidence; Morpholines; Nausea; Neutropenia; Randomized Controlled Trials as Topic; Sample Size; Vomiting | 2009 |
The occurrence of hyponatremia in SCLC and the influence on prognosis: a retrospective study of 453 patients treated in a single institution in a 10-year period.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Disease Progression; Etoposide; Female; Humans; Hyponatremia; Lung Neoplasms; Male; Neoplasm Staging; Plasma; Prognosis; Retrospective Studies; Sex Factors; Small Cell Lung Carcinoma; Sodium; Survival Analysis | 2010 |
Changes in serum tryptophan catabolism as an indicator of disease activity in adult T-cell leukemia/lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Drug Monitoring; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Leukemia-Lymphoma, Adult T-Cell; Metabolic Networks and Pathways; Neoplasm Proteins; Neoplastic Cells, Circulating; Neutropenia; Nitrosourea Compounds; Prednisone; Receptors, Interleukin-2; Tryptophan; Tryptophan Oxygenase; Vincristine; Vindesine | 2009 |
Isolated pancreatic metastases from a bronchogenic small cell carcinoma.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bronchial Neoplasms; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Middle Aged; Pancreatic Neoplasms; Radiography; Ultrasonography | 2009 |
Population analysis of myelosuppression profiles using routine clinical data after the ICE (ifosfamide/carboplatin/etoposide) regimen for malignant gliomas.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Carboplatin; Computer Simulation; Etoposide; Female; Glioma; Humans; Ifosfamide; Immunosuppressive Agents; Kinetics; Leukocyte Count; Male; Middle Aged; Models, Statistical; Monte Carlo Method; Neutropenia; Platelet Count; Reticulocyte Count; Retrospective Studies | 2009 |
A case of extranodal NK/T-cell lymphoma, nasal type mimicking typical manifestations of adult-onset Still's disease (AOSD) with hemophagocytic syndrome: diagnostic consideration between malignant lymphoma without lymphadenopathy and AOSD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Dexamethasone; Diagnosis, Differential; Disease Progression; Etoposide; Herpesvirus 4, Human; Humans; Ifosfamide; Lymph Nodes; Lymphatic Diseases; Lymphoma, Extranodal NK-T-Cell; Male; Radiography; Splenomegaly; Still's Disease, Adult-Onset; Treatment Outcome | 2009 |
A newly developed lung nodule during chemotherapy for small cell lung cancer. Chronic necrotising pulmonary aspergillosis.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chronic Disease; Etoposide; Humans; Lung Neoplasms; Male; Pulmonary Aspergillosis; Pyrimidines; Small Cell Lung Carcinoma; Triazoles; Voriconazole | 2009 |
Retinoma underlying retinoblastoma revealed after tumor response to 1 cycle of chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Calcinosis; Carboplatin; Child, Preschool; Cyclosporine; Etoposide; Eye Enucleation; Humans; Male; Retinal Diseases; Retinal Neoplasms; Retinoblastoma; Vincristine | 2009 |
[Clinical observation on the treatment outcome of 14 children with hepatoblastoma in a single medical center].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Hepatoblastoma; Humans; Ifosfamide; Infant; Liver Neoplasms; Male | 2009 |
The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
Topics: Aged; Anastomosis, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Pneumonectomy; Postoperative Complications; Pulmonary Diffusing Capacity; Radiotherapy Dosage; Retrospective Studies | 2009 |
High dose chemoradiotherapy and ASCT may overcome the prognostic importance of biologic markers in relapsed/refractory Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Biomarkers, Tumor; Carboplatin; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Immunohistochemistry; Membrane Proteins; Middle Aged; Prognosis; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Salvage Therapy; Transplantation, Autologous; Tumor Suppressor Protein p53; Young Adult | 2010 |
[Gastric metastasis from small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Fatal Outcome; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Pneumonia; Stomach Neoplasms; Vincristine | 2009 |
A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Dura Mater; Etoposide; Femur; Humans; Infant; Iodine Radioisotopes; Male; Meningeal Neoplasms; Neoplasm Staging; Neoplasm, Residual; Neuroblastoma; Radionuclide Imaging; Remission Induction; Skin Neoplasms | 2009 |
[A case of primary small cell carcinoma of the esophagus responding remarkably to carboplatin (CBDCA) + etoposide (VP-16) combination therapy and radiation therapy].
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Esophageal Neoplasms; Etoposide; Humans; Male | 2009 |
Neuroblastoma in the newborn. A study of the Italian Neuroblastoma Registry.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Gene Amplification; Humans; Infant; Infant, Newborn; Italy; Male; Neoplasm Staging; Neuroblastoma; Pregnancy; Prenatal Diagnosis; Registries; Survival Rate; Treatment Outcome; Vincristine | 2009 |
Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Irradiation; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Small Cell Lung Carcinoma; Survival Analysis; Tomography, X-Ray Computed | 2010 |
Chemotherapy: Irinotecan or etoposide as front-line therapy for SCLC?
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Camptothecin; Carboplatin; Cisplatin; Clinical Trials, Phase III as Topic; Diarrhea; Drug Therapy; Drug Therapy, Combination; Enzyme Inhibitors; Ethnicity; Etoposide; Female; Follow-Up Studies; Glucuronosyltransferase; Humans; Irinotecan; Lung Neoplasms; Male; Neutropenia; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Small Cell Lung Carcinoma; Survival Analysis; Therapeutic Equivalency; Time Factors; Treatment Outcome | 2009 |
[Uveitis masquerade syndrome as a presenting form of diffuse retinoblastoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aqueous Humor; Biomarkers, Tumor; Carboplatin; Child, Preschool; Etoposide; Eye Enucleation; Eye Neoplasms; Humans; L-Lactate Dehydrogenase; Male; Neoplasm Invasiveness; Neoplasm Proteins; Retinoblastoma; Syndrome; Uveitis, Intermediate; Vincristine | 2009 |
Increased chemoresistance induced by inhibition of HIF-prolyl-hydroxylase domain enzymes.
Topics: Amino Acids, Dicarboxylic; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carboplatin; Drug Resistance, Neoplasm; Etoposide; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Procollagen-Proline Dioxygenase | 2010 |
Neuroblastoma involvement of the falx cerebri.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Lineage; Cyclophosphamide; Doxorubicin; Dura Mater; Etoposide; Female; Humans; Infant; Infant, Newborn; Male; Meningeal Neoplasms; Microphthalmia-Associated Transcription Factor; Neoplasm Staging; Neural Crest; Neuroblastoma; Pulmonary Veins; Remission Induction; Skin Neoplasms; Waardenburg Syndrome | 2009 |
Small-cell lung cancer arising after chemotherapy for a patient with lymphoma of pulmonary mucosa-associated lymphoid tissue-a case report.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Cladribine; Etoposide; Fatal Outcome; Female; Humans; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Mucous Membrane; Neoplasms, Second Primary; Rituximab; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2009 |
Re: Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease Progression; Etoposide; Humans; Incidence; Lung Neoplasms; Randomized Controlled Trials as Topic; Small Cell Lung Carcinoma; Thalidomide; Thromboembolism | 2009 |
From glioblastoma to gangliocytoma: an unforeseen but welcome shift in biological behavior.
Topics: Antigens, Nuclear; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Carboplatin; Cell Differentiation; Cell Proliferation; Etoposide; Female; Ganglioneuroma; Glioblastoma; Humans; Hydrocephalus; Infant; Nerve Tissue Proteins; Neurofilament Proteins; Neurosurgical Procedures; Reverse Transcriptase Polymerase Chain Reaction; Synaptophysin | 2009 |
Trilateral retinoblastoma: potentially curable with intensive chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Meningeal Neoplasms; Pineal Gland; Pinealoma; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Vincristine | 2010 |
[Chemotherapy-induced myelosuppression and treatment efficacy in extensive-stage small cell lung cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Camptothecin; Carboplatin; Cisplatin; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma | 2009 |
Retinoblastoma CSF metastasis cured by multimodality chemotherapy without radiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Cerebrospinal Fluid; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cytarabine; Etoposide; Eye Enucleation; Humans; Infant; Male; Prognosis; Retinal Neoplasms; Retinoblastoma; Transplantation, Autologous; Treatment Outcome; Vincristine | 2009 |
The combination of Young's syndrome and small cell lung cancer-A spiky connection?
Topics: Antineoplastic Agents; Azoospermia; Carboplatin; Etoposide; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Radiography; Sinusitis; Small Cell Lung Carcinoma; Syndrome | 2010 |
Iatrogenic tracheoesophageal fistula.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Fatal Outcome; Female; Humans; Iatrogenic Disease; Lung Neoplasms; Middle Aged; Radiotherapy; Small Cell Lung Carcinoma; Tomography, X-Ray Computed; Tracheoesophageal Fistula | 2009 |
Suprasellar germinoma masquerading as lymphocytic hypophysitis associated with central diabetes insipidus, delayed sexual development, and subsequent hypopituitarism.
Topics: Adolescent; Antineoplastic Agents; Carboplatin; Diabetes Insipidus, Neurogenic; Etoposide; Female; Germinoma; Humans; Hypopituitarism; Pituitary Diseases; Puberty, Delayed | 2010 |
[Small cell lung cancer with Sézary syndrome].
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Sezary Syndrome; Small Cell Lung Carcinoma | 2009 |
Chemotherapy: continued lack of progress in SCLC.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials, Phase III as Topic; Etoposide; Glutamates; Guanine; Humans; Neoplasm Staging; Pemetrexed; Small Cell Lung Carcinoma; Treatment Outcome | 2010 |
Hepatosplenic alphabeta T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Transplantation; Carboplatin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Liver Neoplasms; Lymphoma, T-Cell; Male; Methylprednisolone; Positron-Emission Tomography; Prednisolone; Receptors, Antigen, T-Cell, alpha-beta; Splenic Neoplasms; T-Lymphocytes; Tomography, X-Ray Computed; Transplantation Conditioning; Vincristine | 2010 |
Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Dose-Response Relationship, Radiation; Etoposide; Female; Germinoma; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Young Adult | 2010 |
Bevacizumab in combination with sequential high-dose chemotherapy in solid cancer, a feasibility study.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Combined Modality Therapy; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Sarcoma; Young Adult | 2010 |
Sequential fluctuating paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome and Lambert-Eaton myasthenic syndrome in small-cell lung cancer.
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Opsoclonus-Myoclonus Syndrome; Small Cell Lung Carcinoma | 2011 |
Genome-wide examination of genetic variants associated with response to platinum-based chemotherapy in patients with small-cell lung cancer.
Topics: Carboplatin; Cisplatin; Etoposide; Female; Genes; Genome; Humans; Inuit; Lung Neoplasms; Male; Middle Aged; Nerve Tissue Proteins; Platinum; Polymorphism, Single Nucleotide; R-SNARE Proteins; Small Cell Lung Carcinoma | 2010 |
Renal impairment due to white-cell lysis after G-CSF and chemotherapy during pediatric autologous stem cell transplantation.
Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Combined Modality Therapy; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Male; Melphalan; Neuroblastoma; Peripheral Blood Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Tumor Lysis Syndrome | 2010 |
Use of ifosfamide, carboplatin, and etoposide chemotherapy in choroid plexus carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Damage, Chronic; Carboplatin; Child, Preschool; Choroid Plexus Neoplasms; Cognition Disorders; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Neoadjuvant Therapy; Postoperative Complications; Reoperation; Retrospective Studies | 2010 |
Salvage chemotherapy with high-dose carboplatin and etoposide with peripheral blood stem cell transplant in patients with relapsed pure seminoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Drug Administration Schedule; Etoposide; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Seminoma; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 2011 |
Solitary brain metastasis of an occult and stable small-cell lung cancer in a schizophrenic patient: a 3-year control.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antipsychotic Agents; Brain Neoplasms; Carboplatin; Clozapine; Disease-Free Survival; Etoposide; Female; Humans; Lung Neoplasms; Middle Aged; Radiotherapy; Schizophrenia; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2010 |
Carboplatin and etoposide combined with bevacizumab for the treatment of recurrent glioblastoma multiforme.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Carboplatin; Disease-Free Survival; Etoposide; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome | 2010 |
Successful chemotherapy for small-cell lung cancer in an elderly patient undergoing continuous ambulatory peritoneal dialysis.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lung Neoplasms; Male; Peritoneal Dialysis, Continuous Ambulatory; Small Cell Lung Carcinoma; Treatment Outcome | 2010 |
[Evaluation of chemotherapy, especially combined therapy with Carboplatin Plus Etoposide(CE), in patients aged > or =80 years old with extensive-disease small-cell lung cancer].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lung Neoplasms; Male; Neoplasm Staging; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate | 2010 |
Achievement of a continuous complete remission in a kidney transplant patient with advanced donor-derived small cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cadaver; Carboplatin; Carcinoma, Small Cell; Etoposide; Glomerulonephritis; Humans; Immunosuppressive Agents; Immunotherapy; Kidney Transplantation; Male; Middle Aged; Neoplasm Metastasis; Tissue Donors | 2010 |
Successful treatment of late, recurrent wilms tumor with high-dose chemotherapy and autologous stem cell rescue in third complete response.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Kidney Neoplasms; Male; Melphalan; Neoplasm Recurrence, Local; Salvage Therapy; Wilms Tumor | 2010 |
Chemoreduction for nonvisualized retinoblastoma hidden behind dense cataract.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cataract; Cataract Extraction; Combined Modality Therapy; Etoposide; Female; Humans; Hyperthermia, Induced; Infant; Magnetic Resonance Imaging; Retinal Neoplasms; Retinoblastoma; Tomography, X-Ray Computed; Ultrasonography; Vincristine | 2010 |
Neutropenic enterocolitis during first-line chemotherapy with carboplatin and etoposide in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Enterocolitis, Neutropenic; Etoposide; Female; Humans; Lung Neoplasms; Middle Aged; Neoadjuvant Therapy; Radiography; Small Cell Lung Carcinoma | 2011 |
Merkel cell carcinoma: 27-year experience at the Peter MacCallum Cancer Centre.
Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Lymph Node Excision; Male; Neoplasm Recurrence, Local; Radiotherapy Dosage; Retrospective Studies; Skin Neoplasms; Tumor Burden | 2011 |
Pattern of relapse and outcome of non-metastatic germinoma patients treated with chemotherapy and limited field radiation: the SFOP experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Radiotherapy Dosage; Survival Rate; Treatment Outcome | 2010 |
Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiotherapy; Salvage Therapy; Tomography, X-Ray Computed; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult | 2010 |
Chemoresistance testing of human ovarian cancer cells and its in vitro model.
Topics: Antineoplastic Agents; Carboplatin; Carcinoma; Cell Line, Tumor; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Female; Gemcitabine; Humans; Models, Biological; Ovarian Neoplasms; Paclitaxel; Topotecan | 2010 |
Small cell carcinoma of vulva: curative multimodal treatment in face of resistance to initial standard chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Hyperthermia, Induced; Magnetic Resonance Imaging; Radiography; Tomography, Emission-Computed; Vulvar Neoplasms | 2010 |
Factors for hematopoietic toxicity of carboplatin: refining the targeting of carboplatin systemic exposure.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Blood Platelets; Carboplatin; Cell Proliferation; Deoxycytidine; Etoposide; Female; France; Gemcitabine; Humans; Leukocyte Count; Male; Middle Aged; Models, Biological; Neutropenia; Neutrophils; Paclitaxel; Platelet Count; Prospective Studies; Risk Assessment; Risk Factors; Thrombocytopenia; Young Adult | 2010 |
Second high-dose chemotherapy intensification followed by hematopoietic stem cell transplantation applying a novel high-dose topotecan-based regimen in an adult Wilms' tumor patient: case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Kidney Neoplasms; Male; Melphalan; Nephrectomy; Topotecan; Wilms Tumor; Young Adult | 2011 |
Ophthalmic vasculature alterations following systemic chemotherapy and periocular Carboplatin treatment of advanced retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Cancer, Regional Perfusion; Child, Preschool; Combined Modality Therapy; Cyclosporine; Etoposide; Female; Fluorescein Angiography; Humans; Infant; Injections, Intra-Arterial; Laser Coagulation; Ophthalmic Artery; Retinal Artery; Retinal Neoplasms; Retinoblastoma; Sclerosis; Vincristine | 2010 |
Acute pancreatitis induced by ifosfamide therapy.
Topics: Acute Disease; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Combined Modality Therapy; Drug-Related Side Effects and Adverse Reactions; Etoposide; Female; Humans; Ifosfamide; Pancreatitis; Recurrence; Wilms Tumor | 2010 |
Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hepatoblastoma; Humans; Ifosfamide; Infant; Infant, Newborn; Japan; Liver; Liver Neoplasms; Male; Survival Analysis; Treatment Outcome | 2011 |
Phase II study of dose-intense chemotherapy with sequential topoisomerase-targeting regimens with irinotecan/oxaliplatin followed by etoposide/carboplatin in chemotherapy naive patients with extensive small cell lung cancer.
Topics: Aged; Aged, 80 and over; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Small Cell; Disease-Free Survival; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Endonucleases; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Survival Analysis | 2011 |
Ocular medulloepithelioma chemosensitivity.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Ciliary Body; Etoposide; Humans; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Neoplasm Staging; Neuroectodermal Tumors, Primitive; Uveal Neoplasms; Vincristine | 2010 |
Involved-field radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer: disease control, patterns of failure and survival.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Treatment Outcome | 2010 |
Which therapy works better in choroid plexus carcinomas?
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Choroid Plexus Neoplasms; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Meta-Analysis as Topic; Neoplasm Recurrence, Local; Radiotherapy; Survival Rate; Treatment Outcome; Vincristine | 2011 |
Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide for patients with relapsed primary mediastinal nonseminomatous germ cell tumors: benefit from chemotherapy, surgery, or both?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Salvage Therapy; Testicular Neoplasms | 2010 |
Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Lomustine; Male; Melphalan; Mesna; Neuroblastoma; Pilot Projects; Risk Factors; Thoracic Neoplasms; Topotecan; Treatment Outcome | 2011 |
Genome-wide interrogation identifies YAP1 variants associated with survival of small-cell lung cancer patients.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cohort Studies; Etoposide; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Genome-Wide Association Study; Genotype; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Phosphoproteins; Polymorphism, Single Nucleotide; Prognosis; Promoter Regions, Genetic; Transcription Factors; YAP-Signaling Proteins | 2010 |
[Risk factors for hematologic toxicity and multifaceted analysis of blood in Hodgkin's disease: a model for hematologic toxicity].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Dacarbazine; Discriminant Analysis; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hematologic Diseases; Hodgkin Disease; Humans; Male; Middle Aged; Models, Statistical; Prognosis; Risk Factors; Vinblastine | 2010 |
Successful stem-cell mobilization and transplantation using plerixafor in a patient with a germ cell tumor.
Topics: Antineoplastic Agents; Benzylamines; Carboplatin; Cyclams; Etoposide; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Transplantation, Autologous | 2010 |
Resolution of iris neovascularization following chemoreduction of retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Female; Humans; Iris; Neovascularization, Pathologic; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Ultrasonography; Vincristine; Visual Acuity | 2010 |
Retinocytoma shows lack of response to chemoreduction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Cryotherapy; Esotropia; Etoposide; Female; Humans; Magnetic Resonance Imaging; Neoplasm Seeding; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Vincristine; Visual Acuity; Vitreous Body | 2010 |
Infratentorial brain metastases of pediatric non-epithelial malignant tumors: three case reports.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Infratentorial Neoplasms; Irinotecan; Melphalan; Neoplasm Metastasis; Neuroblastoma; Rhabdomyosarcoma; Thiotepa; Topotecan; Vincristine | 2011 |
Orbital fibrosis and intraocular recurrence of retinoblastoma following periocular carboplatin.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Eye Enucleation; Female; Fibrosis; Humans; Infant; Injections, Intraocular; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Seeding; Orbit; Retinal Neoplasms; Retinoblastoma; Tomography, X-Ray Computed; Vincristine | 2010 |
Percentage tumor necrosis following chemotherapy in neuroblastoma correlates with MYCN status but not survival.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Etoposide; Female; Gene Amplification; Humans; Infant; Male; N-Myc Proto-Oncogene Protein; Necrosis; Neoplasm Staging; Neuroblastoma; Nuclear Proteins; Oncogene Proteins; Pilot Projects; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 2011 |
Neuroblastoma in an adult: case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Brain Neoplasms; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Mesna; Neuroblastoma; Spinal Cord Compression; Spinal Cord Neoplasms; Thoracic Vertebrae; Vincristine; Young Adult | 2010 |
ANZCCSG BabyBrain99; intensified systemic chemotherapy, second look surgery and involved field radiation in young children with central nervous system malignancy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Glioma; Humans; Infant; Male; Melphalan; Radiotherapy Dosage; Remission Induction; Second-Look Surgery; Spinal Neoplasms; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome; Vincristine | 2011 |
Germinoma presenting as a fourth cranial nerve palsy in a patient with adenomatous polyposis coli (APC) gene mutation.
Topics: Adenomatous Polyposis Coli; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Diplopia; Etoposide; Genes, APC; Germinoma; Headache; Humans; Magnetic Resonance Imaging; Male; Papilledema; Point Mutation; Trochlear Nerve Diseases | 2011 |
The feasibility study of Carboplatin plus Etoposide for advanced small cell lung cancer with idiopathic interstitial pneumonias.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Idiopathic Interstitial Pneumonias; Lung Neoplasms; Male; Middle Aged; Prognosis; Prospective Studies; Small Cell Lung Carcinoma; Survival Rate | 2011 |
[Results of combined chemotherapy and local ophtalmic therapy for intraocular retinoblastoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cryotherapy; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Humans; Infant; Infant, Newborn; Light Coagulation; Male; Retinoblastoma; Treatment Outcome; Vincristine | 2010 |
Reversible posterior leukoencephalopathy induced by carboplatin and etoposide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Posterior Leukoencephalopathy Syndrome; Prognosis; Small Cell Lung Carcinoma | 2012 |
Multifaceted chemotherapy for trilateral retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cyclosporine; Cytarabine; Etoposide; Fatal Outcome; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Pineal Gland; Retinal Neoplasms; Retinoblastoma; Tomography, X-Ray Computed; Topotecan; Vincristine | 2011 |
Diffuse infiltrating retinoblastoma with central nervous system metastasis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Etoposide; Humans; Hydrocortisone; Infusions, Intravenous; Injections, Spinal; Magnetic Resonance Imaging; Male; Methotrexate; Retinal Neoplasms; Retinoblastoma; Vincristine | 2011 |
Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Databases, Factual; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Proportional Hazards Models; Retrospective Studies; Salvage Therapy; Thiotepa; Vinblastine; Young Adult | 2011 |
An alternative treatment regimen of advanced seminoma with carboplatin, etoposide, and bleomycin instead of cisplatin-based therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Etoposide; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Remission Induction; Salvage Therapy; Seminoma; Survival Rate; Testicular Neoplasms | 2013 |
Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma.
Topics: Adenocarcinoma, Clear Cell; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Palliative Care; Topotecan; Treatment Outcome | 2011 |
[EBV-associated B-cell lymphoproliferative disorder of the elderly successfully treated with autologous peripheral blood stem cell transplantation and locoregional radiotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Carboplatin; Combined Modality Therapy; Dexamethasone; Etoposide; Herpesvirus 4, Human; Humans; Ifosfamide; Lymphoproliferative Disorders; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Radiotherapy, Adjuvant; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2011 |
Neurocognitive outcomes in pediatric and adolescent patients with central nervous system germinoma treated with a strategy of chemotherapy followed by reduced-dose and volume irradiation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Cognition; Combined Modality Therapy; Etoposide; Germinoma; Humans; Neuropsychological Tests; Radiotherapy; Radiotherapy Dosage; Young Adult | 2011 |
[Diffuse anterior retinoblastoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Humans; Male; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Vincristine | 2011 |
Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Dose Fractionation, Radiation; Etoposide; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Paclitaxel; Retrospective Studies; Risk Assessment; Survival Analysis; Treatment Outcome | 2011 |
[Thoracic radiation therapy improves the prognosis for patients with extensive stage small-cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Humans; Lung Neoplasms; Prognosis; Small Cell Lung Carcinoma; Survival Rate | 2011 |
Copy number polymorphisms and anticancer pharmacogenomics.
Topics: Antineoplastic Agents; Biomarkers, Pharmacological; Carboplatin; Cell Line, Tumor; Cisplatin; Daunorubicin; Etoposide; Gene Dosage; Gene Expression; Genetic Predisposition to Disease; Genetic Variation; Genome-Wide Association Study; Genome, Human; Humans; Inhibitory Concentration 50; Neoplasms; Oligonucleotide Array Sequence Analysis; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Quantitative Trait Loci; Topoisomerase II Inhibitors | 2011 |
First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Survival Rate; Treatment Outcome; Vincristine | 2012 |
Sequential or concomitant chemotherapy in limited stage small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Proportional Hazards Models; Radiotherapy, Conformal; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate; Treatment Outcome | 2011 |
Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Infant; Leucovorin; Magnetic Resonance Imaging; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Radiotherapy; Remission Induction; Survival Rate; Vincristine | 2011 |
Impact of induction chemotherapy on estimated risk of radiation pneumonitis in small cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Radiation Pneumonitis; Radiotherapy, Conformal; Retrospective Studies; Risk Assessment; Small Cell Lung Carcinoma; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
[Successful treatment of a case of advanced adult Wilms' tumor with pre-surgical chemotherapy, irradiation and radical nephrectomy].
Topics: Adult; Androgen Antagonists; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Lung Neoplasms; Male; Nephrectomy; Treatment Outcome; Wilms Tumor | 2011 |
Fertility sparing surgery for ovarian tumors in children and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Child; Cisplatin; Etoposide; Female; Fertility Preservation; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Organ Sparing Treatments; Ovarian Cysts; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Prospective Studies; Young Adult | 2012 |
Intracranial germ cell tumors: efficacy of neoadjuvant chemo-radiotherapy without surgical biopsy.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Carboplatin; Child; Chorionic Gonadotropin; Combined Modality Therapy; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Neoadjuvant Therapy; Neoplasms, Germ Cell and Embryonal; Proportional Hazards Models; Radiotherapy Dosage; Treatment Outcome; Young Adult | 2011 |
Long-term survival in patients with newly diagnosed primary central nervous system lymphoma treated with dexamethasone, etoposide, ifosfamide and carboplatin chemotherapy and whole-brain radiation therapy.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Chemoradiotherapy; Cognition Disorders; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukopenia; Lymphoma; Male; Middle Aged; Outcome Assessment, Health Care; Radiotherapy; Retrospective Studies; Survivors; Young Adult | 2011 |
[Poorly-differentiated neuroendocrine carcinoma of ascending colon with liver metastases successfully treated with carboplatin and etoposide].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cell Differentiation; Colonic Neoplasms; Combined Modality Therapy; Etoposide; Female; Humans; Liver Neoplasms | 2011 |
Physiologically based pharmacokinetic modelling of high- and low-dose etoposide: from adults to children.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carboplatin; Child; Child, Preschool; Computer Simulation; Cyclophosphamide; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Etoposide; Female; Humans; Infant; Male; Melphalan; Metabolic Clearance Rate; Middle Aged; Models, Biological; Neoplasms; Protein Binding | 2012 |
Ifosfamide, carboplatin and etoposide in recurrent malignant glioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Dacarbazine; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Ifosfamide; Male; Middle Aged; Recurrence; Retrospective Studies; Temozolomide; Treatment Failure | 2011 |
Five hundred patients with Merkel cell carcinoma evaluated at a single institution.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Merkel Cell; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Infusion Pumps; Irinotecan; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Research Design; Skin Neoplasms; Treatment Outcome | 2011 |
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Carboplatin; Disease-Free Survival; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Retrospective Studies; Risk Factors; Salvage Therapy; Stem Cell Transplantation; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult | 2012 |
The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Cisplatin; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Germinal Center; Humans; Ifosfamide; Immunohistochemistry; In Situ Hybridization, Fluorescence; Lymphoma, Large B-Cell, Diffuse; Male; Microarray Analysis; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Neoplasm Proteins; Neoplasm, Residual; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Rituximab; Salvage Therapy | 2011 |
Implications of delayed initiation of radiotherapy: accelerated repopulation after induction chemotherapy for stage III non-small cell lung cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Induction Chemotherapy; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Retrospective Studies; Time Factors; Tomography, X-Ray Computed | 2011 |
Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Lung; Lung Transplantation; Male; Middle Aged; Radiation Pneumonitis; Radiotherapy Dosage; Radiotherapy, Conformal; Recurrence; Risk Assessment; Vinblastine; Young Adult | 2012 |
Acinar Cell Carcinoma Responding to Carboplatin/Etoposide Chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Acinar Cell; Chromogranins; Etoposide; Humans; Keratins; Ki-67 Antigen; Lymphatic Metastasis; Male; Pancreatic Neoplasms; Prognosis; Synaptophysin | 2012 |
Application of high-dose rate (60)Co remote after-loading system for local recurrent neuroblastoma.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Busulfan; Carboplatin; Cisplatin; Cobalt Radioisotopes; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Male; Melphalan; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neuroblastoma; Peripheral Blood Stem Cell Transplantation; Radiotherapy Dosage; Radiotherapy, Adjuvant; Remission Induction; Vidarabine; Vincristine | 2011 |
Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child, Preschool; Etoposide; Eye Enucleation; Female; Humans; Infant; Male; Neoplasm Invasiveness; Optic Nerve Neoplasms; Postoperative Care; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Risk Factors; Treatment Outcome; Uveal Neoplasms; Vincristine | 2011 |
Histiocytic sarcoma of the thyroid.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Glutamates; Guanine; Histiocytic Sarcoma; Humans; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Palliative Care; Pemetrexed; Positron-Emission Tomography; Receptors, Cell Surface; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
A huge intraventricular congenital anaplastic astrocytoma: case report with histopathological and genetic consideration.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Combined Modality Therapy; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Etoposide; Female; Humans; Incidental Findings; Infant, Newborn; Isocitrate Dehydrogenase; Neurosurgical Procedures; Pregnancy; Promoter Regions, Genetic; Tumor Suppressor Proteins; Ultrasonography, Prenatal | 2012 |
An unusual cause for weight loss and diabetes.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Diabetes Mellitus; Etoposide; Glucagonoma; Humans; Liver Neoplasms; Male; Octreotide; Pancreatic Neoplasms; Weight Loss | 2011 |
Teratoid Wilms' tumor: case report of a rare variant that can mimic aggressive biology during chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dactinomycin; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Infant; Kidney Neoplasms; Male; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Nephrectomy; Prognosis; Stromal Cells; Vincristine; Wilms Tumor | 2011 |
A child with leukocoria.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blindness; Carboplatin; Child, Preschool; Diagnosis, Differential; Emergencies; Etoposide; Eye Abnormalities; Eye Enucleation; Eye Neoplasms; Eye Pain; Humans; Male; Pupil Disorders; Remission Induction; Retinal Diseases; Retinoblastoma; Vincristine | 2011 |
Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Clinical Trials, Phase III as Topic; Collagen Type XVIII; Disease-Free Survival; DNA-Binding Proteins; Endonucleases; Etoposide; Glutamates; Guanine; Humans; Kaplan-Meier Estimate; Logistic Models; Lung Neoplasms; Methylenetetrahydrofolate Reductase (NADPH2); Pemetrexed; Peptide Synthases; Phosphoribosylglycinamide Formyltransferase; Polymorphism, Single Nucleotide; Randomized Controlled Trials as Topic; Reduced Folate Carrier Protein; Small Cell Lung Carcinoma; Thymidylate Synthase | 2012 |
Successful treatment of ICE-rituximab chemotherapy and subsequent bone marrow transplantation in a patient with early-relapse Burkitt leukemia and inverted duplication of 1q.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Burkitt Lymphoma; Carboplatin; Child; Chromosome Duplication; Chromosomes, Human, Pair 1; Etoposide; Humans; Ifosfamide; Male; Mesna; Neoplasm Recurrence, Local; Rituximab | 2012 |
Hypoxia-inducible factor-1α and excision repair cross-complementing 1 in patients with small cell lung cancer who received front-line platinum-based chemotherapy: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Brain Neoplasms; Camptothecin; Carboplatin; Cisplatin; DNA-Binding Proteins; Endonucleases; Etoposide; Female; Follow-Up Studies; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoenzyme Techniques; Irinotecan; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate | 2012 |
Residual intraretinal retinoblastoma after chemoreduction failure.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Eye Enucleation; Female; Humans; Infant; Male; Neoplasm, Residual; Retinal Neoplasms; Retinoblastoma; Treatment Failure; Ultrasonography; Vincristine | 2012 |
ERCC1 and topoisomerase I expression in small cell lung cancer: prognostic and predictive implications.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Cisplatin; Disease-Free Survival; DNA Topoisomerases, Type I; DNA-Binding Proteins; Doxorubicin; Endonucleases; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Transcription, Genetic; Vincristine | 2012 |
Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase III as Topic; Deoxycytidine; Etoposide; Female; Fibroblast Growth Factor 2; Gemcitabine; Humans; Intercellular Adhesion Molecule-1; Interleukin-8; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Neovascularization, Pathologic; Proportional Hazards Models; Randomized Controlled Trials as Topic; Small Cell Lung Carcinoma; Survival Analysis; Thalidomide; Treatment Outcome; Vascular Endothelial Growth Factor A | 2012 |
Mandibular ameloblastic carcinoma in a young patient.
Topics: Ameloblastoma; Biopsy; Bone Marrow; Carboplatin; Child; Etoposide; Female; Humans; Mandibular Neoplasms; Neoplasm Metastasis; Odontogenic Tumors; Pleural Effusion; Prognosis; Sensitivity and Specificity; Treatment Outcome | 2012 |
Treatment outcomes, growth height, and neuroendocrine functions in patients with intracranial germ cell tumors treated with chemoradiation therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Body Height; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Child; Cranial Irradiation; Craniospinal Irradiation; Disease-Free Survival; Endocrine Glands; Etoposide; Female; Growth; Growth Hormone; Humans; Male; Neoplasms, Germ Cell and Embryonal; Obesity; Pituitary Hormones; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Survival Rate; Treatment Outcome; Trophoblasts; Young Adult | 2012 |
Neuroendocrine carcinoma in an adolescent with hypercortisolemia.
Topics: Adolescent; Adrenalectomy; Adrenocortical Hyperfunction; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Combined Modality Therapy; Etoposide; Humans; Male; Neoadjuvant Therapy; Tomography, X-Ray Computed | 2012 |
HADHA is a potential predictor of response to platinum-based chemotherapy for lung cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Electrophoresis, Gel, Two-Dimensional; Etoposide; Follow-Up Studies; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Mitochondrial Trifunctional Protein; Mitochondrial Trifunctional Protein, alpha Subunit; Multienzyme Complexes; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Small Cell Lung Carcinoma; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tumor Cells, Cultured | 2011 |
Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cross-Sectional Studies; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Prognosis; Survival Rate | 2012 |
Adult T-cell leukemia-lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Nitrosourea Compounds; Prednisolone; Vincristine; Vindesine | 2012 |
Superior vena cava syndrome as the initial manifestation of thymic carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Combined Modality Therapy; Dexamethasone; Diagnosis, Differential; Etoposide; Humans; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Neoplasm Invasiveness; Palliative Care; Prognosis; Radiography; Radiotherapy, Adjuvant; Superior Vena Cava Syndrome; Thymus Neoplasms; Vena Cava, Superior | 2012 |
Selective ophthalmic arterial infusion of chemotherapeutic drugs for recurrent retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Cryotherapy; Electrophysiology; Electroretinography; Etoposide; Female; Humans; Infusions, Intra-Arterial; Melphalan; Neoplasm Recurrence, Local; Ophthalmic Artery; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Vincristine | 2012 |
Intravenous chemoreduction or intra-arterial chemotherapy for cavitary retinoblastoma: long-term results.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Infant; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Melphalan; Ophthalmic Artery; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Vincristine | 2012 |
PDCD5 promotes cisplatin-induced apoptosis of glioma cells via activating mitochondrial apoptotic pathway.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Brain Neoplasms; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Survival; Cisplatin; Etoposide; Gene Expression; Gene Knockdown Techniques; Glioma; Humans; Mitochondria; Neoplasm Proteins; RNA Interference; Vincristine | 2012 |
A novel in vitro three-dimensional retinoblastoma model for evaluating chemotherapeutic drugs.
Topics: Antineoplastic Agents; Biocompatible Materials; Carboplatin; Cell Culture Techniques; Cell Proliferation; Cell Survival; Diffusion; Doxorubicin; Etoposide; Extracellular Matrix; Gene Expression Profiling; Humans; Inhibitory Concentration 50; Kinetics; Lactic Acid; MicroRNAs; Nanoparticles; Oligonucleotide Array Sequence Analysis; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Retinoblastoma; Tissue Engineering; Tissue Scaffolds | 2012 |
[Therapeutic effects and prognostic factors for the limited-stage small cell lung cancer treated with multidisciplinary therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Myelopoiesis; Radiation Pneumonitis; Radiotherapy, Conformal; Remission Induction; Small Cell Lung Carcinoma; Survival Rate | 2012 |
An 82-year-old woman with small-cell lung cancer: relapse after 9 years or a new primary?
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Etoposide; Fatal Outcome; Female; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Small Cell Lung Carcinoma; Time Factors | 2012 |
Comparison of treatment outcomes between involved-field and elective nodal irradiation in limited-stage small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy Dosage; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate; Tomography, X-Ray Computed | 2012 |
Salvage rates and prognostic factors after relapse in children and adolescents with initially localised synovial sarcoma.
Topics: Adolescent; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Italy; Kaplan-Meier Estimate; Male; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Sarcoma, Synovial; Treatment Outcome | 2012 |
Small cell carcinoma of gastro-oesophageal junction with remarkable response to chemo-radiotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Esophagogastric Junction; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Remission Induction; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Toxicity of concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (stage III) non-small cell lung cancer (NSCLC): single institution experience in 600 patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiotherapy Dosage | 2012 |
Normal serum CA125 half-life and normal serum nadir CA125 level in patients with ovarian cancers.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-125 Antigen; Camptothecin; Carboplatin; Carcinoma, Ovarian Epithelial; Cisplatin; Cyclophosphamide; Docetaxel; Doxorubicin; Etoposide; Female; Half-Life; Humans; Irinotecan; Linear Models; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Reference Values; Remission Induction; Taxoids | 2012 |
Salvage therapy with high-dose chemotherapy and peripheral blood stem cell transplant in patients with primary mediastinal nonseminomatous germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Salvage Therapy; Survival Rate; Transplantation, Autologous | 2013 |
Clinical results of high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation in children with advanced stage rhabdomyosarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Rhabdomyosarcoma; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2012 |
Surveillance or adjuvant treatments in stage 1 testis germ-cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Radiotherapy, Adjuvant; Risk Factors; Seminoma; Testicular Neoplasms | 2012 |
Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Child, Preschool; Etoposide; Humans; Infant; Radiotherapy, Intensity-Modulated; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine | 2013 |
Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials, Phase III as Topic; Disease-Free Survival; Etoposide; Female; Glutamates; Guanine; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Staging; Pemetrexed; Prognosis; Proportional Hazards Models; Quality of Life; Randomized Controlled Trials as Topic; Retrospective Studies; Severity of Illness Index; Small Cell Lung Carcinoma | 2012 |
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell tumor: clinical outcome and quality of life in long-term survivors.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cardiovascular Diseases; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Quality of Life; Stem Cell Transplantation; Surveys and Questionnaires; Survivors; Treatment Outcome; Young Adult | 2013 |
5-day/5-drug myeloablative outpatient regimen for resistant neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Irinotecan; Male; Neuroblastoma; Outpatients; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Temozolomide | 2013 |
MRI findings at baseline and after neoadjuvant chemotherapy in orbital retinoblastoma (IRSS stage III).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Etoposide; Eye Enucleation; Female; Humans; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Neoplasm Staging; Optic Nerve Neoplasms; Orbit; Prospective Studies; Radiotherapy, High-Energy; Retinal Neoplasms; Retinoblastoma; Survival Rate; Vincristine | 2013 |
Comparison of outcomes in patients treated with multi-agent regiments of cisplatin, adriamycin, and VP-16 versus carboplatin and paclitaxel for advanced and recurrent endometrial cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Doxorubicin; Endometrial Neoplasms; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel | 2012 |
Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carboplatin; Carcinoma, Neuroendocrine; Cystectomy; Etoposide; Female; Gallbladder Neoplasms; Hepatectomy; Humans; Immunohistochemistry; Liver Neoplasms; Lymph Node Excision; Middle Aged; Neoadjuvant Therapy; Neoplasms, Complex and Mixed; Octreotide; Paclitaxel; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Total gross tumor volume is an independent prognostic factor in patients treated with selective nodal irradiation for stage I to III small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Chemoradiotherapy; Cranial Irradiation; Disease Progression; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Irradiation; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiotherapy Dosage; Severity of Illness Index; Small Cell Lung Carcinoma; Tumor Burden | 2013 |
Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Child, Preschool; Cranial Irradiation; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Methotrexate; Neoplasm Grading; Neoplasm, Residual; Neuroectodermal Tumors, Primitive; Neuropsychological Tests; Pineal Gland; Pinealoma; Prognosis; Prospective Studies; Quality of Life; Survival Rate; Vincristine | 2013 |
Successful allogeneic stem cell transplantation for Lennert lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Female; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Melphalan; Methotrexate; Middle Aged; Nitrosourea Compounds; Pharyngitis; Prednisolone; Recurrence; Rituximab; Salvage Therapy; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Vincristine; Whole-Body Irradiation | 2013 |
[A case of lymph node recurrence of endocrine cell carcinoma of stomach effectively treated with carboplatin and etoposide].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Gastrectomy; Humans; Lymphatic Metastasis; Neoplasm Staging; Recurrence; Stomach Neoplasms | 2012 |
Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Male; Medulloblastoma; Melphalan; Neoplasm Staging; Prognosis; Prospective Studies; Radiotherapy Dosage; Risk Factors; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Thiotepa; Transplantation, Autologous; Young Adult | 2013 |
Prediction of cytotoxic drug concentrations occurring on the day of autologous stem cell rescue during a high-dose chemotherapy regimen.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromatography, High Pressure Liquid; Cytotoxins; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Neoplasms, Germ Cell and Embryonal; Spectrophotometry, Atomic; Thiotepa; Transplantation, Autologous; Young Adult | 2013 |
Thrombocytopenia following high-dose chemotherapy with carboplatin, etoposide and thiotepa in patients with testicular germ cell cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Thiotepa; Thrombocytopenia | 2013 |
Successful treatment of secondary NK/T-cell lymphoma of the testis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Dexamethasone; Etoposide; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Nose Neoplasms; Orchiectomy; Remission Induction; Skin; Testicular Neoplasms; Testis | 2013 |
The translocator protein (TSPO) ligand PK11195 induces apoptosis and cell cycle arrest and sensitizes to chemotherapy treatment in pre- and post-relapse neuroblastoma cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP-Binding Cassette Transporters; Carboplatin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Etoposide; Humans; Isoquinolines; Ligands; Melphalan; Neuroblastoma; Receptors, GABA; Recurrence; RNA, Messenger | 2013 |
Efficacy of rechallenge chemotherapy in patients with sensitive relapsed small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Cohort Studies; Etoposide; Female; Humans; Induction Chemotherapy; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Small Cell Lung Carcinoma; Time Factors; Topotecan; Treatment Outcome | 2015 |
Metastasis of osteosarcoma to stomach made clinically evident by hematemesis: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Gastrectomy; Hematemesis; Humans; Ifosfamide; Male; Neoplasm Staging; Osteosarcoma; Prognosis; Stomach Neoplasms | 2013 |
SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for pat
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Child; Child, Preschool; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Ifosfamide; International Agencies; Male; Neoplasm Grading; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Survival Rate; Young Adult | 2013 |
[Atypical clinical presentation of a neuroblastoma in an infant].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Constipation; Dexamethasone; Diagnosis, Differential; Etoposide; Female; Follow-Up Studies; Humans; Infant; Inpatients; Kidney Neoplasms; Lumbar Vertebrae; Neoplasm Staging; Neuroblastoma; Paraparesis; Peripheral Nervous System Neoplasms; Phosphopyruvate Hydratase; Radiography; Rectal Prolapse; Spinal Nerve Roots; Treatment Outcome | 2013 |
Safety and efficacy of platinum agents plus etoposide for patients with small cell lung cancer with interstitial lung disease.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Female; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Small Cell Lung Carcinoma | 2013 |
Orbital retinoblastoma in an adult.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Combined Modality Therapy; Etoposide; Exophthalmos; Humans; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Orbital Neoplasms; Radiotherapy, High-Energy; Retinal Neoplasms; Retinoblastoma; Ultrasonography; Vincristine; Young Adult | 2013 |
DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Drug Evaluation; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Male; Melphalan; Middle Aged; Mucositis; Peripheral Blood Stem Cell Transplantation; Preoperative Care; Retrospective Studies; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Young Adult | 2013 |
Outcomes of combined modality therapy for patients with stage III or IV mediastinal malignant germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Thoracic Surgical Procedures; Time Factors; Treatment Outcome; Young Adult | 2014 |
Contribution of involved-field radiotherapy to survival in patients with relapsed or refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carmustine; Chemoradiotherapy; Cisplatin; Cohort Studies; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Melphalan; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Vinblastine; Young Adult | 2015 |
Outcomes of small cell lung cancer patients treated with cisplatin-etoposide versus carboplatin-etoposide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cohort Studies; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Small Cell Lung Carcinoma; Treatment Outcome | 2015 |
[Analysis of drug therapy of lung cancer in Hungary].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Databases, Factual; Deoxycytidine; Docetaxel; Drug Administration Schedule; Erlotinib Hydrochloride; Etoposide; Gemcitabine; Glutamates; Guanine; Humans; Hungary; Inpatients; Insurance, Health; Lung Neoplasms; Paclitaxel; Pemetrexed; Prescription Drugs; Quinazolines; Retrospective Studies; Taxoids; Topotecan | 2013 |
Chemotherapy for extensive-stage small-cell lung cancer with idiopathic pulmonary fibrosis.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Female; Humans; Idiopathic Pulmonary Fibrosis; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Small Cell Lung Carcinoma | 2014 |
[Neuroendocrine tumors: analysis of 252 cases].
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoid Tumor; Carcinoma, Merkel Cell; Carcinoma, Neuroendocrine; Cisplatin; Digestive System Neoplasms; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Palliative Care; Retrospective Studies; Sex Factors; Survival Rate; Young Adult | 2013 |
Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas--a single institution experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2013 |
Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Diagnosis, Differential; Etoposide; Female; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Prognosis; Review Literature as Topic | 2013 |
Myeloablative chemotherapy and autologous stem cell transplantation in patients with relapsed or progressed central nervous system germ cell tumors: results of Korean Society of Pediatric Neuro-Oncology (KSPNO) S-053 study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Myeloid Cells; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Thiotepa; Transplantation, Autologous; Young Adult | 2013 |
Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Cyclophosphamide; Disease Progression; Etoposide; Eye Enucleation; Female; Humans; Infant; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Vincristine; Visual Acuity | 2013 |
Treatment outcome of relapsed/refractory primary central nervous system diffuse large B-cell lymphoma: a single-center experience of autologous stem cell transplantation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Young Adult | 2013 |
Is neoadjuvant chemotherapy followed by radical surgery more effective than radiation therapy for stage IIB cervical cancer?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Uterine Cervical Neoplasms | 2013 |
Ofatumumab in diffuse large B cell lymphoma?
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Male | 2013 |
Highly aggressive pathology of non-functional parathyroid carcinoma.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Carcinoma; Etoposide; Female; Humans; Middle Aged; Parathyroid Neoplasms; Parathyroidectomy; Treatment Outcome | 2013 |
Control of relapsed germ cell tumor and SLE nephritis by high-dose chemotherapy and autologous hematopoietic cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Salvage Therapy; Transplantation, Autologous; Young Adult | 2013 |
Loss of CCR4 antigen expression after mogamulizumab therapy in a case of adult T-cell leukaemia-lymphoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clone Cells; Cyclophosphamide; Down-Regulation; Doxorubicin; Etoposide; Fatal Outcome; Female; Gene Expression Regulation, Neoplastic; Humans; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Neoplasm Proteins; Nitrosourea Compounds; Prednisone; Receptors, CCR4; Vincristine; Vindesine | 2013 |
Extranodal NK/T cell lymphoma, nasal type, presenting with meningeal infiltration in a Caucasian female.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Cerebrospinal Fluid; Dexamethasone; Etoposide; Female; Headache; Humans; Ifosfamide; Lumbar Vertebrae; Lymphoma, Extranodal NK-T-Cell; Magnetic Resonance Imaging; Methotrexate; Neoplasm Invasiveness; Pia Mater; Polyradiculopathy | 2013 |
Carboplatin pharmacokinetics in a patient receiving hemodialysis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Neuroendocrine; Etoposide; Humans; Kidney Failure, Chronic; Male; Renal Dialysis | 2014 |
Ovarian cancer in BRCA mutation carriers: improved outcome after intraperitoneal (IP) cisplatin.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; BRCA2 Protein; Carboplatin; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cystadenocarcinoma, Serous; Etoposide; Female; Floxuridine; Follow-Up Studies; Heterozygote; Humans; Injections, Intraperitoneal; Middle Aged; Mutation; Neoplasm Grading; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prognosis; Survival Rate; Topotecan | 2014 |
Survival analysis in advanced non small cell lung cancer treated with platinum based chemotherapy in combination with paclitaxel, gemcitabine and etoposide.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Paclitaxel; Prognosis; Retrospective Studies; Survival Rate | 2013 |
A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Infant; Infant, Newborn; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome; Vincristine; Visual Acuity | 2014 |
Retrospective analysis of bevacizumab in combination with ifosfamide, carboplatin, and etoposide in patients with second recurrence of glioblastoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Glioblastoma; Hematologic Diseases; Humans; Ifosfamide; Interferons; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Temozolomide; Treatment Outcome | 2013 |
Successful treatment of hemorrhagic congenital intracranial immature teratoma with neoadjuvant chemotherapy and surgery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Loss, Surgical; Brain Neoplasms; Carboplatin; Etoposide; Humans; Infant; Infant, Newborn; Male; Neoadjuvant Therapy; Neurosurgical Procedures; Teratoma; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Non-selectivity of ERG reductions in eyes treated for retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Color Vision; Electroretinography; Etoposide; Female; Humans; Infant; Infusions, Intra-Arterial; Male; Night Vision; Photic Stimulation; Retina; Retinal Neoplasms; Retinoblastoma; Vincristine | 2014 |
Dosing of carboplatin in a patient with amputated legs: A case report.
Topics: Aged; Amputees; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Dose-Response Relationship, Drug; Etoposide; Humans; Lung Neoplasms; Male; Small Cell Lung Carcinoma | 2014 |
Outcomes of Intra- and Extraocular Retinoblastomas from a Single Institute in South India.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Developing Countries; Etoposide; Eye Enucleation; Female; Humans; India; Infant; Infant, Newborn; Male; Outcome Assessment, Health Care; Proton Therapy; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Survival Rate; Vincristine | 2015 |
Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel | 2013 |
Long-term survival of a patient with extensive small cell carcinoma of unknown primary etiology complicated by nephrotic syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Cranial Irradiation; Edema; Etoposide; Glomerulonephritis, Membranous; Humans; Irinotecan; Lymphatic Metastasis; Neoplasms, Unknown Primary; Nephrotic Syndrome; Paraneoplastic Syndromes; Pleural Effusion, Malignant; Proteinuria; Radiotherapy, Adjuvant; Remission Induction; Tomography, X-Ray Computed | 2014 |
Effects of chemotherapy on survival of elderly patients with small-cell lung cancer: analysis of the SEER-medicare database.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Comorbidity; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Medicare; Neoplasm Staging; Prognosis; Retrospective Studies; SEER Program; Small Cell Lung Carcinoma; Survival Rate; United States | 2013 |
High-dose chemotherapy with autologous stem cell transplantation for elderly patients with relapsed/refractory diffuse large B cell lymphoma: a nationwide retrospective study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Nitrosourea Compounds; Recurrence; Retrospective Studies; Survival Analysis; Transplantation, Autologous | 2014 |
Asymptomatic primary rectal neuroendocrine carcinoma presented as a large pelvic mass.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asymptomatic Diseases; Carboplatin; Carcinoma, Neuroendocrine; Etoposide; Humans; Incidental Findings; Lymphatic Metastasis; Male; Middle Aged; Rectal Neoplasms; Tomography, X-Ray Computed | 2014 |
A population-based comparative effectiveness study of radiation therapy techniques in stage III non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Comparative Effectiveness Research; Etoposide; Female; Humans; Lung Neoplasms; Male; Radiotherapy Dosage; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; SEER Program; Treatment Outcome | 2014 |
Inhibin B concentration is predictive for long-term azoospermia in men treated for testicular cancer.
Topics: Adolescent; Adult; Azoospermia; Carboplatin; Cisplatin; Cryptorchidism; Etoposide; Humans; Inhibins; Male; Middle Aged; Orchiectomy; Spermatozoa; Testicular Neoplasms; Vinblastine; Young Adult | 2014 |
[Salvage therapy for castration-refractory prostate cancer resistant to docetaxel].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Docetaxel; Drug Combinations; Drug Resistance, Neoplasm; Etoposide; Humans; Male; Middle Aged; Oxonic Acid; Paclitaxel; Prostatic Neoplasms, Castration-Resistant; Salvage Therapy; Streptonigrin; Taxoids; Tegafur; Uracil | 2013 |
Management and outcome of retinoblastoma with vitreous seeds.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Infant; Infusions, Intravenous; Male; Neoplasm Seeding; Radiotherapy, Adjuvant; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome; Vincristine; Visual Acuity; Vitreous Body | 2014 |
Reliability of estimated glomerular filtration rate in patients treated with platinum containing therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Pharmacological; Bleomycin; Carboplatin; Cisplatin; Creatinine; Etoposide; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Reproducibility of Results | 2014 |
Neuroblastoma mRNAs predict outcome in children with stage 4 neuroblastoma: a European HR-NBL1/SIOPEN study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Carboplatin; Child; Child, Preschool; Cisplatin; Computer Simulation; Cyclophosphamide; Disease-Free Survival; Doublecortin Domain Proteins; Doublecortin Protein; Etoposide; Homeodomain Proteins; Humans; Induction Chemotherapy; Infant; Kaplan-Meier Estimate; Microtubule-Associated Proteins; Neuroblastoma; Neuropeptides; Predictive Value of Tests; Proportional Hazards Models; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Transcription Factors; Tyrosine 3-Monooxygenase; Vincristine | 2014 |
In vitro chemosensitivity assay of ascites in epithelial ovarian cancer.
Topics: Antineoplastic Agents; Ascites; Carboplatin; Carcinoma, Ovarian Epithelial; Coloring Agents; Deoxycytidine; Disease Progression; Drug Screening Assays, Antitumor; Epirubicin; Etoposide; Female; Fluorouracil; Gemcitabine; Humans; Kaplan-Meier Estimate; Ki-67 Antigen; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Retrospective Studies; Survival Rate; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2013 |
Etoposide/carboplatin chemotherapy for the treatment of metastatic myxomatous cerebral aneurysms.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Etoposide; Female; Heart Neoplasms; Humans; Intracranial Aneurysm; Myxoma | 2014 |
The patient with ataxia.
Topics: Acute Disease; Aged; Antineoplastic Agents; Ataxia; Carboplatin; Diagnosis, Differential; Etoposide; Humans; Lung; Lung Neoplasms; Male; Palliative Care; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2014 |
Fertility-sparing surgery for advanced juvenile granulosa cell tumor of the ovary.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytoreduction Surgical Procedures; Diaphragm; Etoposide; Female; Fertility Preservation; Granulosa Cell Tumor; Humans; Liver Neoplasms; Omentum; Organ Sparing Treatments; Recurrence; Splenic Neoplasms | 2014 |
Cisplatin versus carboplatin-based regimens for the treatment of patients with metastatic lung cancer. An analysis of Veterans Health Administration data.
Topics: Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Docetaxel; Etoposide; Female; Gemcitabine; Glutamates; Guanine; Hospitalization; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pemetrexed; Registries; Retrospective Studies; Survival Rate; Taxoids; United States; United States Department of Veterans Affairs; Vinblastine; Vinorelbine | 2014 |
A population pharmacodynamic model for lactate dehydrogenase and neuron specific enolase to predict tumor progression in small cell lung cancer patients.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Small Cell; Cisplatin; Disease Progression; Disease-Free Survival; Etoposide; Humans; L-Lactate Dehydrogenase; Lung Neoplasms; Models, Biological; Phosphopyruvate Hydratase; Population; Predictive Value of Tests | 2014 |
Characterization of LGALS3 (galectin-3) as a player in DNA damage response.
Topics: Antineoplastic Agents; Blood Proteins; BRCA1 Protein; Carboplatin; DNA Damage; DNA Repair; Etoposide; G2 Phase Cell Cycle Checkpoints; Galectin 3; Galectins; Gene Silencing; HEK293 Cells; HeLa Cells; Humans; Mitomycin; Protein Interaction Maps; Signal Transduction; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Ubiquitination | 2014 |
Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung Cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Chest Pain; Cohort Studies; Cough; Dyspnea; Esophagitis; Etoposide; Female; Hemoptysis; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Palliative Care; Pemetrexed; Radiation Injuries; Radiation Pneumonitis; Retrospective Studies; Treatment Outcome | 2015 |
The potential role of pretransplant MIBG diagnostic scintigraphy in targeted administration of 131I-MIBG accompanied by ASCT for high-risk and relapsed neuroblastoma: a pilot study.
Topics: 3-Iodobenzylguanidine; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Humans; Infant; Male; Melphalan; Neoplasm Recurrence, Local; Neuroblastoma; Pilot Projects; Prognosis; Prospective Studies; Radionuclide Imaging; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2014 |
Giant thoracoabdominal ganglioneuroblastoma in a 17-year-old patient.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Aorta, Thoracic; Carboplatin; Disease Progression; Etoposide; Fatal Outcome; Ganglioneuroblastoma; Humans; Kidney; Laparotomy; Male; Mediastinal Neoplasms; Neoplasm, Residual; Thoracotomy; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2014 |
Factors determining pbsc mobilization efficiency and nonmobilization following ICE with or without rituximab (R-ICE) salvage therapy for refractory or relapsed lymphoma prior to autologous transplantation.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carboplatin; Combined Modality Therapy; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma; Male; Mesna; Middle Aged; Retrospective Studies; Rituximab; Salvage Therapy; Transplantation, Autologous; Young Adult | 2014 |
Teratoid Wilms' tumor exhibiting extensive squamous differentiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Differentiation; Child; Etoposide; Hematuria; Humans; Kidney Neoplasms; Male; Remission Induction; Teratoma; Tomography, X-Ray Computed; Wilms Tumor | 2015 |
Activity of the polyamine-vectorized anti-cancer drug F14512 against pediatric glioma and neuroblastoma cell lines.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Cell Survival; Cisplatin; Etoposide; Female; Glioma; Humans; Liver Neoplasms; Melphalan; Mice, Inbred BALB C; Neuroblastoma; Podophyllotoxin; Radiation, Ionizing; Spermine | 2014 |
UGT1A1 *6 polymorphism predicts outcome in elderly patients with relapsed or refractory diffuse large B-cell lymphoma treated with carboplatin, dexamethasone, etoposide and irinotecan.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Dexamethasone; Etoposide; Female; Follow-Up Studies; Glucuronosyltransferase; Humans; Irinotecan; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Polymorphism, Genetic; Prospective Studies; Recurrence; Treatment Outcome | 2015 |
Hypersensitivity to chemotherapeutics: a cross sectional study with 35 desensitisations.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Cross-Sectional Studies; Desensitization, Immunologic; Docetaxel; Drug Eruptions; Etoposide; Female; Humans; Hypersensitivity, Delayed; Hypersensitivity, Immediate; Lung Neoplasms; Male; Middle Aged; Pemetrexed; Skin Tests; Taxoids | 2015 |
Adjuvant chemotherapy in patients with completely resected small cell lung cancer: a retrospective analysis of 26 consecutive cases.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Irinotecan; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Small Cell Lung Carcinoma; Treatment Outcome | 2014 |
Toxicity of tandem high-dose chemotherapy and autologous stem cell transplantation using carboplatin-thiotepa-etoposide and cyclophosphamide-melphalan regimens for malignant brain tumors in children and young adults.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Infant; Male; Melphalan; Retrospective Studies; Stem Cell Transplantation; Thiotepa; Transplantation, Autologous; Young Adult | 2014 |
Merkel cell carcinoma expresses vasculogenic mimicry: demonstration in patients and experimental manipulation in xenografts.
Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Agents, Phytogenic; Carboplatin; Carcinoma, Merkel Cell; Cell Line, Tumor; Etoposide; Human Umbilical Vein Endothelial Cells; Humans; Lymph Nodes; Mice, Knockout; Middle Aged; Neoplasm Invasiveness; Neoplasm Transplantation; Neovascularization, Pathologic; Random Allocation; Skin; Skin Neoplasms; Transplantation, Heterologous | 2014 |
Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carboplatin; Cell Line, Tumor; Chemoradiotherapy; Cisplatin; Drug Synergism; Etoposide; Humans; In Vitro Techniques; Lung Neoplasms; Mice; Mice, Nude; Poly(ADP-ribose) Polymerase Inhibitors; Random Allocation; Small Cell Lung Carcinoma; Xenograft Model Antitumor Assays | 2014 |
Peptide receptor chemoradionuclide therapy in small cell carcinoma: from bench to bedside.
Topics: Animals; Antineoplastic Agents; Carboplatin; Carcinoma, Small Cell; Cell Line, Tumor; Etoposide; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Octreotide; Organometallic Compounds; Radiopharmaceuticals; Receptors, Somatostatin; Small Cell Lung Carcinoma; Translational Research, Biomedical | 2015 |
Tumor lysis syndrome in a nonsmall cell lung cancer.
Topics: Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Fatal Outcome; Female; Humans; Liver Neoplasms; Lung Neoplasms; Tumor Lysis Syndrome | 2014 |
Outcomes of immediate perforator flap reconstruction after skin-sparing mastectomy following neoadjuvant chemotherapy.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Docetaxel; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Mammaplasty; Mastectomy, Subcutaneous; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Perforator Flap; Retrospective Studies; Taxoids; Trastuzumab; Treatment Outcome; Young Adult | 2015 |
Radiation therapy to the primary and postinduction chemotherapy MIBG-avid sites in high-risk neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Consolidation Chemotherapy; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Infant; Neoplasm, Residual; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Young Adult | 2014 |
Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies; Salvage Therapy; Sarcoma, Ewing; Survival Rate; Young Adult | 2015 |
Clinical efficacy and prognostic factors of chemoreduction combined with topical treatment for advanced intraocular retinoblastoma.
Topics: Administration, Topical; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Infant; Male; Prognosis; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Vincristine | 2014 |
Topics: Adolescent; Adult; Animals; Antineoplastic Agents; Arachidonic Acids; Asbestos; Asbestosis; Attitude of Health Personnel; Carboplatin; Child; Child, Preschool; Curriculum; Databases, Factual; Education, Medical; Enzyme Inhibitors; Etoposide; Europe; Female; General Surgery; Germany; Hospitals, University; Humans; Ifosfamide; Lung Neoplasms; Male; Medical History Taking; Mesothelioma; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Neurons; Muscular Atrophy; Neoplasms; Neuroprotective Agents; Phospholipase A2 Inhibitors; Phospholipases A2, Cytosolic; Physical Examination; Quality Improvement; Spinal Cord Injuries; Topotecan; Universities; World Health Organization; Young Adult | 2014 |
Modeling non-syndromic autism and the impact of TRPC6 disruption in human neurons.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Autistic Disorder; Carboplatin; Cell Differentiation; Cell Line; Cell Proliferation; Cells, Cultured; Child; Disease Models, Animal; Embryo, Mammalian; Etoposide; Gene Expression Regulation; Humans; In Vitro Techniques; Induced Pluripotent Stem Cells; Inhibitory Postsynaptic Potentials; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitoxantrone; Mutation; Neurons; Prednisolone; Signal Transduction; TRPC Cation Channels; TRPC6 Cation Channel | 2015 |
Association of GWAS-identified lung cancer susceptibility loci with survival length in patients with small-cell lung cancer treated with platinum-based chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Chromosomes, Human, Pair 20; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 5; Etoposide; Female; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Lung Neoplasms; Male; Middle Aged; Polymorphism, Single Nucleotide; Small Cell Lung Carcinoma; Survival Analysis; Treatment Outcome | 2014 |
Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non-small-cell lung cancer: an analysis of Veterans Health Administration data.
Topics: Aged; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Cohort Studies; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome; United States; United States Department of Veterans Affairs | 2015 |
Children with relapsed or refractory nephroblastoma: favorable long-term survival after high-dose chemotherapy and autologous stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kidney Neoplasms; Male; Melphalan; Neoplasm Recurrence, Local; Transplantation Conditioning; Vincristine; Wilms Tumor | 2014 |
High-dose chemotherapy for recurrent ovarian germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Salvage Therapy; Stem Cell Transplantation; Treatment Outcome; Vinblastine | 2015 |
Synergistic Effect of Curcumin in Combination with Anticancer Agents in Human Retinoblastoma Cancer Cell Lines.
Topics: Annexin A5; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Caspase 3; Cell Cycle; Cell Line, Tumor; Curcumin; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Humans; Retinal Neoplasms; Retinoblastoma; Vincristine | 2015 |
Extraskeletal myxoid chondrosarcoma of the thigh in a child: a case report.
Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Chondrosarcoma; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Neoplasms, Connective and Soft Tissue; Soft Tissue Neoplasms; Thigh | 2014 |
Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Etoposide; Eye Enucleation; Female; Germany; Humans; Infant; Male; Neoadjuvant Therapy; Proton Therapy; Referral and Consultation; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Risk Factors; Survival Rate; Vincristine; Vitrectomy | 2015 |
Improving survival of retinoblastoma in Uganda.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Delayed Diagnosis; Disease-Free Survival; Etoposide; Female; Humans; Infant; Male; Neoadjuvant Therapy; Proportional Hazards Models; Retinal Neoplasms; Retinoblastoma; Survival Rate; Uganda; Vincristine | 2015 |
Results of induction chemotherapy in children older than 18 months with stage-4 neuroblastoma treated with an adaptive-to-response modified N7 protocol (mN7).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Cohort Studies; Consolidation Chemotherapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Immunotherapy; Induction Chemotherapy; Infant; Isotretinoin; Male; Neoadjuvant Therapy; Neoplasm Staging; Neuroblastoma; Neurosurgical Procedures; Pilot Projects; Prospective Studies; Radiotherapy; Thiotepa; Topotecan; Treatment Outcome; Vincristine | 2015 |
Fatal hyperammonemia and carbamoyl phosphate synthetase 1 (CPS1) deficiency following high-dose chemotherapy and autologous hematopoietic stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Edema; Carbamoyl-Phosphate Synthase (Ammonia); Carbamyl Phosphate; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Fatal Outcome; Glutamine; Hematopoietic Stem Cell Transplantation; Hep G2 Cells; Humans; Hyperammonemia; Liver; Male; Middle Aged; Neuroblastoma; Ornithine Carbamoyltransferase; Oxidative Phosphorylation | 2015 |
The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Pelvic Neoplasms; Prognosis; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Remission Induction; Retrospective Studies; Survival Rate; Uterine Cervical Neoplasms | 2015 |
Choroid plexus carcinoma in children: the Head Start experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma; Chemoradiotherapy; Child, Preschool; Choroid Plexus Neoplasms; Cisplatin; Cranial Irradiation; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; International Agencies; Male; Neoplasm Staging; Prognosis; Prospective Studies; Survival Rate; Vincristine | 2015 |
De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitors.
Topics: Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Neuroendocrine; Disease Progression; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Etoposide; Fatal Outcome; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Radiography; Small Cell Lung Carcinoma | 2015 |
Superselective intra-arterial chemotherapy for advanced retinoblastoma complicated by metastatic disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Cyclophosphamide; Etoposide; Eye Enucleation; Humans; Infusions, Intra-Arterial; Magnetic Resonance Imaging; Male; Microscopy, Acoustic; Orbital Neoplasms; Retinal Neoplasms; Retinoblastoma; Vincristine | 2015 |
Treatment Results of Extracranial Malignant Germ Cell Tumor with Regimens of Cisplatin, Vinblastine, Bleomycin or Carboplatin, Etoposide, and Bleomycin with Special Emphasis on the Sites of Vagina and Testis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Infant; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Testicular Neoplasms; Treatment Outcome; Vaginal Neoplasms; Vinblastine | 2015 |
Image-defined risk factor assessment of neurogenic tumors after neoadjuvant chemotherapy is useful for predicting intra-operative risk factors and the completeness of resection.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Diagnostic Imaging; Etoposide; Female; Ganglioneuroblastoma; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Neoplasm Staging; Neoplasm, Residual; Neuroblastoma; Postoperative Complications; Risk Assessment; Risk Factors; Thoracic Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2015 |
Rituximab-combination chemotherapy achieves a 10th cycle of remission for Burkitt's lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carboplatin; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Piperidines; Remission Induction; Rituximab | 2015 |
Lack of vincristine infiltrates in patients with retinoblastoma receiving chemotherapy by peripheral intravenous lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Vincristine | 2015 |
Neoadjuvant chemotherapy reduces blood loss during the resection of pediatric choroid plexus carcinomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Loss, Surgical; Carboplatin; Carcinoma; Chemotherapy, Adjuvant; Child, Preschool; Choroid Plexus Neoplasms; Etoposide; Female; Humans; Ifosfamide; Male; Neoadjuvant Therapy; Retrospective Studies; Survival Analysis | 2015 |
A Validated Prediction Model for Overall Survival From Stage III Non-Small Cell Lung Cancer: Toward Survival Prediction for Individual Patients.
Topics: Age Factors; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Models, Statistical; Neoplasm Staging; Nomograms; Probability; Radiotherapy Dosage; Regression Analysis; Severity of Illness Index; Sex Factors; Vinblastine; Vinorelbine | 2015 |
High Risk Retinoblastoma: Prevalence and Success of Treatment in Developing Countries.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Developing Countries; Egypt; Etoposide; Eye Enucleation; Humans; Infant; Neoplasm Invasiveness; Optic Nerve Neoplasms; Prevalence; Retinal Neoplasms; Retinoblastoma; Risk Factors; Vincristine | 2015 |
A hyposensitive anticancer drug induces higher surface expression and release of heat shock proteins in a human hepatocellular carcinoma cell line.
Topics: Antineoplastic Agents; Apoptosis; Carboplatin; Carcinoma, Hepatocellular; Enzyme-Linked Immunosorbent Assay; Etoposide; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; Hep G2 Cells; HSP70 Heat-Shock Proteins; Humans; Liver Neoplasms; Membrane Glycoproteins; Microscopy, Fluorescence; RNA, Messenger | 2015 |
Use of Adjuvant Cisplatin-Based Versus Carboplatin-Based Chemotherapy in Non-Small-Cell Lung Cancer: Findings From the Florida Initiative for Quality Cancer Care.
Topics: Academic Medical Centers; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Docetaxel; Etoposide; Female; Florida; Gemcitabine; Humans; Lung Neoplasms; Male; Medical Audit; Middle Aged; Paclitaxel; Pneumonectomy; Practice Patterns, Physicians'; Quality of Health Care; Taxoids; Time Factors; Vinblastine; Vinorelbine | 2015 |
[Hodgkin's lymphoma and radiotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Radiation Injuries; Radiotherapy Dosage; Recurrence; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 2015 |
Chemotherapy-associated anemia in patients with lung cancer: an epidemiological, retrospective and multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Blood Transfusion; Bridged-Ring Compounds; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Hematinics; Hemoglobins; Humans; Incidence; Iron; Lung Neoplasms; Male; Middle Aged; Observational Studies as Topic; Prevalence; Retrospective Studies; Small Cell Lung Carcinoma; Spain; Taxoids; Vinblastine; Vinorelbine; Young Adult | 2015 |
Mortality in Children with Optic Pathway Glioma Treated with Up-Front BB-SFOP Chemotherapy.
Topics: Antineoplastic Agents; Astrocytoma; Carboplatin; Child; Child, Preschool; Cisplatin; Cohort Studies; Cyclophosphamide; Disease-Free Survival; Drug Therapy, Combination; Etoposide; Female; France; Humans; Infant; Male; Optic Nerve Glioma; Procarbazine; Survival Rate; Vincristine | 2015 |
High-dose chemotherapy and autologous stem cell transplantation with melphalan, etoposide and carboplatin for high-risk osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Osteosarcoma; Transplantation Conditioning; Transplantation, Autologous; Young Adult | 2015 |
Circulating endothelial cells for evaluation of tumor response in non-small cell lung cancer patients receiving first-line chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Cisplatin; Deoxycytidine; Disease-Free Survival; Docetaxel; Endothelial Cells; Etoposide; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplastic Cells, Circulating; Neovascularization, Pathologic; Paclitaxel; Prospective Studies; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 2015 |
Sepsis caused by Listeria monocytogenes during chemotherapy for small cell carcinoma of the thymus.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Antineoplastic Agents; Carboplatin; Carcinoma, Small Cell; Cefepime; Cephalosporins; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Listeria monocytogenes; Listeriosis; Meropenem; Neoplasm Recurrence, Local; Sepsis; Thienamycins; Thymus Gland; Thymus Neoplasms; Treatment Outcome | 2015 |
Effects of Chemotherapy Regimen and Radiation Modality on Hematologic Toxicities in Patients Receiving Definitive Platinum-based Doublet Chemoradiation for Non-Small Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Docetaxel; Etoposide; Female; Hemoglobins; Humans; Leukopenia; Logistic Models; Lung Neoplasms; Lymphopenia; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neutropenia; Paclitaxel; Proportional Hazards Models; Radiation Injuries; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Severity of Illness Index; Survival Rate; Taxoids; Thrombocytopenia | 2017 |
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Child; Cisplatin; Combined Modality Therapy; Deoxycytidine; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gemcitabine; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Retroperitoneal Neoplasms; Salvage Therapy; Survival Rate; Testicular Neoplasms; Transplantation, Autologous; Young Adult | 2015 |
Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Cisplatin; Dose Fractionation, Radiation; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate | 2015 |
Cavernous angioma after chemotherapy for desmoplastic/nodular medulloblastoma associated with anhidrotic ectodermal dysplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cerebellar Neoplasms; Child, Preschool; Cisplatin; Cyclophosphamide; Ectodermal Dysplasia; Etoposide; Hemangioma, Cavernous, Central Nervous System; Humans; Infant; Intracranial Hemorrhages; Male; Medulloblastoma; Melphalan; Methotrexate; Neurosurgical Procedures; Peripheral Blood Stem Cell Transplantation; Vincristine | 2016 |
Foveal microanatomy documented by SD-OCT following treatment of advanced retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Fovea Centralis; Humans; Infant; Male; Microscopy, Acoustic; Retinal Detachment; Retinal Neoplasms; Retinoblastoma; Tomography, Optical Coherence; Vincristine; Visual Acuity | 2015 |
Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal.
Topics: Adult; Aged; Anal Canal; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Camptothecin; Capecitabine; Carboplatin; Carcinoma, Neuroendocrine; Chemoradiotherapy; Cisplatin; Consolidation Chemotherapy; Diarrhea; Digestive System Surgical Procedures; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Induction Chemotherapy; Irinotecan; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Pelvis; Radiation Injuries; Radiodermatitis; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Rectal Neoplasms; Rectum; Retrospective Studies; Survival Rate; Tumor Burden | 2017 |
Anterior Segment Seeding in Eyes With Retinoblastoma Failing to Respond to Intraophthalmic Artery Chemotherapy.
Topics: Adolescent; Anterior Eye Segment; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Humans; Infant; Infusions, Intra-Arterial; Male; Neoplasm Seeding; Ophthalmic Artery; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Failure; Vincristine | 2015 |
Ifosfamide, Cisplatin or Carboplatin, and Etoposide (ICE)-based Chemotherapy for Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Lymphomas.
Topics: Adolescent; Adult; Antineoplastic Agents; Carboplatin; Child; Cisplatin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Retrospective Studies; Stem Cell Transplantation; Transplantation, Autologous; Young Adult | 2015 |
Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Disease-Free Survival; Etoposide; Febrile Neutropenia; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Peripheral Nervous System Diseases; Treatment Outcome | 2015 |
[Malignant lymphoma complicated with posterior reversible encephalopathy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Middle Aged; Posterior Leukoencephalopathy Syndrome; Rituximab | 2015 |
Finding the Optimal Conditioning Regimen for Relapsed/Refractory Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation: A Retrospective Comparison of BEAM and High-Dose ICE.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Recurrence; Retrospective Studies; Severity of Illness Index; Transplantation Conditioning; Transplantation, Autologous; Young Adult | 2016 |
Two cycles of adjuvant carboplatin in stage I seminoma: 8-year experience by the Hellenic Cooperative Oncology Group (HECOG).
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Male; Neoplasm Staging; Retrospective Studies; Seminoma; Testicular Neoplasms; Time Factors | 2016 |
Intraocular surgery with melphalan irrigation for vitreous hemorrhage in an only eye with retinoblastoma.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Combined Modality Therapy; Cryotherapy; Cyclophosphamide; Dacarbazine; Endotamponade; Etoposide; Humans; Infant; Male; Melphalan; Retinal Neoplasms; Retinoblastoma; Silicone Oils; Therapeutic Irrigation; Vincristine; Visual Acuity; Vitrectomy; Vitreous Hemorrhage | 2015 |
Effects of Definitive Chemoradiotherapy on Respiratory Function Tests and Quality of Life Scores During Treatment of Lung Cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Etoposide; Forced Expiratory Volume; Humans; Lung; Lung Neoplasms; Middle Aged; Quality of Life; Retrospective Studies; Small Cell Lung Carcinoma; Vital Capacity | 2015 |
Successful Treatment with Etoposide Base after an Acute Hypersensitivity Reaction to Etoposide Phosphate.
Topics: Acute Disease; Benzyl Alcohols; Carboplatin; Child, Preschool; Drug Hypersensitivity; Etoposide; Female; Humans; Infusions, Intravenous; Medulloblastoma; Organophosphorus Compounds | 2016 |
Carboplatin and Etoposide in Heavily Pretreated Patients with Progressive High-Grade Glioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Disease Progression; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Retrospective Studies | 2014 |
Comparison of the Efficacy between Pemetrexed plus Platinum and Non-Pemetrexed plus Platinum as First-Line Treatment in Patients with Wild-Type Epidermal Growth Factor Receptor Nonsquamous Non-Small Cell Lung Cancer: A Retrospective Analysis.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; ErbB Receptors; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Mutation; Neoplasm Staging; Pemetrexed; Prognosis; Retrospective Studies; Survival Rate; Vinblastine; Vinorelbine | 2016 |
Successful treatment of primary intracranial sarcoma with the ICE chemotherapy regimen and focal radiation in children.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Canada; Carboplatin; Cerebrum; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Intracranial Hemorrhages; Male; Neurofibromatoses; Retrospective Studies; Sarcoma; Treatment Outcome | 2016 |
Comparison of toxicity following different conditioning regimens (busulfan/melphalan and carboplatin/etoposide/melphalan) for advanced stage neuroblastoma: Experience of two transplant centers.
Topics: Adolescent; Antineoplastic Agents; Boston; Brain Neoplasms; Busulfan; Carboplatin; Child; Child, Preschool; Egypt; Etoposide; Humans; Infant; Infant, Newborn; Melphalan; Neuroblastoma; Retrospective Studies; Transplantation Conditioning; Treatment Outcome | 2016 |
Efficacy and Safety of Carboplatin and Etoposide Combination Chemotherapy for Extrapulmonary Neuroendocrine Carcinoma: A Retrospective Case Series.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Disease-Free Survival; Etoposide; Female; Humans; Male; Middle Aged; Retrospective Studies; Survival Rate; Treatment Outcome | 2016 |
Adjuvant Ovarian Suppression, High-dose Chemotherapy and Immunotherapy for Premenopausal Patients with High-risk Breast Cancer.
Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Endpoint Determination; Etoposide; Female; Humans; Ifosfamide; Immunotherapy; Interleukin-2; Isotretinoin; Leuprolide; Nitriles; Premenopause; Receptors, Estrogen; Receptors, Progesterone; Triazoles; Triple Negative Breast Neoplasms | 2015 |
Reduced-dose ICE chemotherapy ± rituximab is a safe and effective salvage therapy for fit elderly patients with diffuse large B-cell lymphoma.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Comorbidity; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Staging; Retrospective Studies; Rituximab; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome | 2016 |
Decision Making in a Data-Poor Environment: Management of Brain Metastases From Testicular and Extragonadal Germ Cell Tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Decision Making; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2016 |
[Small cell neuroendocrine carcinoma of the upper urinary tract: A case report].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Etoposide; Humans; Lymphatic Metastasis; Male; Radiotherapy, Adjuvant; Remission Induction; Ureteral Neoplasms | 2016 |
[SMALL CELL CARCINOMA OF THE PROSTATE: A CASE REPORT OF RELATIVE LONG-TERM SURVIVAL].
Topics: Aged; Anthracyclines; Antineoplastic Agents; Carboplatin; Carcinoma, Small Cell; Etoposide; Fatal Outcome; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Time Factors; Tomography, X-Ray Computed | 2015 |
Comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Radiotherapy Dosage; Retrospective Studies; Taxoids | 2016 |
Resource Utilization and Toxicities After Carboplatin/Etoposide/Melphalan and Busulfan/Melphalan for Autologous Stem Cell Rescue in High-Risk Neuroblastoma Using a National Administrative Database.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Autografts; Busulfan; Carboplatin; Child; Child, Preschool; Critical Care; Databases, Factual; Etoposide; Female; Follow-Up Studies; Humans; Incidence; Infant; Length of Stay; Male; Melphalan; Neuroblastoma; Peripheral Blood Stem Cell Transplantation; Sepsis; Stem Cells; Transplantation Conditioning; United States | 2016 |
[A Case of Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy with Carboplatin plus Etoposide in a Hemodialysis Patient].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Dialysis; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Small Cell Lung Carcinoma | 2016 |
[Prognostic impact of different chemotherapy strategies on small cell esophageal carcinoma].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chi-Square Distribution; Cisplatin; Esophageal Neoplasms; Etoposide; Humans; Multivariate Analysis; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Rate; Treatment Outcome | 2015 |
ABCB5-Targeted Chemoresistance Reversal Inhibits Merkel Cell Carcinoma Growth.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carboplatin; Carcinoma, Merkel Cell; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Etoposide; Flow Cytometry; Humans; Immunohistochemistry; Interleukin Receptor Common gamma Subunit; Mice; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Multidrug Resistance-Associated Proteins; Neoplasm Transplantation; Real-Time Polymerase Chain Reaction; Skin; Skin Neoplasms | 2016 |
A single-centre analysis of 30 patients with relapsed germ cell tumours treated with the TI-CE regimen.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Prospective Studies; Retrospective Studies; Salvage Therapy; Time Factors; Treatment Outcome; Young Adult | 2016 |
Value of Comorbidity Scales for Predicting Survival After Radiochemotherapy of Small Cell Lung Cancer.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Cisplatin; Comorbidity; Decision Support Techniques; Dose Fractionation, Radiation; Dyspnea; Etoposide; Female; Health Status; Health Status Indicators; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Small Cell Lung Carcinoma; Time Factors; Treatment Outcome | 2016 |
Prenatal genetic diagnosis of retinoblastoma and report of RB1 gene mutation from India.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; DNA Mutational Analysis; Etoposide; Exons; Female; Genes, Retinoblastoma; Genetic Predisposition to Disease; Genetic Testing; Germ-Line Mutation; Humans; India; Infant; Pedigree; Prenatal Diagnosis; Proton Therapy; Retinal Neoplasms; Retinoblastoma; Retinoblastoma Binding Proteins; Ubiquitin-Protein Ligases; Vincristine | 2016 |
Spontaneous regression of adult T cell leukemia/lymphoma following development of immune thrombocytopenia.
Topics: Adrenal Cortex Hormones; Allografts; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Nitrosourea Compounds; Prednisolone; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Remission, Spontaneous; Vincristine; Vindesine | 2016 |
Patterns of subretinal fluid resolution in Group D eyes treated with chemoreduction: Experience from the Children's Hospital Los Angeles/University of Southern California.
Topics: Academic Medical Centers; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Hospitals, Pediatric; Humans; Los Angeles; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Subretinal Fluid; Time Factors; Vincristine | 2016 |
Neoadjuvant Chemotherapy in Locally Advanced and Borderline Resectable Nonsquamous Sinonasal Tumors (Esthesioneuroblastoma and Sinonasal Tumor with Neuroendocrine Differentiation).
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Cisplatin; Cohort Studies; Disease-Free Survival; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Follow-Up Studies; Humans; Male; Nasal Cavity; Nausea; Neoadjuvant Therapy; Neuroendocrine Tumors; Palliative Care; Paranasal Sinus Neoplasms; Survival Rate; Treatment Outcome | 2016 |
Trabeculectomy in eyes with unsuspected retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Eye Enucleation; Female; Glaucoma; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Retinal Neoplasms; Retinoblastoma; Tomography, X-Ray Computed; Trabecular Meshwork; Trabeculectomy; Uveal Neoplasms; Vincristine | 2016 |
Prognostic significance of standardised uptake value (SUV
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; L-Lactate Dehydrogenase; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Retrospective Studies; Serum Albumin; Small Cell Lung Carcinoma | 2017 |
Clinical Significance of Tyrosine Hydroxylase mRNA Transcripts in Peripheral Blood at Diagnosis in Patients with Neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Infant; Infant, Newborn; Male; Neuroblastoma; Prognosis; Risk Factors; RNA, Messenger; Tyrosine 3-Monooxygenase | 2016 |
Neoadjuvant Chemotherapy for Facilitating Surgical Resection of Infantile Massive Intracranial Immature Teratoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Etoposide; Humans; Infant; Male; Neoadjuvant Therapy; Teratoma; Treatment Outcome | 2016 |
Advanced unilateral retinoblastoma: a case of sparing enucleation treatment failure.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Eye Enucleation; Fluorescein Angiography; Humans; Infusions, Intra-Arterial; Intravitreal Injections; Magnetic Resonance Imaging; Male; Melphalan; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Seeding; Optic Nerve Neoplasms; Retinal Neoplasms; Retinoblastoma; Treatment Failure | 2016 |
Response of silent corticotroph pituitary carcinoma to chemotherapy: case report.
Topics: Adult; Carboplatin; Corticotrophs; Drug Therapy; Etoposide; Female; Humans; Pituitary Neoplasms; Treatment Outcome | 2016 |
The Potential Benefit of Three vs. Six Cycles of Carboplatin, Etoposide, and Vincristine in Postenucleation High-Risk Patients with IRSS Stage I Retinoblastoma.
Topics: Antineoplastic Agents; Carboplatin; Child, Preschool; China; Dose-Response Relationship, Drug; Drug Therapy, Combination; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Male; Neoplasm Staging; Postoperative Care; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Vincristine | 2016 |
Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carboplatin; Child; Child, Preschool; Cohort Studies; Etoposide; Female; Hepatic Veno-Occlusive Disease; Humans; Hypertension, Pulmonary; Infant; Kidney Diseases; Male; Melphalan; Mucositis; Myeloablative Agonists; Neuroblastoma; Pancytopenia; Retrospective Studies; Stem Cell Transplantation; Transplantation Conditioning; Young Adult | 2016 |
Quality of Life Achieved by Carboplatin Plus Etoposide as Third-Line Chemotherapy Compared with Best Supportive Care in Non-Small Cell Lung Cancer Stage IIIB/IV.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Quality of Life | 2016 |
Quantitative Evaluation of Primordial Follicles in Rat Ovaries during the Early and Delayed Terms after Different Cytostatic Exposures.
Topics: Animals; Carboplatin; Cisplatin; Cytostatic Agents; Epirubicin; Etoposide; Female; Ovarian Follicle; Ovary; Rats; Rats, Wistar | 2016 |
Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Case-Control Studies; Cyclophosphamide; Doxorubicin; Etoposide; Female; Flow Cytometry; Humans; Killer Cells, Natural; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Nitrosourea Compounds; Prednisone; Vincristine; Vindesine | 2016 |
A Case of Urachal Yolk Sac Tumor With Spontaneous Rupture in a Child.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carboplatin; Combined Modality Therapy; Consanguinity; Emergencies; Endodermal Sinus Tumor; Etoposide; Hemoperitoneum; Humans; Infant; Laparotomy; Male; Rupture, Spontaneous; Tomography, X-Ray Computed; Urachus; Urinary Bladder Neoplasms | 2017 |
Evaluation of a method for calculating carboplatin dosage in DeVIC ± R therapy (combination therapy of dexamethasone, etoposide, ifosfamide and carboplatin with or without rituximab) as a salvage therapy in patients with relapsed or refractory non-Hodgkin
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Dexamethasone; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Retrospective Studies; Rituximab; Salvage Therapy; Treatment Outcome | 2016 |
Hematopoietic Progenitor Cell Mobilization with Ifosfamide, Carboplatin, and Etoposide Chemotherapy versus Plerixafor-Based Strategies in Patients with Hodgkin and Non-Hodgkin Lymphoma.
Topics: Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Blood Transfusion; Carboplatin; Cyclams; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Young Adult | 2016 |
Survival and Toxicity After Cisplatin Plus Etoposide Versus Carboplatin Plus Etoposide for Extensive-Stage Small-Cell Lung Cancer in Elderly Patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Female; Hospitalization; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Medicare; Small Cell Lung Carcinoma; Treatment Outcome; United States | 2016 |
Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012.
Topics: Adult; Antineoplastic Agents; Carboplatin; Disease-Free Survival; Etoposide; Humans; Male; Middle Aged; Prognosis; Recurrence; Retrospective Studies; Salvage Therapy; Seminoma; Survival Analysis; Testicular Neoplasms; Treatment Outcome | 2017 |
Clinical Significance of the Relationship between Progression-Free Survival or Postprogression Survival and Overall Survival in Patients with Extensive Disease-Small-Cell Lung Cancer Treated with Carboplatin plus Etoposide.
Topics: Aged; Antineoplastic Agents; Carboplatin; Disease-Free Survival; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Small Cell Lung Carcinoma; Treatment Outcome | 2016 |
Successful Use of Dose Dense Neoadjuvant Chemotherapy and Sodium Valproate with Minimal Toxicity in an Infant with Medulloblastoma in Extremely Poor General Condition.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Critical Care; Cyclophosphamide; Drug Administration Schedule; Etoposide; Histone Deacetylase Inhibitors; Humans; Infant; Longitudinal Studies; Male; Medulloblastoma; Neoadjuvant Therapy; Neurocognitive Disorders; Neurodevelopmental Disorders; Treatment Outcome; Valproic Acid; Vincristine | 2016 |
Karnofsky Performance Score, Radiation Dose and Nodal Status Predict Survival of Elderly Patients Irradiated for Limited-disease Small-cell Lung Cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Cisplatin; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Etoposide; Female; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Multivariate Analysis; Proportional Hazards Models; Retrospective Studies; Small Cell Lung Carcinoma; Treatment Outcome | 2016 |
Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cancer Survivors; Carboplatin; Cardiovascular Diseases; Cisplatin; Combined Modality Therapy; Comorbidity; Etoposide; Follow-Up Studies; Hearing Loss; Humans; Hypogonadism; Luteinizing Hormone; Male; Middle Aged; Norway; Orchiectomy; Peripheral Nervous System Diseases; Surveys and Questionnaires; Testicular Neoplasms; Tinnitus; Vinblastine; Young Adult | 2016 |
[Genetic variation in DNA repair gene RAD52 is associated with the response to platinum-based chemotherapy in SCLC patients].
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Etoposide; Genetic Variation; Genotype; Haplotypes; Humans; Lung Neoplasms; Odds Ratio; Polymorphism, Single Nucleotide; Proportional Hazards Models; Rad52 DNA Repair and Recombination Protein; Regression Analysis; Risk; Small Cell Lung Carcinoma; Treatment Outcome | 2016 |
Clinical and Radiologic Features of Pediatric Basal Ganglia Germ Cell Tumors.
Topics: Adolescent; Aftercare; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Basal Ganglia Diseases; Brain Neoplasms; Carboplatin; Carcinoma, Embryonal; Caudate Nucleus; Child; Choriocarcinoma, Non-gestational; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Cognitive Dysfunction; Corpus Striatum; Cranial Irradiation; Diffusion Tensor Imaging; Endodermal Sinus Tumor; Etoposide; Female; Germinoma; Humans; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Neoplasms, Germ Cell and Embryonal; Neurosurgical Procedures; Paresis; Retrospective Studies; Second-Look Surgery; Seizures; Tomography, X-Ray Computed | 2016 |
Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Clinical Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Hepatoblastoma; Humans; Ifosfamide; Infant; Liver Neoplasms; Male; Neoadjuvant Therapy; Prognosis; Treatment Outcome | 2016 |
Plerixafor mobilization of peripheral blood hematopoietic progenitors to support further high-dose chemotherapy cycles in a patient with germ-cell tumor relapsing after previous tandem high-dose chemotherapy and hematopoietic cell transplantation: report
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Carboplatin; Cyclams; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Lymphatic Metastasis; Male; Neoplasms, Germ Cell and Embryonal; Thiotepa | 2017 |
Clinical impact of post-progression survival on overall survival in elderly patients with extensive disease small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease Progression; Disease-Free Survival; Etoposide; Female; Humans; Lung Neoplasms; Male; Small Cell Lung Carcinoma; Treatment Outcome | 2016 |
A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinoma.
Topics: Adolescent; Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; DNA Mutational Analysis; Etoposide; Fatal Outcome; Genomics; Humans; Male; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Paclitaxel; Rare Diseases; Scalp; Xenograft Model Antitumor Assays | 2016 |
Recurrent Merkel cell carcinoma of the testis with unknown primary site: a case report.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Chemotherapy, Adjuvant; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Orchiectomy; Testicular Neoplasms; Treatment Outcome | 2016 |
Early progression under mitotane and polychemotherapy does not mean failure in adrenocortical carcinoma patient.
Topics: Adrenocortical Carcinoma; Antineoplastic Agents, Hormonal; Carboplatin; Drug Therapy, Combination; Etoposide; Female; Humans; Middle Aged; Mitotane; Survival Rate; Treatment Outcome | 2017 |
Ewing Sarcoma of the Bone With EWS/FLI1 Translocation After Successful Treatment of Primary Osteosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Femoral Neoplasms; Humans; Ifosfamide; Limb Salvage; Methotrexate; Neoplasms, Second Primary; Oncogene Proteins, Fusion; Osteosarcoma; Proto-Oncogene Protein c-fli-1; Remission Induction; RNA-Binding Protein EWS; Sarcoma, Ewing; Vincristine | 2017 |
First-line intra-arterial versus intravenous chemotherapy in unilateral sporadic group D retinoblastoma: evidence of better visual outcomes, ocular survival and shorter time to success with intra-arterial delivery from retrospective review of 20 years of
Topics: Aftercare; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Humans; Infant; Infusions, Intra-Arterial; Infusions, Intravenous; Melphalan; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vision Disorders | 2017 |
Primary intravenous chemotherapy for group D retinoblastoma: a 13-year retrospective analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Female; Humans; Infant; Infant, Newborn; Infusions, Intra-Arterial; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Salvage Therapy; Vincristine | 2017 |
Tumor Regression Patterns in Retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Cryotherapy; Etoposide; Female; Humans; Infant; Lasers, Semiconductor; Male; Neoplasm Staging; Pakistan; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vincristine | 2016 |
Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Chemoradiotherapy; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Japan; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Radiotherapy; Receptors, Interleukin-2; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; Young Adult | 2017 |
Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Grade Gliomas in Children and Adolescents.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Etoposide; Female; Glioma; Humans; Male; Neoplasm Grading; Remission Induction; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Thiotepa; Transplantation, Autologous; Treatment Outcome | 2017 |
Dramatic Reduction in Tumor Size During 5 Months of Pazopanib Therapy in Combination With Ifosfamide, Carboplatin, and Etoposide in an Early Infant With Progressive Soft Tissue Sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Indazoles; Infant; Male; Pyrimidines; Remission Induction; Sarcoma; Sulfonamides | 2017 |
[Etoposide and Carboplatin Effective for Treatment of Small Cell Carcinoma of Prostate : A Report of Two Cases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Humans; Male; Prostatic Neoplasms; Tomography, X-Ray Computed | 2016 |
Preclinical Acute Ocular Safety Study of Combined Intravitreal Carboplatin and Etoposide Phosphate for Retinoblastoma.
Topics: Animals; Antineoplastic Agents; Carboplatin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroretinography; Etoposide; Intravitreal Injections; Male; Neoplasms, Experimental; Ophthalmoscopy; Organophosphorus Compounds; Rabbits; Retina; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Visual Acuity | 2017 |
[Correlations between genetic variations of glutathione synthetase gene and the response to platinum-based chemotherapy and prognosis of small cell lung cancer patients].
Topics: Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Female; Genetic Variation; Genotype; Glutathione Synthase; Haplotypes; Humans; Lung Neoplasms; Male; Middle Aged; Odds Ratio; Platinum Compounds; Polymorphism, Single Nucleotide; Prognosis; Proportional Hazards Models; Risk; Small Cell Lung Carcinoma; Treatment Outcome | 2017 |
Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Infant; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Orbital Neoplasms; Prognosis; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Risk Factors; Salvage Therapy; Vincristine | 2017 |
Prognostic Factors and Treatment of Early-stage Small-cell Lung Cancer.
Topics: Aged; Carboplatin; Chemoradiotherapy; Cisplatin; Cranial Irradiation; Early Detection of Cancer; Etoposide; Female; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Lung Neoplasms; Male; Middle Aged; Prognosis; Proportional Hazards Models; Small Cell Lung Carcinoma; Treatment Outcome | 2017 |
Bilateral sciatic nerve neurolymphomatosis: PET/CT findings.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Craniospinal Irradiation; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Rituximab; Salvage Therapy; Sciatic Nerve; Vincristine | 2017 |
Secondary biopsy of non-oncogenic-driven lung cancer may reveal a clinically sensible histologic change. A brief report of two paradigmatic cases.
Topics: Biopsy; Carboplatin; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Pemetrexed; Protein Kinase Inhibitors; Small Cell Lung Carcinoma; Treatment Outcome | 2017 |
Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Fluid Therapy; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Rhabdomyolysis; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome; Young Adult | 2017 |
The incidence and risk factors of febrile neutropenia in chemotherapy-naïve lung cancer patients receiving etoposide plus platinum.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Febrile Neutropenia; Female; Granulocyte Colony-Stimulating Factor; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Radiotherapy; Retrospective Studies; Risk Factors; Sex Characteristics | 2017 |
Efficacy of Pegylated Liposomal Doxorubicin in Low-Grade Serous Ovarian Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cystadenocarcinoma, Serous; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Polyethylene Glycols; Retrospective Studies | 2017 |
Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cell Transformation, Neoplastic; Cisplatin; Cohort Studies; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Male; Neoplasm Metastasis; Pancreatic Neoplasms; Prognosis | 2017 |
Metastatic Neuroendocrine Carcinoma of Unknown Origin Arising in the Femoral Nerve Sheath.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Etoposide; Female; Femoral Nerve; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Nerve Sheath Neoplasms; Palliative Care; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Impact of induction chemotherapy, hyperfractionated accelerated radiotherapy and high-dose thiotepa on brain volume loss and functional status of children with primitive neuroectodermal tumour.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Child; Child, Preschool; Cyclophosphamide; Dose Fractionation, Radiation; Etoposide; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Male; Neoplasm Staging; Neuroectodermal Tumors, Primitive; Prognosis; Retrospective Studies; Survival Rate; Thiotepa; Tumor Burden | 2017 |
Consideration of alternative causes of lactic acidosis: Thiamine deficiency in malignancy.
Topics: Acidosis, Lactic; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Confusion; Etoposide; Humans; Male; Psychomotor Agitation; Small Cell Lung Carcinoma; Thiamine; Thiamine Deficiency; Treatment Outcome; Vitamin B Complex | 2017 |
Long-Term Survival in a Patient With Metastatic DDR2-Positive Adrenal Cortical Carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Carboplatin; Combined Modality Therapy; Discoidin Domain Receptor 2; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Male; Middle Aged; Mitotane; Mutation; Neoplasm Metastasis; Nephrectomy; Tomography Scanners, X-Ray Computed | 2017 |
Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Intestinal Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Pancreatic Neoplasms; Retrospective Studies; Stomach Neoplasms | 2018 |
Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cryotherapy; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infusions, Intravenous; Intravitreal Injections; Laser Coagulation; Male; Melphalan; Neoplasm Seeding; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Salvage Therapy; Vincristine; Vitreous Body | 2017 |
Report: Small cell neuroendocrine carcinoma (SCNEC) of the tongue: A case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Humans; Male; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Tongue Neoplasms | 2017 |
Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Dose Fractionation, Radiation; Esophagitis; Esophagus; Etoposide; Female; Heart; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Organs at Risk; Prospective Studies; Proton Therapy; Radiation Pneumonitis; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Small Cell Lung Carcinoma; Spinal Cord; Treatment Outcome | 2017 |
Small cell lung carcinoma cell line screen of etoposide/carboplatin plus a third agent.
Topics: Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Computational Biology; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Small Cell Lung Carcinoma; Small Molecule Libraries | 2017 |
[A Case of Merkel Cell Carcinoma Complicated with Severe Thrombocytopenia Treated with Carboplatin/Etoposide Regimen after Surgery].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Etoposide; Female; HLA Antigens; Humans; Platelet Transfusion; Skin Neoplasms; Thrombocytopenia | 2017 |
Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Carboplatin; Chemokines; Cytokines; Disease-Free Survival; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Immunoconjugates; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Tumor Burden; Young Adult | 2017 |
Relapsed subcutaneous panniculitis-like T cell lymphoma: role of haploidentical hematopoietic stem cell transplant.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Ifosfamide; Lupus Erythematosus, Systemic; Lymphoma, T-Cell; Nephrosis, Lipoid; Nephrotic Syndrome; Panniculitis; Paraneoplastic Syndromes; Prednisolone; Recurrence; Remission Induction; Salvage Therapy; Vincristine | 2017 |
Anterior Chamber Invasion in Retinoblastoma: Not an Indication for Adjuvant Chemotherapy.
Topics: Anterior Chamber; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Etoposide; Eye Enucleation; Female; Humans; Infant; Male; Neoplasm Invasiveness; Neoplasm Seeding; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Risk Factors; Survival Rate; Vincristine | 2017 |
Survival advantage for etoposide/cisplatin over paclitaxel/carboplatin concurrent chemoradiation in patients with inoperable stage III NSCLC: a subgroup analysis for ECOG 2 patients would be of great interest.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Lung Neoplasms; Neoplasm Staging; Paclitaxel | 2017 |
Prenatal Diagnosis of a Melanotic Neuroectodermal Tumor of Infancy (MNTI): A Case Report With a Favorable Outcome After Chemotherapy Failure and Incomplete Resection.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fetal Diseases; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Neuroectodermal Tumor, Melanotic; Orbital Neoplasms; Pregnancy; Vincristine | 2018 |
Response to 'Survival advantage for etoposide/cisplatin over paclitaxel/carboplatin concurrent chemoradiation in patients with inoperable stage III NSCLC: a subgroup analysis for ECOG 2 patients would be of great interest'.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Humans; Lung Neoplasms; Neoplasm Staging; Paclitaxel; Survival Analysis | 2017 |
A novel deep intronic low penetrance RB1 variant in a retinoblastoma family.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Infant; Introns; Mutation; Pedigree; Penetrance; Retinal Neoplasms; Retinoblastoma; Retinoblastoma Binding Proteins; Ubiquitin-Protein Ligases; Vincristine; Young Adult | 2018 |
Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutation.
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Disease Progression; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Etoposide; Exons; Genetic Heterogeneity; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Receptor, Fibroblast Growth Factor, Type 3 | 2017 |
Epstein-Barr Virus-Positive Large Cell Neuroendocrine Carcinoma of the Nasopharynx: Report of a Case with Complete Clinical and Radiological Response After Combined Chemoradiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemoradiotherapy; Cisplatin; Epstein-Barr Virus Infections; Etoposide; Humans; Male; Nasopharyngeal Neoplasms; Tuberous Sclerosis | 2018 |
Investigating the potential impact of dose banding for systemic anti-cancer therapy in the paediatric setting based on pharmacokinetic evidence.
Topics: Adolescent; Age Factors; Antineoplastic Agents; Area Under Curve; Busulfan; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Drug Dosage Calculations; Drug Monitoring; Etoposide; Humans; Infant; Models, Biological; Neoplasms; Patient Safety; Risk Factors | 2018 |
Outcome of extraocular retinoblastoma in a resource limited center from low middle income country.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Etoposide; Eye Enucleation; Female; Humans; India; Infant; Male; Neoadjuvant Therapy; Registries; Retinoblastoma; Retrospective Studies; Survival Rate; Vincristine | 2017 |
Efficacy of Platinum-Based Chemotherapy for Relapsed Small-Cell Lung Cancer after Amrubicin Monotherapy in Elderly Patients and Patients with Poor Performance Status.
Topics: Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Disease-Free Survival; Etoposide; Female; Health Status; Humans; Irinotecan; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate; Thrombocytopenia | 2018 |
Comparison of Nutrition-Related Adverse Events and Clinical Outcomes Between ICE (Ifosfamide, Carboplatin, and Etoposide) and MCEC (Ranimustine, Carboplatin, Etoposide, and Cyclophosphamide) Therapies as Pretreatment for Autologous Peripheral Blood Stem C
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Energy Intake; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Nitrosourea Compounds; Nutritional Physiological Phenomena; Peripheral Blood Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Young Adult | 2018 |
Radiation Dose to the Thoracic Vertebral Bodies Is Associated With Acute Hematologic Toxicities in Patients Receiving Concurrent Chemoradiation for Lung Cancer: Results of a Single-Center Retrospective Analysis.
Topics: Acute Disease; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Etoposide; Female; Hematologic Diseases; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neutropenia; Organs at Risk; Paclitaxel; Probability; Radiation Dosage; Retrospective Studies; ROC Curve; Small Cell Lung Carcinoma; Thoracic Vertebrae | 2018 |
Neuroendocrine Carcinoma of Gallbladder: A Step Beyond Palliative Therapy, Experience of 25 Cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cholecystectomy; Cohort Studies; Combined Modality Therapy; Etoposide; Female; Gallbladder Neoplasms; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Treatment Outcome | 2019 |
HAND-HELD OPTICAL COHERENCE TOMOGRAPHY MONITORING OF CHEMORESISTANT RETINOBLASTOMA.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Infant; Infusions, Intra-Arterial; Infusions, Intravenous; Retinal Neoplasms; Retinoblastoma; Tomography, Optical Coherence; Vincristine | 2020 |
[Non-Small Cell Lung Cancer - Development of Parallel Mechanisms of Resistance].
Topics: Acrylamides; Aniline Compounds; Antineoplastic Agents; Carboplatin; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Disease Progression; Drug Resistance, Neoplasm; ErbB Receptors; Etoposide; Humans; Lung Neoplasms; Mutation; Piperazines; Protein Kinase Inhibitors; Treatment Outcome | 2018 |
Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Cohort Studies; Dexamethasone; Disease Progression; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Multivariate Analysis; Prognosis; Survival Analysis; Young Adult | 2018 |
Rechallenge treatment with a platinum-based regimen in patients with sensitive relapsed small-cell lung cancer.
Topics: Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Irinotecan; Kaplan-Meier Estimate; Lung Neoplasms; Male; Paclitaxel; Recurrence; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate | 2018 |
Successful full-dose DeVIC therapy in a patient with advanced-stage extranodal natural killer/T-cell lymphoma refractory to L-asparaginase.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Middle Aged | 2018 |
High-dose chemotherapy without whole lung radiation for refractory pulmonary metastases in an infant with stage IV favorable histology Wilms tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Etoposide; Humans; Infant; Kidney Neoplasms; Lung Neoplasms; Male; Melphalan; Wilms Tumor | 2018 |
Eye salvage in diffuse anterior retinoblastoma using systemic chemotherapy with periocular and intravitreal topotecan.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Etoposide; Gonioscopy; Humans; Infant; Infusions, Intravenous; Intravitreal Injections; Male; Microscopy, Acoustic; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Salvage Therapy; Topoisomerase I Inhibitors; Topotecan; Vincristine | 2018 |
Treatment of Nonmetastatic Unilateral Retinoblastoma in Children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Etoposide; Eye Enucleation; Female; Humans; Hydrophthalmos; Idarubicin; Infant; Male; Mesna; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Survival Rate; Vincristine | 2018 |
Comparison of carboplatin plus etoposide with amrubicin monotherapy for extensive-disease small cell lung cancer in the elderly and patients with poor performance status.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anthracyclines; Carboplatin; Etoposide; Female; Humans; Karnofsky Performance Status; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis; Treatment Outcome | 2018 |
Outcome of newly diagnosed high risk medulloblastoma treated with carboplatin, vincristine, cyclophosphamide and etoposide.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Humans; Infant; Medulloblastoma; Vincristine | 2018 |
Retrospective analysis of primarily treated group D retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cryotherapy; Etoposide; Eye Enucleation; Female; Humans; Infant; Infant, Newborn; Infusions, Intra-Arterial; Infusions, Intravenous; Intravitreal Injections; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Survival Rate; Vincristine | 2018 |
Lung Cancer with a Small Cell Carcinoma Component Diagnosed from Pleural Effusion and a Squamous Cell Carcinoma Component Diagnosed from the Tumor.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Carcinoma, Squamous Cell; Docetaxel; Etoposide; Humans; Immunohistochemistry; Lung Neoplasms; Male; Pleural Effusion, Malignant; Small Cell Lung Carcinoma | 2018 |
Biallelic tumour suppressor loss and DNA repair defects in de novo small-cell prostate carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Small Cell; Cisplatin; Databases, Factual; DNA Repair; Etoposide; Gene Expression Profiling; Genes, Tumor Suppressor; Genetic Predisposition to Disease; Genomic Instability; Humans; Male; Middle Aged; Neoplasms, Complex and Mixed; Phenotype; Prostatic Neoplasms; Retrospective Studies; Time Factors; Treatment Outcome | 2018 |
Resource utilization and toxicities after single versus tandem autologous stem cell rescue in high-risk neuroblastoma using a national administrative database.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Autografts; Busulfan; Carboplatin; Child; Child, Preschool; Databases, Factual; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Length of Stay; Male; Melphalan; Neuroblastoma; Stem Cell Transplantation | 2018 |
R-ICE Chemotherapy with or without Autologous Transplantation for Elderly Patients with Relapsed or Refractory Aggressive B-Cell Lymphomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Progression-Free Survival; Retrospective Studies; Rituximab; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous | 2018 |
Dynamic Changes and Drug-Induced Selection of Resistant Clones in a Patient With EGFR-Mutated Adenocarcinoma That Acquired T790M Mutation and Transformed to Small-Cell Lung Cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Transformation, Neoplastic; Clone Cells; Drug Resistance, Neoplasm; Drug Substitution; ErbB Receptors; Etoposide; Female; Humans; Lung Neoplasms; Middle Aged; Mutation; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Small Cell Lung Carcinoma | 2018 |
Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Autografts; Busulfan; Carboplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Egypt; Etoposide; Female; Humans; Male; Melphalan; Middle Aged; Neuroblastoma; Stem Cell Transplantation; Transplantation Conditioning | 2018 |
Population pharmacokinetics of carboplatin, etoposide and melphalan in children: a re-evaluation of paediatric dosing formulas for carboplatin in patients with normal or mild impairment of renal function.
Topics: Age Factors; Antineoplastic Agents; Area Under Curve; Body Weight; Carboplatin; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Dosage Calculations; Etoposide; Female; Glomerular Filtration Rate; Humans; Infant; Kidney; Male; Melphalan; Models, Biological; Neuroblastoma | 2019 |
Tumor Lysis Syndrome After Platinum-based Chemotherapy in Castration-resistant Prostate Cancer With a BRCA2 Mutation: A Case Report.
Topics: Antineoplastic Combined Chemotherapy Protocols; BRCA2 Protein; Carboplatin; Etoposide; Humans; Male; Middle Aged; Mutation; Prognosis; Prostatic Neoplasms, Castration-Resistant; Tumor Lysis Syndrome | 2019 |
Influence of UGT1A1 polymorphism on etoposide plus platinum-induced neutropenia in Japanese patients with small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Carboplatin; Cisplatin; Etoposide; Female; Glucuronosyltransferase; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Neutropenia; Polymorphism, Genetic; Retrospective Studies; Small Cell Lung Carcinoma; Thrombocytopenia | 2019 |
Outcomes and treatments of IB1 cervical cancers with high recurrence risk: A 13 years' experience.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Iridium Radioisotopes; Kaplan-Meier Estimate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Recurrence; Retrospective Studies; Risk; Treatment Outcome; Uterine Cervical Neoplasms | 2018 |
miR‑34a regulates the chemosensitivity of retinoblastoma cells via modulation of MAGE‑A/p53 signaling.
Topics: Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Child; Child, Preschool; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Infant; Male; Melanoma-Specific Antigens; MicroRNAs; Retinal Neoplasms; Retinoblastoma; Signal Transduction; Tumor Suppressor Protein p53; Vincristine | 2019 |
Safety and effective salvage regimen comprising a novel combination of brentuximab vedotin, L-asparaginase, and dexamethasone for refractory anaplastic large cell lymphoma, anaplastic lymphoma kinase negative.
Topics: Aged; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brentuximab Vedotin; Carboplatin; Cyclophosphamide; Dexamethasone; Disease Progression; Doxorubicin; Etoposide; Humans; Ifosfamide; Immunoconjugates; Lymphoma, Large-Cell, Anaplastic; Male; Neoplasm Proteins; Prednisone; Remission Induction; Salvage Therapy; Tonsillar Neoplasms; Vincristine | 2019 |
Urgent need for consensus: international survey of clinical practice exploring use of platinum-etoposide chemotherapy for advanced extra-pulmonary high grade neuroendocrine carcinoma (EP-G3-NEC).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Follow-Up Studies; Humans; Lung Neoplasms; Needs Assessment; Neoplasm Grading; Practice Guidelines as Topic; Practice Patterns, Physicians' | 2019 |
Lambert-Eaton myasthenic syndrome developing post-diagnosis of small-cell lung cancer.
Topics: Aged; Antineoplastic Agents; Carboplatin; Diagnosis, Differential; Disease Progression; Etoposide; Humans; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Male; Neoplasm Staging; Neurologic Examination; Prognosis; Small Cell Lung Carcinoma; Terminal Care | 2018 |
The clinical conundrum of managing relapsed small cell lung cancer.
Topics: Anthracyclines; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepinones; Carboplatin; Clinical Decision-Making; Disease Progression; Etoposide; Humans; Immunoconjugates; Irinotecan; Liver Neoplasms; Lung Neoplasms; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Nivolumab; Paclitaxel; Piperazines; Pyrimidines; Salvage Therapy; Small Cell Lung Carcinoma; Temozolomide; Thiourea; Topotecan | 2019 |
How reliable are in vitro IC
Topics: Antineoplastic Agents; Apoptosis; Biological Assay; Brain Neoplasms; Carboplatin; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Etoposide; Glioblastoma; Humans; Inhibitory Concentration 50; Necrosis; Neurons; Paraquat; Reproducibility of Results | 2019 |
Retrospective Analysis of Taxane-Based Therapy in Small Bowel Adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Deoxycytidine; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Intestinal Neoplasms; Intestine, Small; Male; Middle Aged; Paclitaxel; Prognosis; Retrospective Studies; Survival Rate | 2019 |
Blastic plasmacytoid dendritic cell neoplasm with response to pralatrexate.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Dendritic Cells; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Hematologic Neoplasms; Humans; Ifosfamide; Male; Prednisone; Skin Neoplasms; Vincristine | 2019 |
Carboplatin in Combination with Oral or Intravenous Etoposide for Extra-Pulmonary, Poorly-Differentiated Neuroendocrine Carcinomas.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cell Differentiation; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Neuroendocrine Tumors; Retrospective Studies; Treatment Outcome; Young Adult | 2019 |
Outcomes of fertility-sparing surgery in ovarian juvenile granulosa cell tumor.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Child; Cisplatin; Etoposide; Female; Fertility Preservation; Granulosa Cell Tumor; Humans; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Treatment Outcome; Young Adult | 2019 |
Preservation of retinoblastoma group E eyes with neovascular glaucoma using intravenous chemotherapy: risk factors and outcomes.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Glaucoma, Neovascular; Humans; Infant; Infusions, Intravenous; Intraocular Pressure; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Risk Factors; Salvage Therapy; Treatment Outcome; Vincristine; Visual Acuity | 2019 |
Primary parotid Merkel cell carcinoma: a first imagery and treatment response assessment by 18F-FDG PET.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Etoposide; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Parotid Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brazil; Carboplatin; Dactinomycin; Drug Resistance, Neoplasm; Drug Substitution; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Retrospective Studies; Treatment Outcome; Young Adult | 2019 |
Treatment and outcome of 432 patients with extensive-stage small cell lung cancer in first, second and third line - Results from the prospective German TLK cohort study.
Topics: Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cohort Studies; Etoposide; Female; Germany; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Platinum Compounds; Prospective Studies; Survival Analysis; Treatment Outcome | 2019 |
Rethinking Our Approach of Combining Novel Agents With Standard Chemotherapy in Small Cell Lung Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Humans; Lung Neoplasms; Pyrimidines; Small Cell Lung Carcinoma; Sulfoxides | 2019 |
A case of merkel leptomeningeal evolution after complete remission upon anti-PD-1 treatment.
Topics: Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Etoposide; Humans; Lower Extremity; Magnetic Resonance Imaging; Male; Meningeal Carcinomatosis; Nivolumab; Peritoneal Neoplasms; Radiotherapy, Adjuvant; Remission Induction; Skin Neoplasms | 2019 |
Diffuse large B cell lymphoma with chromosomal translocation t(14;19)(q32;q13) occurring in IgG4-related disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 19; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Immunoglobulin G4-Related Disease; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Rituximab; Salvage Therapy; Translocation, Genetic | 2019 |
Stage 4S Neuroblastoma: A Report of Two Cases Presenting with Extremes of Biological Behavior.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Infant; Infant, Newborn; Liver Neoplasms; Male; Neoplasm Staging; Neuroblastoma; Treatment Outcome | 2019 |
Sustained Remission After Maintenance Irinotecan in Patient With Multiply Relapsed Hepatoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chemotherapy, Adjuvant; Disease-Free Survival; Etoposide; Hepatoblastoma; Humans; Ifosfamide; Infant; Irinotecan; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Remission Induction | 2020 |
Outcome of treatment in patients with small cell lung cancer in poor performance status.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Small Cell Lung Carcinoma; Survival Rate; Treatment Outcome | 2019 |
Evaluation of thiamine for the prevention of ifosfamide-induced encephalopathy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Carboplatin; Cohort Studies; Etoposide; Female; Humans; Ifosfamide; Incidence; Lymphoma; Male; Middle Aged; Neurotoxicity Syndromes; Retrospective Studies; Thiamine | 2020 |
Japanese Case of Enzalutamide-Resistant Prostate Cancer Harboring a SPOP Mutation With Scattered Allelic Imbalance: Response to Platinum-Based Therapy.
Topics: Aged; Allelic Imbalance; Benzamides; Carboplatin; Drug Resistance, Neoplasm; Etoposide; Humans; Japan; Male; Mutation; Nitriles; Nuclear Proteins; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Repressor Proteins; Treatment Outcome | 2019 |
Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3 months of age.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Catheterization; Child, Preschool; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Infusions, Intra-Arterial; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 2019 |
Tandem high-dose chemotherapy with topotecan-thiotepa-carboplatin and melphalan-etoposide-carboplatin regimens for pediatric high-risk brain tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Male; Melphalan; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Thiotepa; Topotecan; Transplantation, Autologous; Treatment Outcome | 2019 |
Large-Cell Neuroendocrine Carcinoma of the Gallbladder: A Rare Case.
Topics: Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Female; Gallbladder Neoplasms; Humans; Mastectomy, Segmental; Radiotherapy; Treatment Outcome | 2019 |
Delayed Enucleation With Neoadjuvant Chemotherapy in Advanced Intraocular Unilateral Retinoblastoma: AHOPCA II, a Prospective, Multi-Institutional Protocol in Central America.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central America; Chemotherapy, Adjuvant; Child; Child, Preschool; Disease Progression; Etoposide; Eye Enucleation; Female; Humans; Infant; Male; Neoadjuvant Therapy; Neoplasm Staging; Progression-Free Survival; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Risk Factors; Time Factors; Time-to-Treatment; Treatment Refusal; Vincristine | 2019 |
Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Disease Progression; Etoposide; Eye Enucleation; Female; Humans; India; Infant; Infant, Newborn; Male; Neoplasm Recurrence, Local; Progression-Free Survival; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Risk Assessment; Risk Factors; Time Factors; United States; Vincristine | 2019 |
Role of KEAP1/NFE2L2 Mutations in the Chemotherapeutic Response of Patients with Non-Small Cell Lung Cancer.
Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Kelch-Like ECH-Associated Protein 1; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; Neoplasm Staging; NF-E2-Related Factor 2; Paclitaxel; Prognosis; Spheroids, Cellular; Survival Rate | 2020 |
Current management of stage I testicular germ cell tumors in a French cancer institute. A practice analysis over the 10 past years.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cancer Care Facilities; Carboplatin; Cisplatin; Etoposide; France; Humans; Lymph Node Excision; Male; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Population Surveillance; Radiotherapy; Retrospective Studies; Testicular Neoplasms; Time Factors | 2019 |
The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Carboplatin; Cisplatin; Cognition; Cognitive Dysfunction; Etoposide; Female; Humans; Male; Middle Aged; Prospective Studies; Testicular Neoplasms | 2020 |
High Dose Chemotherapy with Autologous Stem Cell Transplantation in Hepatoblastoma does not Improve Outcome. Results of the GPOH Study HB99.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hepatoblastoma; Humans; Ifosfamide; Liver Neoplasms; Neoplasm Recurrence, Local; Transplantation, Autologous; Treatment Outcome | 2019 |
lncRNA
Topics: Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cisplatin; Down-Regulation; Drug Resistance, Multiple; Etoposide; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Retinoblastoma; RNA, Long Noncoding; Vincristine | 2020 |
Partial response to carboplatin, etoposide phosphate, and atezolizumab in a pediatric patient with high-grade metastatic tumor with rhabdoid and focal neuroendocrine features.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Etoposide; Humans; Liver Neoplasms; Male; Neoplasm Grading; Neuroendocrine Tumors; Organophosphorus Compounds; Rhabdoid Tumor; Treatment Outcome | 2020 |
Pediatric nasal NK/T-cell lymphoma microscopically mimicking carcinoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma; Chemoradiotherapy; Dexamethasone; Diagnosis, Differential; Etoposide; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Nose; Nose Neoplasms; Skin Neoplasms | 2020 |
Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Chemoradiotherapy; Cisplatin; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Survival Rate | 2020 |
Survival, Chemotherapy Treatments, and Health Care Utilization Among Patients with Advanced Small Cell Lung Cancer: An Observational Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Medicare; Middle Aged; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis; Treatment Outcome; United States | 2020 |
Salvage treatment for children with relapsed/refractory germ cell tumors: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Oxaliplatin; Paclitaxel; Prognosis; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate | 2020 |
Intensity-modulated ventricular irradiation for intracranial germ-cell tumors: Survival analysis and impact of salvage re-irradiation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Child; Cranial Irradiation; Cyclophosphamide; Dose Fractionation, Radiation; Etoposide; Female; Humans; Male; Neoplasms, Germ Cell and Embryonal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome | 2019 |
An autoimmune-based, paraneoplastic neurologic syndrome following checkpoint inhibition and concurrent radiotherapy for merkel cell carcinoma: case report.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases of the Nervous System; Axilla; Carboplatin; Carcinoma, Merkel Cell; Combined Modality Therapy; Deglutition Disorders; Etoposide; Fatal Outcome; Fingers; Hallucinations; Humans; Lymphatic Metastasis; Male; Neuralgia; Palliative Care; Paraneoplastic Syndromes, Nervous System; Parenteral Nutrition, Total; Pneumonia, Aspiration; Positron Emission Tomography Computed Tomography; Radioimmunotherapy; Radiotherapy, High-Energy; Radiotherapy, Intensity-Modulated; Skin Neoplasms | 2020 |
Pegylated recombinant human granulocyte colony-stimulating factor regulates the immune status of patients with small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Case-Control Studies; Cisplatin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Lymphocytes; Male; Polyethylene Glycols; Prognosis; Prospective Studies; Receptors, Antigen, T-Cell; Recombinant Proteins; Small Cell Lung Carcinoma; Survival Rate | 2020 |
Durable Response to Carboplatin, Etoposide, Nivolumab, and Ipilimumab in Metastatic High-Grade Neuroendocrine Carcinoma of the Gallbladder.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Etoposide; Female; Gallbladder; Humans; Ipilimumab; Ki-67 Antigen; Middle Aged; Mutation; Neoplasm Grading; Neoplasm Metastasis; Nivolumab; Retinoblastoma Binding Proteins; Treatment Outcome; Tumor Suppressor Protein p53; Ubiquitin-Protein Ligases | 2020 |
Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Child, Preschool; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Infant; Infusions, Intravenous; Male; Proportional Hazards Models; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Vincristine | 2020 |
Evaluating primary intra-arterial chemotherapy versus intravenous plus intra-arterial chemotherapy for advanced intraocular retinoblastoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infusions, Intra-Arterial; Infusions, Intravenous; Intraocular Pressure; Male; Melphalan; Middle Aged; Prognosis; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Survival Rate; Vincristine; Young Adult | 2020 |
Metastatic Malignant Peripheral Nerve Sheath Tumor With NF1 Successfully Treated With 'Gradual Subtraction' ICE Chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Male; Neoplasm Metastasis; Nerve Sheath Neoplasms; Neurofibromatosis 1; Prognosis | 2020 |
Effect of Hospitalization During First Chemotherapy and Performance Status on Small-cell Lung Cancer Outcomes.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Follow-Up Studies; Hospitalization; Humans; Lung Neoplasms; Male; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate | 2020 |
Chemotherapy exacerbates ovarian cancer cell migration and cancer stem cell-like characteristics through GLI1.
Topics: Antineoplastic Agents; Carboplatin; Cell Movement; Epithelial-Mesenchymal Transition; Etoposide; Female; Humans; Neoplastic Stem Cells; Ovarian Neoplasms; Zinc Finger Protein GLI1 | 2020 |
Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Clinical Trials, Phase III as Topic; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Paclitaxel; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Survival Rate | 2020 |
Cancer Stem Cells with Overexpression of Neuronal Markers Enhance Chemoresistance and Invasion in Retinoblastoma.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Carboplatin; Cell Line, Tumor; Drug Resistance, Neoplasm; Etoposide; Humans; Multidrug Resistance-Associated Proteins; Nanog Homeobox Protein; Neoplasm Invasiveness; Neoplastic Stem Cells; Neural Stem Cells; Octamer Transcription Factor-3; Retinal Neoplasms; Retinoblastoma; Signal Transduction; SOXB1 Transcription Factors | 2020 |
Changes in glomerular filtration rate and clinical course after sequential doses of carboplatin in children with embryonal brain tumors undergoing autologous stem cell transplantation.
Topics: Acute Kidney Injury; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Creatinine; Dose-Response Relationship, Drug; Etoposide; Female; Glomerular Filtration Rate; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Medulloblastoma; Retrospective Studies; Rhabdoid Tumor; Teratoma; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2020 |
Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Comorbidity; Cyclophosphamide; Deprescriptions; Docetaxel; Doxorubicin; Drug Tapering; Etoposide; Female; Functional Status; Humans; Lung Neoplasms; Male; Middle Aged; Netherlands; Paclitaxel; Practice Patterns, Physicians'; Progression-Free Survival; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate; Topotecan | 2020 |
Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells.
Topics: A549 Cells; Adenocarcinoma of Lung; Adenosine Triphosphate; Alarmins; Antineoplastic Agents; Apoptosis; Autophagy; Calreticulin; Carboplatin; Caspase 3; Cell Survival; Cisplatin; Deoxycytidine; Etoposide; Gemcitabine; HMGB1 Protein; Humans; Immunogenic Cell Death; Lung Neoplasms; Paclitaxel; Prognosis | 2020 |
Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Disease-Free Survival; Etoposide; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Orchiectomy; Rete Testis; Retroperitoneal Neoplasms; Retrospective Studies; Seminoma; Spain; Testicular Neoplasms; Treatment Outcome; Watchful Waiting | 2021 |
Tandem high-dose chemotherapy with autologous stem cell rescue for stage M high-risk neuroblastoma: Experience using melphalan/etoposide/carboplatin and busulfan/melphalan regimens.
Topics: Adrenal Gland Neoplasms; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carboplatin; Child; Child, Preschool; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Neoplasm Staging; Neuroblastoma; Retrospective Studies; Transplantation, Autologous | 2020 |
Effects of cryotherapy on high-dose melphalan-induced oral mucositis in pediatric patients undergoing autologous stem cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Melphalan; Neoplasms; Prognosis; Retrospective Studies; Stomatitis; Transplantation, Autologous; Young Adult | 2020 |
A single-arm study of systemic and sub-Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Follow-Up Studies; Humans; Infant; Male; Prognosis; Retinal Neoplasms; Retinoblastoma; Tenon Capsule; Vincristine; Young Adult | 2020 |
Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Female; Fluorescein Angiography; Humans; Hyperthermia, Induced; Infant; Infant, Newborn; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Risk Factors; Tomography, Optical Coherence; Ultrasonography; Vincristine | 2020 |
Atezolizumab in combination with carboplatin and etoposide for heavily treated small cell lung cancer.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Small Cell Lung Carcinoma | 2020 |
Successful treatment of hepatosplenic T cell lymphoma in an adolescent with Turner syndrome using ifosfamide, carboplatin, and etoposide followed by allogeneic hematopoietic stem cell transplant.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Liver Neoplasms; Lymphoma, T-Cell; Prognosis; Splenic Neoplasms; Turner Syndrome | 2020 |
Atezolizumab plus carboplatin and etoposide in small cell lung cancer patients previously treated with platinum-based chemotherapy.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carboplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Small Cell Lung Carcinoma | 2021 |
Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Medulloblastoma; Middle Aged; Neutropenia; Progression-Free Survival; Radiotherapy; Rare Diseases; Risk; Thrombocytopenia; Young Adult | 2020 |
Comparison of oral versus intravenous etoposide in the management of small-cell lung cancer; A real-world, population-based study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lung Neoplasms; Quality of Life; Small Cell Lung Carcinoma; Treatment Outcome | 2021 |
Carboplatin plus etoposide or topotecan for small-cell lung cancer.
Topics: Carboplatin; Etoposide; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Topotecan | 2020 |
5-Hydroxytryptamine-3 receptor antagonist and dexamethasone as prophylaxis for chemotherapy-induced nausea and vomiting during moderately emetic chemotherapy for solid tumors: a multicenter, prospective, observational study.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Capecitabine; Carboplatin; Dexamethasone; Etoposide; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; Oxaliplatin; Paclitaxel; Pre-Exposure Prophylaxis; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2020 |
Treating relapsed and refractory metastatic germ cell tumours with high-dose chemotherapy with carboplatin and etoposide and autologous haematopoietic stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Transplantation, Autologous | 2021 |
[A Case of Adult T-Cell Leukemia/Lymphoma with Severe Hand-Foot Syndrome during Administration of Modified LSG15 Regimen].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hand-Foot Syndrome; Humans; Leukemia-Lymphoma, Adult T-Cell; Lymphoma; Middle Aged; Nitrosourea Compounds; Prednisolone; Vincristine; Vindesine | 2020 |
Carboplatin plus etoposide for sensitive relapsed small-cell lung cancer.
Topics: Carboplatin; Etoposide; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Small Cell Lung Carcinoma; Topotecan | 2020 |
Carboplatin plus etoposide for sensitive relapsed small-cell lung cancer - Authors' reply.
Topics: Carboplatin; Etoposide; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Topotecan | 2020 |
Gemcitabine, cisplatin, and dexamethasone and ifosfamide, carboplatin, and etoposide regimens have similar efficacy as salvage treatment for relapsed/refractory aggressive lymphoma: A retrospectively comparative study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Dexamethasone; Etoposide; Female; Gemcitabine; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Salvage Therapy; Young Adult | 2020 |
Tandem High-dose Chemotherapy without Craniospinal Irradiation in Treatment of Non-metastatic Malignant Brain Tumors in Very Young Children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Craniospinal Irradiation; Etoposide; Female; Hearing Loss; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Infant; Male; Neoplasm Recurrence, Local; Progression-Free Survival; Risk Factors; Salvage Therapy; Survival Rate; Thiotepa; Transplantation, Autologous | 2020 |
Combination of brentuximab-vedotin and ifosfamide, carboplatin, etoposide in relapsed/refractory peripheral T-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Carboplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Treatment Outcome | 2021 |
Outcomes of Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma Based on Patient Age in 964 Eyes of 554 Patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Eye Enucleation; Humans; Infant; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Vincristine | 2021 |
Berberine inhibits chemotherapy-exacerbated ovarian cancer stem cell-like characteristics and metastasis through GLI1.
Topics: Antineoplastic Agents; Berberine; Carboplatin; Cell Line, Tumor; Cell Movement; Coculture Techniques; Epithelial-Mesenchymal Transition; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Metastasis; Neoplastic Stem Cells; Ovarian Neoplasms; Polycomb Repressive Complex 1; Signal Transduction; Snail Family Transcription Factors; Vimentin; Zinc Finger Protein GLI1 | 2021 |
COVID-19 reinfection in two children with cancer.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Child, Preschool; Cisplatin; COVID-19; Cyclophosphamide; Daunorubicin; Etoposide; Humans; Male; Neuroblastoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Reinfection; SARS-CoV-2; Vincristine | 2021 |
Durable Complete Remission of PD-L1 Positive NUT Carcinoma Treated With Concurrent Chemotherapy and Radiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carboplatin; Carcinoma; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Remission Induction | 2020 |
Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Etoposide; Humans; Induction Chemotherapy; Infant; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Retrospective Studies | 2022 |
Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the E
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Immunohistochemistry; Male; Middle Aged; Prognosis; Progression-Free Survival; Retinoblastoma Binding Proteins; Retrospective Studies; Risk Assessment; Ubiquitin-Protein Ligases; Young Adult | 2021 |
Recurrence and new tumor development after frontline intravenous chemotherapy for retinoblastoma: Risk factors and treatment results.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Infant; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Risk Factors; Treatment Outcome | 2022 |
Sequencing therapies in Hodgkin lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Carboplatin; Dacarbazine; Disease Management; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Vinblastine | 2021 |
Clinical significance of TP53 mutations in adult T-cell leukemia/lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; CD28 Antigens; Cyclophosphamide; DNA Copy Number Variations; Doxorubicin; Etoposide; Female; Genes, p53; Hematopoietic Stem Cell Transplantation; Humans; INDEL Mutation; Kaplan-Meier Estimate; Lenalidomide; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Mutation; Nitrosourea Compounds; Polymorphism, Single Nucleotide; Prednisolone; Prednisone; Prognosis; Receptors, CCR4; Vincristine; Vindesine | 2021 |
Efficacy and safety of atezolizumab, in combination with etoposide and carboplatin regimen, in the first-line treatment of extensive-stage small-cell lung cancer: a single-center experience.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lung Neoplasms; Retrospective Studies; Small Cell Lung Carcinoma | 2022 |
[A Case of Primary Neuroendocrine Carcinoma of the Retroperitoneum].
Topics: Aged, 80 and over; Carboplatin; Carcinoma, Neuroendocrine; Etoposide; Humans; Male; Retroperitoneal Neoplasms; Tomography, X-Ray Computed | 2021 |
[Management of small cell lung cancer patient in the regions of Lazio, Umbria and Sardinia.]
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Italy; Lung Neoplasms; Small Cell Lung Carcinoma | 2021 |
Cisplatin-Based versus Carboplatin-Based Chemotherapy for Extrapulmonary Neuroendocrine Carcinomas: A Real-World Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Humans; Lung Neoplasms; Platinum | 2022 |
Outcome of pediatric germ cell tumor with comparison of carboplatin and cisplatin based regimens: A 10-year analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Cisplatin; Etoposide; Female; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Testicular Neoplasms | 2022 |
Carboplatin- and Etoposide-Loaded Lactoferrin Protein Nanoparticles for Targeting Cancer Stem Cells in Retinoblastoma In Vitro.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biological Availability; Carboplatin; Chromatography, High Pressure Liquid; Culture Media; Drug Carriers; Drug Delivery Systems; Etoposide; Flow Cytometry; Humans; Lactoferrin; Microscopy, Confocal; Microscopy, Electron, Transmission; Nanoparticles; Neoplastic Stem Cells; Retinal Neoplasms; Retinoblastoma; Spectroscopy, Fourier Transform Infrared | 2021 |
FRESC: French Real world Extensive stage SCLC Cohorts: A retrospective study on patient characteristics and treatment strategy based on KBP-2010.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Small Cell Lung Carcinoma | 2022 |
A 33-Year-Old Man With Chest Pain.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Carboplatin; Carcinoma; Etoposide; Fatal Outcome; Gene Rearrangement; Humans; Liver Failure; Liver Neoplasms; Lung Neoplasms; Lymphadenopathy; Male; Neoplasm Proteins; Nuclear Proteins; Positron-Emission Tomography; Tomography, X-Ray Computed; Transcription Factors; Tumor Lysis Syndrome | 2022 |
Combined carboplatin and etoposide chemotherapy for patients with recurrent glioma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Etoposide; Glioma; Humans; Retrospective Studies; Treatment Outcome | 2021 |
Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Vincristine; Wilms Tumor | 2022 |
[A Case of Pancreas Neuroendocrine Carcinoma Achieved Long-Term Survival by Carboplatin plus Etoposide Therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Etoposide; Fluorouracil; Humans; Male; Pancreas; Pancreatic Neoplasms | 2021 |
Systemic adjuvant chemotherapy for advanced malignant ocular medulloepithelioma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Etoposide; Eye Enucleation; Humans; Male; Neuroectodermal Tumors, Primitive; Retrospective Studies; Vincristine | 2023 |
Therapeutic strategy analysis of patients with advanced stage high-grade neuroendocrine cervical cancer: A real-world multicenter study.
Topics: Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Neoplasm Staging; Paclitaxel; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2022 |
Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Central Nervous System; Dexamethasone; Etoposide; Humans; Ifosfamide; Killer Cells, Natural; Lymphoma, Extranodal NK-T-Cell; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies | 2022 |
Antibody-Drug Conjugate Targeting c-Kit for the Treatment of Small Cell Lung Cancer.
Topics: Animals; Antibodies, Monoclonal, Humanized; Carboplatin; Cell Line, Tumor; Cell Proliferation; Etoposide; Female; Humans; Immunoconjugates; Lung Neoplasms; Maytansine; Mice; Proto-Oncogene Proteins c-kit; Receptor Protein-Tyrosine Kinases; Receptor, ErbB-2; Small Cell Lung Carcinoma; Trastuzumab; Tubulin Modulators; Xenograft Model Antitumor Assays | 2022 |
Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin for refractory or relapsed neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Etoposide; Humans; Irinotecan; Neoplasm Recurrence, Local; Neuroblastoma; Neutropenia; Retrospective Studies | 2022 |
Use of ifosfamide, carboplatin and etoposide in combination with brentuximab vedotin or romidepsin based on CD30 positivity in relapsed/refractory peripheral T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Carboplatin; Depsipeptides; Etoposide; Humans; Ifosfamide; Ki-1 Antigen; Lymphoma, T-Cell, Peripheral; Neoplasm Recurrence, Local; Retrospective Studies | 2022 |
Dose Modification of Etoposide plus Platinum in Elderly Patients with Extensive-Disease Small-Cell Lung Cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Humans; Lung Neoplasms; Platinum Compounds; Retrospective Studies; Small Cell Lung Carcinoma | 2022 |
Treatment outcomes of T and natural-killer/T-cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Lymphoma; Lymphoma, T-Cell; Retrospective Studies; Treatment Outcome | 2022 |
Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Latin America; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Prednisone; Recurrence; Registries; Retrospective Studies; Rituximab; Vincristine | 2022 |
Daratumumab with ifosfamide, carboplatin and etoposide for the treatment of relapsed plasmablastic lymphoma.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Neoplasm Recurrence, Local; Plasmablastic Lymphoma; Salvage Therapy | 2022 |
Combination of chemotherapy and immune checkpoint therapy by the immunoconjugates-based nanocomplexes synergistically improves therapeutic efficacy in SCLC.
Topics: Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carboplatin; Etoposide; Humans; Immunoconjugates; Lung Neoplasms; Peptides; Retrospective Studies; Small Cell Lung Carcinoma | 2022 |
Systemic Anticancer Therapy Details and Dental Adverse Effects in Children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Craniofacial Abnormalities; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Infant; Vincristine | 2022 |
Real-world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive-disease small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lung Neoplasms; Middle Aged; Retrospective Studies; Small Cell Lung Carcinoma | 2023 |
Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.
Topics: Anthracyclines; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Retrospective Studies; Small Cell Lung Carcinoma | 2022 |
Autoimmune Encephalitis Associated with Anti-N-methyl-D-aspartate Receptor and Anti-Hu Antibodies Successfully Treated with Carboplatin and Etoposide for Small-cell Lung Cancer.
Topics: Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Autoantibodies; Carboplatin; Etoposide; Female; Humans; Lung Neoplasms; Middle Aged; Receptors, N-Methyl-D-Aspartate | 2023 |
Sequential small cell transformation and T790M mutation in an epidermal growth factor-mutant lung adenocarcinoma: A rare occurrence with significant management implications.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Carboplatin; Carcinoma, Small Cell; Drug Resistance, Neoplasm; Epidermal Growth Factor; ErbB Receptors; Etoposide; Female; Gefitinib; Humans; Lung Neoplasms; Mutation; Protein Kinase Inhibitors | 2022 |
A 75-Year-Old Female Smoker with Advanced Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Performance Status 2 who Responded to Combination Immunochemotherapy with Atezolizumab, Etoposide, and Carboplatin.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Group Processes; Humans; Immunotherapy; Lung Neoplasms; Small Cell Lung Carcinoma; Smokers | 2022 |
Ocular toxicity following carboplatin chemotherapy for neuroendocrine tumour of the bladder.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Humans; Male; Neuroendocrine Tumors; Toxic Optic Neuropathy; Urinary Bladder; Vision Disorders | 2023 |
Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Platinum; Small Cell Lung Carcinoma | 2022 |
Development and application of a liquid chromatography coupled to mass spectrometry method for the simultaneous determination of 23 antineoplastic drugs at trace levels.
Topics: Antineoplastic Agents; Busulfan; Carboplatin; Chromatography, Liquid; Cyclophosphamide; Cytarabine; Dacarbazine; Daunorubicin; Docetaxel; Doxorubicin; Epirubicin; Etoposide; Fluorouracil; Ganciclovir; Humans; Idarubicin; Ifosfamide; Irinotecan; Methanol; Methotrexate; Oxaliplatin; Paclitaxel; Pemetrexed; Tandem Mass Spectrometry; Topotecan; Vinblastine; Vincristine; Water | 2022 |
Safety and efficacy of anlotinib in combination with standard chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A multi-center, prospective study (ACTION-2).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Humans; Lung Neoplasms; Platinum; Prospective Studies; Small Cell Lung Carcinoma; Treatment Outcome | 2022 |
Comparison of Carboplatin With Cisplatin in Small Cell Lung Cancer in US Veterans.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cohort Studies; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Small Cell Lung Carcinoma; Veterans | 2022 |
Long-term complete response in small cell bladder carcinoma treated with carboplatin, etoposide, and atezolizumab.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Humans; Lung Neoplasms; Male; Urinary Bladder; Urinary Bladder Neoplasms | 2022 |
Outcomes of relapsed/refractory extracranial germ cell tumors treated on conventional salvage chemotherapy without stem cell rescue: Experience from a tertiary cancer center.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Salvage Therapy; Testicular Neoplasms | 2023 |
Serplulimab plus chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: A cost-effectiveness analysis.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cost-Benefit Analysis; Cost-Effectiveness Analysis; Etoposide; Humans; Lung Neoplasms; Small Cell Lung Carcinoma | 2022 |
Efficacy and safety of carboplatin and etoposide in older extensive-stage small-cell lung cancer patients with a poor performance status.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Retrospective Studies; Small Cell Lung Carcinoma | 2023 |
Strategies for the Treatment of Infantile Soft Tissue Sarcomas With BCOR Alterations.
Topics: Biomarkers, Tumor; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Neoplasm Recurrence, Local; Proto-Oncogene Proteins; Repressor Proteins; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Vincristine | 2023 |
Iris metastasis as resistance mechanism to atezolizumab, carboplatin, and etoposide but responds to additional irinotecan and anlotinib in a small cell lung cancer patient.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blindness; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Irinotecan; Iris; Lung Neoplasms; Small Cell Lung Carcinoma | 2023 |
Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis.
Topics: Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Humans; Lung; Lung Neoplasms; Neuroendocrine Tumors; Platinum; Retrospective Studies | 2023 |
Real-world evaluation of atezolizumab and etoposide-carboplatin as a first-line treatment for extensive-stage small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lung Neoplasms; Platinum; Retrospective Studies; Small Cell Lung Carcinoma | 2023 |
Concomitant Chemoradiotherapy Using Carboplatin and Etoposide-induced Cutaneous Vasculitis in a Patient with Small Cell Lung Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Etoposide; Humans; Lung Neoplasms; Skin Diseases, Vascular; Small Cell Lung Carcinoma | 2022 |
Treatment outcome after sequential chemotherapy with cisplatin-etoposide, amrubicin and nogitecan in patients with treatment-related pure small-cell neuroendocrine prostate cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Humans; Lung Neoplasms; Male; Prostatic Neoplasms; Retrospective Studies; Small Cell Lung Carcinoma; Treatment Outcome | 2023 |
Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multicenter and retrospective study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Conservative Treatment; Etoposide; Female; Humans; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Paclitaxel; Pregnancy; Prognosis; Retrospective Studies; Young Adult | 2023 |
Second-line treatment of pediatric patients with relapsed rhabdomyosarcoma adapted to initial risk stratification: Data of the European Soft Tissue Sarcoma Registry (SoTiSaR).
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Chronic Disease; Cyclophosphamide; Etoposide; Humans; Polyketides; Recurrence; Retrospective Studies; Rhabdomyosarcoma; Sarcoma; Soft Tissue Neoplasms; Topotecan | 2023 |
Toxicity and feasibility of vincristine, etoposide, and carboplatin alternating with vincristine, doxorubicin, and cyclophosphamide in children with advanced retinoblastoma in Guatemala.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Guatemala; Humans; Retinal Neoplasms; Retinoblastoma; Vincristine | 2023 |
Tolerability of ifosfamide-containing regimen in patients with high-risk renal and INI-1-deficient tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Infant; Kidney; Neoplasms; Vincristine | 2023 |
PD-1 blockade combined with ICE regimen in relapsed/refractory diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Programmed Cell Death 1 Receptor; Retrospective Studies; Rituximab | 2023 |
The combination of etoposide and platinum for the treatment of thymic neuroendocrine neoplasms: A retrospective analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Humans; Lung Neoplasms; Neuroendocrine Tumors; Platinum; Retrospective Studies | 2023 |
Esophageal Neuroendocrine Carcinoma With Pathological Complete Response After Neoadjuvant Chemotherapy Followed by Robot-assisted Surgery: A Case Report.
Topics: Aged; Carboplatin; Carcinoma, Neuroendocrine; Esophageal Neoplasms; Etoposide; Female; Humans; Neoadjuvant Therapy; Robotic Surgical Procedures | 2023 |
Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry study.
Topics: Adult; Aged; Aged, 80 and over; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Female; Humans; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Prognosis; Registries; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult | 2023 |
Benmelstobart Ups ES-SCLC Survival.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lung Neoplasms; Small Cell Lung Carcinoma; Treatment Outcome | 2023 |
Case report: Remarkable response to a novel combination of mitotane, etoposide, paraplatin, and sintilimab in a patient with metastatic adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Carboplatin; Etoposide; Humans; Male; Mitotane | 2023 |
Atezolizumab addition to platinum doublet: evaluating survival outcomes for patients with extensive disease small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Humans; Lung Neoplasms; Male; Platinum; Retrospective Studies; Small Cell Lung Carcinoma | 2023 |
Individualized chemotherapy and efficacy analysis of hepatoblastoma in children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Cisplatin; Cyclophosphamide; Etoposide; Hepatoblastoma; Humans; Ifosfamide; Liver Neoplasms; Vincristine | 2024 |